<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005001.pub3" GROUP_ID="BREASTCA" ID="133304022611223112" MERGED_FROM="" MODIFIED="2016-09-22 00:14:53 +0100" MODIFIED_BY="Melina Willson" REVIEW_NO="63" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2016-09-22 09:10:10 +1000" MODIFIED_BY="Melina L Willson">
<TITLE>Exercise for women receiving adjuvant therapy for breast cancer</TITLE>
<CONTACT>
<PERSON ID="z1303102210438809665558378173458" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Anna</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Furmaniak</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>anna.furmaniak@mri.tum.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Psychosomatic Medicine and Psychotherapy, Klinikum Rechts der Isar</DEPARTMENT>
<ORGANISATION>Technische Universität München</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Munich</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2016-09-22 09:07:39 +1000" MODIFIED_BY="Melina Willson">
<PERSON ID="z1303102210438809665558378173458" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Anna</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Furmaniak</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>anna.furmaniak@mri.tum.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Psychosomatic Medicine and Psychotherapy, Klinikum Rechts der Isar</DEPARTMENT>
<ORGANISATION>Technische Universität München</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Munich</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="z1309090600291756284910103040453" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Matthias</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Menig</LAST_NAME>
<SUFFIX>MD</SUFFIX>
<POSITION/>
<EMAIL_1/>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Federal Office of Public Health FOPH</DEPARTMENT>
<ORGANISATION>Health and Accident Insurance Directorate</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Bern</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="D319C6A582E26AA20080535FB6D112FC" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Martina</FIRST_NAME>
<MIDDLE_INITIALS>H</MIDDLE_INITIALS>
<LAST_NAME>Markes</LAST_NAME>
<SUFFIX/>
<POSITION>Research Officer</POSITION>
<EMAIL_1>martina.markes@googlemail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department Non-Drug Interventions</DEPARTMENT>
<ORGANISATION>Institute for Quality and Efficiency in Health Care (IQWiG)</ORGANISATION>
<ADDRESS_1>Im Mediapark 8</ADDRESS_1>
<ADDRESS_2/>
<CITY>Köln</CITY>
<ZIP>50670</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 221 35685-371</PHONE_1>
<PHONE_2/>
<FAX_1>+49 221 35685-1</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2016-09-21 10:06:30 +1000" MODIFIED_BY="Melina Willson">
<UP_TO_DATE>
<DATE DAY="30" MONTH="3" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="11" MONTH="1" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="9" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-09-22 09:05:42 +1000" MODIFIED_BY="Melina L Willson">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-09-22 09:05:42 +1000" MODIFIED_BY="Melina L Willson">
<DATE DAY="22" MONTH="9" YEAR="2016"/>
<DESCRIPTION>
<P>Amended an author's affiliation</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-09-22 09:10:10 +1000" MODIFIED_BY="Melina L Willson">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-09-22 09:10:10 +1000" MODIFIED_BY="Melina L Willson">
<DATE DAY="30" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>24 new studies added, with 2174 new participants. We added full 'Risk of bias' tables. Conclusions changed</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-09-22 09:10:08 +1000" MODIFIED_BY="Melina L Willson">
<DATE DAY="30" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>Performed searches for new studies on 30 March 2015</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-08-28 11:49:16 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-09-16 13:02:22 +1000" MODIFIED_BY="Melina L Willson">
<SUMMARY MODIFIED="2016-09-16 12:58:40 +1000" MODIFIED_BY="Melina L Willson">
<TITLE MODIFIED="2016-08-22 12:31:46 +1000" MODIFIED_BY="[Empty name]">Exercise for women receiving chemotherapy or radiation therapy or both (adjuvant therapy) for breast cancer</TITLE>
<SUMMARY_BODY MODIFIED="2016-09-16 12:58:40 +1000" MODIFIED_BY="Melina L Willson">
<P>
<B>What is the issue?</B>
</P>
<P>In the past, women receiving cancer treatment were usually advised to rest and avoid physical activity. But, we now know that too much rest and too little physical activity can lead to muscle wasting. This reduces women's physical fitness level and may limit their regular activities. Women also often have other side effects that can affect their daily lives, such as extreme tiredness (fatigue), depression, and reduced mental functioning, for example being able to remember things or keep focused.</P>
<P>
<B>Why does it matter?</B>
</P>
<P>The side effects of breast cancer treatment can interfere with daily activities and return to work. It is important to learn of ways to reduce these side effects.</P>
<P>
<B>We asked</B> if physical exercise during chemotherapy or radiation therapy or both helped to reduce treatment side effects. Side effects studied included tiredness, depression, and reduced physical fitness and mental functioning. We also studied general effects such as health-related, cancer-specific, and cancer site-specific quality of life. Questionnaires for cancer-specific quality of life ask questions that are important for patients with cancer in general, for example about pain or nausea. Cancer site-specific quality of life is measured with questionnaires that ask women with breast cancer about topics that are especially important to them, for example about breast symptoms or body image. We only included questionnaires that have been shown to be reliable.</P>
<P>
<B>We found</B> 32 studies involving 2626 women. The included studies were published up through March 2015. Not all studies considered all of these potential side effects. Combining the results of these studies suggests that physical exercise probably improves physical fitness and slightly lessens fatigue. These studies also suggest that physical exercise probably results in little or no improvement in cancer-specific quality of life and depression. Exercise may improve mental function and slightly improve cancer site-specific quality of life, although the quality of the evidence was low for both of these outcomes. It may result in little or no improvement in health-related quality of life, however the quality of evidence was low for this outcome. The quality of evidence may have been low because many of the studies did not have enough participants to observe small differences and because results may be biased due to people assessing the outcomes knowing which participants were in the control group.</P>
<P>Importantly, physical exercise did not harm most women. Very few women experienced discomfort or pain in their arms or legs.</P>
<P>
<B>What does this mean? </B>
</P>
<P>It appears that exercise during cancer treatment can help lessen fatigue and improve physical fitness. It probably results in little or no improvement in cancer-specific quality of life and depression. It is unknown whether it helps for other side effects. At least nine current studies will help to answer the question if and how much exercise helps with the mentioned side effects and other side effects.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-09-16 12:27:46 +1000" MODIFIED_BY="Melina L Willson">
<ABS_BACKGROUND MODIFIED="2016-08-02 13:37:30 +1000" MODIFIED_BY="Melina L Willson">
<P>A huge clinical research database on adjuvant cancer treatment has verified improvements in breast cancer outcomes such as recurrence and mortality rates. On the other hand, adjuvant and neoadjuvant therapy with chemotherapy and radiotherapy impacts on quality of life due to substantial short- and long-term side effects. A number of studies have evaluated the effect of exercise interventions on those side effects. This is an updated version of the original Cochrane review published in 2006. The original review identified some benefits of physical activity on physical fitness and the resulting capacity for performing activities of daily life. It also identified a lack of evidence for other outcomes, providing clear justification for an updated review.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-08-22 12:03:26 +1000" MODIFIED_BY="[Empty name]">
<P>To assess the effect of aerobic or resistance exercise interventions during adjuvant treatment for breast cancer on treatment-related side effects such as physical deterioration, fatigue, diminished quality of life, depression, and cognitive dysfunction.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-09-16 12:26:49 +1000" MODIFIED_BY="Melina L Willson">
<P>We carried out an updated search in the Cochrane Breast Cancer Group Specialised Register (30 March 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 2, 2015), MEDLINE (1966 to 30 March 2015), and EMBASE (1966 to 30 March 2015). We did not update the original searches in CINAHL (1982 to 2004), SPORTDiscus (1975 to 2004), PsycINFO (1872 to 2003), SIGLE (1880 to 2004), and ProQuest Digital Dissertations (1861 to 2004). We searched the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov for ongoing trials on 30 March 2015. We screened references in relevant reviews and published clinical trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-08-22 12:40:32 +1000" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials that examined aerobic or resistance exercise or both in women undergoing adjuvant treatment for breast cancer. Published and unpublished trials were eligible.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-09-16 12:27:46 +1000" MODIFIED_BY="Melina L Willson">
<P>Two review authors independently performed data extraction, assessed trials, and graded the methodological quality using Cochrane's 'Risk of bias' tool. Any disagreements were resolved through discussion or by consulting the third review author. We entered data into Review Manager for analysis. For outcomes assessed with a variety of instruments, we used the standardised mean difference (SMD) as a summary statistic for meta-analysis; for those assessed with the same instrument, we used the mean difference (MD).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-09-10 23:08:51 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>For this 2015 update we included a total of 32 studies with 2626 randomised women, 8 studies from the original search and 24 studies from the updated search. We found evidence that physical exercise during adjuvant treatment for breast cancer probably improves physical fitness (SMD 0.42, 95% confidence interval (CI) 0.25 to 0.59; 15 studies; 1310 women; moderate-quality evidence) and slightly reduces fatigue (SMD -0.28, 95% CI -0.41 to -0.16; 19 studies; 1698 women; moderate-quality evidence). Exercise may lead to little or no improvement in health-related quality of life (MD 1.10, 95% CI -5.28 to 7.48; 1 study; 68 women; low-quality evidence), a slight improvement in cancer site-specific quality of life (MD 4.24, 95% CI -1.81 to 10.29; 4 studies; 262 women; low-quality evidence), and an improvement in cognitive function (MD -11.55, 95% CI -22.06 to -1.05; 2 studies; 213 women; low-quality evidence). Exercise probably leads to little or no difference in cancer-specific quality of life (SMD 0.12, 95% CI 0.00 to 0.25; 12 studies; 1012 women; moderate-quality evidence) and little or no difference in depression (SMD -0.15, 95% CI -0.30 to 0.01; 5 studies; 674 women; moderate-quality evidence). Evidence for other outcomes ranged from low to moderate quality. Seven trials reported a very small number of adverse events.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-08-28 14:01:33 +1000" MODIFIED_BY="[Empty name]">
<P>Exercise during adjuvant treatment for breast cancer can be regarded as a supportive self care intervention that probably results in less fatigue, improved physical fitness, and little or no difference in cancer-specific quality of life and depression. Exercise may also slightly improve cancer site-specific quality of life and cognitive function, while it may result in little or no difference in health-related quality of life. This review is based on trials with a considerable degree of clinical heterogeneity regarding adjuvant cancer treatments and exercise interventions. Due to the difficulty of blinding exercise trials, all included trials were at high risk for performance bias. Furthermore, the majority of trials were at high risk for detection bias, largely due to most outcomes being self reported.</P>
<P>The findings of the updated review have enabled us to make a more precise conclusion that both aerobic and resistance exercise can be regarded as beneficial for individuals with adjuvant therapy-related side effects. Further research is required to determine the optimal type, intensity, and timing of an exercise intervention. Furthermore, long-term evaluation is required due to possible long-term side effects of adjuvant treatment.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-09-16 13:02:22 +1000" MODIFIED_BY="Melina L Willson">
<BACKGROUND MODIFIED="2016-08-22 13:25:37 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-08-22 13:15:07 +1000" MODIFIED_BY="[Empty name]">
<P>Breast cancer detection and management have undergone dramatic changes over the past three decades. Women are increasingly diagnosed with early-stage disease, leaving them with treatment choices ranging from breast-conserving options to mastectomy (<LINK REF="REF-Newman-2003" TYPE="REFERENCE">Newman 2003</LINK>). With the majority of breast cancers diagnosed at an early stage, treatment is focused on cure and the prevention of relapse due to micrometastatic disease. The mainstay of care is local therapy, consisting of mostly breast-conserving surgery followed by radiotherapy. Adjuvant systemic therapy includes chemotherapy (cytotoxic agents) when there is an increased risk for systemic relapse and hormonal and/or antibody therapy (trastuzumab), depending on the expression of hormone and HER2/neu receptors.</P>
<P>Besides these major advances in managing both early and locally advanced breast cancer, women still have to deal with severe side effects and psychological distress during adjuvant therapy. This has a substantial impact on their quality of life. Side effects that appear with adjuvant cancer treatment differ depending on the mode of treatment, that is radiotherapy, chemotherapy, hormonal, or antibody therapy.</P>
<P>Radiotherapy is frequently associated with short-term side effects such as fatigue and skin reactions, and relatively rare long-term side effects including lymphoedema, cardiac and pulmonary toxicities, and secondary malignancy (<LINK REF="REF-Brown-2015" TYPE="REFERENCE">Brown 2015</LINK>). Chemotherapy is associated with short-term side effects such as nausea, emesis, stomatitis, alopecia, myelosuppression, thromboembolism, myalgias, neuropathy, and fatigue. Long-term side effects of chemotherapy are premature menopause, weight gain, fatigue, cardiac dysfunction, and cognitive dysfunction (<LINK REF="REF-Partridge-2001" TYPE="REFERENCE">Partridge 2001</LINK>). Furthermore, people receiving radiotherapy or chemotherapy report anxiety and depression prior to, during, and after therapy due to treatment side effects (<LINK REF="REF-Spiegel-1997" TYPE="REFERENCE">Spiegel 1997</LINK>). Adjuvant hormonal therapy produces symptoms secondary to oestrogen withdrawal, such as hot flushes, bone demineralisation, and psychosexual effects (<LINK REF="REF-Rutqvist-2004" TYPE="REFERENCE">Rutqvist 2004</LINK>). A particular concern with antibody therapy in combination with anthracycline chemotherapy is cardiac toxicity (<LINK REF="REF-Rayson-2008" TYPE="REFERENCE">Rayson 2008</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-08-22 13:17:01 +1000" MODIFIED_BY="[Empty name]">
<P>Although research is producing increasingly hopeful insights into the causes and cures for cancer, efforts to manage the side effects of adjuvant therapy have not kept apace (<LINK REF="REF-Patrick-2003" TYPE="REFERENCE">Patrick 2003</LINK>). Exercise interventions may be effective in managing some of these side effects, such as fatigue, depression, and cognitive dysfunction.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-08-22 13:23:56 +1000" MODIFIED_BY="[Empty name]">
<P>Evidence concerning the natural progression of physical activity suggests that women with breast cancer significantly decrease physical activity and exercise from pre-diagnosis to postdiagnosis (<LINK REF="REF-Irwin-2003" TYPE="REFERENCE">Irwin 2003</LINK>). These decreases are associated with adjuvant cancer treatment; observed decreases in physical activity were greater among women who were treated with radiation and chemotherapy (50% decrease) compared with women who underwent surgery only (24% decrease) or who were treated with surgery and radiation only (23% decrease) (<LINK REF="REF-Irwin-2003" TYPE="REFERENCE">Irwin 2003</LINK>).</P>
<P>The National Comprehensive Cancer Network defines cancer-related fatigue as a "persistent, subjective sense of tiredness related to cancer or cancer treatment that interferes with usual functioning" (<LINK REF="REF-NCCN-2004" TYPE="REFERENCE">NCCN 2004</LINK>). Fatigue results in substantial physical, psychosocial, cognitive, and socioeconomic consequences (<LINK REF="REF-Holley-2000" TYPE="REFERENCE">Holley 2000</LINK>). During and after adjuvant chemotherapy and radiotherapy the prevalence of fatigue is high and fluctuating (<LINK REF="REF-de-Jong-2002" TYPE="REFERENCE">de Jong 2002</LINK>; <LINK REF="REF-Jereczek_x002d_Fossa-2001" TYPE="REFERENCE">Jereczek-Fossa 2001</LINK>). Fatigue is also associated with factors such as depression, impaired quality of sleep, or pain (<LINK REF="REF-de-Jong-2002" TYPE="REFERENCE">de Jong 2002</LINK>).</P>
<P>The rationale supporting exercise interventions for cancer-related fatigue is based on the proposition that the combined effects of a toxic treatment and a decreased level of activity during treatment result in a reduction in the capacity for physical performance. Patients must in turn use greater effort and expend more energy to perform daily activities, which leads to fatigue (<LINK REF="REF-NCCN-2004" TYPE="REFERENCE">NCCN 2004</LINK>). Physical exercise training programmes may increase functional capacity, leading to reduced effort and decreased fatigue.</P>
<P>Women treated for breast cancer frequently experience higher levels of emotional distress than the general population (<LINK REF="REF-Spiegel-1997" TYPE="REFERENCE">Spiegel 1997</LINK>). The rationale for considering exercise as an intervention to reduce distress in women receiving adjuvant therapy for breast cancer is based upon literature that has demonstrated ameliorating effects of exercise on these problems. Results of studies with non-cancer populations indicate that aerobic exercise training has antidepressant and anxiolytic effects and protects against harmful consequences of stress (<LINK REF="REF-Salmon-2001" TYPE="REFERENCE">Salmon 2001</LINK>). There is evidence that cognitive dysfunction may also occur in women receiving adjuvant chemotherapy for breast cancer (<LINK REF="REF-O_x0027_Shaughnessy-2003" TYPE="REFERENCE">O'Shaughnessy 2003</LINK>; <LINK REF="REF-Rugo-2003" TYPE="REFERENCE">Rugo 2003</LINK>; <LINK REF="REF-Tchen-2003" TYPE="REFERENCE">Tchen 2003</LINK>). A meta-analytic study conducted to examine the hypothesis that aerobic fitness training enhances the cognitive vitality of healthy but sedentary older adults indicated that fitness training has robust benefits for cognition (<LINK REF="REF-Colcombe-2003" TYPE="REFERENCE">Colcombe 2003</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-08-22 13:25:37 +1000" MODIFIED_BY="[Empty name]">
<P>The majority of research focused on rehabilitation and health promotion in women who had completed cancer treatment. This review aims to evaluate the role of exercise in managing common side effects of adjuvant and neoadjuvant therapy for breast cancer. We conducted this review update to incorporate and analyse the increasing number of studies in women undergoing adjuvant treatment.<BR/>
</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-08-22 13:25:56 +1000" MODIFIED_BY="[Empty name]">
<P>To assess the effect of aerobic or resistance exercise interventions during adjuvant treatment for breast cancer on treatment-related side effects such as physical deterioration, fatigue, diminished quality of life, depression, and cognitive dysfunction.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-09-16 13:02:22 +1000" MODIFIED_BY="Melina L Willson">
<SELECTION_CRITERIA MODIFIED="2016-09-16 09:59:45 +1000" MODIFIED_BY="Melina L Willson">
<CRIT_STUDIES MODIFIED="2016-08-22 13:26:12 +1000" MODIFIED_BY="[Empty name]">
<P>We considered randomised controlled trials of exercise training during adjuvant (including neoadjuvant) treatment (radiotherapy, chemotherapy) for women with non-metastatic breast cancer.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-08-22 13:27:10 +1000" MODIFIED_BY="[Empty name]">
<P>We included studies involving women who were diagnosed with breast cancer stages I, II, and III and who were undergoing adjuvant (including neoadjuvant) chemotherapy, radiotherapy, or a combination concurrently with an exercise intervention in the active group.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-08-22 13:29:08 +1000" MODIFIED_BY="[Empty name]">
<P>We included studies that assessed the effects of all forms of repeatedly performed aerobic or resistance exercise or both with programme duration of at least six weeks. To be included in this review, the exercise intervention had to coincide with the adjuvant treatment regimen rather than follow it. We excluded studies where the exercise intervention was part of a complex intervention (for example complete decongestive lymphatic therapy). We also excluded trials with interventions restricted to local muscular endurance (for example training of shoulders, back, or legs only) instead of including all major muscle groups or restricted to stretching exercises.</P>
<P>We included trials making the following comparisons:<BR/>
</P>
<UL>
<LI>exercise versus no exercise;</LI>
<LI>exercise versus other interventions (e.g. psychosocial interventions).</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-09-16 09:59:45 +1000" MODIFIED_BY="Melina L Willson">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-08-27 08:44:13 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>physical fitness: objective tests measuring VO<SUB>2</SUB> max or distance walked per time</LI>
<LI>fatigue: using a validated questionnaire such as Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)</LI>
<LI>quality of life (cancer-specific quality of life, health-related quality of life, cancer site-specific quality of life): using a validated questionnaire such as Functional Assessment of Cancer Therapy-General (FACT-G), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 36 (EORTC QLQ-C30), Functional Assessment of Cancer Therapy-Breast (FACT-B)</LI>
<LI>depression: using a validated questionnaire such as Beck Depression Inventory (BDI)</LI>
<LI>cognitive function: using a validated test such as the Trail Making Test</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-09-16 09:59:45 +1000" MODIFIED_BY="Melina L Willson">
<OL>
<LI>strength</LI>
<LI>other psychological distress outcomes</LI>
<LI>physical activity behaviour</LI>
<LI>multidimensional outcomes (e.g. pain)</LI>
<LI>harms</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-09-15 14:04:17 +1000" MODIFIED_BY="Melina L Willson">
<ELECTRONIC_SEARCHES MODIFIED="2016-09-15 14:04:17 +1000" MODIFIED_BY="Melina L Willson">
<UL>
<LI>We searched the Cochrane Breast Cancer Group Specialised Register on 30 March 2015 (details of search strategies used by the group for the identification of studies and the procedure used to code references are outlined in the group's module at <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/BREASTCA/frame.html">www.mrw.interscience.wiley.com/cochrane/clabout/articles/BREASTCA/frame.html</A>). We extracted studies including the text words 'early', 'locally advanced', local recurrence', 'locoregional', 'exercise', and 'exercise therapy' on the Specialised Register for consideration.</LI>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL) (via the Cochrane Library, Issue 2, 2015). See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</LI>
<LI>MEDLINE (via OvidSP) from 1966 until 30 March 2015. See <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</LI>
<LI>EMBASE (via <A HREF="http://embase.com">Embase.com</A>) from 1966 until 30 March 2015. See <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>.</LI>
<LI>The World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<A HREF="http://apps.who.int/trialsearch/Default.aspx">apps.who.int/trialsearch/Default.aspx</A>) for all prospectively registered and ongoing trials on 30 March 2015. See <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.</LI>
<LI>ClinicalTrials.gov (<A HREF="http://clinicaltrials.gov/ct2/home">clinicaltrials.gov/ct2/home</A>) until 30 March 2015. See <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>.</LI>
</UL>
<P>We did not update the searches in the original review in the following databases:</P>
<UL>
<LI>CINAHL (1982 to 2004)</LI>
<LI>SPORTDiscus (1975 to 2004)</LI>
<LI>PsycINFO (1872 to 2003)</LI>
<LI>SIGLE (1880 to 2004)</LI>
<LI>ProQuest Digital Dissertations (1861 to 2004)</LI>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-08-22 13:54:28 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">References from published studies</HEADING>
<P>We screened references in relevant reviews and in published clinical trials for further trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other</HEADING>
<P>We consulted six experts in the field of cancer and exercise to identify additional trials. We applied no language restrictions.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-09-16 13:02:22 +1000" MODIFIED_BY="Melina L Willson">
<P>
<BR/>
</P>
<STUDY_SELECTION MODIFIED="2016-08-28 11:55:34 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (either ACF and MHM or ACF and MM) independently reviewed the titles and abstracts of reports identified by the search and selected those that potentially fulfilled the inclusion criteria of this review. We retrieved these potentially relevant reports for more detailed evaluation. Both review authors then independently made a final selection of studies to be included in the review. A report was excluded according to the first criterion that it did not fulfil. We resolved disagreements by consensus, or if necessary by consulting a third person (MM or MHM) to reach a final decision.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-08-23 13:56:30 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (ACF, MHM) independently extracted data (including study characteristics, study results, and point estimates together with measures of variability for selected outcome variables). We reviewed all discrepancies and achieved consensus through discussion, if necessary consulting a third person (MM) to reach a final decision. Where we found more than one publication for a study, we extracted data from all available publications if applicable. When a design publication and a results publication were available, we considered the results publication to be the primary reference. In cases where a doctoral dissertation was available, we considered this to be the primary reference for the study. In other cases, we considered the publication with the most relevant reported information for the review, especially regarding results, to be the primary reference.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-09-16 13:02:22 +1000" MODIFIED_BY="Melina L Willson">
<P>In the original version of the review, we assessed the included studies for quality using van Tulder methodological quality criteria. In the updated review, we used the Cochrane 'Risk of bias' tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Two review authors (either ACF and MM or ACF and MHM) assessed the risk of bias of all included studies. This included assessment of sequence generation, allocation concealment, masking or blinding (of participants, researchers/healthcare providers, and outcome assessors), methods of addressing incomplete outcome data, selective reporting of outcomes, and other possible sources of bias including attrition from the exercise intervention. We graded each risk of bias parameter as high risk, low risk, or unclear risk based on recommendations for judging risk of bias provided in Chapter 8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). For attrition bias, we judged studies to be at high risk when more than 20% of data were missing for short-term follow-up and more than 30% for long-term follow-up, as these are commonly used thresholds. We resolved disagreement through consensus, if necessary consulting a third review author (MHM or MM) for a final decision.</P>
<P>We used the last two rows in the 'Risk of bias' assessment tables to document reporting and amount of adherence and contamination in the exercise and control groups. If participants allocated to the exercise group do not exercise (non-adherence), and at the same time participants allocated to the control group do exercise (contamination), the originally intended study groups are distorted into groups with participants who exercise and those who do not (moreover in unknown proportions). Effects may be underestimated as a result.</P>
<P>There are several bias issues inherent to exercise studies, that is blinding of participants and exercise supervising personnel is difficult or impossible, leading to high risk of performance bias in every study. It is therefore important to point out that the bias assessment for those items does not reflect a low quality of study design as such, but expresses the inevitable bias introduced by lack of blinding. Nevertheless, exercise intervention studies should be subjected to the same 'Risk of bias' assessment as other studies, for example drug intervention studies. A similar challenge applies to adherence and contamination in exercise studies. It is difficult to maximise exercise adherence, especially in a participant cohort with cancer, and a certain amount of contamination and imperfect adherence is to be expected. Confidence in the results might therefore be lowered, even if studies are well planned and reported.</P>
<P>When high risk of bias for a study was due to lack of blinding, contamination, and/or non-adherence, we did not downgrade the quality of evidence for this alone. We only downgraded the evidence one level for risk of bias when other factors such as unclear allocation procedures or high attrition rates were present.</P>
<P>&#8217;Risk of bias&#8217; tables for each study are presented in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table and a summary of the risk of bias is presented.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-08-28 11:07:53 +1000" MODIFIED_BY="[Empty name]">
<P>Outcome measurements were presented as continuous data across included studies. As the first step, we extracted data on outcomes in the format in which they were reported. For selected outcomes we extracted group means for final values and change scores with the corresponding measures of variability such as standard deviations (SD) or confidence intervals (CI) and the number of participants on whom the outcome was assessed per group.</P>
<P>As a summary statistic for meta-analysis of continuous outcomes, we either used the standardised mean difference (SMD) or the weighted mean difference (WMD). We chose the SMD in cases where different assessment instruments measuring the same construct were used across studies (for example for fatigue and physical fitness outcomes). We did not combine final values and change scores in meta-analyses since the difference in standard deviation does not reflect "differences in measurement scale, but differences in the reliability of the measurements" (<LINK REF="REF-Deeks-2005" TYPE="REFERENCE">Deeks 2005</LINK>).</P>
<P>We did not include data for outcomes assessed with subscales of questionnaires (for example physical functioning subscale of the 36-Item Short Form Health Survey (SF-36) or vitality subscale of the SF-36, nausea item of the Symptom Checklist-90 (SCL-90)), because we only wanted to assess the respective full construct in this review as well as only include validated questionnaires, which often is not the case for subscales.</P>
<P>As a summary statistic for dichotomous outcomes we chose the risk ratio (RR). Lymphoedema was the only outcome that was analysed as a dichotomous outcome: two studies reported the number of participants with lymphoedema (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>). For those outcomes with data available from only one study, we calculated and presented a summary statistic for this particular study.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-09-16 11:48:57 +1000" MODIFIED_BY="Melina L Willson">
<P>Five studies were three-arm trials (<LINK REF="REF-Courneya-2007" TYPE="REFERENCE">Courneya 2007</LINK> split into <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="REF-Hayes-2013" TYPE="REFERENCE">Hayes 2013</LINK>: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="REF-Schwartz-2007" TYPE="REFERENCE">Schwartz 2007</LINK>: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; <LINK REF="REF-Segal-2001" TYPE="REFERENCE">Segal 2001</LINK>: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>), and they contributed to the meta-analysis of physical fitness with two exercise groups. For all five studies, we incorporated both exercise arms into the meta-analysis and allocated a control group to each of them (that is by halving the number of participants and events observed in the control group).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-06-07 16:28:43 +1000" MODIFIED_BY="Melina L Willson">
<P>Whenever possible, we tried to contact the investigators or sponsors of studies with missing data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-08-23 14:35:07 +1000" MODIFIED_BY="[Empty name]">
<P>We used the random-effects model to obtain the average effect of exercise because, in addition to the presence of random error, differences between exercise studies during adjuvant cancer treatment can also result from real differences between study populations, adjuvant cancer treatment, and the training stimulus. The random-effects model considers these additional sources of between-study variability as well as within-study variability.<BR/>
</P>
<P>We evaluated inconsistency of results across studies using the I<SUP>2</SUP> statistic, which describes the percentage of variability in the point estimates that is due to heterogeneity rather than sampling error (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). Following Higgins (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>), we considered I<SUP>2</SUP> values of 25% as indicating low heterogeneity, I<SUP>2</SUP> values of 50% moderate heterogeneity, and I<SUP>2</SUP> values of 75% large heterogeneity.</P>
<P>We also used visual assessment of forest plots; if no or small overlap of CIs for the results of individual studies was present, we assumed statistical heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-08-23 14:27:05 +1000" MODIFIED_BY="[Empty name]">
<P>If we identified a sufficient number of studies (that is more than 10), we prepared funnel plots and visually examined them for signs of asymmetry to detect publication bias.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-09-09 22:07:21 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>We used the random-effects model to obtain the average effect of exercise because, in addition to the presence of random error, differences between exercise studies during adjuvant cancer treatment can also result from real differences between study populations, adjuvant cancer treatment, and the training stimulus. The random-effects model considers these additional sources of between-study variability as well as within-study variability.</P>
<P>We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach to assess the quality of the evidence, grading the following main outcomes for quality: physical fitness, fatigue, cancer-specific quality of life, health-related quality of life, cancer site-specific quality of life, depression, cognitive function, and lymphoedema. We used <LINK REF="REF-GRADEproGDT" TYPE="REFERENCE">GRADEproGDT</LINK> software to develop the 'Summary of findings' table, and two review authors (either ACF and MM or ACF and MHM) graded the quality of the evidence for each outcome. We resolved disagreement by consensus, if necessary consulting a third review author (MHM or MM) for a final decision.</P>
<P>As blinding of participants and exercise supervising personnel is difficult or impossible, and as self reported outcomes inherently carry a high risk of detection bias, those items were assessed with a high risk of bias, but did not lead to downgrading unless there were additional high risks of bias (for example sequence generation and allocation concealment).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-08-23 14:59:56 +1000" MODIFIED_BY="[Empty name]">
<P>We did not conduct subgroup analyses.</P>
<P>If possible, in future updates we will consider conducting the following subgroup analyses: adjuvant treatment received, chemo- and radiotherapy or radiotherapy only, type of exercise intervention (aerobic or resistance exercise, self directed or supervised exercise).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-08-23 15:05:12 +1000" MODIFIED_BY="[Empty name]">
<P>Where important statistical inconsistency existed as measured by the I<SUP>2</SUP> statistic, we conducted sensitivity analyses to assess the robustness of the review results by removing those studies that seemed to be estimating a different effect.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-09-16 12:59:03 +1000" MODIFIED_BY="Melina L Willson">
<STUDY_DESCRIPTION MODIFIED="2016-09-16 11:50:50 +1000" MODIFIED_BY="Melina L Willson">
<SEARCH_RESULTS MODIFIED="2016-09-15 15:49:55 +1000" MODIFIED_BY="Melina L Willson">
<P>See: <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>; <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>; <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>.</P>
<P>In the original review published in 2006, we retrieved 32 full-text references for more detailed evaluation after screening of 1612 potentially relevant references. From the 32 full-text references, 22 publications were excluded, one trial was awaiting assessment (pending publication), and nine trials were included. We considered seven of the nine trials to be appropriate for inclusion in this updated review (<LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; Segal (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> &amp; <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>); <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>). We excluded two of these in this updated review because they were not randomised controlled trials (<LINK REF="STD-MacVicar-1986" TYPE="STUDY">MacVicar 1986</LINK>; <LINK REF="STD-Mock-1997" TYPE="STUDY">Mock 1997</LINK>). We included the trial that was awaiting assessment in the original review in this updated review (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>).</P>
<P>In this updated review, we retrieved a further 146 full-text references following screening of 3297 titles and abstracts. From these 146 full-text references we excluded 86 and identified 60 records as appropriate for inclusion in this review. Three records belonged to a study that had been included in the first version of this review, and 55 records related to 24 new studies. One study is awaiting assessment due to pending publication (<LINK REF="STD-Petrella-2012" TYPE="STUDY">Petrella 2012</LINK>), and another study was due to be published after our analyses were finished (<LINK REF="STD-Lotzke-2016" TYPE="STUDY">Lotzke 2016</LINK>). For further details see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-09-16 11:50:50 +1000" MODIFIED_BY="Melina L Willson">
<P>The eight studies from the original review and the 24 new studies amounted to a total of 32 studies (2626 participants) for inclusion in the review. Trial characteristics and outcomes are found in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables. We included only randomised controlled trials in this updated version of the review. Five of the included studies incorporated two separate exercise groups and are therefore entered twice for the purposes of statistical analysis (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of participants</HEADING>
<P>Women obtained different regimens of adjuvant treatment across these 32 exercise intervention studies: they received either chemotherapy or radiotherapy in one trial (<LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>); either chemotherapy or radiotherapy or a combination of the two in another 10 trials (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>), sequential chemo- and radiotherapy in one trial (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>), chemotherapy only in nine trials (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>); neoadjuvant chemotherapy in two trials (<LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Rao-2012" TYPE="STUDY">Rao 2012</LINK>), neoadjuvant and adjuvant chemotherapy in one trial (<LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>), and radiotherapy only in three trials (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). Five trials included women who were scheduled for chemotherapy, some of whom underwent radiation therapy as well (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the intervention</HEADING>
<P>Mode of exercise differed across trials. Thirteen trials (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>), and one of two intervention arms in two studies (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK>
<I>)</I> tested aerobic exercise interventions, with three studies using cycle ergometer interval training (<LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>), and six studies offering walking programmes (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). Aerobic exercise also consisted of Nia exercise, in <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>, and aerobic exercise self chosen by the participants in two studies, <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK> and <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>, and in one intervention arm of one study (Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK>). Fifteen studies (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>; <LINK REF="STD-Rao-2012" TYPE="STUDY">Rao 2012</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>), and one of two intervention arms in one study (van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK>) applied a combined aerobic-resistance programme. Exercise was implemented as a supervised group exercise programme in seven studies (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>), and in one of two intervention arms in two studies (Segal 2001: <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK>). Two studies tested resistance exercise interventions (<LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>), as well as one intervention arm of two further studies (Courneya 2007: <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>). One study started with supervised resistance training at the hospital, followed by a combined self directed aerobic-resistance programme (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>).</P>
<P>Four studies used a stretching intervention as a comparison arm (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>), two studies used progressive muscle relaxation as the comparison arm (<LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>), and the remaining 26 studies compared an exercise intervention with no intervention.</P>
<P>Exercise interventions lasted six to seven weeks for women undergoing radiation treatment in two trials (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>), 10 weeks in two trials for women undergoing chemotherapy (<LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>), and 12 to 13 weeks in 11 trials (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). In nine trials, the exercise intervention lasted 18 to 32 weeks (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>).The longest intervention period was 52 weeks, in two trials (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>). Trials with shorter intervention periods (six to seven weeks) were those in which women received radiation treatment, which is of shorter duration than chemotherapy. In five trials (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>), the exercise intervention was implemented to span the period of time from initiation to cessation of the woman's adjuvant therapy, and subsequently the intervention periods of women in the intervention arm of the trial varied in length (either six weeks with radiation treatment or three to six months with chemotherapy).</P>
<P>In 12 trials (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Rao-2012" TYPE="STUDY">Rao 2012</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>), and in one of the two intervention arms in three trials (Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>), the exercise intervention was supervised. Women's exercise was self directed in 15 trials (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET </LINK>and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>), and in the second intervention arm of Hayes 2013 (<LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>), Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK>), and van Waart 2014 (<LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). Two studies started with supervised sessions, which were followed by self directed sessions in the home (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>). Two trials applied supervised, one-on-one sessions, <LINK REF="STD-Rao-2012" TYPE="STUDY">Rao 2012</LINK> home based and <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK> at the clinical institution.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the outcome measures</HEADING>
<P>The most frequently assessed outcomes were physical fitness and fatigue, with 22 studies measuring physical fitness (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>), and 21 studies measuring fatigue (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). Other outcomes assessed were quality of life, strength, depression, anxiety, cognitive function, self esteem, mood disturbances, physical activity level, gait and balance, subjective upper body function, neuropathy symptoms, chemotherapy completion, shoulder mobility, arm morbidity, nausea relief, sleep disturbances, endocrine symptoms, and adverse effects. For detailed information on outcome measures see the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other study characteristics</HEADING>
<P>Small sample size was common among the included studies. Sixteen studies randomised fewer than 50 women. Ten of the 32 studies randomised more than 50 women per group (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). Sample sizes ranged from 10 to 242 women. The median sample size was 50 women, interquartile range (IQR) 22 to 124. Sample size was reported to be based on power calculations in 14 studies, and 12 of the 14 studies reached the target sample size.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-08-24 07:14:46 +1000" MODIFIED_BY="[Empty name]">
<P>In the majority of cases, we excluded studies because the exercise intervention took place after the adjuvant treatment period. Other reasons were that studies were not randomised controlled trials, exercise was part of a complex intervention or no exercise intervention was implemented, the majority of participants were not women with breast cancer, or the exercise intervention had a duration of less than six weeks. Furthermore, we excluded studies assessing yoga or qigong because we regard both as a complex intervention. Some studies could not be characterised as controlled trials (they were study protocols or reviews). For a detailed description of the reasons for exclusion, see the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table. Note that this table contains not only clinical studies but also review articles that were part of our full-text retrieval to confirm our decision to exclude studies when abstracts were ambiguous.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-09-16 11:50:54 +1000" MODIFIED_BY="Melina L Willson">
<P>We assessed the risk of bias for each included study and reported the judgements for the individual 'Risk of bias' domains in the &#8217;Risk of bias&#8217; table. We have presented these in the &#8217;Risk of bias&#8217; summary in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2016-08-24 07:19:17 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Random sequence generation</HEADING>
<P>Twenty trials were at a low risk of selection bias as they reported to have adequately generated their randomised sequence with a random component. One trial used a non-random component to generate the sequence (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>), and was thus judged to be at a high risk of selection bias. We considered 11 trials to have an unclear risk of selection bias, largely because the generation of the random sequence was not described.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Nine trials adequately concealed allocation to the intervention so that participants and investigators could not foresee assignment to the study groups, and were thus judged to be at low risk of selection bias. Twenty-three trials did not describe the method of allocation concealment or did not describe it in detail enough to allow for a definitive judgement, and were considered to have an unclear risk of selection bias.</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2016-09-15 16:13:59 +1000" MODIFIED_BY="Melina L Willson">
<SUBSECTION>
<HEADING LEVEL="4">Blinding of participants and personnel</HEADING>
<P>All trials included in this review were at high risk for performance bias because, owing to the nature of the intervention (exercise), it was not possible to blind the participants and the study personnel. Three studies mentioned a placebo group (<LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>), in which women were instructed to do stretching in a similar setting to the exercise groups. But as knowledge about the difference between physical exercise and stretching is usually present in the population, we cannot assume that participants and personnel were unaware of being in the exercise or the stretching group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding of outcome assessors (detection bias)</HEADING>
<P>Eight studies reported blinding of outcome assessors (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>). Blinding was performed for assessment of fitness outcomes, as well as for lymphoedema in one study (Hayes 2013), and for upper limb swelling and shoulder range of motion in another study (<LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>), with a low risk of bias for these outcomes, but not for the remaining self reported outcomes, for which risk of bias was high. <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK> did not report the assessed fitness outcomes. In the remaining 24 studies, no information was given on blinding of outcome assessors, which we judged as lack of blinding and therefore high risk of bias for this item for all outcomes. In cases where no fitness outcomes or no self reported outcomes were measured in a trial, this appears as unclear risk of bias in the tables and as an empty cell in the &#8217;Risk of bias&#8217; summary.</P>
</SUBSECTION>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-08-28 12:13:08 +1000" MODIFIED_BY="[Empty name]">
<P>Twenty-three of the 32 studies reported to have analysed data according to the intention-to-treat (ITT) principle. Twenty of these 23 studies had low drop-out rates or less than 20% missing data and were thus judged to be at low risk of attrition bias. Of the remaining three studies, one reported imbalanced drop-out rates between the exercise group and the control group (<LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>), with almost twice as many dropped-out participants in the intervention group (19 of 101) than in the control group (10 of 102); we therefore judged this study to be at high risk of attrition bias. The second study had more than 30% missing data (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>). In spite of the trial authors undertaking an ITT analysis with imputation of missing data, we judged this study to be at high risk of attrition bias due to the amount of missing data. It remained unclear if there had been missing data in the third study, leading to a judgement of unclear risk of attrition bias (<LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>).</P>
<P>Five studies did not report if data were analysed by intention to treat. Three of these studies had more than 20% dropouts or missing data and were thus judged to be at high risk of attrition bias (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>). Another study did not report if there were missing data (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>), and was thus judged to be at an unclear risk of attrition bias. The remaining study had a low drop-out rate (4 of 44 women) and was judged to be at low risk of attrition bias (<LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>).</P>
<P>We judged one study to be at high risk of attrition bias (<LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>), because it only reported a per-protocol analysis of participants that adhered to the exercise intervention (12 of 22 women). In one study (<LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>), the numbers randomised to each arm as well as completion rates were unclear. The authors reported that they used regression modelling to impute missing values to conduct the analyses. We thus judged risk of attrition bias for this study as unclear and extracted no data. One study reported no outcome data as the study was closed early due to changes in the chemotherapy protocol (<LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>); we judged this study to be at unclear risk of attrition bias. <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK> undertook an analysis of 45 of 62 women; nine of the excluded women were reclassified to more advanced stages of disease than stage II during participation and not analysed for that reason. We judged this study to be at high risk of attrition bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-08-24 07:47:29 +1000" MODIFIED_BY="[Empty name]">
<P>Six studies were at a low risk of reporting bias, as the studies had been registered prospectively or study protocols had been published and the prospectively registered outcomes were in line with the published ones. We considered 10 studies to be at high risk of reporting bias, because reporting of assessed outcomes in the final paper differed from entries in trial registries or study protocols, and no explanation was given. We considered 16 studies to be at an unclear risk for reporting bias, as no study protocol or design paper was available, and no trial registration had taken place; the information was therefore insufficient to judge this item for those studies.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-09-16 11:50:54 +1000" MODIFIED_BY="Melina L Willson">
<P>Nineteen studies were at low risk of selection bias owing to adequate group similarity at baseline, three studies were at unclear risk for selection bias, and 10 studies were at high risk for selection bias, because group similarity at baseline was inadequate.</P>
<SUBSECTION>
<HEADING LEVEL="4">Adherence and contamination</HEADING>
<P>Different approaches were used among the included studies to measure adherence, that is the level of exercise participation achieved once the woman had agreed to undertake it. Fifteen studies reported exercise levels in non-exercising control groups (contamination) (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). A high percentage of women (up to 70% in <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>) in the control groups reported to be regularly exercising or had a high level of activity. In a study with two exercise groups (Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>), the usual-care group was more active than one of the exercise groups and as active as the other exercise group, according to the survey used.</P>
<P>In six studies, women adhered adequately to the exercise intervention, and in four studies this was unclear. In the remaining 22 studies, adherence to the exercise intervention was so low that we judged it to cause a high risk of bias. The amount of contamination was low in two studies, high in 10 studies, and unclear in the remaining 20 studies.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-09-16 12:59:03 +1000" MODIFIED_BY="Melina L Willson">
<SUBSECTION>
<HEADING LEVEL="3">Effectiveness of exercise programmes</HEADING>
<P>Most trial authors reported study results as follow-up values, which we pooled. When outcomes were assessed with different instruments, follow-up values and change scores could not be pooled. We performed meta-analyses for physical fitness, fatigue, cancer-specific quality of life, cancer site-specific quality of life, depression, cognitive function, strength, subjective upper body function, arm morbidity, anxiety, mood disturbance, self esteem, physical activity, gait and balance, and lymphoedema.</P>
<P>Studies that were included in the meta-analysis for physical fitness predominantly either measured performance, for example distance walked in a given time, or maximum oxygen uptake. Studies that were included in the meta-analysis for fatigue predominantly applied the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale. Studies that were included in the meta-analysis for cancer-specific quality of life either used the Functional Assessment of Cancer Therapy-General (FACT-G) or the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 36 (EORTC QLQ-C30) questionnaires. Studies that were included in the meta-analysis for cancer site-specific quality of life all used the Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnaire. Studies that were included in the meta-analysis for depression predominantly used the Center for Epidemiological Studies-Depression scale (CES-D). The two studies that were included in the meta-analysis for cognitive function both used the Trail Making Test.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Physical fitness</HEADING>
<P>Twelve studies applied tests of cardiorespiratory fitness (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>); <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>), eight studies assessed physical performance via timed walking distances (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; Schwartz 2007 (<LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>)), and two studies used other physical performance tests (Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>); van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>)). Hayes 2013 assessed heart rate at the end of test completion, and van Waart 2014 assessed endurance time in minutes.</P>
<P>Meta-analysis was feasible for 15 of those 22 studies (1310 women) yielding 20 comparisons (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>); <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; Schwartz 2007 (<LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>); Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>); <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>)). The standardised mean difference (SMD) for the pooled data was 0.42 (95% confidence interval (CI) 0.25 to 0.59; I<SUP>2</SUP> = 49%; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). There was moderate heterogeneity with an I<SUP>2</SUP> of 49%, which could be explained by the wide range of exercise interventions and outcome assessment protocols in the different studies.</P>
<P>We could not transform data from two studies for meta-analysis requirements (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-MacVicar-1989" TYPE="STUDY">MacVicar 1989</LINK>). Both studies reported small but statistically significant improvements. Another study reported no group differences in the ITT analysis for the 12-minute walk test but presented no data for the ITT analysis (<LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>). Four studies reported neither data nor descriptive results for cardiorespiratory fitness. One study provided only a comparison of means without standard deviations for cardiorespiratory fitness data (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>).</P>
<P>We rated the result of a statistically significant improvement in physical fitness as moderate-quality evidence due to lack of blinding, low adherence, and high or unclear contamination in most of the studies and because many randomisation and allocation procedures were unclear. Furthermore, there was a considerable number of women (390 in 4 studies) for whom no data were reported. There was no indication of publication bias from examination of the funnel plot for this outcome. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Fatigue</HEADING>
<P>Meta-analysis was possible for 19 studies (1698 women) yielding 22 comparisons (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>); <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>)). Several tools were used to measure fatigue: the FACIT-F scale, the (revised) Piper Fatigue Scale, the Multidimensional Fatigue Inventory, the Schwartz Cancer Fatigue Scale, and the Fatigue Assessment Questionnaire and the Fatigue Quality List. The SMD between intervention and control was -0.28 (95% CI -0.41 to -0.16; I<SUP>2</SUP> = 29%; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>), favouring the exercise group. Two studies did not report data for fatigue (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>). Both studies reported that there were no statistically significant group differences. We assumed that their results would not have substantially influenced the pooled result because they involved only 22 and 119 women, respectively. We rated the result as moderate-quality evidence due to lack of blinding, low adherence, and high or unclear contamination and because the allocation concealment procedures in many studies were unclear. The funnel plot was asymmetrical when <LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK> was included; otherwise there was no indication of publication bias from examination of the funnel plot for this outcome, and we did not downgrade for publication bias. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cancer-specific quality of life</HEADING>
<P>Sixteen studies examined effects of exercise on cancer-specific quality of life (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>); <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>); <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>). Cancer-specific quality of life was measured with either the FACT-G scale or the EORTC QLQ-C30 questionnaire. Twelve studies (1012 women) reported final values, and one study reported change scores for this outcome (<LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>). Meta-analysis of the 12 studies reporting final values showed a SMD of 0.12 (95% CI 0.00 to 0.25; I<SUP>2</SUP> = 0%; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>) (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>). The study reporting change scores found statistically significant differences between groups, favouring the exercise group, in cancer-specific quality of life, using the FACT-G (<LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>).</P>
<P>Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>) reported no significant differences between groups for cancer-specific quality of life measured with FACT-G, but reported no data. van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>) assessed cancer-specific quality of life with the EORTC QLQ-C30, but reported no summary score and no score for global health, therefore we did not use data in the meta-analysis. Results for the subscales were all in favour of the exercise groups, some reaching statistical significance and some not. One publication related to another study reported assessment of cancer-specific quality of life with the Multidimensional Quality of Life scale, Cancer version (MQOLS-Ca) (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>), but neither data nor descriptive results were reported. Taken together, the reported results of studies that could not be included in the meta-analysis seem to be in line with the pooled result. Results that were not reported concerned less than 10% of all women. We rated the result as moderate-quality evidence due to lack of blinding, low adherence and unclear or high contamination, and a high rate of incomplete outcome data. We did not detect an indication of publication bias from the funnel plot. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Health-related quality of life</HEADING>
<P>Four studies examined generic health-related quality of life (assessed via MOS 36-Item Short Form Health Survey (MOS SF-36)) (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>); <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>). We did not perform a meta-analysis because only data for subscales, but no data for physical and mental health summary measures, were presented. The studies did not find statistically significant differences between groups. Another study assessed generic health-related quality of life via the EQ-5D VAS (score range 0 to 100) and did not find statistically significant differences between groups: mean difference (MD) 1.10 (95% CI -5.28 to 7.48; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>) (<LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>). We rated this result as low-quality evidence due to lack of blinding, low adherence and high contamination, a high rate of incomplete outcome data, and high risk of bias for group similarity at baseline. Additionally, we further downgraded for imprecision because of a small number of participants and because the null effect and an appreciable benefit were included in the confidence interval for the mean difference. With only one study extracted for the analysis, examination of the funnel plot for publication bias was not possible. We did not downgrade for publication bias. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cancer site-specific quality of life</HEADING>
<P>Ten studies examined the effects of exercise on cancer site-specific quality of life (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>); <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>); <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). We could extract data for meta-analysis from four studies (262 women) (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>), which had all used the FACT-B questionnaire (score range 0 to 144): MD 4.24 (95% CI -1.81 to 10.29; I<SUP>2</SUP> = 25%; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). Three studies did not report a summary score of the EORTC QLQ-BR23 questionnaire and were therefore not included in the meta-analysis (<LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). Segal 2001 (<LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK> - 123 women) reported finding no significant differences between groups for cancer site-specific quality of life measured with the FACT-B questionnaire, but reported no data. We rated the result for cancer site-specific quality of life as low-quality evidence due to lack of blinding, low adherence, an unclear or high amount of contamination in three of the four studies in the meta-analysis, and because two of four allocation concealment procedures were unclear. Furthermore, the number of women included in the meta-analysis was small (n = 262), and the null effect as well as an appreciable benefit were included in the confidence interval for the mean difference, leading to further downgrading for imprecision. The four studies in the meta-analysis were not sufficient for the examination of publication bias in the funnel plot, as at least 10 studies were considered a sufficient number. We did not downgrade for publication bias. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Depression</HEADING>
<P>Seven studies examined group differences for depression (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). Meta-analysis was possible for five studies (674 women) yielding six comparisons. Depression was assessed either with the Beck Depression Inventory (BDI) or with the Center for Epidemiological Studies-Depression scale (CES-D). The SMD between intervention and control was -0.15 (95% CI -0.30 to 0.01; I<SUP>2</SUP> = 0%; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). Two studies involving 51 and 119 women (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK> and <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>, respectively) did not report their data for depression, or it was not possible to extract data due to lack of information. Being borderline significant, their reported results might not necessarily alter that of the meta-analysis, but they might contribute to a more or less clear inclusion of the null effect: one study reported finding a statistically significant effect in favour of the exercise group (<LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>), and the second study reported that depression scores did not change in any of the groups (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>). We rated the result as moderate-quality evidence due to lack of blinding, low adherence, and unclear or high contamination. The five studies in the meta-analysis were not sufficient for the examination of publication bias in the funnel plot, as at least 10 studies were considered a sufficient number. We did not downgrade for publication bias. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cognitive function</HEADING>
<P>Two studies including a total of 213 women examined the effects of exercise on cognitive function with the Trail Making Test (<LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). The MD between intervention and control was -11.55 (95% CI -22.06 to -1.05; I<SUP>2</SUP> = 0%; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). Another study reported in their published study protocol that it aimed to assess cognitive function besides psychosocial well-being, but the results paper did not mention the cognitive function outcome (<LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>). <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK> reported having assessed attention performance with the Attention Functional Index, finding no statistically significant difference between groups. Data could not be extracted. Considering the relatively small number of women in the meta-analysis, and missing data or no evidence of a difference for another 72 women outside the meta-analysis, we can make a conclusion on the effect only under reservation. We rated the result as low-quality evidence due to lack of blinding, low and unclear adherence and unclear contamination, and because group similarity at baseline for <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK> was at high risk of bias. <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK> reported a higher number of participants with depression, which often leads to impairment of cognitive function, in the control group. Our confidence in the result was lowered further because of imprecision (a small number of women). The two studies in the meta-analysis were not sufficient for the examination of publication bias in the funnel plot as at least 10 studies were considered a sufficient number. We did not downgrade for publication bias. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Strength</HEADING>
<P>Fourteen studies reported assessment of changes in muscular strength (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>); <LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; Schwartz 2007 (<LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>); <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>); <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>). We could extract data from nine studies yielding 13 comparisons for the meta-analysis (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>); <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>); Schwartz 2007 (<LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>); <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>)), which showed a SMD of 0.27 (95% CI 0.04 to 0.50; I<SUP>2</SUP> = 59%; 912 women; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). The heterogeneity could be explained by a wide range of interventions and outcome assessment protocols.</P>
<P>Two studies reported significant improvements in muscle strength (<LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>), but did not report data for the results. One study reported finding no significant change in upper or lower body strength between the two groups across the study period (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>), but did not report data for the results. One study measuring strength was finished early with no reported results (<LINK REF="STD-Ingram-2010" TYPE="STUDY">Ingram 2010</LINK>), while another study did not report results about strength (<LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>).</P>
<P>We rated the result of a statistically significant improvement in strength as moderate-quality evidence due to lack of blinding, low adherence and mostly unclear amount of contamination, and because many allocation procedures were unclear. We did not detect an indication of publication bias from the funnel plot.</P>
<P>The studies used different assessment protocols to measure muscular strength. Extracted data for the studies in the meta-analysis is from the following assessment protocols: leg press strength (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>), grip strength (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK> - right hand; van Waart 2014), overhead press, chest (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET</LINK> and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>), overall muscular strength (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>), and upper body function (strength and endurance) (Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Subjective upper body function</HEADING>
<P>Furthermore, two studies reported subjective upper body function measured with the Disability of Arm, Shoulder and Hand Questionnaire (DASH) (<LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>). There was no statistically significant difference between groups in the meta-analysis: MD -0.52 (95% -4.45 to 3.41; 231 women; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). We rated the result as low-quality evidence due to lack of blinding, low adherence and high contamination, and because the allocation concealment procedures were unclear. The group similarity at baseline was at high risk of bias as well. Furthermore, the number of participants was small, and confidence intervals were wide, raising concerns about imprecision, which further lowered our confidence in the result.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Shoulder mobility</HEADING>
<P>Two studies measured shoulder range of motion (<LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Reis-2013" TYPE="STUDY">Reis 2013</LINK>), and one study reported a shoulder mobility score (<LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>). We could only extract data for the shoulder mobility score, and found a statistically significant difference between groups: MD 3.10 (95% CI 1.54 to 4.66; 174 women; 1 study; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>). Two further studies reported assessment of shoulder range of motion in their respective design papers, but did not mention the outcome in the final publications (<LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). We rated the result as low-quality evidence due to lack of blinding, low adherence, and an unclear amount of contamination in the one study that reported results. The small number of participants and the lack of data reporting in four of five studies further lowered our confidence in the result.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Arm morbidity</HEADING>
<P>Two studies used the FACT-B + 4 questionnaire, which for cancer site-specific quality of life includes four questions in addition to the FACT-B about arm morbidity and lymphoedema (higher scores mean less upper extremity impairment) (<LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>). Meta-analysis of the two studies yielding three comparisons showed a MD between groups of 1.11 (95% CI -4.07 to 6.29; I<SUP>2</SUP> = 0%; 240 women; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). We rated the result as low-quality evidence due to lack of blinding, unclear allocation concealment, low adherence and high contamination, and imprecision (small number of participants).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other psychological distress outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Anxiety</HEADING>
<P>Three studies assessed anxiety using the State-Trait Anxiety Inventory (STAI) (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>); <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK> used the short form of the questionnaire, and <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK> reported that they only used the state anxiety and not the trait anxiety scale. <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK> found a small, not statistically significant effect. Meta-analysis of the two studies using the whole questionnaire yielding three comparisons found no statistically significant difference between groups: MD -1.45 (95% CI -4.36 to 1.46; 331 women; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>) (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>). We rated the result as low-quality evidence due to lack of blinding, low adherence, and high or unclear contamination. The rather small number of participants further lowered our confidence in the results.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mood disturbances</HEADING>
<P>Meta-analysis of data from three small studies assessing mood disturbances showed a SMD of -1.00 (95% CI -1.40 to -0.60; I<SUP>2</SUP> = 0%; 111 women; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>) (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). One study used the long version of the Profile of Mood States (POMS) questionnaire (<LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>), whereas the other two studies used the short form of the questionnaire (<LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). We rated the statistically significant result of diminished mood disturbances as low-quality evidence due to lack of blinding, low adherence and unclear contamination in two of the three studies, and because the allocation concealment procedures of the three studies were unclear. The small number of participants (n = 111) further lowered our confidence in the results.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Psychological distress</HEADING>
<P>Another study used the General Health Questionnaire to assess psychological distress and did not find a statistically significant difference between groups: MD -1.47 (95% CI -9.38 to 6.44) (<LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>). One study measured negative and positive affects with the Positive and Negative Affect Schedule and found a statistically significant difference for positive affects but not for negative affects (positive affects: MD 4.10, 95% CI 1.38 to 6.82; negative affects: MD -2.10, 95% CI -4.18 to -0.02) (<LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>). <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK> reported perceived stress and happiness; in this one study stress did not show a statistically significant difference (MD -3.10; 95% CI -6.63 to 0.43), and neither did happiness (MD -0.90; 95% CI -9.92 to 8.12).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Anxiety and Depression</HEADING>
<P>Four studies used the Hospital Anxiety and Depression Scale to examine symptoms of depression and anxiety in one questionnaire (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK> reported final values for the summary score and found a statistically significant difference between groups: MD -6.10 (95% CI -9.65 to -2.55; 20 women; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). The other three studies reported finding no statistically significant differences between groups for the summary score. van Waart 2014 did not report any data. <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK> and <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK> additionally reported final values for the depression and anxiety subscales.</P>
<P>Due to the differences of the outcome assessment instruments and the differing utilisation of summary scores and subscales, we did not pool the data from the studies, apart from those using the POMS. We rated the results from the single studies as low-quality evidence due to the high risk of bias in all of the studies and the small numbers of participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sleep disturbances</HEADING>
<P>
<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK> and van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>) reported sleep quality as an outcome, measured with the General Sleep Disturbance Scale and the Pittsburgh Sleep Quality Index respectively, but did not report results. <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK> reported only that no group differences were detected over time.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Self esteem</HEADING>
<P>Three studies examined the effects of exercise on self esteem with the Rosenberg self-esteem scale (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>). We found no statistically significant difference in the meta-analysis: MD 1.69 (95% CI -0.01 to 3.39; 323 women; <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). The heterogeneity of 57% was introduced by <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>. Removal of <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK> in a sensitivity analysis lowered the heterogeneity to 0% with a MD of 0.97 (95% CI -0.28 to 2.21). We rated the result as low-quality evidence due to lack of blinding, low adherence and high or unclear contamination in two studies, and unexplained heterogeneity.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Physical activity behaviour</HEADING>
<P>Meta-analysis of seven studies showed a SMD of 0.29 (95% CI 0.12 to 0.47; 549 women; <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>) (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). Six further studies also examined the effects of exercise on physical activity, but they did not report data that could be used for meta-analysis (<LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Gokal-2013" TYPE="STUDY">Gokal 2013</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). However, three of these studies reported that there were no statistically significant group differences for physical activity (<LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). On the other hand, <LINK REF="STD-Perna-2010" TYPE="STUDY">Perna 2010</LINK> reported that there were significantly higher LTEQ (leisure time exercise questionnaire) scores in the intervention group than in controls.</P>
<P>We rated the result as moderate-quality evidence due to lack of blinding, low adherence and high or unclear contamination, and because many (six of seven) allocation concealment procedures were unclear.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Multidimensional outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Self efficacy</HEADING>
<P>One study reported that confidence to exercise (self efficacy) increased significantly more in the intervention group than in the control group (<LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>). We could not extract data. A second study reported that there were no statistically significant differences between groups for physical self efficacy (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>). Another study reported assessment of self efficacy regarding the performance of physical activity in the design paper, but did not mention the outcome in the publication of study results (<LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Functioning in daily life and return to work</HEADING>
<P>One study reported that there were no statistically significant differences for functioning in daily life for either of the two exercise groups (van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). Functioning in daily life was measured with the Impact on Participation and Autonomy (IPA) instrument. Another study reported assessment of perceived impact of the disease on participation and autonomy assessed with the same instrument (IPA) in the study design paper, but did not mention the outcome in the final publication (<LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>). The first study, van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>), additionally used the study-specific "Return to work questionnaire", and reported that at the end of the intervention a significantly greater number of participants in the exercise groups were working than in the usual-care group, and that at follow-up the intervention groups had significantly higher return-to-work rates than the usual-care group and worked a significantly higher percentage of the pre-illness hours on the job. We could not extract data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Symptom severity and symptom interference</HEADING>
<P>One small study used the Taiwanese version of the MD Anderson Symptom Inventory (MDASI-T) to assess symptom severity and symptom interference with daily life and reached statistically significant results for both outcomes: symptom severity MD -1.49 (95% CI -2.36 to -0.62) and symptom interference MD -1.10 (95% CI -1.89 to -0.31) (<LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). Another study used the Symptom Experience Scale, but did not report results (<LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>). We rated the results as low-quality evidence due to lack of blinding, low adherence and unclear amount contamination, and because the allocation concealment procedure was unclear. The small number of participants (n = 40) further lowered our confidence in the results.</P>
<P>One study reported finding no statistically significant differences between groups for satisfaction with life (<LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>). Another study developed a study-specific functional wellness questionnaire, and did not find a statistically significant difference between groups (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Chemotherapy completion</HEADING>
<P>Two studies assessed chemotherapy completion rates, but different outcome measures did not allow for meta-analysis (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>) reported how many women in each group required a dose adjustment of the chemotherapy and the average dose reduction among these women. Statistically significantly fewer women required a dose adjustment for the high-intensity exercise group compared to the low-intensity exercise and the control groups. There was also a statistically significant difference in the average dose reduction between the two exercise groups and the control group.</P>
<P>Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>) assessed chemotherapy completion rate as the "average relative dose-intensity (RDI) for the originally planned regimen based on standard formulas". The study reported the percentage of women in each group that received at least 85% of their planned RDI, and found no statistically significant differences between groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other side effects relating to adjuvant cancer treatment: neuropathy symptoms, endocrine symptoms, pain, gait and balance, nausea</HEADING>
<P>Neuropathic pain was measured with the neuropathic pain scale in one study (Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>), while another study, <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>, measured neuropathy symptoms with the FACT-Taxane scale in women treated with taxanes. Neither study reached statistically significant results: neuropathic pain (Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>): MD 3.64 (95% CI -1.32 to 8.60; 130 women; <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>) and neuropathy symptoms (<LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>): MD -0.21 (95% CI -0.75 to 0.33; 19 women; <LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>). We rated these results as low-quality evidence due to lack of blinding, unclear allocation concealment procedures, low or unclear adherence, and high or unclear contamination. Group similarity at baseline was unclear or at high risk of bias as well. Imprecision due to a small number of participants and wide confidence intervals further lowered our confidence in the results. <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK> also reported assessment of cold thermal sensation and vibratory sensation in the trial registration, but did not report these outcomes in the results paper.</P>
<P>Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>) measured menopausal symptoms with the Greene Climacteric Scale and found no group differences. No summary score was presented. <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK> assessed endocrine symptoms with the FACT for endocrine symptoms (FACT-ES): MD 1.30 (95% CI -1.49 to 4.09; 174 women; <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>). We rated the result as low-quality evidence due to lack of blinding, low adherence, and unclear contamination. The small number of participants in this one study reporting a summary score further lowered our confidence in the results.</P>
<P>
<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK> reported pain measured with the Worst Pain Intensity Scale and found no statistically significant differences between groups. No data were reported.</P>
<P>Gait and balance was measured with the Timed Get-up-and-Go Test in two studies (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>), and with a step test in one study (<LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>). There was no statistically significant difference between groups in the meta-analysis: SMD 0.10 (95% CI -0.25 to 0.46; 122 women; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>). We rated the result as low-quality evidence due to lack of blinding, low and unclear adherence, and unclear and high contamination. Allocation concealment procedures were unclear in two studies. The small number of participants further lowered our confidence in the result.</P>
<P>Two studies reported nausea as an outcome (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK>). <LINK REF="STD-Winningham-1988" TYPE="STUDY">Winningham 1988</LINK> assessed nausea with the Symptom Checklist-90 (SCL-90) item for nausea, whereas <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK> assessed nausea intensity with a subscale of a symptom checklist of 25 commonly experienced symptoms. We did not consider either of these to be valid methods of assessment and therefore did not report data here.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Harms</HEADING>
<P>Twenty-one studies assessed adverse effects due to exercise (<LINK REF="STD-Battaglini-2004" TYPE="STUDY">Battaglini 2004</LINK>; <LINK REF="STD-Cadmus-2007" TYPE="STUDY">Cadmus 2007</LINK>; <LINK REF="STD-Campbell-2005" TYPE="STUDY">Campbell 2005</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010;</LINK> <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mock-2004" TYPE="STUDY">Mock 2004</LINK>; <LINK REF="STD-Moros-2010" TYPE="STUDY">Moros 2010</LINK>; <LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; Schwartz 2007: <LINK REF="STD-Schwartz-2007-AET" TYPE="STUDY">Schwartz 2007 AET </LINK>and <LINK REF="STD-Schwartz-2007-RET" TYPE="STUDY">Schwartz 2007 RET</LINK>; Segal 2001: <LINK REF="STD-Segal-2001-SD" TYPE="STUDY">Segal 2001 SD</LINK> and <LINK REF="STD-Segal-2001-SU" TYPE="STUDY">Segal 2001 SU</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>; <LINK REF="STD-Yang-2011" TYPE="STUDY">Yang 2011</LINK>). Seven studies observed adverse effects (<LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK>; <LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>; <LINK REF="STD-Drouin-2002" TYPE="STUDY">Drouin 2002</LINK>; <LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>; <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>). Details of these adverse effects can be found in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. In general, adverse effects concerned only a very small number of women.</P>
<P>Seven studies described how relevant information on adverse effects was collected. In two studies this was done by the exercise trainers who supervised the intervention (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>). In one of these studies (<LINK REF="STD-Hornsby-2014" TYPE="STUDY">Hornsby 2014</LINK>), safety of the supervised aerobic exercise intervention was the primary outcome, and all adverse effects during aerobic training were monitored and reported on the participant case report forms. In one study with a telephone group (<LINK REF="STD-Eakin-2012" TYPE="STUDY">Eakin 2012</LINK>), exercise physiologists recorded adverse effects after each call in case management folders; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK> used biweekly telephone calls to monitor adverse effects. The participants in <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK> were told to document adverse effects and accidental falls in a log book. Two studies used standardised questionnaires where participants recorded adverse effects (<LINK REF="STD-Schmidt-2014" TYPE="STUDY">Schmidt 2014</LINK>; <LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>). In one of these two studies (<LINK REF="STD-Steindorf-2014" TYPE="STUDY">Steindorf 2014</LINK>), adverse effects reported spontaneously by the participant or observed by therapists were also recorded. Many of the studies did not describe how relevant information was collected or whether surveillance of adverse effects was passive (spontaneously reported by participants) or active (based on structured questionnaires or interviews).</P>
<SUBSECTION>
<HEADING LEVEL="5">Lymphoedema</HEADING>
<P>Two studies (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>) systematically assessed the incidence of lymphoedema. Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>) reported four objectively measured cases each in both exercise groups (face to face: n = 67 and telephone: n = 67) and six cases in the usual-care group (n = 60). These numbers reported for Hayes 2013 (<LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>) were for all women and not only women who exercised concurrently with their adjuvant treatment. Meta-analysis of the two studies yielding four comparisons showed a risk ratio for lymphoedema of 0.71 (95% CI 0.35 to 1.45; 436 women; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>). <LINK REF="STD-Crowley-2003" TYPE="STUDY">Crowley 2003</LINK> reported lymphoedema as an adverse effect in one woman. <LINK REF="STD-Haines-2010" TYPE="STUDY">Haines 2010</LINK> measured the circumference of upper limb segments and reported that changes in the circumference of upper limb segments favoured the intervention group.</P>
<P>We rated the results as low-quality evidence due to lack of blinding, low adherence and a high or unclear amount of contamination, the allocation concealment procedure was unclear in one of the two studies, and group similarity at baseline was at high risk of bias for one study. Furthermore, the null effect and appreciable harm and benefit were included in the confidence interval for the risk ratio. The two studies in the meta-analysis were not sufficient for the examination of publication bias in the funnel plot as at least 10 studies were considered to be a sufficient number. We did not downgrade for publication bias. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effectiveness and adverse effects during follow-up</HEADING>
<P>Several studies assessed effectiveness of exercise during adjuvant therapy after a follow-up period of several months.</P>
<P>Five studies measured physical fitness 18 weeks, in <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>, to six months after the intervention: SMD 0.26 (95% CI -0.06 to 0.57; 612 women; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). We rated the result as low-quality evidence due to lack of blinding, low adherence, and unclear or high contamination. Additionally, randomisation and allocation concealment procedures were unclear in several studies. Heterogeneity with an I<SUP>2</SUP> of 70% could be only partly explained by introduction of <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>, which was the only study with a follow-up period shorter than six months. Removal of the study in the sensitivity analysis still resulted in an I<SUP>2</SUP> of 40% and a SMD of 0.38 (95% CI 0.121 to 0.63). It remained unclear why a shorter follow-up period would result in a smaller effect for cardiorespiratory fitness. With regard to all of these studies, the large variation in effect and confidence intervals that did not overlap raised concerns about inconsistency, which further lowered our confidence in the result.</P>
<P>Six studies assessed fatigue 18 weeks, in <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>, to six months after the intervention period: SMD -0.21 (95% CI -0.35 to -0.07; 814 women; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). We rated the result as moderate-quality evidence due to lack of blinding, low adherence, and unclear or high contamination. Furthermore, randomisation and allocation concealment procedures were unclear in several studies. A sensitivity analysis including only the five studies with a six-month follow-up period also showed a SMD between intervention and control of -0.21 (95% CI -0.37 to -0.05).</P>
<P>Six studies assessed cancer-specific quality of life 12 weeks, in <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>, to six months after the intervention: SMD 0.18 (95% CI 0.01 to 0.35; 583 women; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>) (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>; <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>). van Waart 2014 (<LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>) only presented data for subscales and no summary score. We rated the result as moderate-quality evidence due to lack of blinding, low adherence and unclear or high contamination, and because risk of attrition bias was high in two of the five studies in the meta-analysis. Furthermore, randomisation and allocation concealment procedures were unclear in two studies. A sensitivity analysis including only the three studies with a six-month follow-up period showed a SMD between intervention and control of 0.25 (95% CI 0.04 to 0.45) (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>).</P>
<P>Two studies assessed depression six months after the intervention period: SMD -0.27 (95% CI -0.48 to -0.06; 378 women; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>) (Courneya 2007: <LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>). We rated the result as moderate-quality evidence due to lack of blinding, low adherence, and unclear contamination.</P>
<P>Three studies assessed strength at six months' follow-up: SMD 0.00 (95% CI -0.30 to 0.30; 386 women; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Travier-2015" TYPE="STUDY">Travier 2015</LINK>; van Waart 2014: <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and <LINK REF="STD-van-Waart-2014-low" TYPE="STUDY">van Waart 2014 low</LINK>). The heterogeneity, with an I<SUP>2</SUP> of 49%, was introduced by the high-intensity group (resistance training) of <LINK REF="STD-van-Waart-2014-high" TYPE="STUDY">van Waart 2014 high</LINK> and was reduced to 0% when this study was removed in a sensitivity analysis (SMD -0.11; 95% CI -0.35 to 0.13); thus heterogeneity could be explained. We rated the result as low-quality evidence due to lack of blinding, low adherence and unclear or high contamination, and because there was a high risk of selection bias in two of three studies. Furthermore, allocation concealment procedures were unclear in two studies. The wide confidence interval introduced uncertainty about the magnitude of the effect, and thus confidence in the result was lowered further.</P>
<P>Three studies assessed physical activity at six months' follow-up: SMD 0.28 (95% CI -0.05 to 0.61; 261 women; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>) (<LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>; <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>). We rated the result as low-quality evidence due to lack of blinding, low adherence, and unclear or high contamination. Additionally, randomisation and allocation concealment procedures were unclear in two of the three studies and there was attrition bias in two studies. Furthermore, imprecision (rather small number of participants and null effect and appreciable benefit included in confidence interval for SMD) further lowered our confidence in the result.</P>
<P>Courneya 2007 (<LINK REF="STD-Courneya-2007-AET" TYPE="STUDY">Courneya 2007 AET</LINK> and <LINK REF="STD-Courneya-2007-RET" TYPE="STUDY">Courneya 2007 RET</LINK>) also reported results for anxiety (MD -3.61; 95% CI -7.24 to 0.03; 201 women; <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>) and self esteem (MD 1.20; 95% CI -0.41 to 2.81; 201 women; <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>) six months after the intervention, and <LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK> reported results for endocrine symptoms (MD 1.30; 95% CI -1.65 to 4.25; 177 women; <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>) and positive affects (MD -0.59; 95% CI -1.63 to 0.45) and negative affects (MD -1.70; 95% CI -3.62 to 0.22). One study also assessed neuropathy symptoms (MD -0.45; 95% CI -0.98 to 0.08; 19 women; <LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>) and gait and balance (MD -0.59; 95% CI -1.63 to 0.45; 19 women; <LINK REF="CMP-002.11" TYPE="ANALYSIS">Analysis 2.11</LINK>) 12 weeks after the end of the intervention (<LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK>). We rated all these results as low-quality evidence due to the small number of women in the single studies, lack of blinding, low adherence, and unclear contamination. All 'Risk of bias' items for <LINK REF="STD-Visovsky-2014" TYPE="STUDY">Visovsky 2014</LINK> were at high or unclear risk of bias.</P>
<P>One study with an intervention period of one year reported no significant differences for any outcome after one year, but did not report data (<LINK REF="STD-Dodd-2010" TYPE="STUDY">Dodd 2010</LINK>).</P>
<P>One study reported long-term follow-up data for 18 months and five years in an additional paper from 2012 (<LINK REF="STD-Mutrie-2007" TYPE="STUDY">Mutrie 2007</LINK>), which was the longest follow-up period of the included studies. For both follow-up periods, less than 70% of the original participants were included in the analysis, therefore we did not present data here.</P>
<SUBSECTION>
<HEADING LEVEL="5">Lymphoedema</HEADING>
<P>One study reported lymphoedema incidence eight weeks after the intervention (Hayes 2013: <LINK REF="STD-Hayes-2013-FtF" TYPE="STUDY">Hayes 2013 FtF</LINK> and <LINK REF="STD-Hayes-2013-Tel" TYPE="STUDY">Hayes 2013 Tel</LINK>). The numbers reported were for all women and not only women who exercised concurrently with their adjuvant treatment (risk ratio 0.79; 95% CI 0.37 to 1.69; 194 women; <LINK REF="CMP-002.12" TYPE="ANALYSIS">Analysis 2.12</LINK>). Otherwise, harms or adverse effects were not reported after a follow-up period.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-09-16 11:10:29 +1000" MODIFIED_BY="Melina L Willson">
<SUMMARY_OF_RESULTS MODIFIED="2016-09-16 11:10:29 +1000" MODIFIED_BY="Melina L Willson">
<P>Exercise during adjuvant treatment for breast cancer improves physical fitness and probably slightly reduces fatigue. It likely leads to little or no difference in depression and cancer-specific quality of life. Women with breast cancer may benefit from exercise during adjuvant cancer treatment through improved cognitive function and slightly improved cancer site-specific quality of life. Exercise may lead to little or no improvement in health-related quality of life and may lower the risk of lymphoedema.</P>
<P>Exercise also probably slightly improves muscular strength and leads to a slightly higher amount of physical activity. Women with breast cancer who exercise during adjuvant treatment may experience fewer mood disturbances, and their shoulder mobility might be slightly improved. For other outcomes such as self esteem, exercise may lead to little or no difference. For some of the outcomes not all studies could be included in the meta-analyses, therefore the results do not reflect the body of evidence as a whole. An improvement for several other outcomes is uncertain, mostly due to scarcity or lack of data.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-08-25 14:52:48 +1000" MODIFIED_BY="[Empty name]">
<P>This review is based on studies with a considerable degree of clinical heterogeneity regarding adjuvant cancer treatment and exercise interventions. It remains to be explored whether differences in adjuvant cancer treatment and exercise intervention actually affect results. In spite of our comprehensive attempts to identify all relevant studies, we retrieved predominantly English language studies for inclusion in this review. This may reflect selective publication of English language studies with statistically significant findings. In addition, most of the included studies were primarily conducted among white women in high-income countries, which makes generalisation of the results to different ethnic groups and countries questionable.</P>
<SUBSECTION>
<HEADING LEVEL="5">Type of intervention</HEADING>
<P>Exercise interventions varied widely regarding implementation of aerobic or resistance exercise or a combination of both, supervised or home-based, frequency, duration, and intensity. Furthermore, the reporting of the exercise intervention differed, and details were not always available.</P>
<P>As exercise as such can be seen as a complex intervention, the evaluation of exercise interventions is prone to the diverse challenges associated with evaluating complex interventions.</P>
<P>Key features of complex interventions (according to <LINK REF="REF-Craig-2008" TYPE="REFERENCE">Craig 2008</LINK>: the Medical Research Council guidance on complex interventions) applicable to exercise are the:</P>
<UL>
<LI>number of interacting components, e.g. exercise in a group versus alone; aerobic or resistance exercise; or the empathy of an exercise instructor;</LI>
<LI>number and difficulty of behaviours required by those delivering or receiving the intervention, e.g. adherence to the prescribed intensity of exercise or challenging participants to exercise at a higher heart rate;</LI>
<LI>number and variability of outcomes, e.g. fatigue, depression, anxiety with a range of scales to assess;</LI>
<LI>degree of flexibility or tailoring of the intervention permitted (non-standardisation/reproducibility), e.g. tailoring the exercise intervention according to the motivation level of the group or to the current physical condition of the woman with breast cancer.</LI>
</UL>
<P>The aim of this review was to answer quite a broad review question, namely to assess the effect of exercise per se on several patient-relevant outcomes for women undergoing adjuvant treatment for breast cancer, which is why we included exercise interventions delivered at diverse levels and with a variety of components. Based on this evidence, further steps could be taken to identify and differentiate all the interacting components of exercise interventions.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Type of control</HEADING>
<P>Most studies reported usual care as the control intervention, but they often did not describe this in detail. As studies were conducted in different settings, home-based or at the treatment clinic, and with different types of adjuvant treatment, variation in usual care in the included studies should be taken into account. Some studies offered control interventions in order to establish similar circumstances with regards to time and attention and, if applicable, group interaction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Type of adjuvant treatment</HEADING>
<P>Women were treated in some studies with radiation treatment only, chemotherapy only, or a combination of the two, resulting in large variation in the duration and frequency of adjuvant treatment as well as differences in possible side effects. We included studies with the latest treatment protocols as well as studies from the 1980s onward, meaning that not only treatment protocols but also drugs to treat side effects were used in many different ways in the included studies. Details on treatment protocols were provided in some, but not all studies, whereas drug treatment of side effects was most often not described.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Timing of outcome assessment and follow-up</HEADING>
<P>As it has been shown that, for example psychological distress of women, diminishes with time after diagnosis, timing of measuring outcomes can make a difference in the magnitude and direction of the effect of the intervention. The same may apply to other outcomes assessed in our review. Timing of outcome assessments was very heterogeneous in the included studies, which should be kept in mind when comparing different studies and interpreting results. Follow-up ranged from no follow-up to five years in one study. Analyses were only possible for a few studies with a maximum follow-up period of six months, as either data reporting was poor or attrition rates were too high for studies with longer follow-up periods. Apart from lymphoedema, which was reported after a short follow-up period in one study, harms or adverse effects were not reported after a follow-up period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Reporting of outcome measures </HEADING>
<P>A wide range of outcome measures was assessed across the studies, making it difficult to combine outcomes in meta-analysis. Moreover, data reporting was often poor and did not provide estimates of effect size that could be pooled. Assessment and reporting of harms-related data from exercise intervention studies during adjuvant cancer treatment also needs improvement. Future studies should apply so-called core outcome sets to facilitate comparison and meta-analysis (<LINK REF="REF-Gargon-2014" TYPE="REFERENCE">Gargon 2014</LINK>).</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-08-25 15:04:59 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Quality of studies</HEADING>
<P>Due to the nature of exercise as an intervention, blinding of participants and exercise supervisors is not possible. The precise effect of the absence of blinding on the magnitude and direction of the treatment effect is unclear, but constitutes a high risk for performance bias. Furthermore, many outcomes were self reported, which leads to a high inherent risk of detection bias, when blinding of participants is not possible. We decided not to downgrade studies for those 'Risk of bias' items alone. However, reasons for assigning studies a high risk of bias was never due only to lack of blinding, contamination, and/or non-adherence, because other factors such as unclear allocation procedures or high attrition rates were present as well, leading to downgrading of the evidence one level for risk of bias. We included only randomised controlled studies in this version of the review, but 11 studies reported insufficient details on random sequence generation, and 23 provided insufficient details on allocation concealment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Statistical power </HEADING>
<P>Benefits of exercise interventions may be relatively small. Subsequently, the number of included participants should be great enough to allow for the detection of small differences between groups. The sample sizes in the included studies ranged from 5 to 91 in the intervention group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Initial fitness level</HEADING>
<P>The individual's level of fitness is an important factor to consider before determining the level of exercise intensity (<LINK REF="REF-ACSM-2000" TYPE="REFERENCE">ACSM 2000</LINK>). According to the American College of Sports Medicine (<LINK REF="REF-ACSM-2000" TYPE="REFERENCE">ACSM 2000</LINK>), deconditioned individuals may demonstrate increases in their cardiorespiratory fitness with exercise intensities at the lower end of the intensity continuum, whereas more fit individuals need to work at the higher end of the intensity continuum to improve fitness. A small number of studies limited participation to sedentary women; however, definitions of sedentary varied.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adherence and contamination </HEADING>
<P>For sedentary individuals, a change in personal health behaviour is required in order to take up regular exercise. Thus, any exercise intervention can additionally be evaluated according to the degree of behavioural change achieved in the intervention group; a lack of adherence can compromise the training stimulus as well as the sustainability of exercise behaviour. According to the American College of Sports Medicine (<LINK REF="REF-ACSM-2000" TYPE="REFERENCE">ACSM 2000</LINK>), the art of exercise prescription is the "successful integration of exercise science with behavioral techniques that result in long-term program compliance". Some studies applied theory-based methods focused on changing behaviour. Adherence problems do not only arise in terms of participation in exercise sessions and frequency of sessions, but also in terms of the training intensity and duration actually achieved during each exercise session. Insufficient exercise intensity or duration may compromise the training stimulus as a whole. However, these two facets of the training stimulus were poorly evaluated and reported in many of the included studies.</P>
<P>Besides adherence, the extent to which the control group performs exercise (contamination) is a second critical component in exercise studies. Exercise contamination is rarely reported and often only when the exercise programme is home-based. Furthermore, reports of adherence and contamination most often rely on self report by participants, which can lead to over-reporting of adherence but also contamination.</P>
</SUBSECTION>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-08-25 15:09:48 +1000" MODIFIED_BY="[Empty name]">
<P>Despite a well-established methodology for conducting systematic reviews, subjective judgement is inevitable throughout the process. The main limitation of this review was the lack of sufficient information or data in many studies to make a clear judgement in various bias domains. Other limitations were the heterogeneity in the intervention delivered, adjuvant treatment, timing of outcome measurement, and the assessment and reporting of outcome measures with a wide range of outcome measures.</P>
<P>We did not systematically evaluate assessment instruments with regards to their strengths and weaknesses. However, we noted that for the outcome physical activity, the reported activity levels of women with breast cancer were surprisingly high in some studies. Three of seven studies in the meta-analysis for physical activity used the International Physical Activity Questionnaire (IPAQ) (<LINK REF="STD-Caldwell-2009" TYPE="STUDY">Caldwell 2009</LINK>; <LINK REF="STD-Cornette-2013" TYPE="STUDY">Cornette 2013</LINK>; <LINK REF="STD-Husebo-2014" TYPE="STUDY">Husebo 2014</LINK>), which has been reported to lead to over-reporting of physical activity (<LINK REF="REF-Lee-2011" TYPE="REFERENCE">Lee 2011</LINK>).</P>
<P>Mostly due to limited resources, we did not systematically assess the training stimulus in this version of the review as well as the baseline activity and fitness levels of participants and the application of behaviour change theories in the studies.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-08-28 12:40:37 +1000" MODIFIED_BY="[Empty name]">
<P>Another Cochrane systematic review assessed the effect of exercise during adjuvant therapy for cancer on quality of life (<LINK REF="REF-Mishra-2012" TYPE="REFERENCE">Mishra 2012</LINK>), and another on fatigue (<LINK REF="REF-Cramp-2012" TYPE="REFERENCE">Cramp 2012</LINK>). Both reviews included adults with different cancer diagnoses, not only breast cancer. <LINK REF="REF-Cramp-2012" TYPE="REFERENCE">Cramp 2012</LINK> also included studies evaluating the effect of exercise after adjuvant therapy, and <LINK REF="REF-Mishra-2012" TYPE="REFERENCE">Mishra 2012</LINK> included 10 studies with participants both during and after adjuvant therapy. Both reviews identified benefits on fatigue for participants with breast cancer, which is in agreement with the results of our review. <LINK REF="REF-Mishra-2012" TYPE="REFERENCE">Mishra 2012</LINK> reported that exercise interventions resulted in improvements in overall quality of life for all participants, but found no statistically significant difference for women with breast cancer. We did not perform a meta-analysis for overall quality of life because only one study presented a summary measure, whereas the others only reported data for subscales. The single studies reporting that outcome did not result in a significant difference between groups.</P>
<P>
<LINK REF="REF-Meneses_x002d_Echavez-2015" TYPE="REFERENCE">Meneses-Echavez 2015</LINK> reviewed the effect of supervised exercise during or after adjuvant therapy for breast cancer on cancer-related fatigue, and found benefits as well.</P>
<P>
<LINK REF="REF-Bourke-2014" TYPE="REFERENCE">Bourke 2014</LINK> published another Cochrane systematic review with the main goal of assessing the effects of interventions to promote exercise behaviour in sedentary people living with and beyond cancer. Eleven of 14 studies were conducted in women with breast cancer, but mostly in women who had finished adjuvant treatment. Interventions resulted in improvements in aerobic exercise tolerance at 8 to 12 weeks in intervention participants compared with controls. Aerobic exercise tolerance was also improved at six months. These findings are in agreement with our review, but participants differed with regard to cancer diagnosis and treatment status.</P>
<P>One systematic review assessed depression and anxiety in addition to fatigue and cancer-specific quality of life in women with breast cancer undergoing adjuvant therapy (<LINK REF="REF-Carayol-2013" TYPE="REFERENCE">Carayol 2013</LINK>). The authors reported that the exercise intervention led to statistically significant improvements for fatigue, cancer-specific quality of life, and depression, while the decrease in anxiety was "borderline significant". Our results for both cancer-specific quality of life and depression were close to showing a statistically significant difference between groups, favouring exercise, with a lower respectively upper limit of the confidence interval of 0.00 and 0.01. In three of the 17 included studies in the review by <LINK REF="REF-Carayol-2013" TYPE="REFERENCE">Carayol 2013</LINK>, the intervention was yoga, which we excluded, regarding it as a complex intervention. For depression and anxiety, the authors pooled data from the Hamilton Anxiety and Depression Score with data from the Beck Depression Inventory and Center for Epidemiological Studies-Depression scale, which we did not. Keeping in mind the similar but not identical inclusion criteria, the findings of this review are thus mostly in line with our review.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-09-09 20:37:14 +1000" MODIFIED_BY="Anna C Furmaniak">
<IMPLICATIONS_PRACTICE MODIFIED="2016-08-25 15:43:41 +1000" MODIFIED_BY="[Empty name]">
<P>Exercising while receiving adjuvant treatment for breast cancer is a feasible, supportive self care intervention. Based on current evidence, exercise probably slightly reduces fatigue and improves physical fitness. It likely leads to little or no difference in depression and cancer-specific quality of life. Women with breast cancer may benefit from exercise during adjuvant cancer treatment through improved cognitive function and slightly improved cancer site-specific quality of life. Exercise may lead to little or no improvement in health-related quality of life. Muscular strength and physical activity are probably improved by exercising. Several further outcomes such as shoulder mobility showed slight improvements, and several such as self esteem showed little or no difference, but the quality of the evidence was low.</P>
<P>Exercise adherence during cancer treatment constitutes a challenge, and thus attempts to foster exercise participation might enhance effectiveness. For behaviour changes to occur (the adoption of regular exercise in this instance), it is essential that intervention programmes focus on underlying principles from theories about why people change their behaviours. The social cognitive theory appears to be a promising theoretical framework for promoting exercise behaviour in women with breast cancer (<LINK REF="REF-Pinto-2002" TYPE="REFERENCE">Pinto 2002</LINK>; <LINK REF="REF-Rogers-2004" TYPE="REFERENCE">Rogers 2004</LINK>; <LINK REF="REF-Rogers-2005" TYPE="REFERENCE">Rogers 2005</LINK>). The key construct in the social cognitive theory is self efficacy. Exercise self efficacy can be described either as the confidence to overcome barriers to exercise or as confidence in the ability to perform certain exercise tasks. Self efficacy has proven to be an important correlate of exercise among women with breast cancer. Exercise self efficacy among women with breast cancer during cancer treatment is reported to be lowest when women are nauseated, tired, not interested, lacking time, and lacking exercise enjoyment (<LINK REF="REF-Rogers-2006" TYPE="REFERENCE">Rogers 2006</LINK>).</P>
<P>Future exercise interventions should target the exercise barriers. Exercise enjoyment, for example, may be addressed through picking up recent trends in the field of fitness, such as Pilates, Nordic walking, Tai Chi, step aerobics, and dancing, of course adequately adjusted to the needs and limitations of the target group. Group exercise or partner-assisted exercises may also increase exercise enjoyment. Time management may be addressed by exercise classes taking place in different locations, choosing venues that are accessible by public transport, and by scheduling classes at various times in the day and evening.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-09-09 20:37:14 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>At this stage there is still a lack of evidence for several relevant potential benefits of exercise as well as for harms. The increasing number of studies assessing the benefits and harms of exercise during adjuvant therapy is promising, but while study quality and reporting of studies have certainly improved since the first studies assessing this question, the quality of the evidence is still low for many outcomes. This is due in part to the difficulty of blinding participants and supervising personnel in studies with exercise as an intervention. For other factors that diminish the quality of evidence, such as lack of outcome assessor blinding, or the reporting of methodology and data, an improvement is feasible.</P>
<P>As described above, the actual training stimulus may substantially deviate from the assigned exercise regimen. In efficacy trials investigators need to ensure adherence to the intervention to determine whether exercise interventions in this population work. Exercise programmes should be designed to address exercise facilitators such as exercise enjoyment; this may be achieved by offering a variety of alternating exercise modes that assure an adequate training stimulus. Inclusion of sedentary participants only may be a way to deal with contamination issues, utilising the observation that physical activity and exercise decline during cancer treatment (<LINK REF="REF-Irwin-2003" TYPE="REFERENCE">Irwin 2003</LINK>). While efforts can and should be made to maximise adherence and to minimise contamination, imperfect adherence and an amount of contamination is even to be expected in efficacy studies, lowering the confidence in the results. In effectiveness trials, we recommend that both adherence and contamination are reported as an outcome measure because poor adherence can render an efficacious intervention ineffective. To date, effectiveness trials are rare, but would be of additional value for this field of research.</P>
<P>Consensus of researchers on outcome measures for exercise studies involving women with breast cancer receiving adjuvant treatment is needed in order to facilitate interpretation and comparison of results across various interventions. The long-term follow-up of exercise interventions also requires attention because some side effects of adjuvant cancer treatment are long term, such as fatigue or deconditioning, and the effects of exercise themselves might have a long-term component. Besides health-related outcome measures, adherence and contamination as well as potential harms should be assessed and reported systematically. Reporting standards for harms should help to inform practitioners and the public on potential harms of exercise interventions during adjuvant cancer treatment (<LINK REF="REF-Ioannidis-2004" TYPE="REFERENCE">Ioannidis 2004</LINK>).</P>
<P>Regarding recruitment difficulties and thus the problem of small sample sizes, multisite trials are advisable.</P>
<P>The seven ongoing studies and the two studies awaiting assessment identified during our search also have small sample sizes and assess a wide variety of outcomes with different outcome measures. The majority include interventions with aerobic exercise of moderate intensity and compare exercise to usual care, apart from one study awaiting assessment in which yoga is the control intervention (<LINK REF="STD-Lotzke-2016" TYPE="STUDY">Lotzke 2016</LINK>). One study is notable for its rather long intervention period of 12 months, a large estimated number of enrolment of 600 participants, and a planned follow-up of 10 years, including relapse of breast cancer disease, breast cancer-specific mortality, and overall mortality as secondary outcomes (<LINK REF="STD-NCT02240836" TYPE="STUDY">NCT02240836</LINK>).</P>
<P>Once the effectiveness of exercise - even in widely varying frequency and intensity - for women with breast cancer during adjuvant therapy for different outcomes has been established, the next step is to assess which frequency, intensity, and type of exercise (aerobic, resistance, combination) is most effective for which outcome. There are ongoing and published studies comparing different dose regimens to each other, but which we could not include in our review because they had no usual care or non-exercising control group. The number of studies comparing exercise to not exercising is still much higher, and there are even still feasibility studies underway or currently being published, although feasibility of exercise studies has certainly been proven. The comparison of different dosages of exercise for different outcomes might be a question for several reviews of their own.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-08-25 16:25:57 +1000" MODIFIED_BY="[Empty name]">
<P>We would like to thank Melina Wilson, who rendered assistance in her role as Managing Editor of the Cochrane Breast Cancer Group and the Editorial Base of the Cochrane Breast Cancer Group. Moreover, we would like to thank the referees who provided valuable feedback during the peer review process and the authors of primary trials for additional information about their trials. Anke Schulz rendered support in statistics for this update version of the review. Juyoung Byun from the Korean Branch of the Australasian Cochrane Centre assisted with one Korean language publication. We also thank Karl-Ludwig Resch for obtaining several dissertations and for help with data extraction and 'Risk of bias' assessment of one trial.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-08-25 16:28:12 +1000" MODIFIED_BY="[Empty name]">
<P>ACF, MM, MHM: None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-08-25 16:27:46 +1000" MODIFIED_BY="[Empty name]">
<P>ACF: handsearching and screening search results, study selection, data extraction, contacted experts for unpublished trials and trial investigators for additional data, methodological assessments, quantitative and qualitative synthesis of included studies, reporting.</P>
<P>MM: screening search results, study selection, methodological assessments, contributed to consensus finding when disagreement in study selection, data extraction or methodological assessments persisted between the other two review authors (ACF, MHM), quantitative and qualitative synthesis of included studies, manuscript review.</P>
<P>MHM: handsearching and screening search results, study selection, data extraction, methodological assessments, contributed to consensus finding when disagreement in study selection or methodological assessments persisted between the other two review authors (ACF, MM), quantitative and qualitative synthesis of included studies, reporting.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-09-16 12:59:15 +1000" MODIFIED_BY="Melina L Willson">
<P>We included only randomised controlled trials in this updated version of the review, as opposed to the original version of the review, in which we also included controlled trials without a randomisation procedure. This was due to the increasing number of randomised trials.</P>
<P>We excluded hormonal therapy only as adjuvant therapy in this version of the review as we did not consider the side effects of hormonal therapy comparable in their severity to chemo- or radiotherapy or both. We did not include biological outcomes like immune function measured with T-cells in this version of the review, as the focus of the review is on directly participant-relevant outcomes. The same applied to morphological outcomes (changes in body weight or body composition).</P>
<P>We classified outcomes into primary and secondary outcomes in this version of the review.</P>
<P>We did not include data for outcomes assessed with subscales of questionnaires (for example physical functioning subscale of the SF-36 or vitality subscale of the SF-36, nausea item of the SCL-90) in this version of the review.</P>
<P>We also assessed the quality of evidence for the main outcomes using the GRADE methodology and developed a 'Summary of findings' table. This ensures that the review complies with new Cochrane methodological standards.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-09-22 00:14:53 +0100" MODIFIED_BY="Melina Willson">
<STUDIES MODIFIED="2016-09-16 11:48:57 +1000" MODIFIED_BY="Melina L Willson">
<INCLUDED_STUDIES MODIFIED="2016-09-16 11:48:57 +1000" MODIFIED_BY="Melina L Willson">
<STUDY DATA_SOURCE="PUB" ID="STD-Battaglini-2004" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Battaglini 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Battaglini C, Bottaro M, Dennehy C, Barfoot D, Shields E, Kirk D, et al</AU>
<TI>The effects of resistance training on muscular strength and fatigue levels in breast cancer patients</TI>
<SO>Brazilian Journal of Sports Medicine</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>3</NO>
<PG>139e-44e</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243794"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-29 02:20:24 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>Battaglini CL, Bottaro M, Dennehy C, Rae L, Shields E, Kirk D, et al</AU>
<TI>The effects of an individualized exercise intervention on body composition in breast cancer patients undergoing treatment</TI>
<SO>São Paulo Medical Journal</SO>
<YR>2007</YR>
<VL>125</VL>
<NO>1</NO>
<PG>22-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243795"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Battaglini CL, Mihalik JP, Bottaro M, Dennehy C, Petschauer MA, Hairston LS, et al</AU>
<TI>Effect of exercise on the caloric intake of breast cancer patients undergoing treatment</TI>
<SO>Brazilian Journal of Medical &amp; Biological Research</SO>
<YR>2008</YR>
<VL>41</VL>
<NO>8</NO>
<PG>709-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243796"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-29 03:27:02 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="BOOK">
<AU>Battaglini CL</AU>
<SO>A randomized study on the effects of a prescribed exercise intervention on lean mass and fatigue changes in breast cancer patients during treatment [PhD thesis]</SO>
<YR>2004</YR>
<PG>197</PG>
<PB>University of Northern Colorado</PB>
<CY>Greeley, USA.</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243797"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243793"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cadmus-2007" MODIFIED="2016-09-11 03:09:37 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Cadmus 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-11-29 02:20:42 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>Cadmus LA, Chung G, Yu H, Salovey P, Irwin ML</AU>
<TI>Feasibility of institutional registry-based recruitment for enrolling newly diagnosed breast cancer patients in an exercise trial</TI>
<SO>Journal of Physical Activity &amp; Health</SO>
<YR>2011</YR>
<VL>8</VL>
<NO>7</NO>
<PG>955-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243799"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cadmus LA, Salovey P, Yu H, Chung G, Kasl S, Irwin ML</AU>
<TI>Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials</TI>
<SO>Psycho-Oncology</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>4</NO>
<PG>343-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243800"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-11 03:09:37 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="BOOK">
<AU>Cadmus LA</AU>
<SO>Exercise and quality of life during and after treatment for breast cancer [PhD thesis]</SO>
<YR>2007</YR>
<PB>Yale University</PB>
<CY>New Haven, USA</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243801"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243798"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caldwell-2009" MODIFIED="2016-09-11 03:10:25 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Caldwell 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-09-11 03:10:25 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="BOOK">
<AU>Caldwell MG</AU>
<SO>The effects of an endurance exercise regimen on cancer-related fatigue and physical performance in women with breast cancer [PhD thesis]</SO>
<YR>2009</YR>
<PB>Louisiana State University</PB>
<CY>Louisiana, USA</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243803"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243802"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Campbell-2005" MODIFIED="2016-01-09 22:57:54 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Campbell 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campbell A, Mutrie N, White F, McGuire F, Kearney N</AU>
<TI>A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment</TI>
<SO>European Journal of Oncology Nursing</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>1</NO>
<PG>56-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243805"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243804"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cornette-2013" MODIFIED="2016-08-28 05:59:07 +1000" MODIFIED_BY="[Empty name]" NAME="Cornette 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-25 19:38:24 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cornette T, Vincent F, Antonini MT, Leobon S, Lavau-Denes S, Tubiana N</AU>
<TI>Adapted physical activity effect on aerobic function and fatigue in patients with breast cancer treated in adjuvant or neoadjuvant phase (SAPA)</TI>
<SO>European Journal of Cancer</SO>
<YR>2013</YR>
<VL>49</VL>
<PG>S434</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243807"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-29 02:27:00 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>Cornette T, Vincent F, Mandigout S, Antonini MT, Leobon S, Labrunie A, et al</AU>
<TI>Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (sapa)</TI>
<SO>European Journal of Physical and Rehabilitation Medicine</SO>
<YR>2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243808"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 05:59:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="BOOK">
<AU>Cornette T</AU>
<SO>Effets de l&#8217;activité physique adaptée sur la fonction aérobie et la fatigue chez des patientes atteintes d&#8217;un cancer du sein en situation adjuvante et néo-adjuvante [Adapted physical activity effect on aerobic function and fatigue in patients with breast cancer treated in adjuvant or neoadjuvant phase] [PhD thesis]</SO>
<YR>2013</YR>
<PB>University of Limoges</PB>
<CY>Limoges, France</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243809"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243806"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Courneya-2007-AET" MODIFIED="2016-08-28 06:01:32 +1000" MODIFIED_BY="[Empty name]" NAME="Courneya 2007 AET" YEAR="2007">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Friedenreich CM, Reid RD, Gelmon K, Mackey JR, Ladha AB, et al</AU>
<TI>Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy</TI>
<SO>Breast Cancer Research &amp; Treatment</SO>
<YR>2009</YR>
<VL>114</VL>
<NO>1</NO>
<PG>179-87</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243811"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al</AU>
<TI>Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial</TI>
<SO>Cancer</SO>
<YR>2008</YR>
<VL>112</VL>
<NO>8</NO>
<PG>1845-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243812"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, McKenzie DC, Reid RD, Mackey JR, Gelmon K, Friedenreich CM, et al</AU>
<TI>Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2008</YR>
<VL>35</VL>
<NO>1</NO>
<PG>116-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243813"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-10 11:48:21 +1000" MODIFIED_BY="Melina L Willson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Reid RD, Friedenreich CM, Gelmon K, Proulx C, Vallance JK, et al</AU>
<TI>Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial</TI>
<SO>International Journal of Behavioral Nutrition and Physical Activity</SO>
<YR>2008</YR>
<VL>5</VL>
<NO>52</NO>
<PG>9 pages</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243814"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Gelmon K, Reid RD, Mackey JR, Friedenreich CM, et al</AU>
<TI>Predictors of supervised exercise adherence during breast cancer chemotherapy</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2008</YR>
<VL>40</VL>
<NO>6</NO>
<PG>1180-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243815"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Gelmon K, Reid RD, Mackey JR, Friedenreich CM, et al</AU>
<TI>Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapy</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>12</NO>
<PG>2572-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243816"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al</AU>
<TI>Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>28</NO>
<PG>4396-404</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243817"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:01:32 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dolan LB, Gelmon K, Courneya KS, MacKey JR, Segal RJ, Lane K, et al</AU>
<TI>Hemoglobin and aerobic fitness changes with supervised exercise training in breast cancer patients receiving chemotherapy</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>11</NO>
<PG>2826-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243818"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243810"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Courneya-2007-RET" MODIFIED="2016-08-28 06:03:44 +1000" MODIFIED_BY="[Empty name]" NAME="Courneya 2007 RET" YEAR="2007">
<REFERENCE MODIFIED="2014-06-05 06:38:08 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Friedenreich CM, Reid RD, Gelmon K, Mackey JR, Ladha AB, et al</AU>
<TI>Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy</TI>
<SO>Breast Cancer Research &amp; Treatment</SO>
<YR>2009</YR>
<VL>114</VL>
<NO>1</NO>
<PG>179-87</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243821"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-05 06:38:08 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al</AU>
<TI>Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial</TI>
<SO>Cancer</SO>
<YR>2008</YR>
<VL>112</VL>
<NO>8</NO>
<PG>1845-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243822"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-05 06:38:08 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, McKenzie DC, Reid RD, Mackey JR, Gelmon K, Friedenreich CM, et al</AU>
<TI>Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2008</YR>
<VL>35</VL>
<NO>1</NO>
<PG>116-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243823"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-05 06:38:08 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Reid RD, Friedenreich CM, Gelmon K, Proulx C, Vallance JK, et al</AU>
<TI>Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial</TI>
<SO>International Journal of Behavioral Nutrition and Physical Activity</SO>
<YR>2008</YR>
<VL>5</VL>
<PG>52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243824"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-05 06:38:08 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Gelmon K, Reid RD, Mackey JR, Friedenreich CM, et al</AU>
<TI>Predictors of supervised exercise adherence during breast cancer chemotherapy</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2008</YR>
<VL>40</VL>
<NO>6</NO>
<PG>1180-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243825"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-05 06:38:08 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Gelmon K, Reid RD, Mackey JR, Friedenreich CM, et al</AU>
<TI>Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapy</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>12</NO>
<PG>2572-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243826"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-27 00:41:11 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al</AU>
<TI>Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>28</NO>
<PG>4396-404</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243820"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:03:44 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dolan LB, Gelmon K, Courneya KS, MacKey JR, Segal RJ, Lane K, et al</AU>
<TI>Hemoglobin and aerobic fitness changes with supervised exercise training in breast cancer patients receiving chemotherapy</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>11</NO>
<PG>2826-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243827"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243819"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crowley-2003" MODIFIED="2015-11-29 03:34:22 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Crowley 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-11-29 03:34:22 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="BOOK">
<AU>Crowley SA</AU>
<SO>The effect of a structured exercise program on fatigue, strength, endurance, physical self-efficacy, and functional wellness in women with early stage breast cancer [PhD thesis]</SO>
<YR>2003</YR>
<PG>127</PG>
<PB>University of Michigan</PB>
<CY>Ann Arbor, USA</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243829"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243828"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dodd-2010" MODIFIED="2016-08-28 06:16:21 +1000" MODIFIED_BY="[Empty name]" NAME="Dodd 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chou FY, Dodd MJ, Paul SM</AU>
<TI>Timing and sustainability of an exercise intervention in women with breast cancer during and after cancer treatment</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2012</YR>
<VL>39</VL>
<NO>1</NO>
<PG>91-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243831"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>DeNysschen CA, Brown JK, Cho MH, Dodd MJ</AU>
<TI>Nutritional symptom and body composition outcomes of aerobic exercise in women with breast cancer</TI>
<SO>Clinical Nursing Research</SO>
<YR>2011</YR>
<VL>20</VL>
<NO>1</NO>
<PG>29-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243832"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dodd MJ, Cho MH, Cooper BA, Miaskowski C</AU>
<TI>The effect of symptom clusters on functional status and quality of life in women with breast cancer</TI>
<SO>European Journal of Oncology Nursing</SO>
<YR>2010</YR>
<VL>14</VL>
<PG>101-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243834"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:04:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dodd MJ, Cho MH, Miaskowski C, Painter PL, Paul SM, Cooper BA, et al</AU>
<TI>A randomized controlled trial of home-based exercise for cancer-related fatigue in women during and after chemotherapy with or without radiation therapy</TI>
<SO>Cancer Nursing</SO>
<YR>2010</YR>
<VL>33</VL>
<NO>4</NO>
<PG>245-57</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243833"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee J, Dodd MJ, Dibble SL, Abrams DI</AU>
<TI>Nausea at the end of adjuvant cancer treatment in relation to exercise during treatment in patients with breast cancer</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2008</YR>
<VL>35</VL>
<NO>5</NO>
<PG>830-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243835"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:16:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu HS, Dodd MJ, Cho MH</AU>
<TI>Patterns of fatigue and effect of exercise in patients receiving chemotherapy for breast cancer</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2008</YR>
<VL>35</VL>
<NO>5</NO>
<PG>E90-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243836"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243830"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drouin-2002" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Drouin 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drouin JS, Armstrong H, Krause S</AU>
<TI>Effects of aerobic exercise training on peak aerobic capacity, fatigue, and psychological factors during radiation for breast cancer</TI>
<SO>Rehabilitation Oncology</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>1</NO>
<PG>11-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243838"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-29 02:15:05 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drouin JS, Birk TJ, Wirth JC</AU>
<TI>Random control clinical trial on effects of aerobic exercise training on weight management during radiation treatment for breast cancer</TI>
<SO>Rehabilitation Oncology</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>3</NO>
<PG>6-10</PG>
<IDENTIFIERS MODIFIED="2015-01-03 02:41:55 +1100" MODIFIED_BY="Anna C Furmaniak"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243839"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drouin JS, Young TJ, Beeler J, Byrne K, Birk TJ, Hryniuk WM, et al</AU>
<TI>Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer</TI>
<SO>Cancer</SO>
<YR>2006</YR>
<VL>107</VL>
<NO>10</NO>
<PG>2490-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243840"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-29 03:34:51 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="BOOK">
<AU>Drouin JS</AU>
<SO>Aerobic exercise training effects on physical function, fatigue and mood, immune status, and oxidative stress in subjects undergoing radiation treatment for breast cancer [PhD thesis]</SO>
<YR>2002</YR>
<PG>142</PG>
<PB>Wayne State University</PB>
<CY>Detroit, USA</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243841"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243837"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Eakin-2012" MODIFIED="2016-08-28 06:07:18 +1000" MODIFIED_BY="[Empty name]" NAME="Eakin 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-28 06:07:18 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eakin EG, Lawler SP, Winkler EA, Hayes SC</AU>
<TI>A randomized trial of a telephone-delivered exercise intervention for non-urban dwelling women newly diagnosed with breast cancer: exercise for health</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2012</YR>
<VL>43</VL>
<NO>2</NO>
<PG>229-38</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243843"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243842"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gokal-2013" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Gokal 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gokal K, Munir F, Wallis D, Ahmed S, Boiangiu I, Kancherla K</AU>
<TI>Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol</TI>
<SO>BMC Public Health</SO>
<YR>2015</YR>
<VL>15</VL>
<PG>414</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243845"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-08-21 18:06:07 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gokal K, Munir F, Wallis D, Ahmed S, Boiangiu I, Kancherla K</AU>
<TI>Physical activity intervention for cognitive &amp; emotional functioning in breast cancer patients receiving chemotherapy</TI>
<SO>Psycho-Oncology</SO>
<YR>2013</YR>
<VL>22</VL>
<PG>254</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243846"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-12-01 23:35:59 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Gokal K, Wallis D, Ahmed S, Boiangiu I, Kancherla K, Munir F</AU>
<TI>Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243847"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243844"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haines-2010" MODIFIED="2015-11-29 02:10:11 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Haines 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-11-29 02:10:11 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haines TP, Sinnamon P, Wetzig NG, Lehman M, Walpole E, Pratt T, et al</AU>
<TI>Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation</TI>
<SO>Breast Cancer Research and Treatment</SO>
<YR>2010</YR>
<VL>124</VL>
<NO>1</NO>
<PG>163-75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243849"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243848"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hayes-2013-FtF" MODIFIED="2016-08-28 06:08:56 +1000" MODIFIED_BY="[Empty name]" NAME="Hayes 2013 FtF" YEAR="2011">
<REFERENCE MODIFIED="2016-08-28 06:08:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hayes S, Rye S, Battistutta D, Yates P, Pyke C, Bashford J, et al</AU>
<TI>Design and implementation of the Exercise for Health trial - a pragmatic exercise intervention for women with breast cancer</TI>
<SO>Contemporary Clinical Trials</SO>
<YR>2011</YR>
<VL>32</VL>
<NO>4</NO>
<PG>577-85</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243851"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-22 13:30:55 +1100" MODIFIED_BY="Melina L Willson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hayes SC, Rye S, DiSipio T, Yates P, Bashford J, Pyke C</AU>
<TI>Exercise for health: A randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer</TI>
<SO>Breast Cancer Research and Treatment</SO>
<YR>2013</YR>
<VL>137</VL>
<NO>1</NO>
<PG>175-86</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243852"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243850"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hayes-2013-Tel" MODIFIED="2016-08-28 06:09:30 +1000" MODIFIED_BY="[Empty name]" NAME="Hayes 2013 Tel" YEAR="2011">
<REFERENCE MODIFIED="2016-08-28 06:09:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hayes S, Rye S, Battistutta D, Yates P, Pyke C, Bashford J, et al</AU>
<TI>Design and implementation of the Exercise for Health trial - a pragmatic exercise intervention for women with breast cancer</TI>
<SO>Contemporary Clinical Trials</SO>
<YR>2011</YR>
<VL>32</VL>
<NO>4</NO>
<PG>577-85</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243854"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-22 13:31:13 +1100" MODIFIED_BY="Melina L Willson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hayes SC, Rye S, DiSipio T, Yates P, Bashford J, Pyke C</AU>
<TI>Exercise for health: A randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer</TI>
<SO>Breast Cancer Research and Treatment</SO>
<YR>2013</YR>
<VL>137</VL>
<NO>1</NO>
<PG>175-86</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243855"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243853"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hornsby-2014" MODIFIED="2014-05-25 20:05:37 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Hornsby 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-05-25 19:38:24 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornsby WE, Douglas PS, West MJ, Kenjale AA, Lane AR, Schwitzer ER, et al</AU>
<TI>Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial</TI>
<SO>Acta Oncologica</SO>
<YR>2014</YR>
<VL>53</VL>
<NO>1</NO>
<PG>65-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243857"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243856"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Husebo-2014" MODIFIED="2016-08-10 11:46:34 +1000" MODIFIED_BY="Melina L Willson" NAME="Husebo 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-08-10 11:46:34 +1000" MODIFIED_BY="Melina L Willson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Husebo AML, Dyrstad SM, Mjaaland I, Soreide JA, Bru E</AU>
<TI>Effects of scheduled exercise on cancer-related fatigue in women with early breast cancer</TI>
<SO>The Scientific World Journal</SO>
<YR>2014</YR>
<VL>2014</VL>
<PG>Article ID 271828, 9 pages</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243859"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243858"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ingram-2010" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Ingram 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-11-24 06:02:26 +1100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ingram C, Wessel J, Courneya KS</AU>
<TI>Evaluating the benefits of exercise for women receiving adjuvant therapy for breast cancer: research challenges</TI>
<SO>Canadian Oncology Nursing Journal</SO>
<YR>2010</YR>
<VL>20</VL>
<NO>2</NO>
<PG>96-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243861"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ingram C, Wessel J, Courneya KS</AU>
<TI>Women's perceptions of home-based exercise performed during adjuvant chemotherapy for breast cancer</TI>
<SO>European Journal of Oncology Nursing</SO>
<YR>2010</YR>
<VL>14</VL>
<NO>3</NO>
<PG>238-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243862"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243860"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacVicar-1989" NAME="MacVicar 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacVicar MG, Winningham ML, Nickel JL</AU>
<TI>Effects of aerobic interval training on cancer patients' functional capacity</TI>
<SO>Nursing Research</SO>
<YR>1989</YR>
<VL>38</VL>
<NO>6</NO>
<PG>348-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243864"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winningham ML, MacVicar MG, Bondoc M, Anderson JI, Minton JP</AU>
<TI>Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1989</YR>
<VL>16</VL>
<PG>683-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243865"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243863"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mock-2004" MODIFIED="2016-06-27 00:52:03 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Mock 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-06-27 00:52:03 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V, Frangakis C, Davidson NE, Ropka ME, Pickett M, Poniatowski B, et al</AU>
<TI>Exercise manages fatigue during breast cancer treatment: A randomized controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2005</YR>
<VL>14</VL>
<PG>464-77</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243867"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243866"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moros-2010" MODIFIED="2016-08-28 06:11:50 +1000" MODIFIED_BY="[Empty name]" NAME="Moros 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-08-28 06:11:50 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Moros MT, Ruidiaz M, Caballero A, Serrano E, Martínez V, Tres A</AU>
<TI>Effects of an exercise training program on the quality of life of women with breast cancer on chemotherapy</TI>
<TO>Ejercicio físico en mujeres con cáncer de mama</TO>
<SO>Revista Médica de Chile</SO>
<YR>2010</YR>
<VL>138</VL>
<NO>6</NO>
<PG>715-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243869"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243868"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mutrie-2007" MODIFIED="2016-08-28 06:12:59 +1000" MODIFIED_BY="[Empty name]" NAME="Mutrie 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mutrie N, Campbell A, Barry S, Hefferon K, McConnachie A, Ritchie D, et al</AU>
<TI>Five-year follow-up of participants in a randomised controlled trial showing benefits from exercise for breast cancer survivors during adjuvant treatment. Are there lasting effects?</TI>
<SO>Journal of Cancer Survivorship</SO>
<YR>2012</YR>
<VL>6</VL>
<NO>4</NO>
<PG>420-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243871"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:12:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mutrie N, Campbell AM, Whyte F, McConnachie A, Emslie C, Lee L, et al</AU>
<TI>Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2007</YR>
<VL>334</VL>
<NO>7592</NO>
<PG>517</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243872"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:12:59 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trinh L, Mutrie N, Campbell AM, Crawford JJ, Courneya KS</AU>
<TI>Effects of supervised exercise on motivational outcomes in breast cancer survivors at 5-year follow-up</TI>
<SO>European Journal of Oncology Nursing</SO>
<YR>2014</YR>
<VL>18</VL>
<NO>6</NO>
<PG>557-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243873"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243870"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perna-2010" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Perna 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perna FM, Craft L, Freund KM, Skrinar G, Stone M, Kachnic L</AU>
<TI>The effect of a cognitive behavioral exercise intervention on clinical depression in a multiethnic sample of women with breast cancer: A randomized controlled trial</TI>
<SO>International Journal of Sport and Exercise Psychology</SO>
<YR>2010</YR>
<VL>8</VL>
<NO>1</NO>
<PG>36-47</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243875"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243874"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rao-2012" MODIFIED="2016-08-28 06:14:58 +1000" MODIFIED_BY="[Empty name]" NAME="Rao 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-28 06:14:58 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rao R, Cruz V, Peng Y, Harker-Murray A, Haley BB, Zhao H, et al</AU>
<TI>Bootcamp during neoadjuvant chemotherapy for breast cancer: A randomized pilot trial</TI>
<SO>Breast Cancer: Basic and Clinical Research</SO>
<YR>2012</YR>
<VL>6</VL>
<PG>39&#8211;46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243877"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243876"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reis-2013" MODIFIED="2016-08-28 06:15:31 +1000" MODIFIED_BY="[Empty name]" NAME="Reis 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-08-28 06:15:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reis D, Walsh ME, Young-McCaughan S, Jones T</AU>
<TI>Effects of Nia exercise in women receiving radiation therapy for breast cancer</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2013</YR>
<VL>40</VL>
<PG>E374-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243879"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243878"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-2014" MODIFIED="2016-08-28 06:17:28 +1000" MODIFIED_BY="[Empty name]" NAME="Schmidt 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-08-28 06:16:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K</AU>
<TI>Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial</TI>
<SO>International Journal of Cancer</SO>
<YR>2014</YR>
<VL>137</VL>
<NO>2</NO>
<PG>417-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243881"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:17:28 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, et al</AU>
<TI>Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study)</TI>
<SO>Contemporary Clinical Trials</SO>
<YR>2013</YR>
<VL>34</VL>
<NO>1</NO>
<PG>117-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243882"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243880"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-2007-AET" MODIFIED="2014-06-07 17:44:03 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Schwartz 2007 AET" YEAR="2007">
<REFERENCE MODIFIED="2014-06-07 17:44:03 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz AL, Winters-Stone K, Gallucci B</AU>
<TI>Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>3</NO>
<PG>627-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243884"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243883"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-2007-RET" MODIFIED="2014-06-07 17:44:27 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Schwartz 2007 RET" YEAR="2007">
<REFERENCE MODIFIED="2014-06-07 17:44:27 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz AL, Winters-Stone K, Gallucci B</AU>
<TI>Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>3</NO>
<PG>627-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243886"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243885"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Segal-2001-SD" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Segal 2001 SD" YEAR="2001">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J, et al</AU>
<TI>Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2001</YR>
<VL>19</VL>
<NO>3</NO>
<PG>657-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243888"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243887"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Segal-2001-SU" MODIFIED="2016-08-28 06:18:24 +1000" MODIFIED_BY="[Empty name]" NAME="Segal 2001 SU" YEAR="2001">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J, et al</AU>
<TI>Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2001</YR>
<VL>19</VL>
<PG>657-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243890"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243889"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steindorf-2014" MODIFIED="2016-08-28 06:20:51 +1000" MODIFIED_BY="[Empty name]" NAME="Steindorf 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-08-28 06:20:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Potthoff K, Schmidt ME, Wiskemann J, Hof H, Klassen O, Habermann N, et al</AU>
<TI>Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study</TI>
<SO>BMC Cancer</SO>
<YR>2013</YR>
<VL>13</VL>
<PG>162</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243892"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:20:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, et al</AU>
<TI>Randomized controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life</TI>
<SO>Annals of Oncology</SO>
<YR>2014</YR>
<VL>25</VL>
<NO>11</NO>
<PG>2237-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243893"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243891"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Travier-2015" MODIFIED="2016-08-28 06:22:14 +1000" MODIFIED_BY="[Empty name]" NAME="Travier 2015" YEAR="2010">
<REFERENCE MODIFIED="2015-11-30 21:21:50 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>May AM, Velthuis M, Travier N, Steins Bisschop CN, Wall E, Peeters P</AU>
<TI>Physical activity during cancer treatment (PACT) study: Short- and long-term effects on fatigue of an 18-week exercise intervention during adjuvant chemotherapy in patients with breast or colon cancer</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2014</YR>
<VL>32</VL>
<NO>15 suppl 1</NO>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243901"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:22:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Travier N, Velthuis MJ, Steins Bisschop CN, van den Buijs B, Monninkhof EM, Backx F, et al</AU>
<TI>Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial</TI>
<SO>BMC Medicine</SO>
<YR>2015</YR>
<VL>13</VL>
<PG>121</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243902"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Velthuis MJ, May AM, Koppejan-Rensenbrink RA, Gijsen BC, van Breda E, de Wit GA, et al</AU>
<TI>Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial</TI>
<SO>BMC Cancer</SO>
<YR>2010</YR>
<VL>10</VL>
<PG>272</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243903"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243900"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Waart-2014-high" MODIFIED="2016-09-16 11:48:44 +1000" MODIFIED_BY="Melina L Willson" NAME="van Waart 2014 high" YEAR="">
<REFERENCE MODIFIED="2016-06-27 00:42:07 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="OTHER">
<AU>van Waart H, Stuiver MM, Sonke GS, van Harten WH, Aaronson NK</AU>
<TI>Effect of low versus high intensity physical exercise during chemotherapy on physical fitness, fatigue and chemotherapy completion rates: Results of a randomized, controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2014</YR>
<VL>23</VL>
<PG>93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243895"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-27 00:42:17 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Waart H, Stuiver MM, van Harten WH, Sonke GS, Aaronson NK</AU>
<TI>Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): A randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue</TI>
<SO>BMC Cancer</SO>
<YR>2010</YR>
<VL>10</VL>
<PG>673</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243896"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243894"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Waart-2014-low" MODIFIED="2016-09-16 11:48:57 +1000" MODIFIED_BY="Melina L Willson" NAME="van Waart 2014 low" YEAR="">
<REFERENCE MODIFIED="2016-01-22 13:34:19 +1100" MODIFIED_BY="Melina L Willson" PRIMARY="YES" TYPE="OTHER">
<AU>van Waart H, Stuiver MM, Sonke GS, van Harten WH, Aaronson NK</AU>
<TI>Effect of low versus high intensity physical exercise during chemotherapy on physical fitness, fatigue and chemotherapy completion rates: Results of a randomized, controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2014</YR>
<VL>23</VL>
<PG>93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243898"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-27 00:42:23 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Waart H, Stuiver MM, van Harten WH, Sonke GS, Aaronson NK</AU>
<TI>Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): A randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue</TI>
<SO>BMC Cancer</SO>
<YR>2010</YR>
<VL>10</VL>
<PG>673</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243899"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243897"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Visovsky-2014" MODIFIED="2016-08-28 06:24:53 +1000" MODIFIED_BY="[Empty name]" NAME="Visovsky 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-08-28 06:24:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Visovsky C, Bovaird JA, Tofthagen C, Rice J</AU>
<TI>Heading Off Peripheral Neuropathy With Exercise: The HOPE Study</TI>
<SO>Nursing and Health</SO>
<YR>2014</YR>
<VL>2</VL>
<NO>6</NO>
<PG>115-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243905"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243904"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winningham-1988" NAME="Winningham 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winningham ML, MacVicar MG</AU>
<TI>The effect of aerobic exercise on patient reports of nausea</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1988</YR>
<VL>15</VL>
<NO>4</NO>
<PG>447-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243907"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243906"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2011" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Yang 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang CY, Tsai JC, Huang YC, Lin CC</AU>
<TI>Effects of a home-based walking program on perceived symptom and mood status in postoperative breast cancer women receiving adjuvant chemotherapy</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>2011</YR>
<VL>67</VL>
<NO>1</NO>
<PG>158-68</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243909"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243908"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-09-11 03:47:09 +1000" MODIFIED_BY="Anna C Furmaniak">
<STUDY DATA_SOURCE="PUB" ID="STD-Aaronson-2011" MODIFIED="2016-09-11 03:12:04 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Aaronson 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-09-11 03:12:04 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aaronson TN, Duijts S, Van Beurden M, Hunter M, Oldenburg H</AU>
<TI>Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment induced menopause: Final results of a multicenter randomized controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2011</YR>
<VL>20</VL>
<PG>94-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243911"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243910"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Adamsen-2009" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Adamsen 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adamsen L, Quist M, Andersen C, Moller T, Herrstedt J, Kronborg D, et al</AU>
<TI>Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: Randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2009</YR>
<VL>339</VL>
<NO>7726</NO>
<PG>895-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243913"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243912"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aghili-2007" MODIFIED="2015-11-29 04:42:56 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Aghili 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-11-29 04:42:56 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aghili M, Farhan F, Rade M</AU>
<TI>A pilot study of the effects of programmed aerobic exercise on the severity of fatigue in cancer patients during external radiotherapy</TI>
<SO>European Journal of Oncology Nursing</SO>
<YR>2007</YR>
<VL>11</VL>
<NO>2</NO>
<PG>179-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243915"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243914"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Backman-2013" MODIFIED="2015-11-30 21:20:54 +1100" MODIFIED_BY="[Empty name]" NAME="Backman 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-11-30 21:20:54 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Backman M, Wengstrom Y, Johansson B, Skoldengen I, Berglund A</AU>
<TI>Daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer - A randomized pilot study</TI>
<SO>European Journal of Cancer</SO>
<YR>2013</YR>
<VL>49</VL>
<PG>S397</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243917"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243916"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Banasik-2011" MODIFIED="2016-08-28 06:28:23 +1000" MODIFIED_BY="[Empty name]" NAME="Banasik 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-08-28 06:28:23 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Banasik J, Williams H, Haberman M, Blank SE, Bendel R</AU>
<TI>Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors</TI>
<SO>Journal of the American Academy of Nurse Practitioners</SO>
<YR>2011</YR>
<VL>23</VL>
<NO>3</NO>
<PG>135-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243919"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243918"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Banerjee-2007" MODIFIED="2016-08-28 06:29:11 +1000" MODIFIED_BY="[Empty name]" NAME="Banerjee 2007" YEAR="2007">
<REFERENCE MODIFIED="2016-08-28 06:29:11 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Banerjee B, Vadiraj HS, Ram A, Rao R, Jayapal M, Gopinath KS, et al</AU>
<TI>Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiotherapy</TI>
<SO>Integrative Cancer Therapies</SO>
<YR>2007</YR>
<VL>6</VL>
<NO>3</NO>
<PG>242-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243921"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243920"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Basen-2006" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Basen 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Basen EK, Taylor CL, Rosenblum C, Smith MA, Shinn EH, Greisinger A, et al</AU>
<TI>Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors</TI>
<SO>Patient Education and Counseling</SO>
<YR>2006</YR>
<VL>64</VL>
<PG>225-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243923"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243922"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baumann-2009" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Baumann 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baumann FT, Drosselmeyer N, Knicker A, Krakowski-Roosen H, Schule K, Bloch W, et al</AU>
<TI>Effects of a 3-month resistance training intervention on the cognitive abilities of breast cancer patients during chemotherapy</TI>
<SO>Deutsche Zeitschrift fur Onkologie</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>2</NO>
<PG>70-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243925"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243924"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baumann-2011" MODIFIED="2016-08-28 06:30:10 +1000" MODIFIED_BY="[Empty name]" NAME="Baumann 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-08-28 06:30:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baumann FT, Drosselmeyer N, Leskaroski A, Knicker A, Krakowski-Roosen H, Zopf EM, et al</AU>
<TI>12-week resistance training with breast cancer patients during chemotherapy: Effects on cognitive abilities</TI>
<SO>Breast Care</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>2</NO>
<PG>142-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243927"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243926"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bower-2012" MODIFIED="2015-12-05 20:22:55 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Bower 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-12-05 20:22:55 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bower JE, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, et al</AU>
<TI>Yoga for persistent fatigue in breast cancer survivors: A randomized controlled trial</TI>
<SO>Cancer</SO>
<YR>2012</YR>
<VL>118</VL>
<NO>15</NO>
<PG>3766-75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243929"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243928"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burnham-2002" MODIFIED="2016-08-28 06:31:26 +1000" MODIFIED_BY="[Empty name]" NAME="Burnham 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-08-28 06:31:26 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burnham TR, Wilcox A</AU>
<TI>Effects of exercise on physiological and psychological variables in cancer survivors</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2002</YR>
<VL>34</VL>
<NO>12</NO>
<PG>1863-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243931"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243930"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cantarero_x002d_Villanueva-2012" MODIFIED="2016-08-28 06:32:35 +1000" MODIFIED_BY="[Empty name]" NAME="Cantarero-Villanueva 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-28 06:32:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cantarero-Villanueva I, Fernandez-Lao C, Fernandez-De-Las-Penas C, Lopez-Barajas IB, Del-Moral-Avila R, de la-Llave-Rincon AI, et al</AU>
<TI>Effectiveness of water physical therapy on pain, pressure pain sensitivity, and myofascial trigger points in breast cancer survivors: a randomized, controlled clinical trial</TI>
<SO>Pain Medicine</SO>
<YR>2012</YR>
<VL>13</VL>
<NO>11</NO>
<PG>1509-19</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243933"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243932"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cantarero_x002d_Villanueva-2013" MODIFIED="2016-08-28 06:33:55 +1000" MODIFIED_BY="[Empty name]" NAME="Cantarero-Villanueva 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-08-28 06:33:55 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cantarero-Villanueva I, Fernandez-Lao C, Cuesta-Vargas AI, Del Moral-Avila R, Fernandez-De-Las-Penas C, Arroyo-Morales M</AU>
<TI>The effectiveness of a deep water aquatic exercise program in cancer-related fatigue in breast cancer survivors: A randomized controlled trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2013</YR>
<VL>94</VL>
<NO>2</NO>
<PG>221-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243935"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243934"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carson-2009" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Carson 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL</AU>
<TI>Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>10</NO>
<PG>1301-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243937"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243936"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charbonnier-2012" MODIFIED="2016-09-11 03:16:41 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Charbonnier 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-09-11 03:16:41 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charbonnier J, Levy A, Guichard JB, Garet M, Auberdiac P, Roche F, et al</AU>
<TI>Establishment of a pilot study of awareness retraining in physical activity in two selected populations of patients with breast cancer [French]</TI>
<TO>Mise en place d'une étude pilote de sensibilisation au rëentraînement à l'activité physique dans deux populations sélectionnées atteintes d'un cancer du sein</TO>
<SO>Bulletin du Cancer</SO>
<YR>2012</YR>
<VL>99</VL>
<NO>7-8</NO>
<PG>753-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243939"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243938"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chetiyawardana-2004" MODIFIED="2016-09-11 03:19:36 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Chetiyawardana 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-09-11 03:19:36 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Chetiyawardana AD</AU>
<TI>A pilot study to investigate the effects on fitness and quality of life of an individualised exercise programme for breast cancer patients undergoing radiotherapy</TI>
<SO>http://www.controlled-trials.com/ISRCTN26140710</SO>
<YR>(accessed 20 March 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243941"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243940"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Courneya-2003a" MODIFIED="2016-08-28 06:38:25 +1000" MODIFIED_BY="[Empty name]" NAME="Courneya 2003a" YEAR="2003">
<REFERENCE MODIFIED="2016-08-28 06:38:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Friedenreich CM, Sela RA, Quinney HA, Rhodes RE, Handman M</AU>
<TI>The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes</TI>
<SO>Psycho-Oncology</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>4</NO>
<PG>357-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243943"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243942"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Courneya-2003b" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Courneya 2003b" YEAR="2003">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS</AU>
<TI>Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>9</NO>
<PG>1660-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243945"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243944"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Courneya-2006" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Courneya 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Jones LW, Mackey JR, Fairey AS</AU>
<TI>Exercise beliefs of breast cancer survivors before and after participation in a randomized controlled trial</TI>
<SO>International Journal of Behavioral Medicine</SO>
<YR>2006</YR>
<VL>13</VL>
<NO>3</NO>
<PG>259-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243947"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243946"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Culos_x002d_Reed-2006" MODIFIED="2016-08-28 06:39:41 +1000" MODIFIED_BY="[Empty name]" NAME="Culos-Reed 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-08-28 06:39:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Culos-Reed SN, Carlson LE, Daroux LM, Hately-Aldous S</AU>
<TI>A pilot study of yoga for breast cancer survivors: physical and psychological benefits</TI>
<SO>Psycho-Oncology</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>10</NO>
<PG>891-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243949"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243948"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danhauer-2009" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Danhauer 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danhauer SC, Mihalko SL, Russell GB, Campbell CR, Felder L, Daley K, et al</AU>
<TI>Restorative yoga for women with breast cancer: findings from a randomized pilot study</TI>
<SO>Psycho-Oncology</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>4</NO>
<PG>360-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243951"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243950"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demark_x002d_Wahnefried-2002" MODIFIED="2016-09-11 03:18:23 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Demark-Wahnefried 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-09-11 03:18:23 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>Demark-Wahnefried W</AU>
<TI>Randomized study of a diet and exercise-based counseling program versus a standard counseling program for patients with early-stage breast or prostate cancer</TI>
<SO>http://www.clinicaltrials.gov/ct/show/NCT00044980?order=128</SO>
<YR>(accessed 8 May 2002)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243953"/><IDENTIFIER TYPE="OTHER" VALUE="Ref Type: Unpublished Work"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243952"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demark_x002d_Wahnefried-2003" MODIFIED="2016-08-28 06:42:21 +1000" MODIFIED_BY="[Empty name]" NAME="Demark-Wahnefried 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-08-28 06:42:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demark-Wahnefried W, Morey MC, Clipp EC, Pieper CF, Snyder DC, Sloane R, et al</AU>
<TI>Leading the way in exercise and diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors</TI>
<SO>Controlled Clinical Trials</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>2</NO>
<PG>206-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243955"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243954"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demark_x002d_Wahnefried-2005" MODIFIED="2016-08-28 06:44:38 +1000" MODIFIED_BY="[Empty name]" NAME="Demark-Wahnefried 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-08-28 06:44:38 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demark-Wahnefried W, Morey MC, Clipp EC, Snyder DC, Sloane R, Pieper F, et al</AU>
<TI>Results of Project LEAD (Leading the Way in Exercise and Diet) - A trial testing an intervention of telephone-counseling and mailed materials in improving physical functioning among older breast and prostate cancer survivors</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>16 Suppl</NO>
<PG>763S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243957"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243956"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demark_x002d_Wahnefried-2006" MODIFIED="2016-08-28 06:45:30 +1000" MODIFIED_BY="[Empty name]" NAME="Demark-Wahnefried 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-08-28 06:45:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demark-Wahnefried W, Clipp EC, Morey MC, Pieper CF, Sloane R, Snyder DC, et al</AU>
<TI>Lifestyle intervention development study to improve physical function in older adults with cancer: Outcomes from Project LEAD</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2006</YR>
<VL>24</VL>
<PG>3465-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243959"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243958"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demark_x002d_Wahnefried-2008" MODIFIED="2014-05-25 20:10:32 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Demark-Wahnefried 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-05-25 20:10:32 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, et al</AU>
<TI>Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy</TI>
<SO>Clinical Breast Cancer</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>70-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243961"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243960"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dimeo-1999" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Dimeo 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J</AU>
<TI>Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy</TI>
<SO>Cancer</SO>
<YR>1999</YR>
<VL>85</VL>
<NO>10</NO>
<PG>2273-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243963"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243962"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duijts-2009" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Duijts 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duijts SF, Oldenburg HS, van BM, Aaronson NK</AU>
<TI>Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: design of a multicenter trial</TI>
<SO>BMC Women's Health</SO>
<YR>2009</YR>
<VL>9</VL>
<PG>15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243965"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243964"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duijts-2012" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Duijts 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duijts SFA, Van Beurden M, Oldenburg HSA, Hunter MS, Kieffer JM, Stuiver MM, et al</AU>
<TI>Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: Results of a randomized, controlled, multicenter trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2012</YR>
<VL>30</VL>
<NO>33</NO>
<PG>4124-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243967"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243966"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emami-2012" MODIFIED="2015-07-23 01:09:25 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Emami 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-07-23 01:09:25 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Emami H, Rahnama N, Nuri R, Damirchi A, Rahmani-Nia F, fshar-Nejad T</AU>
<TI>Effect of combination exercise training on sex hormone binding globulin in postmenopausal women with breast cancer</TI>
<SO>Gazzetta Medica Italiana Archivio per le Scienze Mediche</SO>
<YR>2012</YR>
<VL>171</VL>
<PG>633-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243969"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243968"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ergun-2013" MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Ergun 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ergun M, Eyigor S, Karaca B, Kisim A, Uslu R</AU>
<TI>Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients</TI>
<SO>European Journal of Cancer Care</SO>
<YR>2013</YR>
<VL>22</VL>
<NO>5</NO>
<PG>626-37</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243971"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243970"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fairey-2003" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Fairey 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR</AU>
<TI>Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>8</NO>
<PG>721-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243973"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243972"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fairey-2005" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Fairey 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR</AU>
<TI>Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors</TI>
<SO>Journal of Applied Physiology</SO>
<YR>2005</YR>
<VL>98</VL>
<NO>4</NO>
<PG>1534-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243975"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243974"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fairey-2005a" MODIFIED="2016-08-28 06:48:39 +1000" MODIFIED_BY="[Empty name]" NAME="Fairey 2005a" YEAR="2005">
<REFERENCE MODIFIED="2016-08-28 06:48:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Martin BS, et al</AU>
<TI>Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial</TI>
<SO>Brain, Behavior, and Immunity</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>5</NO>
<PG>381-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243977"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243976"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-2013" MODIFIED="2016-08-28 06:52:08 +1000" MODIFIED_BY="[Empty name]" NAME="Fernandez 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-08-28 06:52:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez-Lao C, Cantarero-Villanueva I, Ariza-Garcia A, Courtney C, Fernandez-de-las-Penas C, Arroyo-Morales M</AU>
<TI>Water versus land-based multimodal exercise program effects on body composition in breast cancer survivors: A controlled clinical trial</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2013</YR>
<VL>21</VL>
<PG>521-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243979"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243978"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Galantino-2010" MODIFIED="2015-11-30 03:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Galantino 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-11-30 03:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Galantino ML, Schmid P, Botis S, Dagan C, Leonard SM, Milos A</AU>
<TI>Exploring wellness coaching and traditional group support for breast cancer survivors: A pilot study</TI>
<SO>Rehabilitation Oncology</SO>
<YR>2010</YR>
<VL>28</VL>
<NO>1</NO>
<PG>19-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243981"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243980"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Given-2002" MODIFIED="2016-08-28 06:53:38 +1000" MODIFIED_BY="[Empty name]" NAME="Given 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-08-28 06:53:38 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Given B, Given C, McCorkle R, Kozachik S, Cimprich B, Rahbar M, et al</AU>
<TI>Pain and fatigue management: results of a nursing randomized clinical trial</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2002</YR>
<VL>29</VL>
<NO>6</NO>
<PG>949-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243983"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243982"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gomes-2011" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Gomes 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomes A, Fernandes EL, Carvalho MP, Fabricio VC</AU>
<TI>Effectiveness of brief exercise orientation program on breast cancer induced fatigue</TI>
<SO>European Journal of Cancer</SO>
<YR>2011</YR>
<VL>47</VL>
<PG>S238-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243985"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-11-29 04:32:00 +1100" MODIFIED_BY="Anna C Furmaniak"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243984"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gomez-2011" MODIFIED="2015-11-30 21:19:56 +1100" MODIFIED_BY="[Empty name]" NAME="Gomez 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-11-30 21:19:56 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gómez AM, Martínez C, Fiuza-Luces C, Herrero F, Pérez M, Madero L, et al</AU>
<TI>Exercise training and cytokines in breast cancer survivors</TI>
<SO>International Journal of Sports Medicine</SO>
<YR>2011</YR>
<VL>32</VL>
<NO>6</NO>
<PG>461-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243987"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243986"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Griffith-2009" MODIFIED="2016-08-28 06:55:29 +1000" MODIFIED_BY="[Empty name]" NAME="Griffith 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffith K, Wenzel J, Shang J, Thompson C, Stewart K, Mock V</AU>
<TI>Impact of a walking intervention on cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors</TI>
<SO>Cancer</SO>
<YR>2009</YR>
<VL>115</VL>
<NO>20</NO>
<PG>4874-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243989"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:55:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V, Krumm S, Belcher A, Stewart K, DeWeese T, Shang J, et al</AU>
<TI>Exercise during prostate cancer treatment: effects on functional status and symptoms</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>1</NO>
<PG>189&#8211;90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243990"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 06:55:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V, St Ours C, Hall S, Bositis A, Tillery M, Belcher A, et al</AU>
<TI>Using a conceptual model in nursing research - mitigating fatigue in cancer patients</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>2007</YR>
<VL>58</VL>
<NO>5</NO>
<PG>503-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243991"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-11-29 04:30:46 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wenzel JA, Griffith KA, Shang J, Thompson CB, Hedlin H, Stewart KJ, et al</AU>
<TI>Impact of a home-based walking intervention on outcomes of sleep quality, emotional distress, and fatigue in patients undergoing treatment for solid tumors</TI>
<SO>The Oncologist</SO>
<YR>2013</YR>
<VL>18</VL>
<NO>4</NO>
<PG>476-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243992"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243988"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartmann-2013" MODIFIED="2016-08-28 06:56:39 +1000" MODIFIED_BY="[Empty name]" NAME="Hartmann 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-08-28 06:56:39 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartmann I, Lethan C, Dalvad E, Koehler U, Sigaard L, Dieperink K</AU>
<TI>Fatigue in breast cancer patients undergoing curative radiotherapy treatment</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2013</YR>
<VL>21</VL>
<PG>S60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243994"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243993"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hatchett-2013" MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Hatchett 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hatchett A, Hallam JS, Ford MA</AU>
<TI>Evaluation of a social cognitive theory-based email intervention designed to influence the physical activity of survivors of breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>2013</YR>
<VL>22</VL>
<NO>4</NO>
<PG>829-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243996"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243995"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herrero-2006" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Herrero 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herrero F, San Juan AF, Fleck SJ, Balmer J, Perez M, Canete S, et al</AU>
<TI>Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial</TI>
<SO>International Journal of Sports Medicine</SO>
<YR>2006</YR>
<VL>27</VL>
<NO>7</NO>
<PG>573-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3243998"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243997"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ho-1986" NAME="Ho 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Ho C</AU>
<TI>Psychological adaptation and coping resources of breast cancer patients: Comparisons across three treatment modalities</TI>
<SO>Dissertation-Abstracts-International</SO>
<YR>1986</YR>
<VL>47</VL>
<PG>2617</PG>
<PB>Dissertation-Abstracts-International, Vol 47 (6-B): 2617</PB>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244000"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3243999"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2014" MODIFIED="2016-09-11 03:26:33 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Huang 2014" YEAR="">
<REFERENCE MODIFIED="2016-09-11 03:26:33 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang HP, Wen FH, Tsai JC, Lin YC, Shun SC, Chang HK, et al</AU>
<TI>Adherence to prescribed exercise time and intensity declines as the exercise program proceeds: findings from women under treatment for breast cancer</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2015</YR>
<VL>23</VL>
<NO>7</NO>
<PG>2061-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244002"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244001"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irwin-2008" MODIFIED="2016-08-28 06:59:08 +1000" MODIFIED_BY="[Empty name]" NAME="Irwin 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-08-28 06:59:08 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Irwin ML, Cadmus L, Alvarez-Reeves M, O'Neil M, Mierzejewski E, Latka R, et al</AU>
<TI>Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study</TI>
<SO>Cancer</SO>
<YR>2008</YR>
<VL>112</VL>
<NO>11 Suppl</NO>
<PG>606</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244004"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244003"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irwin-2009" MODIFIED="2015-12-01 01:42:29 +1100" MODIFIED_BY="[Empty name]" NAME="Irwin 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-12-01 01:42:29 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Irwin ML, Alvarez-Reeves M, Cadmus L, Mierzejewski E, Mayne ST, Yu H, et al</AU>
<TI>Exercise improves body fat, lean mass, and bone mass in breast cancer survivors</TI>
<SO>Obesity</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>8</NO>
<PG>1534-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244006"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244005"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Irwin-2009a" MODIFIED="2015-12-01 01:42:35 +1100" MODIFIED_BY="[Empty name]" NAME="Irwin 2009a" YEAR="2009">
<REFERENCE MODIFIED="2015-12-01 01:42:35 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, et al</AU>
<TI>Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>1</NO>
<PG>306-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244008"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244007"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janelsins-2011" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Janelsins 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janelsins MC, Davis PG, Wideman L, Katula JA, Sprod LK, Peppone LJ, et al</AU>
<TI>Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors</TI>
<SO>Clinical Breast Cancer</SO>
<YR>2011</YR>
<VL>11</VL>
<NO>3</NO>
<PG>161-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244010"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244009"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2006" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Kim 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim CJ, Kang DH, Smith BA, Landers KA</AU>
<TI>Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy</TI>
<SO>Cancer Nursing</SO>
<YR>2006</YR>
<VL>29</VL>
<NO>2</NO>
<PG>156-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244012"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244011"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Kleine_x002d_Tebbe-2006" MODIFIED="2016-09-11 03:21:33 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Kleine-Tebbe 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-09-11 03:21:33 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Kleine-Tebbe A</AU>
<TO>Untersuchung zum Einfluss eines Bewegungstrainings auf die Leistungsfähigkeit, die Lebensqualität und den Immunstatus, sowie die Rezidivrate im Vergleich zu einem Entspannungsverfahren bei Frauen mit Mammakarzinom während der adjuvanten Chemotherapie] (Influence of exercise training vs. relaxation training on performance, quality of life, immune status and rate of recurrence in women with breast cancer during adjuvant chemotherapy)</TO>
<SO>Personal communication</SO>
<YR>February 2006 and September 2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244014"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244013"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kohler-2008" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Kohler 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kohler N, Damm F, Bauer K, Klee C, Rach S, Lintz D, et al</AU>
<TI>Supportive effects of moderate physical exercise during cytotoxic/endocrine treatment of breast cancer patients - Results of a pilot study</TI>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>2008</YR>
<VL>68</VL>
<NO>8</NO>
<PG>805-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244016"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244015"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kovacic-2011" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Kovacic 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kovacic T, Kovacic M</AU>
<TI>Impact of relaxation training according to yoga in daily life (registered trademark) system on self-esteem after breast cancer surgery</TI>
<SO>Journal of Alternative and Complementary Medicine</SO>
<YR>2011</YR>
<VL>17</VL>
<NO>12</NO>
<PG>1157-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244018"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244017"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Latikka-1997" MODIFIED="2016-08-28 07:03:07 +1000" MODIFIED_BY="[Empty name]" NAME="Latikka 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-08-28 07:03:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Latikka P, Pukkala E, Vihko V</AU>
<TI>Exercise and breast cancer</TI>
<SO>Duodecim</SO>
<YR>1997</YR>
<VL>113</VL>
<NO>4</NO>
<PG>317-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244020"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244019"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Latka-2009" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Latka 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Latka RN, varez-Reeves M, Cadmus L, Irwin ML</AU>
<TI>Adherence to a randomized controlled trial of aerobic exercise in breast cancer survivors: the Yale exercise and survivorship study</TI>
<SO>Journal of Cancer Survivorship</SO>
<YR>2009</YR>
<VL>3</VL>
<NO>3</NO>
<PG>148-57</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244022"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244021"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lauridsen-2005" MODIFIED="2016-08-28 07:04:12 +1000" MODIFIED_BY="[Empty name]" NAME="Lauridsen 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-08-28 07:04:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lauridsen MC, Christiansen P, Hessov I</AU>
<TI>The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study</TI>
<SO>Acta Oncologica</SO>
<YR>2005</YR>
<VL>44</VL>
<NO>5</NO>
<PG>449-57</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244024"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244023"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2006" MODIFIED="2016-08-28 07:04:41 +1000" MODIFIED_BY="[Empty name]" NAME="Lee 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-08-28 07:04:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee TI, Chen HH, Yeh ML</AU>
<TI>Effects of chan-chuang qigong on improving symptom and psychological distress in chemotherapy patients</TI>
<SO>The American Journal of Chinese Medicine</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>1</NO>
<PG>37-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244026"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244025"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ligibel-2006" MODIFIED="2016-09-11 03:28:13 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Ligibel 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-09-11 03:28:13 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ligibel JA, Chen W, Keshaviah A, Adloff K, Partridge A, Salinardi T, et al</AU>
<TI>The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>18 Suppl</NO>
<PG>25s-s</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244028"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244027"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ligibel-2008" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Ligibel 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, et al</AU>
<TI>Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2008</YR>
<VL>26</VL>
<NO>6</NO>
<PG>907-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244030"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244029"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ligibel-2009" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Ligibel 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ligibel JA, Giobbie-Hurder A, Olenczuk D, Campbell N, Salinardi T, Winer EP, et al</AU>
<TI>Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors</TI>
<SO>Cancer Causes &amp; Control</SO>
<YR>2009</YR>
<VL>20</VL>
<NO>8</NO>
<PG>1523-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244032"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244031"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacVicar-1986" MODIFIED="2015-07-15 02:58:30 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="MacVicar 1986" YEAR="1986">
<REFERENCE MODIFIED="2015-07-15 02:58:30 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>MacVicar MG, Winningham ML</AU>
<TI>Promoting the functional capacity of cancer patients</TI>
<SO>Cancer Bulletin</SO>
<YR>1986</YR>
<VL>38</VL>
<PG>235-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244034"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244033"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mamom-2012" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Mamom 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mamom J</AU>
<TI>Effectiveness of an education-combining exercise programme for chemotherapy-related fatigue in women with breast cancer</TI>
<SO>European Journal of Cancer</SO>
<YR>2012</YR>
<VL>48</VL>
<PG>S6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244036"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244035"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin-2013" MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Martin 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin E, Battaglini C, Groff D, Naumann F</AU>
<TI>Improving muscular endurance with the MVe Fitness Chair in breast cancer survivors: a feasibility and efficacy study</TI>
<SO>Journal of Science &amp; Medicine in Sport</SO>
<YR>2013</YR>
<VL>16</VL>
<NO>4</NO>
<PG>372-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244038"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244037"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maryam-2010" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Maryam 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maryam A, Fazlollah A, Eesa M, Ebrahim H, Abbas VF</AU>
<TI>The effect of designed exercise programme on quality of life in women with breast cancer receiving chemotherapy</TI>
<SO>Scandinavian Journal of Caring Sciences</SO>
<YR>2010</YR>
<VL>24</VL>
<PG>251-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244040"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244039"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McGuire-2011" MODIFIED="2014-05-25 20:00:56 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="McGuire 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-25 20:00:56 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McGuire R, Waltman N, Zimmerman L</AU>
<TI>Intervention components promoting adherence to strength training exercise in breast cancer survivors with bone loss</TI>
<SO>Western Journal of Nursing Research</SO>
<YR>2011</YR>
<VL>33</VL>
<NO>5</NO>
<PG>671-89</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244042"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244041"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKenzie-2003" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="McKenzie 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McKenzie DC, Kalda AL</AU>
<TI>Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>3</NO>
<PG>463-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244044"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244043"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milecki-2013" MODIFIED="2014-07-21 01:50:51 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Milecki 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-07-21 01:50:51 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Milecki P, Hojan K, Ozga-Majchrzak O, Molinska-Glura M</AU>
<TI>Exercise tolerance in breast cancer patients during radiotherapy after aerobic training</TI>
<SO>Wspolczesna Onkologia</SO>
<YR>2013</YR>
<VL>17</VL>
<NO>2</NO>
<PG>205-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244046"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244045"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moadel-2007" MODIFIED="2015-11-30 21:17:05 +1100" MODIFIED_BY="[Empty name]" NAME="Moadel 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-11-30 21:17:05 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Moadel AB, Shah C, Wylie-Rosett J, Harris MS, Patel SR, Hall CB, et al</AU>
<TI>Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>28</NO>
<PG>4387-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244048"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244047"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mock-1994" MODIFIED="2016-08-28 07:09:21 +1000" MODIFIED_BY="[Empty name]" NAME="Mock 1994" YEAR="1994">
<REFERENCE MODIFIED="2016-08-28 07:09:21 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V, Burke MB, Sheehan P, Creaton EM, Winningham ML, McKenney Tedder S, et al</AU>
<TI>A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1994</YR>
<VL>21</VL>
<NO>5</NO>
<PG>899-907</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244050"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244049"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mock-1997" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Mock 1997" YEAR="1997">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V, Dow KH, Meares CJ, Grimm PM, Dienemann JA, Haisfield Wolfe ME, et al</AU>
<TI>Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1997</YR>
<VL>24</VL>
<NO>6</NO>
<PG>991-1000</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244052"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244051"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mock-2001" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Mock 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA, et al</AU>
<TI>Fatigue and quality of life outcomes of exercise during cancer treatment</TI>
<SO>Cancer Practice</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>3</NO>
<PG>119-27</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244054"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244053"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mock-2002" MODIFIED="2013-11-22 00:08:42 +1100" MODIFIED_BY="[Empty name]" NAME="Mock 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-11-22 00:08:42 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mock V</AU>
<TI>Fatigue and physical functioning during breast cancer treatment</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2002</YR>
<VL>29</VL>
<PG>338</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244056"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244055"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moller-2013" MODIFIED="2016-08-28 07:11:14 +1000" MODIFIED_BY="[Empty name]" NAME="Moller 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-08-28 07:11:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Møller T, Lillelund C, Andersen C, Bloomquist K, Christensen KB, Ejlertsen B, et al</AU>
<TI>The challenge of preserving cardiorespiratory fitness in physically inactive patients with colon or breast cancer during adjuvant chemotherapy: a randomised feasibility study</TI>
<SO>BMJ Open Sport &amp; Exercise Medicine</SO>
<YR>2015</YR>
<VL>1</VL>
<NO>1</NO>
<PG>e000021</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4384576"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-05-29 04:15:04 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moller T, Lillelund C, Andersen C, Ejlertsen B, Norgaard L, Christensen KB, et al</AU>
<TI>A randomised feasibility study in patients with colon and breast cancer</TI>
<SO>BMJ Open</SO>
<YR>2013</YR>
<VL>3(11)</VL>
<PG>e003556</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244141"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244140"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mulero-2008" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Mulero 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mulero Portela AL, Colon Santaella CL, Cruz Gomez C, Burch A</AU>
<TI>Feasibility of an exercise program for Puerto Rican women who are breast cancer survivors</TI>
<SO>Rehabilitation Oncology</SO>
<YR>2008</YR>
<VL>26</VL>
<NO>2</NO>
<PG>20-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244058"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244057"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Murtezani-2014" MODIFIED="2015-11-29 04:26:40 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Murtezani 2014" YEAR="">
<REFERENCE MODIFIED="2015-11-29 04:26:40 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murtezani A, Ibraimi Z, Bakalli A, Krasniqi S, Disha ED, Kurtishi I</AU>
<TI>The effect of aerobic exercise on quality of life among breast cancer survivors: A randomized controlled trial</TI>
<SO>Journal of Cancer Research and Therapeutics</SO>
<YR>2014</YR>
<VL>10</VL>
<NO>3</NO>
<PG>658</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244060"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244059"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Musanti-2012" MODIFIED="2014-05-25 20:02:49 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Musanti 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-05-25 20:02:49 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Musanti R</AU>
<TI>A study of exercise modality and physical self-esteem in breast cancer survivors</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2012</YR>
<VL>44</VL>
<NO>2</NO>
<PG>352-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244062"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244061"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mustian-2002" MODIFIED="2016-08-28 07:13:10 +1000" MODIFIED_BY="[Empty name]" NAME="Mustian 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-08-28 07:13:10 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Mustian KM, Katula JA, Gill DL</AU>
<TI>Exercise: complementary therapy for breast cancer rehabilitation</TI>
<SO>Exercise and Sport in Feminist Therapy: Constructing Modalities and Assessing Outcomes</SO>
<YR>2002</YR>
<PG>105-18</PG>
<ED>Hall RL</ED>
<PB>Haworth Press</PB>
<CY>New York</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244064"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244063"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mustian-2006" MODIFIED="2016-08-28 07:13:28 +1000" MODIFIED_BY="[Empty name]" NAME="Mustian 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-08-28 07:13:28 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mustian KM, Morrow GR, Yates J, Gillies L, Boles C</AU>
<TI>A randomized controlled pilot of home-based exercise (HBEX) versus standard care (SC) among breast cancer (BC) and prostate cancer (PC) patients receiving radiation therapy (RTH)</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>18 Suppl</NO>
<PG>8504</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244066"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244065"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pickett-2002" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Pickett 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pickett M, Mock V, Ropka ME, Cameron L, Coleman M, Podewils L</AU>
<TI>Adherence to moderate-intensity exercise during breast cancer therapy</TI>
<SO>Cancer Practice</SO>
<YR>2002</YR>
<VL>10</VL>
<NO>6</NO>
<PG>284-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244068"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244067"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pinto-2003" MODIFIED="2016-08-28 07:14:31 +1000" MODIFIED_BY="[Empty name]" NAME="Pinto 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-08-28 07:14:31 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pinto BM, Clark MM, Maruyama NC, Feder SI</AU>
<TI>Psychological and fitness changes associated with exercise participation among women with breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>2</NO>
<PG>118-26</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244070"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244069"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pinto-2008" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Pinto 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pinto BM, Rabin C, Papandonatos GD, Frierson GM, Trunzo JJ, Marcus BH</AU>
<TI>Maintenance of effects of a home-based physical activity program among breast cancer survivors</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2008</YR>
<VL>16</VL>
<NO>11</NO>
<PG>1279-89</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244072"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244071"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pinto-2009" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Pinto 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pinto BM, Rabin C, Dunsiger S</AU>
<TI>Home-based exercise among cancer survivors: adherence and its predictors</TI>
<SO>Psycho-Oncology</SO>
<YR>2009</YR>
<VL>18</VL>
<NO>4</NO>
<PG>369-76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244074"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244073"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rabin-2006" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Rabin 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rabin C, Pinto B, Frierson G</AU>
<TI>Mediators of a randomized controlled physical activity intervention for breast cancer survivors</TI>
<SO>Journal Sport Exercise Psychology</SO>
<YR>2006</YR>
<VL>28</VL>
<PG>269-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244076"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244075"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raghavendra-2007" MODIFIED="2015-12-06 06:44:10 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Raghavendra 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-12-06 06:44:10 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raghavendra RM, Nagarathna R, Nagendra HR, Gopinath KS, Srinath BS, Ravi BD, et al</AU>
<TI>Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients</TI>
<SO>European Journal of Cancer Care</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>6</NO>
<PG>462-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244078"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244077"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rahnama-2010" MODIFIED="2015-11-30 03:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Rahnama 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-11-30 03:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rahnama N, Nouri R, Rahmaninia F, Damirchi A, Emami H</AU>
<TI>The effects of exercise training on maximum aerobic capacity, resting heart rate, blood pressure and anthropometric variables of postmenopausal women with breast cancer</TI>
<SO>Journal of Research in Medical Sciences</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>2</NO>
<PG>78-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244080"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244079"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rao-2008" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Rao 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rao RM, Telles S, Nagendra HR, Nagarathna R, Gopinath K, Srinath S, et al</AU>
<TI>Effects of yoga on natural killer cell counts in early breast cancer patients undergoing conventional treatment. Comment to: recreational music-making modulates natural killer cell activity, cytokines, and mood states in corporate employees Masatada Wachi, Masahiro Koyama, Masanori Utsuyama, Barry B. Bittman, Masanobu Kitagawa, Katsuiku Hirokawa Med Sci Monit, 2007; 13(2): CR57-70</TI>
<SO>Medical Science Monitor</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>2</NO>
<PG>LE3-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244082"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244081"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rao-2009" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Rao 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rao MR, Raghuram N, Nagendra HR, Gopinath KS, Srinath BS, Diwakar RB, et al</AU>
<TI>Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial</TI>
<SO>Complementary Therapies in Medicine</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>1</NO>
<PG>1-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244084"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244083"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rogers-2011" MODIFIED="2015-11-30 21:16:20 +1100" MODIFIED_BY="[Empty name]" NAME="Rogers 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-11-30 21:16:20 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rogers LQ, Markwell S, Hopkins-Price P, Vicari S, Courneya KS, Hoelzer K, et al</AU>
<TI>Reduced barriers mediated physical activity maintenance among breast cancer survivors</TI>
<SO>Journal of Sport &amp; Exercise Psychology</SO>
<YR>2011</YR>
<VL>33</VL>
<NO>2</NO>
<PG>235-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244086"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244085"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sandel-2005" MODIFIED="2015-11-30 21:13:36 +1100" MODIFIED_BY="[Empty name]" NAME="Sandel 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-11-30 21:13:36 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sandel SL, Judge JO, Landry N, Faria L, Ouellette R, Majczak M</AU>
<TI>Dance and movement program improves quality-of-life measures in breast cancer survivors</TI>
<SO>Cancer Nursing</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>4</NO>
<PG>301-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244088"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244087"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitz-2005" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Schmitz 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitz KH, Ahmed RL, Hannan PJ, Yee D</AU>
<TI>Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>7</NO>
<PG>1672-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244090"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244089"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-1999" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Schwartz 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz AL</AU>
<TI>Fatigue mediates the effects of exercise on quality of life</TI>
<SO>Quality of Life Research</SO>
<YR>1999</YR>
<VL>8</VL>
<NO>6</NO>
<PG>529-38</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244092"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244091"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwartz-2001" MODIFIED="2016-08-28 07:19:15 +1000" MODIFIED_BY="[Empty name]" NAME="Schwartz 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-08-28 07:19:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz AL, Mori M, Gao R, Nail LM, King ME</AU>
<TI>Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2001</YR>
<VL>33</VL>
<NO>5</NO>
<PG>718-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244094"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244093"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scott-2013" MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Scott 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-05-25 19:58:45 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scott E, Daley AJ, Doll H, Woodroofe N, Coleman RE, Mutrie N</AU>
<TI>Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial</TI>
<SO>Cancer Causes &amp; Control</SO>
<YR>2013</YR>
<VL>24</VL>
<PG>181-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244096"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244095"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Segar-1998" MODIFIED="2016-08-28 07:19:51 +1000" MODIFIED_BY="[Empty name]" NAME="Segar 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-08-28 07:19:51 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Segar ML, Katch VL, Roth RS, Garcia AW, Portner TI, Glickman SG, et al</AU>
<TI>The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1998</YR>
<VL>25</VL>
<NO>1</NO>
<PG>107-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244098"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244097"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaw-2003" MODIFIED="2016-09-11 03:28:43 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Shaw 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-09-11 03:28:43 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>Shaw E, Demark-Wahnefried W, Andersen R</AU>
<TI>STRENGTH (Survival TRaining for ENhancing Total Health): Phase II randomized pilot study of distance medicine-based exercise and dietary approach to prevent body composition change during adjuvant chemotherapy in patients with stage I, II or IIIA breast cancer</TI>
<SO>http://www.clinicaltrials.gov/ct/show/NCT00068458?order=47</SO>
<YR>(accessed 1 October 2003)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244100"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244099"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-So-2006" MODIFIED="2016-08-28 07:22:15 +1000" MODIFIED_BY="[Empty name]" NAME="So 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-08-28 07:22:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>So HS, Kim IS, Yoon JH, Park OJ</AU>
<TI>Effects of aerobic exercise using a flex-band on physical functions &amp; body image in women undergoing radiation therapy after a mastectomy</TI>
<SO>Taehan Kanho Hakhoe chi</SO>
<YR>2006</YR>
<VL>36</VL>
<NO>7</NO>
<PG>1111-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244102"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244101"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sprod-2012" MODIFIED="2015-12-06 06:45:52 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Sprod 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-12-06 06:45:52 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sprod LK, Janelsins MC, Palesh OG, Carroll JK, Heckler CE, Peppone LJ, et al</AU>
<TI>Health-related quality of life and biomarkers in breast cancer survivors participating in Tai chi chuan</TI>
<SO>Journal of Cancer Survivorship</SO>
<YR>2012</YR>
<VL>6</VL>
<NO>2</NO>
<PG>146-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244104"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244103"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stevinson-2009" MODIFIED="2015-12-05 20:28:28 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Stevinson 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-12-05 20:28:28 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stevinson C</AU>
<TI>Inconclusive trial on yoga for anxiety among breast cancer patients: Commentary</TI>
<SO>Focus on Alternative and Complementary Therapies</SO>
<YR>2009</YR>
<VL>14</VL>
<NO>2</NO>
<PG>123-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244106"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244105"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swenson-2009" MODIFIED="2014-05-25 20:14:26 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Swenson 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-05-25 20:14:26 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swenson KK, Nissen MJ, Anderson E, Shapiro A, Schousboe J, Leach J</AU>
<TI>Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy</TI>
<SO>The Journal of Supportive Oncology</SO>
<YR>2009</YR>
<VL>7</VL>
<NO>3</NO>
<PG>101-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244108"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244107"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swenson-2010" MODIFIED="2015-11-30 03:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Swenson 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-11-30 03:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swenson KK, Nissen MJ, Henly SJ</AU>
<TI>Physical activity in women receiving chemotherapy for breast cancer: adherence to a walking intervention</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2010</YR>
<VL>37</VL>
<NO>3</NO>
<PG>321-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244110"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244109"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Twiss-2009" MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Twiss 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-11-30 01:45:25 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Twiss JJ, Waltman NL, Berg K, Ott CD, Gross GJ, Lindsey AM</AU>
<TI>An exercise intervention for breast cancer survivors with bone loss</TI>
<SO>Journal of Nursing Scholarship</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>1</NO>
<PG>20-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244112"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244111"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vadiraja-2009" MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Vadiraja 2009" YEAR="2009">
<REFERENCE MODIFIED="2016-01-11 09:45:27 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vadiraja HS, Rao MR, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, et al</AU>
<TI>Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial</TI>
<SO>Complementary Therapies in Medicine</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>5-6</NO>
<PG>274-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244114"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244113"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vadiraja-2010" MODIFIED="2015-12-05 20:28:28 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Vadiraja 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-12-05 20:28:28 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vadiraja HS, Rao MR, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, et al</AU>
<TI>Yoga leads to improved QoL in breast cancer patients receiving radiotherapy</TI>
<SO>Focus on Alternative and Complementary Therapies</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>2</NO>
<PG>149-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244116"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244115"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vallance-2007" MODIFIED="2015-11-30 21:14:35 +1100" MODIFIED_BY="[Empty name]" NAME="Vallance 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-11-30 21:14:35 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vallance JK, Courneya KS, Plotnikoff RC, Yasui Y, Mackey JR</AU>
<TI>Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>17</NO>
<PG>2352-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244118"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244117"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vallance-2008" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Vallance 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vallance JK, Courneya KS, Plotnikoff RC, Dinu I, Mackey JR</AU>
<TI>Maintenance of physical activity in breast cancer survivors after a randomized trial</TI>
<SO>Medicine &amp; Science in Sports &amp; Exercise</SO>
<YR>2008</YR>
<VL>40</VL>
<NO>1</NO>
<PG>173-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244120"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244119"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vallance-2008a" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Vallance 2008a" YEAR="2008">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vallance JK, Courneya KS, Plotnikoff RC, Mackey JR</AU>
<TI>Analyzing theoretical mechanisms of physical activity behavior change in breast cancer survivors: results from the activity promotion (ACTION) trial</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>2008</YR>
<VL>35</VL>
<NO>2</NO>
<PG>150-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244122"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244121"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vincent-2013" MODIFIED="2015-11-29 04:22:39 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Vincent 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-11-29 04:22:39 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vincent F, Labourey JL, Leobon S, Antonini MT, Lavau-Denes S, Tubiana-Mathieu N</AU>
<TI>Effects of a home-based walking training program on cardiorespiratory fitness in breast cancer patients receiving adjuvant chemotherapy: a pilot study</TI>
<SO>European Journal of Physical and Rehabilitation Medicine</SO>
<YR>2013</YR>
<VL>49</VL>
<NO>3</NO>
<PG>319-29</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244124"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244123"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waltman-2010" MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Waltman 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-11-30 03:32:09 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waltman NL, Twiss JJ, Ott CD, Gross GJ, Lindsey AM, Moore TE, et al</AU>
<TI>The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: A 24-month randomized controlled trial</TI>
<SO>Osteoporosis International</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>8</NO>
<PG>1361-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244126"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244125"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2010" MODIFIED="2016-09-11 03:30:30 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Wang 2010" YEAR="2010">
<REFERENCE MODIFIED="2016-08-28 07:26:52 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang YJ, Boehmke M, Wu YWB, Dickerson SS, Fisher N</AU>
<TI>Effects of a 6-week walking program on Taiwanese women newly diagnosed with early-stage breast cancer</TI>
<SO>Cancer Nursing</SO>
<YR>2011</YR>
<VL>34</VL>
<NO>2</NO>
<PG>E1-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244128"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-09-11 03:30:30 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="BOOK">
<AU>Wang YJ</AU>
<SO>Effects of a six-week home-based walking program on Taiwanese women newly diagnosed with early stage breast cancer [PhD thesis]</SO>
<YR>2010</YR>
<PG>143</PG>
<PB>State University of New York at Buffalo</PB>
<CY>Buffalo, USA</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244129"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244127"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilkie-2003" MODIFIED="2016-09-11 03:47:09 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Wilkie 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-09-11 03:47:09 +1000" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wilkie DJ, Schwartz AL, Huang H-Y, Ko N-Y, Liao W-C, Hairabedian D, et al</AU>
<SO>Innovations in Cancer Communication. Proceedings of the American Public Health Association, 131st Annual Meeting; 2003 Nov 15-19; San Francisco</SO>
<YR>2003</YR>
<PB>American Public Health Association</PB>
<CY>San Francisco</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244131"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244130"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yeh-2006" MODIFIED="2015-12-06 06:42:10 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Yeh 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-12-06 06:42:10 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yeh ML, Lee TI, Chen HH, Chao TY</AU>
<TI>The influences of Chan-Chuang Qi-gong therapy on complete blood cell counts in breast cancer patients treated with chemotherapy</TI>
<SO>Cancer Nursing</SO>
<YR>2006</YR>
<VL>29</VL>
<NO>2</NO>
<PG>149-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244133"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244132"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yuen-2007" MODIFIED="2015-11-30 21:15:34 +1100" MODIFIED_BY="[Empty name]" NAME="Yuen 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-11-30 21:15:34 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yuen HK, Sword D</AU>
<TI>Home-based exercise to alleviate fatigue and improve functional capacity among breast cancer survivors</TI>
<SO>Journal of Allied Health</SO>
<YR>2007</YR>
<VL>36</VL>
<NO>4</NO>
<PG>e257-75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244135"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244134"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2016-08-28 10:29:07 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Lotzke-2016" MODIFIED="2016-08-28 10:29:07 +1000" MODIFIED_BY="[Empty name]" NAME="Lotzke 2016" YEAR="2016">
<REFERENCE MODIFIED="2016-08-28 10:27:03 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lotzke D, Wiedemann F, Rodrigues Recchia D, Ostermann T, Sattler D, Ettl J, et al</AU>
<TI>Iyengar-yoga compared to exercise as a therapeutic intervention during (neo)adjuvant therapy in women with stage I-III breast cancer: health-related quality of life, mindfulness, spirituality, life satisfaction, and cancer-related fatigue</TI>
<SO>Evidence-Based Complementary and Alternative Medicine</SO>
<YR>2016</YR>
<VL>2016</VL>
<PG>5931816</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4384578"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-28 10:29:07 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiedemann F, Buessing A, Halle M, Kiechle M, Kohls N, Ostermann T, et al</AU>
<TI>Iyengar yoga compared to exercise in women with stage I-III breast cancer: Feasibility of therapeutic interventions during adjuvant cytotoxic or endocrine therapy</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2013</YR>
<VL>31</VL>
<NO>15</NO>
<PG>e20623</PG>
<IDENTIFIERS MODIFIED="2016-08-28 10:29:07 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4384579"/><IDENTIFIER MODIFIED="2016-08-28 10:29:07 +1000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="CRSREF: 3244155"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4384577"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petrella-2012" MODIFIED="2016-08-28 10:28:52 +1000" MODIFIED_BY="[Empty name]" NAME="Petrella 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-08-28 10:28:52 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrella TM, Laredo S, Oh P, Marzolini S, Warner E, Dent R, et al</AU>
<TI>A pilot study evaluating the benefits and feasibility of an exercise program for breast cancer patients receiving adjuvant chemotherapy</TI>
<SO>Cancer Research</SO>
<YR>2012</YR>
<VL>72</VL>
<NO>24</NO>
<PG>P2-12</PG>
<IDENTIFIERS MODIFIED="2016-08-28 10:28:52 +1000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-08-28 10:28:52 +1000" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244137"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244136"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2016-08-28 10:33:02 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-ACTRN12614000051640" MODIFIED="2016-08-10 11:49:27 +1000" MODIFIED_BY="Melina L Willson" NAME="ACTRN12614000051640" YEAR="2014">
<REFERENCE MODIFIED="2016-08-10 11:49:27 +1000" MODIFIED_BY="Melina L Willson" PRIMARY="NO" TYPE="OTHER">
<AU>ACTRN12614000051640</AU>
<TI>Preventing &#8216;chemo-brain&#8217;: Can exercise mitigate chemotherapy-induced cognitive impairment in breast cancer patients?</TI>
<SO>www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365594</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244139"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244138"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01943695" MODIFIED="2016-08-28 10:29:54 +1000" MODIFIED_BY="[Empty name]" NAME="NCT01943695" YEAR="">
<REFERENCE MODIFIED="2016-08-28 10:29:54 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01943695</AU>
<TI>Supervised aerobic training during or after adjuvant therapy for operable breast cancer</TI>
<SO>clinicaltrials.gov/ct2/show/NCT01943695</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244143"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244142"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02117011" MODIFIED="2016-08-28 10:31:16 +1000" MODIFIED_BY="[Empty name]" NAME="NCT02117011" YEAR="2013">
<REFERENCE MODIFIED="2016-08-28 10:31:16 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02117011</AU>
<TI>Effects of a structured exercise program on cancer-related fatigue in women receiving radiation therapy for breast cancer</TI>
<SO>clinicaltrials.gov/ct2/show/NCT02117011</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244145"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244144"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02159157" MODIFIED="2016-08-28 10:32:00 +1000" MODIFIED_BY="[Empty name]" NAME="NCT02159157" YEAR="2014">
<REFERENCE MODIFIED="2016-08-28 10:32:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02159157</AU>
<TI>A randomized, controlled trial to determine the effects of an exercise intervention on physical activity during chemotherapy for patients with early stage breast cancer</TI>
<SO>clinicaltrials.gov/ct2/show/NCT02159157</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244147"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244146"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02240836" MODIFIED="2015-11-29 08:16:54 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="NCT02240836" YEAR="2014">
<REFERENCE MODIFIED="2015-11-29 08:16:54 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02240836</AU>
<TI>Energy Balance and Breast Cancer Aspects-II (EBBA-II)</TI>
<SO>clinicaltrials.gov/ct2/show/NCT02240836</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244149"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244148"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02252991" MODIFIED="2015-11-29 08:13:10 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="NCT02252991" YEAR="2014">
<REFERENCE MODIFIED="2015-11-29 08:13:10 +1100" MODIFIED_BY="Anna C Furmaniak" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02252991</AU>
<TI>Adaptated Physical Activity in Cancerology (APACAN)</TI>
<SO>clinicaltrials.gov/ct2/show/study/NCT02252991</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244151"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244150"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02350582" MODIFIED="2016-08-28 10:33:02 +1000" MODIFIED_BY="[Empty name]" NAME="NCT02350582" YEAR="2012">
<REFERENCE MODIFIED="2016-08-28 10:33:02 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02350582</AU>
<TI>e-CUIDACHEMO: Telerehabilitation during chemotherapy in breast cancer</TI>
<SO>clinicaltrials.gov/ct2/show/study/NCT02350582</SO>
<YR>(accessed 28 October 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3244153"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3244152"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-09-16 13:01:39 +1000" MODIFIED_BY="Melina L Willson">
<ADDITIONAL_REFERENCES MODIFIED="2016-09-16 13:01:39 +1000" MODIFIED_BY="Melina L Willson">
<REFERENCE ID="REF-ACSM-2000" MODIFIED="2016-08-28 10:33:51 +1000" MODIFIED_BY="[Empty name]" NAME="ACSM 2000" TYPE="BOOK">
<AU>Franklin BA, Whaley MH (editors)</AU>
<SO>ACSM's Guidelines for Exercise Testing and Prescription</SO>
<YR>2000</YR>
<EN>6th</EN>
<PB>Lippincott Williams &amp; Wilkins</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bourke-2014" MODIFIED="2015-11-29 02:30:01 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Bourke 2014" TYPE="JOURNAL_ARTICLE">
<AU>Bourke L, Homer KE, Thaha MA, Steed L, Rosario DJ, Robb KA, et al</AU>
<TI>Interventions to improve exercise behaviour in sedentary people living with and beyond cancer: a systematic review</TI>
<SO>British Journal of Cancer</SO>
<YR>2014</YR>
<VL>110</VL>
<NO>4</NO>
<PG>831-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-2015" MODIFIED="2016-08-28 10:34:21 +1000" MODIFIED_BY="[Empty name]" NAME="Brown 2015" TYPE="JOURNAL_ARTICLE">
<AU>Brown LC, Mutter RW, Halyard MY</AU>
<TI>Benefits, risks, and safety of external beam radiation therapy for breast cancer</TI>
<SO>International Journal of Women's Health</SO>
<YR>2015</YR>
<VL>7</VL>
<PG>449-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carayol-2013" MODIFIED="2015-12-26 08:38:56 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Carayol 2013" TYPE="JOURNAL_ARTICLE">
<AU>Carayol M, Bernard P, Boiche J, Riou F, Mercier B, Cousson-Gelie F, et al</AU>
<TI>Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed?</TI>
<SO>Annals of Oncology</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>2</NO>
<PG>291-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colcombe-2003" NAME="Colcombe 2003" TYPE="JOURNAL_ARTICLE">
<AU>Colcombe S, Kramer AF</AU>
<TI>Fitness effects on the cognitive function of older adults: a meta-analytic study</TI>
<SO>Psychological Science</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>2</NO>
<PG>125-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Courneya-2007" MODIFIED="2016-01-22 13:30:19 +1100" MODIFIED_BY="Melina L Willson" NAME="Courneya 2007" TYPE="JOURNAL_ARTICLE">
<AU>Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al</AU>
<TI>Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>28</NO>
<PG>4396-404</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Craig-2008" MODIFIED="2016-08-28 10:35:22 +1000" MODIFIED_BY="[Empty name]" NAME="Craig 2008" TYPE="JOURNAL_ARTICLE">
<AU>Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al</AU>
<TI>Developing and evaluating complex interventions: the new Medical Research Council guidance</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>337</VL>
<PG>a1655</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cramp-2012" MODIFIED="2015-11-29 03:43:13 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Cramp 2012" TYPE="COCHRANE_REVIEW">
<AU>Cramp F, Byron-Daniel J</AU>
<TI>Exercise for the management of cancer-related fatigue in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>11</NO>
<PG>CD006145</PG>
<IDENTIFIERS MODIFIED="2015-11-29 03:42:39 +1100" MODIFIED_BY="Anna C Furmaniak"><IDENTIFIER MODIFIED="2015-11-29 03:42:39 +1100" MODIFIED_BY="Anna C Furmaniak" TYPE="DOI" VALUE="10.1002/14651858.CD006145.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Jong-2002" NAME="de Jong 2002" TYPE="JOURNAL_ARTICLE">
<AU>de Jong N, Courtens AM, Abu-Saad HH, Schouten HC</AU>
<TI>Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature</TI>
<SO>Cancer Nursing</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>4</NO>
<PG>283-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2005" MODIFIED="2016-08-28 10:40:18 +1000" MODIFIED_BY="[Empty name]" NAME="Deeks 2005" TYPE="OTHER">
<AU>Deeks JJ, Higgins, JPT, Altman DG (editors)</AU>
<TI>Chapter 8: Analysing and presenting results. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 4.2.5 [updated May 2005]. The Cochrane Collaboration, 2005</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gargon-2014" MODIFIED="2016-09-11 03:50:41 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="Gargon 2014" TYPE="JOURNAL_ARTICLE">
<AU>Gargon E, Gurung B, Medley N, Altman DG, Blazeby JM, Clarke M, et al</AU>
<TI>Choosing important health outcomes for comparative effectiveness research: a systematic review</TI>
<SO>PLoS ONE</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>6</NO>
<PG>e99111</PG>
<IDENTIFIERS MODIFIED="2015-11-29 03:45:13 +1100" MODIFIED_BY="Anna C Furmaniak"/>
</REFERENCE>
<REFERENCE ID="REF-GRADEproGDT" MODIFIED="2016-08-29 17:26:49 +1000" MODIFIED_BY="Melina L Willson" NAME="GRADEproGDT" TYPE="OTHER">
<TI>GRADEproGDT: GRADEpro Guideline Development Tool [Software]</TI>
<SO>McMaster University, 2015 (developed by Evidence Prime, Inc). Available from www.gradepro.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hayes-2013" MODIFIED="2016-01-22 13:31:42 +1100" MODIFIED_BY="Melina L Willson" NAME="Hayes 2013" TYPE="JOURNAL_ARTICLE">
<AU>Hayes SC, Rye S, DiSipio T, Yates P, Bashford J, Pyke C</AU>
<TI>Exercise for health: A randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer</TI>
<SO>Breast Cancer Research and Treatment</SO>
<YR>2013</YR>
<VL>137</VL>
<NO>1</NO>
<PG>175-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-08-28 10:43:33 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holley-2000" NAME="Holley 2000" TYPE="JOURNAL_ARTICLE">
<AU>Holley S</AU>
<TI>Cancer-related fatigue. Suffering a different fatigue</TI>
<SO>Cancer Practice</SO>
<YR>2000</YR>
<VL>8</VL>
<NO>2</NO>
<PG>87-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ioannidis-2004" MODIFIED="2016-08-28 10:44:12 +1000" MODIFIED_BY="[Empty name]" NAME="Ioannidis 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ioannidis JPA, Evans SJW, Gøtzsche PC, O&#8217;Neill RT, Altman DG, Schulz K, et al</AU>
<TI>Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2004</YR>
<VL>141</VL>
<NO>10</NO>
<PG>781-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Irwin-2003" NAME="Irwin 2003" TYPE="JOURNAL_ARTICLE">
<AU>Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, et al</AU>
<TI>Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study</TI>
<SO>Cancer</SO>
<YR>2003</YR>
<VL>97</VL>
<NO>7</NO>
<PG>1746-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jereczek_x002d_Fossa-2001" NAME="Jereczek-Fossa 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jereczek-Fossa BA, Marsiglia HR, Orecchia R</AU>
<TI>Radiotherapy-related fatigue: how to assess and how to treat the symptom. A commentary</TI>
<SO>Tumori</SO>
<YR>2001</YR>
<VL>87</VL>
<NO>3</NO>
<PG>147-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lee-2011" MODIFIED="2016-08-28 10:45:40 +1000" MODIFIED_BY="[Empty name]" NAME="Lee 2011" TYPE="JOURNAL_ARTICLE">
<AU>Lee PH, Macfarlane DJ, Lam TH, Stewart SM</AU>
<TI>Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review</TI>
<SO>International Journal of Behavioral Nutrition and Physical Activity</SO>
<YR>2011</YR>
<VL>8</VL>
<PG>115</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meneses_x002d_Echavez-2015" MODIFIED="2015-12-26 09:07:50 +1100" MODIFIED_BY="Anna C Furmaniak" NAME="Meneses-Echavez 2015" TYPE="JOURNAL_ARTICLE">
<AU>Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R</AU>
<TI>Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis</TI>
<SO>BMC Cancer</SO>
<YR>2015</YR>
<VL>15</VL>
<PG>77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mishra-2012" MODIFIED="2016-08-28 10:47:07 +1000" MODIFIED_BY="[Empty name]" NAME="Mishra 2012" TYPE="COCHRANE_REVIEW">
<AU>Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O</AU>
<TI>Exercise interventions on health-related quality of life for people with cancer during active treatment</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>8</NO>
<IDENTIFIERS MODIFIED="2015-11-29 03:45:56 +1100" MODIFIED_BY="Anna C Furmaniak"><IDENTIFIER MODIFIED="2015-11-29 03:45:56 +1100" MODIFIED_BY="Anna C Furmaniak" TYPE="DOI" VALUE="10.1002/14651858.CD008465.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-NCCN-2004" MODIFIED="2016-09-11 03:52:41 +1000" MODIFIED_BY="Anna C Furmaniak" NAME="NCCN 2004" TYPE="OTHER">
<AU>National Comprehensive Cancer Network</AU>
<TI>Cancer related fatigue: Clinical practice guidelines in oncology</TI>
<SO>http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf (version 1.2004)</SO>
<YR>(accessed 11 February 2004)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newman-2003" NAME="Newman 2003" TYPE="JOURNAL_ARTICLE">
<AU>Newman LA, Sabel M</AU>
<TI>Advances in breast cancer detection and management</TI>
<SO>The Medical Clinics of North America</SO>
<YR>2003</YR>
<VL>87</VL>
<NO>5</NO>
<PG>997-1028</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Shaughnessy-2003" NAME="O'Shaughnessy 2003" TYPE="JOURNAL_ARTICLE">
<AU>O'Shaughnessy J</AU>
<TI>Chemotherapy-related cognitive dysfunction in breast cancer</TI>
<SO>Seminars in Oncology Nursing</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4 Suppl 2</NO>
<PG>17-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Partridge-2001" NAME="Partridge 2001" TYPE="JOURNAL_ARTICLE">
<AU>Partridge AH, Burstein HJ, Winer EP</AU>
<TI>Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer</TI>
<SO>Journal of the National Cancer Institute. Monographs</SO>
<YR>2001</YR>
<VL>30</VL>
<PG>135-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Patrick-2003" NAME="Patrick 2003" TYPE="JOURNAL_ARTICLE">
<AU>Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, et al</AU>
<TI>National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2003</YR>
<VL>95</VL>
<NO>15</NO>
<PG>1110-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pinto-2002" MODIFIED="2016-08-28 10:50:06 +1000" MODIFIED_BY="[Empty name]" NAME="Pinto 2002" TYPE="JOURNAL_ARTICLE">
<AU>Pinto BM, Trunzo JJ, Reiss P, Shiu SY</AU>
<TI>Exercise participation after diagnosis of breast cancer: trends and effects on mood and quality of life</TI>
<SO>Psycho-Oncology</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>5</NO>
<PG>389-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rayson-2008" MODIFIED="2016-08-28 10:50:42 +1000" MODIFIED_BY="[Empty name]" NAME="Rayson 2008" TYPE="JOURNAL_ARTICLE">
<AU>Rayson D, Richel D, Chia S, Jackisch C, van der Vegt S, Suter T</AU>
<TI>Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies</TI>
<SO>Annals of Oncology</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>9</NO>
<PG>1530-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogers-2004" NAME="Rogers 2004" TYPE="JOURNAL_ARTICLE">
<AU>Rogers LQ, Matevey C, Hopkins-Price P, Shah P, Dunnington G, Courneya KS</AU>
<TI>Exploring social cognitive theory constructs for promoting exercise among breast cancer patients</TI>
<SO>Cancer Nursing</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>6</NO>
<PG>462-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogers-2005" MODIFIED="2016-08-28 10:51:27 +1000" MODIFIED_BY="[Empty name]" NAME="Rogers 2005" TYPE="JOURNAL_ARTICLE">
<AU>Rogers LQ, Shah P, Dunnington G, Greive A, Shanmugham A, Dawson B, et al</AU>
<TI>Social cognitive theory and physical activity during breast cancer treatment</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2005</YR>
<VL>32</VL>
<NO>4</NO>
<PG>807-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogers-2006" MODIFIED="2016-08-28 10:52:05 +1000" MODIFIED_BY="[Empty name]" NAME="Rogers 2006" TYPE="JOURNAL_ARTICLE">
<AU>Rogers LQ, Courneya KS, Verhulst S, Markwell S, Lanzotti V, Shah P</AU>
<TI>Exercise barrier and task self-efficacy in breast cancer patients during treatment</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2006</YR>
<VL>14</VL>
<NO>1</NO>
<PG>84-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rugo-2003" NAME="Rugo 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rugo HS, Ahles T</AU>
<TI>The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research</TI>
<SO>Seminars in Oncology</SO>
<YR>2003</YR>
<VL>30</VL>
<NO>6</NO>
<PG>749-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rutqvist-2004" NAME="Rutqvist 2004" TYPE="JOURNAL_ARTICLE">
<AU>Rutqvist LE</AU>
<TI>Adjuvant endocrine therapy</TI>
<SO>Best practice &amp; research. Clinical Endocrinology &amp; Metabolism</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>1</NO>
<PG>81-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Salmon-2001" NAME="Salmon 2001" TYPE="JOURNAL_ARTICLE">
<AU>Salmon P</AU>
<TI>Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory</TI>
<SO>Clinical Psychology Review</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>1</NO>
<PG>33-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schwartz-2007" MODIFIED="2016-01-22 13:32:56 +1100" MODIFIED_BY="Melina L Willson" NAME="Schwartz 2007" TYPE="JOURNAL_ARTICLE">
<AU>Schwartz AL, Winters-Stone K, Gallucci B</AU>
<TI>Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>3</NO>
<PG>627-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Segal-2001" MODIFIED="2016-01-22 13:33:19 +1100" MODIFIED_BY="Melina L Willson" NAME="Segal 2001" TYPE="JOURNAL_ARTICLE">
<AU>Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J, et al</AU>
<TI>Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2001</YR>
<VL>19</VL>
<PG>657-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spiegel-1997" NAME="Spiegel 1997" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D</AU>
<TI>Psychosocial aspects of breast cancer treatment</TI>
<SO>Seminars in Oncology</SO>
<YR>1997</YR>
<VL>24</VL>
<NO>1 Suppl 1</NO>
<PG>1-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tchen-2003" NAME="Tchen 2003" TYPE="JOURNAL_ARTICLE">
<AU>Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, et al</AU>
<TI>Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>22</NO>
<PG>4175-83</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-08-28 10:54:09 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Markes-2006" MODIFIED="2016-08-28 10:54:09 +1000" MODIFIED_BY="[Empty name]" NAME="Markes 2006" TYPE="COCHRANE_REVIEW">
<AU>Markes M, Brockow T, Resch KL</AU>
<TI>Exercise for women receiving adjuvant therapy for breast cancer</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2016-01-06 22:58:14 +1100" MODIFIED_BY="Anna C Furmaniak"><IDENTIFIER MODIFIED="2016-01-06 22:58:14 +1100" MODIFIED_BY="Anna C Furmaniak" TYPE="DOI" VALUE="10.1002/14651858.CD005001.pub2"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-11-26 01:00:36 +1100" MODIFIED_BY="Anna C Furmaniak"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-09-16 12:59:38 +1000" MODIFIED_BY="Melina L Willson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-09-16 12:59:38 +1000" MODIFIED_BY="Melina L Willson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-09-16 11:35:20 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Battaglini-2004">
<CHAR_METHODS MODIFIED="2016-08-26 14:51:39 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported</P>
<P>Length of intervention: 15 weeks</P>
<P>Length of follow-up: 5 to 7 weeks after the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-01-10 03:55:53 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>20 breast cancer patients due to receive adjuvant therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:35:20 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention (n = 10): Aerobic and resistance training at 40% to 60% maximum exercise capacity and stretching; 2/week, up to 60 minutes per session</P>
<P>Control (n = 10): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-26 13:57:12 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Fatigue: Revised Piper Fatigue Scale</LI>
<LI>Cardiovascular endurance: Modified Bruce treadmill protocol</LI>
<LI>Dynamic muscular endurance: Submaximal muscle endurance protocol after Kuramoto and Payne</LI>
<LI>Body composition: lean body mass (LBM in %), body fat (BF in %)</LI>
<LI>Total caloric intake: 3-day food diary</LI>
</UL>
<P>Outcomes were measured at baseline and postintervention and at 3 time points during treatment</P>
<P>Adverse events: "No cases of injury or any cancer treatment complications impeded subjects in the exercise group from completing the exercise protocol two times a week."</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-10 06:04:34 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Grants obtained through the University of Northern Colorado (Dissertation), University of Northern Colorado, Sponsored Programs and Academic Research Center (2007)</P>
<P>Conflicts of interest: The authors declared there was no potential conflict of interest<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:35:35 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Cadmus-2007">
<CHAR_METHODS MODIFIED="2016-08-26 14:51:43 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: March 2004 to July 2006<BR/>Length of intervention: 6 months<BR/>Length of follow-up: to end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-26 13:59:50 +1000" MODIFIED_BY="[Empty name]">
<P>50 newly diagnosed breast cancer patients, aged 35 to 75, who had not yet begun or had only recently begun adjuvant treatment (completed fewer than 2 weeks of radiation or 2 cycles of chemotherapy)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:35:31 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention (n = 25): home-based exercise program, type of exercise up to the women&#8217;s choice, weekly telephone calls, information, heart monitor, activity logs, 60% to 80% of predicted maximal heart rate, 5 days per week, 30 minutes, 120 sessions<BR/>Control (n = 25): usual care<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-16 11:35:35 +1000" MODIFIED_BY="Melina L Willson">
<UL>
<LI>happiness: 2-item Fordyce Happiness Measure</LI>
<LI>self esteem: Rosenberg self-esteem scale</LI>
<LI>depression: CES-D</LI>
<LI>anxiety: Spielberger State-Trait Anxiety Inventory (STAI)</LI>
<LI>stress: Cohen&#8217;s 10-item Perceived Stress Scale</LI>
<LI>cancer site-specific quality of life: FACT-B</LI>
<LI>cancer-specific quality of life: FACT-G</LI>
<LI>health-related quality of life: MOS SF-36</LI>
<LI>body composition: weight change and body fat</LI>
<LI>physical activity: 7-Day PAL and 7-day pedometer log</LI>
</UL>
<P>Outcomes were measured at baseline and 6 months</P>
<P>Adverse events: none reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 14:10:19 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: Lance Armstrong Foundation, American Cancer Society, Susan G. Komen, National Institutes of Health</P>
<P>Conflict of interest: None reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:35:43 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Caldwell-2009">
<CHAR_METHODS MODIFIED="2016-08-26 14:51:48 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: 2 weeks after last chemotherapy</P>
<P>Study was discontinued due to peripheral neuropathy</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-01-10 04:02:04 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>25 breast cancer patients undergoing neoadjuvant or adjuvant chemotherapy treatment<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-26 14:44:10 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 13): home-based, low-intensity level strength training and functional endurance regimen (strength training combined with walking)</P>
<P>Control (n = 12): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-16 11:35:43 +1000" MODIFIED_BY="Melina L Willson">
<P>Primary outcome:</P>
<UL>
<LI>Fatigue: Schwartz Cancer Fatigue Scale (SCFS)</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Physical activity: IPAQ</LI>
<LI>Timed Get-up-and-Go Test (TGUG)</LI>
<LI>Cardiorespiratory fitness: 6-MWT</LI>
</UL>
<P>Adverse events: Detailed adverse event data were not collected for participants in this study.</P>
<P>Outcomes were measured at baseline and 2 weeks after the last chemotherapy treatment<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 14:57:18 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: None reported</P>
<P>Conflict of interest: None reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:35:51 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Campbell-2005">
<CHAR_METHODS MODIFIED="2015-12-26 23:51:29 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: to end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-01-10 04:03:32 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>22 breast cancer patients, after surgery, receiving chemotherapy or radiotherapy<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:35:50 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention (n = 12): supervised group exercise: aerobic and resistance training (walking, cycling, low-level aerobics, muscle-strengthening exercises, circuits), behaviour change communication, 60% to 75% HRmax, 10 to 20 min per session exercise, plus warm-up, cool-down, relaxation, 2 sessions per week</P>
<P>Control (n = 10): no intervention<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-16 11:35:51 +1000" MODIFIED_BY="Melina L Willson">
<UL>
<LI>quality of life (cancer-specific, cancer site-specific): FACT-G and FACT-B</LI>
<LI>fatigue: PFS</LI>
<LI>cardiorespiratory fitness: 12-minute walk test (12-MWT)</LI>
<LI>physical activity: Scottish Physical Activity Questionnaire (SPAQ)</LI>
<LI>perceived expectation of treatment: Perceived Expectations and Benefits of Total Care (study-specific questionnaire)</LI>
<LI>satisfaction with life: SWLS</LI>
</UL>
<P>Outcomes were measured at baseline and 12 weeks.</P>
<P>Adverse events: "There were no adverse reactions to taking part in the exercise intervention"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-12-26 23:55:26 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Greater Glasgow NHS Trust</P>
<P>Conflicts of interest: None reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:35:57 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Cornette-2013">
<CHAR_METHODS MODIFIED="2016-01-04 20:37:14 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: Recruitment between June 2011 and June 2012<BR/>Length of intervention: 27 weeks<BR/>Length of follow-up: 27 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-26 15:02:27 +1000" MODIFIED_BY="[Empty name]">
<P>44 outpatient breast cancer patients with HER2-negative status randomised, scheduled for adjuvant or neoadjuvant chemotherapy with 6 cycles (3FEC100+3 taxanes), followed by radiotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-26 15:05:19 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 22): aerobic and resistance training, 9 supervised sessions of resistance training and 72 unsupervised home-based sessions (resistance and aerobic training): bicycle or walking 20 to 40 minutes 2/week, resistance training with resistance bands 1/week.</P>
<P>Control (n = 22): adjuvant treatment only</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-16 11:35:57 +1000" MODIFIED_BY="Melina L Willson">
<P>Primary outcome:</P>
<UL>
<LI>Cardiorespiratory fitness: VO<SUB>2</SUB> peak at 27 weeks</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Cardiorespiratory fitness: 6-minute walk test (6-MWT)</LI>
<LI>Cancer-specific QoL: EORTC QLQ-C30</LI>
<LI>Fatigue: MFI</LI>
<LI>Strength: leg press strength</LI>
<LI>Physical activity: IPAQ</LI>
<LI>Depression and anxiety: HADS</LI>
<LI>Body composition: lean body mass, % body fat, bone density, BMI, weight change</LI>
</UL>
<P>Outcomes were measured at time point: before start of chemotherapy, after 27 weeks of treatment, and after 27 weeks of follow-up</P>
<P>Adverse events: no adverse events were reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 15:13:08 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: Sponsored by Limoges University Hospital. Supported by a grant from the Ligue Contre le Cancer (19-87) and the ALAIR-AVD.</P>
<P>Conflicts of interest: Not reported.</P>
<P>Study registration: NCT01322412</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:36:13 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Courneya-2007-AET">
<CHAR_METHODS MODIFIED="2016-08-26 15:20:23 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: 2003 and 2005<BR/>Length of intervention: Duration of the chemotherapy, median 17 weeks (9 to 24 weeks)<BR/>Length of follow-up: 6 months for patient-reported outcomes, for objectively measured outcomes 3 to 4 weeks after chemotherapy</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-12-02 20:35:58 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>242 breast cancer patients initiating adjuvant chemotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:36:13 +1000" MODIFIED_BY="Melina L Willson">
<P>
<B>Intervention group 1 (n = 78): 'Courneya AET' aerobic - endurance exercise: cycle ergometer, treadmill, elliptical</B>
</P>
<P>Intervention group 2 (n = 82): 'Courneya RET' muscular endurance exercise: weight machines (set with 9 exercises)</P>
<P>Control group (n = 82): Usual care; women were asked not to initiate an exercise programme</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-10 23:12:30 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Primary outcome:</P>
<UL>
<LI>Cancer-specific quality of life: FACT-An</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Fatigue: FACT-An</LI>
<LI>Self esteem: Rosenberg self-esteem scale</LI>
<LI>Depression: CES-D</LI>
<LI>Anxiety: Spielberger State-Trait Anxiety Inventory (STAI)</LI>
<LI>Aerobic fitness: maximal incremental exercise protocol on a treadmill</LI>
<LI>Cardiorespiratory capacity: peak oxygen consumption</LI>
<LI>Strength: 8-repetition maximum on the horizontal bench press and leg extension. The maximum weight and number of repetitions were used to estimate the 1-repetition maximum.</LI>
<LI>Body composition (whole body fat, lean tissue): dual X-ray absorptiometry scan, weight</LI>
<LI>Lymphoedema: standard volumetric arm measurements based on water displacement.</LI>
<LI>Chemotherapy completion rate: assessed as the average relative dose intensity (RDI) for the originally planned regimen based on standard formulas.</LI>
</UL>
<P>Patient-rated outcomes were assessed at baseline (1 to 2 weeks after starting chemotherapy), midpoint (middle of chemotherapy), after the intervention (3 to 4 weeks after chemotherapy), and at the 6-month follow-up.</P>
<P>Objectively measured outcomes were assessed at baseline and after intervention.</P>
<P>Adverse events: "exercise did not cause adverse events"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 15:29:16 +1000" MODIFIED_BY="[Empty name]">
<P>Study description for Courneya AET (aerobic exercise training) and Courneya RET (resistance exercise training)</P>
<P>Funding: Canadian Breast Cancer Research Alliance; the Canada Research Chairs Program, Research Team Grant from the National Cancer Institute of Canada with funds from the Canadian Cancer Society (CCS) and the NCIC/CCS Sociobehavioral Cancer Research Network, New Investigator Award from the Heart and Stroke Foundation of Canada; a New Investigator Award from the Canadian Institutes of Health Research and a Health Scholar Award from the Alberta Heritage Foundation for Medical Research; Canada Graduate Scholarship from the Canadian Institutes of Health Research and an Incentive Award from the Alberta Heritage Foundation for Medical Research.</P>
<P>Conflict of interest: Authors declared no potential conflict of interest</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:36:18 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Courneya-2007-RET">
<CHAR_METHODS MODIFIED="2016-08-26 15:36:19 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: 2003 and 2005<BR/>Length of intervention: Duration of the chemotherapy, median 17 weeks (9 to 24 weeks)<BR/>Length of follow-up: 6 months for patient-reported outcomes, for objectively measured outcomes 3 to 4 weeks after chemotherapy</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-01-11 01:11:08 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>242 breast cancer patients initiating adjuvant chemotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:36:18 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention group 1 (n = 78): 'Courneya AET' aerobic - endurance exercise: cycle ergometer, treadmill, elliptical</P>
<P>
<B>Intervention group 2 (n = 82): 'Courneya RET' muscular endurance exercise: weight machines (set with 9 exercises)</B>
</P>
<P>Control group (n = 82): Usual care; women were asked not to initiate an exercise programme</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-10 23:12:42 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Primary outcome:</P>
<UL>
<LI>Cancer-specific quality of life: FACT-An</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Fatigue: FACT-An</LI>
<LI>Self esteem: Rosenberg self-esteem scale</LI>
<LI>Depression: CES-D</LI>
<LI>Anxiety: Spielberger State-Trait Anxiety Inventory (STAI)</LI>
<LI>Aerobic fitness: maximal incremental exercise protocol on a treadmill</LI>
<LI>Cardiorespiratory capacity: peak oxygen consumption</LI>
<LI>Strength: 8-repetition maximum on the horizontal bench press and leg extension.The maximum weight and number of repetitions were used to estimate the 1-repetition maximum.</LI>
<LI>Body composition (whole body fat, lean tissue): dual X-ray absorptiometry scan, weight</LI>
<LI>Lymphoedema: standard volumetric arm measurements based on water displacement.</LI>
<LI>Chemotherapy completion rate: Chemotherapy completion rate was assessed as the average relative dose intensity (RDI) for the originally planned regimen based on standard formulas.</LI>
</UL>
<P>Patient-rated outcomes were assessed at baseline (1 to 2 weeks after starting chemotherapy), midpoint (middle of chemotherapy), after the intervention (3 to 4 weeks after chemotherapy), and at the 6-month follow-up.</P>
<P>Objectively measured outcomes were assessed at baseline and after intervention.</P>
<P>Adverse events: "exercise did not cause adverse events"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 15:40:24 +1000" MODIFIED_BY="[Empty name]">
<P>Study description for Courneya AET (aerobic exercise training) and Courneya RET (resistance exercise training)</P>
<P>Funding: Canadian Breast Cancer Research Alliance; the Canada Research Chairs Program, Research Team Grant from the National Cancer Institute of Canada with funds from the Canadian Cancer Society (CCS) and the NCIC/CCS Sociobehavioral Cancer Research Network, New Investigator Award from the Heart and Stroke Foundation of Canada; a New Investigator Award from the Canadian Institutes of Health Research and a Health Scholar Award from the Alberta Heritage Foundation for Medical Research; Canada Graduate Scholarship from the Canadian Institutes of Health Research and an Incentive Award from the Alberta Heritage Foundation for Medical Research.</P>
<P>Conflict of interest: Authors declared no potential conflict of interest</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 12:59:38 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Crowley-2003">
<CHAR_METHODS MODIFIED="2015-11-21 05:59:30 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 13 weeks<BR/>Length of follow-up: to the end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-26 15:43:46 +1000" MODIFIED_BY="[Empty name]">
<P>22 breast cancer patients, stage I, II; after surgery, receiving adjuvant chemotherapy (doxorubicin (Adriamycin), cyclophosphamide (Cytoxan)), radiation therapy excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 12:59:38 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention (n = 13): Aerobic training (walking) and resistance training (tubing), self directed, 60% of HRmax, 20 to 60 min per session, 3 to 5 d/week. Resistance training: 12 to 15 repetitions, approximately 20 minutes, 1 to 2 sets, 2 to 3 d/week, 13 weeks.</P>
<P>Control (n = 9): Usual care, the same scheduled contact with the nurse researcher as the intervention group during weeks 1, 4, 7, 10, and 13, activity log</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 08:23:54 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>cardiorespiratory fitness: VO<SUB>2 </SUB>max/kg - symptom-limited graded exercise test (GXT), Cornell Treadmill Protocol</LI>
<LI>muscular fitness: 1-repetition maximum (1-RM) chest press and leg press</LI>
<LI>fatigue: revised PFS</LI>
<LI>physical self efficacy: items from the Self-Efficacy to Perform Self-Management Behaviors and the Self-Efficacy to Achieve Outcomes scales</LI>
<LI>attention performance: Attentional Functional Index (AFI)</LI>
<LI>functional wellness: investigator-developed Functional Wellness Questionnaire on perceptions of physical function, wellness, and health</LI>
<LI>physical activity: activity log</LI>
</UL>
<P>Outcomes were measured at: </P>
<UL>
<LI>physical performance (endurance and strength) week 1 (prior to initiation of the first chemotherapy treatment) and week 13 (3 weeks after the last chemotherapy treatment)</LI>
<LI>fatigue, attention performance, physical self efficacy, functional wellness: week 1, week 7 (midpoint of the treatment cycles), week 13</LI>
</UL>
<P>Adverse events: lymphoedema in 1 participant</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-09 20:30:59 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Not reported</P>
<P>Conflicts of interest: Not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-26 16:34:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dodd-2010">
<CHAR_METHODS MODIFIED="2014-11-05 00:21:35 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: 1999 to 2006<BR/>Length of intervention: 1 year<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-26 16:16:41 +1000" MODIFIED_BY="[Empty name]">
<P>119 participants randomised, majority with breast cancer (n = 112), but people with ovarian and colorectal cancer also included, undergoing chemotherapy, Karnofsky score &gt; = 60. Excluded if they were having concurrent radiation therapy, and if pain intensity score greater than 3</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-26 16:20:25 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>intervention group: cardiovascular/aerobic exercise, e.g. walking, jogging, or bicycling during chemotherapy (n = 44); home-based for 1 year, 3 to 5 times/week, 20- to 30-minute/session at 60% to 80% VO<SUB>2</SUB> peak or 12 to 14 on Borg scale</LI>
<LI>intervention group: cardiovascular/aerobic exercise, e.g. walking, jogging, or bicycling postchemotherapy (n = 36); home-based for 6 to 8 months, otherwise as group 1</LI>
<LI>control group (n = 39): usual care, no exercise prescription. Telephoned weekly to inquire about health and general response to cancer treatment</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-26 16:34:27 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:</P>
<UL>
<LI>Fatigue: PFS</LI>
<LI>Sleep disturbance: General Sleep Disturbance Scale</LI>
<LI>Depression: CES-D</LI>
<LI>Pain: Worst Pain Intensity Scale</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>MQOLS-CA: reported in 1 related publication</LI>
<LI>Cardiorespiratory fitness: peak VO<SUB>2</SUB>
</LI>
<LI>Nutritional symptoms</LI>
<LI>Body composition: % body fat, lean body mass (kg) (DEXA), BMI, weight</LI>
<LI>Nausea: Nausea intensity was measured using a 0 to 10 numeric scale (participants were asked how much nausea they were experiencing at the time of data collection). The nausea intensity scale was derived from a symptom checklist of 25 commonly experienced symptoms.</LI>
</UL>
<P>Outcomes were measured at time point: baseline (T1: the week before the second chemotherapy treatment), at the end of cancer treatment (T2: 4 to 6 months after T1), and at the end of the study (T3: approximately 1 year after the start of T1).</P>
<P>Adverse events: hip pain, sciatica (n = 16), arm discomfort (n = 4), knee discomfort (n = 10), ankle discomfort (n = 3), and foot discomfort (n = 8)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 16:27:51 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: National Cancer Institute (CA83316), and the Clinical Translational Research Institute, Clinical Research Center (CTSI-CRC) (Dodd 2010)</P>
<P>Conflicts of interest: The authors declared no potential conflicts of interest in 2 related publications<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-26 16:53:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Drouin-2002">
<CHAR_METHODS MODIFIED="2016-01-08 01:23:12 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 7 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-26 16:45:01 +1000" MODIFIED_BY="[Empty name]">
<P>23 breast cancer patients, stages 0 to III; after surgery, receiving radiotherapy, sedentary</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-26 16:47:38 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 13): aerobic training (walking), self directed, 50% to 70% HRmax, 20 to 45 min per session, 3 to 5/week</P>
<P>Control (n = 10): stretching, 3 to 5/week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-26 16:52:36 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>fatigue: PFS</LI>
<LI>cardiorespiratory fitness: peak aerobic capacity</LI>
<LI>muscular fitness: grip tests, handgrip testing using a Jamar Dynamometer</LI>
<LI>mood: POMS</LI>
<LI>body composition: skin caliper technique, body mass, BMI, waist-to-hip ratio</LI>
<LI>immune function (CD4+/CD8+ ratio, natural killer cytotoxic activity)</LI>
<LI>oxidative stress (8-isoprostane)</LI>
</UL>
<P>Outcomes were measured within 1 week prior to and within 1 week following a 7-week radiation regimen.</P>
<P>Adverse events: shoulder tendonitis and decreases in strength due to overtraining in 1 participant<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 16:53:03 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: grants from the Elsa U. Pardee Foundation in Midland, MI, USA, and the Max and Victoria Dreyfus Foundation in White Plains, NY, USA</P>
<P>Conflict of interest: None reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-26 17:09:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eakin-2012">
<CHAR_METHODS MODIFIED="2015-08-17 17:30:31 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: data were collected from April 2007 to April 2009<BR/>Length of intervention: 8 months<BR/>Length of follow-up: 8 weeks after end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-26 17:00:01 +1000" MODIFIED_BY="[Empty name]">
<P>142 non-urban-dwelling breast cancer patients, 111 underwent adjuvant therapy (chemotherapy, radiotherapy, or a combination) during the study intervention (unpublished data for these participants used in the analyses of this review)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-26 17:00:55 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 58): home-based, telephone-delivered mixed (aerobic and resistance training) exercise</P>
<P>Control (n = 53): usual care; did not receive any study exercise intervention-related material until study completion</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-26 17:07:47 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:</P>
<UL>
<LI>Physical Activity (minutes per week): Active Australia Survey</LI>
<LI>Strength training (sessions per week): CHAMPS (Community Healthy Activities Models Programs for Seniors)</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>QoL: Functional Assessment of Cancer Therapy-Breast questionnaire - for patients with breast cancer and lymphoedema (FACT-B+4)</LI>
<LI>Fatigue: FACIT-F</LI>
<LI>State anxiety: State-Trait Anxiety Inventory (STAI)</LI>
<LI>Upper body function: DASH</LI>
</UL>
<P>Outcomes measures at 6 and 12 months</P>
<P>Adverse events: muscle soreness in 2 participants and musculoskeletal injury in 1 participant</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-26 17:09:03 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: The National Breast Cancer Foundation (NBCF, Australia) and a Queensland Health Core Infrastructure grant funded the trial. EGE is supported by a National Health and Medical Research Council Senior Research Fellowship. SCH is supported by an Early Career Research Fellowship from the NBCF.</P>
<P>Conflict of interest: The authors have no conflict of interest to disclose.</P>
<P>Registered at: ACTRN12609000809235</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 07:03:18 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gokal-2013">
<CHAR_METHODS MODIFIED="2015-12-27 00:09:34 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 06:59:06 +1000" MODIFIED_BY="[Empty name]">
<P>50 sedentary (&lt; 30 minutes of moderate-intensity exercise 5 times a week) breast cancer patients (stage I to III) during adjuvant or neoadjuvant chemotherapy. Recruited from outpatient clinics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 06:59:56 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 25): home-based, moderate-intensity walking intervention (defined as walking at brisk pace) after 2 cycles of chemotherapy. 30 minutes of moderate-intensity walking 5 times a week, encouraged to gradually increase walking duration from 10- to 30-minute bouts through the course of the intervention.</P>
<P>Control group (n = 25): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 07:03:18 +1000" MODIFIED_BY="[Empty name]">
<P>Primary:</P>
<UL>
<LI>Anxiety and depression: HADS</LI>
<LI>Fatigue: FACT-F</LI>
<LI>Self esteem: Rosenberg self-esteem scale</LI>
<LI>Emotional distress: Profile of Mood States-Short Form</LI>
</UL>
<P>Secondary:</P>
<UL>
<LI>Physical activity: General Practice Physical Activity Questionnaire</LI>
</UL>
<P>Outcomes measured at: midway through chemotherapy (pre-intervention) and after the completion of chemotherapy (postintervention). All participants also completed outcome measures prior to receiving chemotherapy<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-09 20:43:41 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Loughborough University as part of a PhD project.<BR/>Conflict of interest: There were no conflicts of interest to report.</P>
<P>Study registration: ISRCTN50709297</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 07:14:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haines-2010">
<CHAR_METHODS MODIFIED="2016-01-08 00:47:37 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: recruitment between May 2006 and September 2007<BR/>Length of intervention: 12 months<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 07:06:50 +1000" MODIFIED_BY="[Empty name]">
<P>89 breast cancer patients undergoing adjuvant therapy: chemotherapy, radiation, or a combination of both (more than 90% radiation)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 07:07:26 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 46): home-based strength, balance, shoulder mobility, and cardiovascular endurance program. 36 minutes, of which 20 minutes were walking. Frequency not reported.</P>
<P>Control group (n = 43): Static stretching, supine relaxation program following the Feldenkrais method</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 07:14:20 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome measure:</P>
<UL>
<LI>health-related quality of life: EQ-5D</LI>
<LI>cancer-specific quality of life: EORTC C30 with BR23 supplement was also used to measure elements of disease-specific health-related quality of life that might explain changes in generic HRQoL</LI>
<LI>breast cancer-specific quality of life: EORTC C30 with BR23 supplement</LI>
</UL>
<P>Secondary outcome measures:</P>
<UL>
<LI>upper limb swelling</LI>
<LI>cancer-related fatigue: MFI</LI>
<LI>balance: Functional Reach, Step Test</LI>
<LI>Strength: grip, leg press</LI>
<LI>cardiorespiratory fitness: 6-min walk test</LI>
<LI>shoulder range of motion (flexion, abduction, and external rotation, measured using plurimeter)</LI>
<LI>body composition (muscle mass %, body fat %)</LI>
</UL>
<P>Outcomes were measured at baseline, 3, 6, and 12 months</P>
<P>Adverse events: 9 participants with musculoskeletal pain, 3 of which reported pain whilst performing exercises as a part of the intervention program and 1 as a part of the control program. 8 participants with 1 fall each, 1 of which was the result of an intervention group participant tripping on a tree stump whilst undertaking the walking program</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 07:14:52 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: Project grant from the Princess Alexandra Hospital Cancer Collaborative Group, National Health and Medical Research Council Career Development Award (606732)</P>
<P>Conflict of interest: No conflicts of interest declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 07:43:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayes-2013-FtF">
<CHAR_METHODS MODIFIED="2016-08-27 07:22:04 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: recruitment between October 2006 and June 2008<BR/>Length of intervention: 8 months<BR/>Length of follow-up: 8 weeks after end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 07:22:19 +1000" MODIFIED_BY="[Empty name]">
<P>194 breast cancer patients, of which 142 underwent adjuvant therapy concurrently with the exercise intervention (unpublished data for these patients used in the analyses of this review)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 07:23:33 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention group 1: 'Hayes 2013 Tel' Telephone (n = 50) - incorporating both aerobic and strength-based exercises</P>
<P>
<B>Intervention group 2: '</B>Hayes 2013<B> FtF' Face to face (n = 51) - incorporating both aerobic and strength-based exercises</B>
</P>
<P>Control group (n = 41): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 07:28:07 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome:</P>
<UL>
<LI>Cancer site-specific QoL: Functional Assessment of Cancer Therapy-Breast (FACT-B+4) - for patients with breast cancer and lymphoedema</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Subjective upper body function: DASH</LI>
<LI>Upper body function, clinically measured: strength and endurance test</LI>
<LI>Fatigue: FACIT-F</LI>
<LI>Menopausal symptoms: Greene Climacteric Scale</LI>
<LI>Neuropathic pain: Neuropathic Pain Scale</LI>
<LI>Cardiorespiratory fitness: 3-min step test</LI>
<LI>Lymphoedema status: bioimpedance spectroscopy (L-Dex score)</LI>
<LI>Minutes of physical activity per week (Active Australia Survey)</LI>
<LI>Body composition: BMI</LI>
</UL>
<P>Outcomes measured at: 6 months, 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 07:43:09 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: This research project was supported by the National Breast Cancer Foundation. The research positions of SH and EE are supported via an NBCF Early Career Research Fellowship and an NHMRC Senior Research Fellowship, respectively.</P>
<P>Conflict of interest: Authors declare that they have no conflict of interest.</P>
<P>Registered at ACTRN: 012606000233527</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 07:43:17 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayes-2013-Tel">
<CHAR_METHODS MODIFIED="2016-08-27 07:38:00 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: recruitment between October 2006 and June 2008<BR/>Length of intervention: 8 months<BR/>Length of follow-up: 8 weeks after end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 07:38:33 +1000" MODIFIED_BY="[Empty name]">
<P>194 breast cancer patients, of which 142 underwent adjuvant therapy concurrently with the exercise intervention (unpublished data for these patients used in the analyses of this review)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 07:38:58 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention group 1: '</B>Hayes 2013<B> Tel' Telephone (n = 50) - incorporating both aerobic and strength-based exercises</B>
</P>
<P>Intervention group 2: 'Hayes 2013 FtF' Face to face (n = 51) - incorporating both aerobic and strength-based exercises</P>
<P>Control group (n = 41): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 07:42:13 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome:</P>
<UL>
<LI>Cancer site-specific QoL: Functional Assessment of Cancer Therapy-Breast (FACT-B+4) - for patients with breast cancer and lymphoedema</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Subjective upper body function: DASH</LI>
<LI>Upper body function, clinically measured: strength and endurance test</LI>
<LI>Fatigue: FACIT-F</LI>
<LI>Menopausal symptoms: Greene Climacteric Scale</LI>
<LI>Neuropathic pain: Neuropathic Pain Scale</LI>
<LI>Cardiorespiratory fitness: 3-min step test</LI>
<LI>Lymphoedema status: bioimpedance spectroscopy (L-Dex score)</LI>
<LI>Minutes of physical activity per week (Active Australia Survey)</LI>
<LI>Body composition: BMI</LI>
</UL>
<P>Outcomes measured at: 6 months, 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 07:43:17 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: This research project was supported by the National Breast Cancer Foundation. The research positions of SH and EE are supported via an NBCF Early Career Research Fellowship and an NHMRC Senior Research Fellowship, respectively.</P>
<P>Conflict of interest: Authors declare that they have no conflict of interest.</P>
<P>Registered at ACTRN: 012606000233527</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 07:59:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hornsby-2014">
<CHAR_METHODS MODIFIED="2015-08-17 17:27:12 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: recruitment between March 2007 and January 2010<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 07:54:26 +1000" MODIFIED_BY="[Empty name]">
<P>20 breast cancer patients, stage IIB to IIIC operable breast cancer, neoadjuvant chemotherapy consisted of 4 cycles of doxorubicin (60 mg/m<SUP>2</SUP>) and cyclophosphamide (600 mg/m<SUP>2</SUP>) every 3 weeks (i.e. 12 weeks in duration)</P>
<P>Eligible if: Karnofsky performance status &gt; 70</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 07:55:43 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 10): Aerobic training consisted of 3 one-on-one supervised cycle ergometry sessions per week on non-consecutive days for 12 weeks.</P>
<P>Control (n = 10): Neoadjuvant therapy only, participants were instructed to maintain their usual exercise levels throughout the duration of the study</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 07:58:53 +1000" MODIFIED_BY="[Empty name]">
<P>Safety outcomes:</P>
<UL>
<LI>exercise testing</LI>
<LI>treatment- and exercise training-related adverse events (AEs)</LI>
</UL>
<P>Efficacy outcomes:</P>
<UL>
<LI>cardiopulmonary exercise test (CPET)</LI>
<LI>cancer-specific quality of life: FACT-G</LI>
<LI>cancer site-specific quality of life: FACT-B</LI>
<LI>Fatigue: FACIT-F</LI>
</UL>
<P>Outcomes were measured at: CPET, echocardiogram, and self administered questionnaire were conducted at baseline and postintervention (12 weeks), whereas treatment-related events were serially assessed across the study (i.e. baseline, 3, 6, 9, and 12 weeks). Exercise-related events were monitored during CPET procedures and aerobic training sessions.</P>
<P>Adverse event: unexplained leg pain in 1 participant</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 07:59:31 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: United States Department of Defense Breast Cancer Research Program of the Office of the Congressionally Directed Medical Research Programs &#8211; Ideas Award and funds from George and Susan Beischer (1 author). 1 author is supported by research grants from the National Cancer Institute (CA143254, CA142566, CA138634, CA133895, CA164751).</P>
<P>Conflict of interest: The authors report no conflicts of interest</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 08:08:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Husebo-2014">
<CHAR_METHODS MODIFIED="2016-08-27 08:02:48 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: 2010 to 2012<BR/>Length of intervention: 17 weeks on average<BR/>Length of follow-up: 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 08:03:10 +1000" MODIFIED_BY="[Empty name]">
<P>67 breast cancer patients, stage I to III, surgically treated (mastectomy or lumpectomy), and allocated to adjuvant chemotherapy according to the national treatment guidelines of the Norwegian Breast Cancer Group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-01-08 03:54:17 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Intervention: Scheduled home-based exercise intervention (n = 33), combined strength (resistance bands exercises 3 times a week) and aerobic (30 minutes of brisk walking daily) training</P>
<P>Control group (n = 34): were advised to remain on their regular physical activity</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 08:07:53 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>cancer-related fatigue: Schwartz Cancer Fatigue Scale (SCFS-6)</LI>
<LI>physical fitness: 6-minute walk test</LI>
<LI>activity level: MET-minutes per week, IPAQ, exercise diary</LI>
</UL>
<P>The study sample completed questionnaires and physical tests after surgery prior to chemotherapy (baseline), 18 to 24 weeks after baseline, and at the end of chemotherapy (Post1), and approximately 6 months after completing the chemotherapy regimen (Post2).</P>
<P>Adverse events: 1 participant with knee discomfort and 1 participant with a syncope related to a secondary chronic condition</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 08:08:11 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: None reported.</P>
<P>No conflict of interest declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 08:18:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ingram-2010">
<CHAR_METHODS MODIFIED="2016-08-27 08:15:40 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups, parallel-group design</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 24 weeks<BR/>Length of follow-up: study was closed early</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 08:16:08 +1000" MODIFIED_BY="[Empty name]">
<P>13 breast cancer patients due to commence adjuvant chemotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 08:17:20 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 8): home-based combined aerobic and resistance exercise program, 30 to 45 min of aerobic exercise, at least 4 times per week. 8 resistance exercises, which included the arms, legs, and trunk, 3 times per week with enough resistance so that she tired after 6 to 12 repetitions.</P>
<P>Control group (n = 5): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 08:18:21 +1000" MODIFIED_BY="[Empty name]">
<P>Primary:</P>
<UL>
<LI>Body weight</LI>
<LI>Body composition (TANITA body composition scale; dual-energy X-ray absorptiometry scans)</LI>
</UL>
<P>Secondary:</P>
<UL>
<LI>Arm and hip strength (hand-held dynamometry)</LI>
<LI>Quality of life (FACT-B)</LI>
<LI>Fatigue (FACT-F)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-05 00:45:40 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>No outcomes reported as study was closed early.</P>
<P>Funding: Canadian Breast Cancer Research Alliance Developmental and Explanatory Grant #16542</P>
<P>Conflict of interest: none declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:37:23 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-MacVicar-1989">
<CHAR_METHODS MODIFIED="2016-08-27 08:21:10 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups, stratified by functional capacity</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 10 to 12 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 08:22:15 +1000" MODIFIED_BY="[Empty name]">
<P>62 breast cancer patients, stage II; after surgery, receiving chemotherapy, entered the study;</P>
<P>45 patients were analysed for cardiorespiratory fitness; 24 patients (without placebo group and further patients excluded) were analysed for weight change and body composition</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:37:23 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention (n = 18): aerobic training (cycling, interval training), 60% to 85% HRmax, 20 to 30 min per session, 3/week</P>
<P>Control group 1 (n = 11): flexibility and stretching exercises ("placebo group")</P>
<P>Control group 2 (n = 16): no intervention</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 08:23:16 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cardiorespiratory fitness: VO<SUB>2</SUB> max</LI>
<LI>Body composition (described in related publication)</LI>
</UL>
<P>Outcomes measured at baseline and end of intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 08:26:13 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: National Institutes of Health Grants RO1 NR 01078, National Center for Nursing Research and P 3OCA 16058 14, National Cancer Institute</P>
<P>Conflict of interest: Not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 08:33:14 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mock-2004">
<CHAR_METHODS MODIFIED="2016-08-27 08:29:39 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: Potential participants were identified between 1998 and 2001<BR/>Length of intervention: 6 weeks to 6 months, depending on the duration of the adjuvant therapy</P>
<P>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 08:29:52 +1000" MODIFIED_BY="[Empty name]">
<P>119 breast cancer patients, stages 0 to III, after surgery, receiving chemotherapy or radiotherapy, sedentary</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 08:31:47 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 60): aerobic training (walking), self directed, 50% to 70% HRmax, 15 min per session, increased to 30 min as training progressed, 5 to 6/x week. Radiotherapy: 6 weeks exercise; chemotherapy: 3 to 6 months exercise.</P>
<P>Control (n = 59): usual care<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 08:32:16 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>fatigue: PFS</LI>
<LI>physical performance: 12-minute walk test</LI>
<LI>physical activity: Physical Activity Questionnaire (PAQ)</LI>
<LI>symptoms: Symptom Assessment Scales</LI>
</UL>
<P>Outcomes measured at: baseline and end of the adjuvant therapy/intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 08:33:14 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: FIRE (Fatigue Initiative in Research and Education) multi-institutional award from the Oncology Nursing Society Foundation</P>
<P>Conflict of interest: Not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 08:39:57 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moros-2010">
<CHAR_METHODS MODIFIED="2016-08-27 08:35:52 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 18 to 22 weeks<BR/>Length of follow-up: 10 to 15 days after end of intervention<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 08:36:01 +1000" MODIFIED_BY="[Empty name]">
<P>22 breast cancer patients, chemotherapy, not exercising regularly</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 08:36:18 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 11): &#8220;dynamic aerobic exercise&#8221; adapted individually, 60-minute sessions at 60% to 70% of maximum heart rate, 3/week</P>
<P>Control group (n = 11): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 08:39:51 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>psychological status, assessed using the General Health Questionnaire</LI>
<LI>cancer-specific quality of life: EORTC QLQ-C30</LI>
</UL>
<P>Outcomes measured at time point: 10 to 15 days after end of intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 08:39:57 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: not reported</P>
<P>Conflict of interest: not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:37:37 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Mutrie-2007">
<CHAR_METHODS MODIFIED="2016-08-27 10:32:03 +1000" MODIFIED_BY="[Empty name]">
<P>RCT; 2 groups, stratification for hospital and treatment</P>
<P>Study start and stop dates: recruitment from January 2004 to January 2005<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 10:32:57 +1000" MODIFIED_BY="[Empty name]">
<P>203 breast cancer patients during treatment, chemo- or radiotherapy or both</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:37:37 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention (n = 101): supervised 12-week group exercise 2 times/week, 45 minutes/session at moderate intensity (aerobic and strength). Participants encouraged to exercise 1x/week at home</P>
<P>Control (n = 102): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 10:42:34 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:</P>
<UL>
<LI>Cancer-specific quality of life: FACT-G</LI>
<LI>Cancer site-specific quality of life: FACT-B</LI>
<LI>Fatigue: FACT-F</LI>
<LI>Endocrine symptoms: FACT-ES</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Depression: BDI</LI>
<LI>Mood: PANAS</LI>
<LI>Physical functioning: 12-minute walk test</LI>
<LI>Shoulder mobility: shoulder mobility test</LI>
<LI>Physical activity: seven-day recall of physical activity (SPAQ)</LI>
<LI>Body composition: BMI</LI>
</UL>
<P>Outcomes measured at time point: baseline, 12 weeks (intervention: 82, control: 92), and 6-month follow-up (intervention: 82, control: 95), 18 months and 5 years after the intervention</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-08 03:41:44 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Cancer Research UK. One author was funded by the UK Medical Research Council.<BR/>
</P>
<P>Conflict of interest: None declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 10:51:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perna-2010">
<CHAR_METHODS MODIFIED="2016-08-27 10:46:32 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: recruitment between April 2001 and July 2005<BR/>Length of intervention: 3 months<BR/>Length of follow-up: end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 10:47:51 +1000" MODIFIED_BY="[Empty name]">
<P>51 breast cancer patients, sedentary lifestyle (i.e. exercise less than 3/week for greater than 30 min/session in last 6 months); numbers in each group not reported. Many (44.1%) women received both radiation and chemotherapy, 26.5% received radiation only, 8.8% received chemotherapy only, and 20.6% received no adjuvant therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 10:49:43 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention: individualised walking and resistance training program, 2 phases with a hospital-based portion followed by a transition to home-based exercise. Two 30-min exercise adherence counselling sessions during the hospital-based phase.</P>
<P>Hospital based: 3 times per week for 4 weeks, aerobic: treadmill walking at 50% to 70% of GXT-derived maximal heart rate (MHR). In subsequent weeks, duration was gradually increased by 5 min for a maximum of 40 min and a minimum of 30 min; intensity was increased to be within 70% to 85% of MHR according to participant comfort.</P>
<P>Home based: instructed to walk 3 times per week, encouraged to walk every day for 30 minutes or more.</P>
<P>Control: information control, 45 min session and informational brochure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 10:51:11 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Depression: CES-D</LI>
<LI>Physical activity: GLTEQ</LI>
</UL>
<P>Outcomes measured at baseline and 3 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 10:51:27 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: National Cancer Institute (CAR0178801) and National Institutes of Health, General Clinical Research Grant (M01RR00533)</P>
<P>Conflict of interest: Not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 11:01:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rao-2012">
<CHAR_METHODS MODIFIED="2016-08-27 10:57:02 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: all participants were diagnosed and treated between March 2009 and April 2011</P>
<P>Length of intervention: 4 to 6 months (duration of chemotherapy)<BR/>Length of follow-up: a median follow-up of 21.6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 10:59:19 +1000" MODIFIED_BY="[Empty name]">
<P>Women undergoing neoadjuvant chemotherapy for locally advanced, non-metastatic breast cancer.</P>
<P>Women had to have oestrogen receptor-positive breast cancer, a BMI greater than 25, and a Karnofsky score &gt; 80%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 10:59:27 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 5): home-based exercise program, supervised, one on one, 3 times per week. Aerobic exercises and light weight lifting.</P>
<P>Control (n = 5): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 11:01:18 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>"Improving fitness levels" (stated as an outcome in the trial registration)</LI>
<LI>Body composition: BMI, per cent body fat</LI>
<LI>Ki-67</LI>
<LI>C-peptide</LI>
<LI>Tumour size</LI>
</UL>
<P>Outcomes measured before and after neoadjuvant chemotherapy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 11:01:37 +1000" MODIFIED_BY="[Empty name]">
<P>ClinicalTrials.gov (NCT01411787)</P>
<P>Funding: Grant given by the Commercial Real Estate Women of Dallas</P>
<P>Conflict of interest: None declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 11:15:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reis-2013">
<CHAR_METHODS MODIFIED="2016-01-08 00:37:09 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: November 2008 to January 2010<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 11:13:42 +1000" MODIFIED_BY="[Empty name]">
<P>41 breast cancer patients randomised, stage I to III, starting adjuvant radiotherapy. 26 participants (13 in each group) additionally received chemotherapy, 19 (10 in the exercise group and 9 in the control group) received hormone therapy, the latter "typically after chemotherapy and radiation therapy"</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 11:14:03 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 22 randomised): Nia exercise ("cardiovascular and whole-body conditioning program") 20 to 60 minutes 3 x per week for 12 weeks, and 3 meetings with principal investigator</P>
<P>Control group (n = 19 randomised): usual care and 3 meetings with principal investigator, instructed to continue normal activities</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 11:15:40 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Fatigue: FACIT-F</LI>
<LI>Quality of life: FACT-G</LI>
<LI>Cardiorespiratory fitness: 6-MWT</LI>
<LI>Shoulder flexibility: goniometer</LI>
</UL>
<P>Outcomes were measured at start of radiation therapy, the completion of radiation therapy, and 6 weeks after completion of radiation therapy. Some participants received more than 6 weeks of radiotherapy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-25 01:52:38 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Not reported. </P>
<P>Conflict of interest: "No financial relationships to disclose."</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 11:31:23 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmidt-2014">
<CHAR_METHODS MODIFIED="2014-12-26 03:11:57 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: April 2010 and August 2013<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: "Follow-up data were also collected but not considered in the primary analyses"</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 11:20:54 +1000" MODIFIED_BY="[Empty name]">
<P>101 randomised patients with breast cancer under adjuvant chemotherapy<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 11:22:42 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 52): 12-week supervised machine-based progressive resistance training program, 60 minutes 2x/week, 3 sets, 8 to 12 repetitions at 60% to 80% of 1 repetition maximum (1-RM)</P>
<P>Control group (n = 49): supervised group-based progressive muscle relaxation training according to Jacobson, 60 minutes 2x/week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 11:30:41 +1000" MODIFIED_BY="[Empty name]">
<P>Primary endpoint:</P>
<UL>
<LI>Cancer-related fatigue: Fatigue Assessment Questionnaire (FAQ)</LI>
</UL>
<P>Secondary endpoints:</P>
<UL>
<LI>Cancer site-specific quality of life: EORTC QLQ-BR23 questionnaire</LI>
<LI>Depression: CES-D</LI>
<LI>Cognitive function: Trail Making Test</LI>
<LI>Safety of the resistance training during chemotherapy is monitored</LI>
<LI>Body composition: bioimpedance analysis, weight, height, waist and hip circumference</LI>
<LI>Muscle strength: isometric and isokinetic strength of representative muscle groups for upper and lower extremity measured at the IsoMed2000W</LI>
<LI>Cardiorespiratory fitness: spiroergometry (VO<SUB>2</SUB> peak)</LI>
<LI>Shoulder flexibility: range of motion measured at the IsoMed2000W</LI>
<LI>Biomarkers: inflammatory parameters, cortisol, and oxidative stress in blood, saliva, and urine</LI>
</UL>
<P>Outcomes measured during the first or second chemotherapy cycle pre-intervention (baseline) and postintervention (week 13)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 11:31:23 +1000" MODIFIED_BY="[Empty name]">
<P>BEATE study, ClinicalTrials.gov registration: NCT01106820</P>
<P>Funding: German Cancer Research Center (DKFZ), Division of Preventive Oncology. Foundations: &#8220;Stiftung Leben mit Krebs&#8221; and &#8220;Manfred-Lautenschlaeger-Stiftung&#8221;.</P>
<P>Conflict of interest: Not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:37:57 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Schwartz-2007-AET">
<CHAR_METHODS MODIFIED="2016-08-27 11:41:35 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, parallel 3-group design, stratified according to menopausal status (premenopausal or postmenopausal).</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 6 months<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 11:42:13 +1000" MODIFIED_BY="[Empty name]">
<P>72 breast cancer patients, stages I to III (histologically confirmed); planning to begin chemotherapy with doxorubicin or methotrexate and receiving a glucocorticoid as part of the antiemetic regimen.</P>
<P>Strenuous regular exercisers, that is women who exercised more than 250 minutes per week, were excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:37:57 +1000" MODIFIED_BY="Melina L Willson">
<P>
<B>Intervention group 1 (n = 22): 'Schwartz AET' Aerobic exercise training (participant preferences); 77% weight-bearing activities (walking/running), 15 to 30 minutes, 4 days per week</B>
</P>
<P>Intervention group 2 (n = 21): 'Schwartz RET' Resistance exercise (Thera-Band), 2 sets of 8 exercises (4 upper and 4 lower body)</P>
<P>Control group (n = 23): usual care, women were instructed to continue usual activities, were not instructed to avoid exercise<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 11:46:05 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cardiorespiratory fitness: 12-minute walk test</LI>
<LI>Strength: 1 repetition maximum</LI>
<LI>Bone mass density: Dual-energy X-ray absorptiometry</LI>
</UL>
<P>Outcomes measured at baseline and 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-11 01:07:18 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Not reported</P>
<P>Conflict of interest: Not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:38:01 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Schwartz-2007-RET">
<CHAR_METHODS MODIFIED="2016-08-27 11:48:35 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, parallel 3-group design, stratified according to menopausal status (premenopausal or postmenopausal).</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 6 months<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 11:49:41 +1000" MODIFIED_BY="[Empty name]">
<P>72 breast cancer patients, stages I to III (histologically confirmed); planning to begin chemotherapy with doxorubicin or methotrexate and receiving a glucocorticoid as part of the antiemetic regimen.</P>
<P>Strenuous regular exercisers, that is women who exercised more than 250 minutes per week, were excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:38:01 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention group 1 (n = 22): 'Schwartz AET' Aerobic exercise training (participant preferences); 77% weight-bearing activities (walking/running), 15 to 30 minutes, 4 days per week</P>
<P>
<B>Intervention group 2 (n = 21): 'Schwartz RET' Resistance exercise (Thera-Band), 2 sets of 8 exercises (4 upper and 4 lower body)</B>
</P>
<P>Control group (n = 23): usual care, women were instructed to continue usual activities, were not instructed to avoid exercise<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 11:50:53 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cardiorespiratory fitness: 12-minute walk test</LI>
<LI>Strength: 1 repetition maximum</LI>
<LI>Bone mass density: Dual-energy X-ray absorptiometry</LI>
</UL>
<P>Outcomes measured at baseline and 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-11 01:07:28 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Not reported</P>
<P>Conflict of interest: Not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:38:09 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Segal-2001-SD">
<CHAR_METHODS MODIFIED="2016-08-27 11:53:32 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: not reported</P>
<P>Length of intervention: 26 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 11:53:54 +1000" MODIFIED_BY="[Empty name]">
<P>123 patients within 2 weeks of the initiation of their prescribed adjuvant therapy (radiotherapy, hormonal therapy, or chemotherapy). Patients receiving only alternative or dose-intensive chemotherapy regimens were excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:38:04 +1000" MODIFIED_BY="Melina L Willson">
<P>
<B>Intervention group 1: 'Segal 2001 SD' self directed aerobic training (n = 40): progressive walking program at an exercise intensity of 50% to 60% of the predicted maximal oxygen uptake</B>
</P>
<P>Intervention group 2: 'Segal 2001 SU' supervised training (n = 42): progressive walking program at an exercise intensity of 50% to 60% of the predicted maximal oxygen uptake</P>
<P>Control group (n = 41): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-16 11:38:09 +1000" MODIFIED_BY="Melina L Willson">
<P>Primary outcome:</P>
<UL>
<LI>physical functioning scale of the SF-36</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>generic QoL: MOS SF-36</LI>
<LI>cancer-specific QoL: FACT-G</LI>
<LI>cancer site-specific QoL: FACT-B</LI>
<LI>cardiorespiratory fitness: mL of O<SUB>2</SUB>/kg/min</LI>
<LI>body composition: body weight</LI>
</UL>
<P>Outcomes measured at baseline and 26 weeks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-11 01:01:41 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: National Cancer Institute of Canada with funds from the Canadian Cancer Society (Grant in Aid of Research No. 7191)</P>
<P>Conflict of interest: Not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:38:15 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Segal-2001-SU">
<CHAR_METHODS MODIFIED="2016-08-27 11:59:57 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: not reported</P>
<P>Length of intervention: 26 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 12:00:19 +1000" MODIFIED_BY="[Empty name]">
<P>123 patients within 2 weeks of the initiation of their prescribed adjuvant therapy (radiotherapy, hormonal therapy, or chemotherapy). Patients receiving only alternative or dose-intensive chemotherapy regimens were excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:38:15 +1000" MODIFIED_BY="Melina L Willson">
<P>Intervention group 1: 'Segal 2001 SD' self directed aerobic training (n = 40): progressive walking program at an exercise intensity of 50% to 60% of the predicted maximal oxygen uptake</P>
<P>
<B>Intervention group 2: 'Segal 2001 SU' supervised training (n = 42): progressive walking program at an exercise intensity of 50% to 60% of the predicted maximal oxygen uptake</B>
<BR/>Control group (n = 41): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 12:01:42 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome:</P>
<UL>
<LI>physical functioning scale of the SF-36</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>generic QoL: MOS SF-36</LI>
<LI>cancer-specific QoL: FACT-G</LI>
<LI>cancer site-specific QoL: FACT-B</LI>
<LI>cardiorespiratory fitness: mL of O<SUB>2</SUB>/kg/min</LI>
<LI>body composition: body weight</LI>
</UL>
<P>Outcomes measured at baseline and 26 weeks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-11 01:01:54 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: National Cancer Institute of Canada with funds from the Canadian Cancer Society (Grant in Aid of Research No. 7191)</P>
<P>Conflict of interest: Not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 12:20:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steindorf-2014">
<CHAR_METHODS MODIFIED="2015-08-17 04:28:58 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: February 2011 and March 2013<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: end of intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 12:04:18 +1000" MODIFIED_BY="[Empty name]">
<P>160 randomised participants with breast cancer (stage I to III after lumpectomy or mastectomy) undergoing adjuvant radiotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 12:06:15 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 80): supervised machine-based progressive resistance training, 60 minutes, 2x/week, 3 sets, 8 to 12 repetitions at 60% to 80% of 1 repetition maximum</P>
<P>Control (n = 80): supervised muscle relaxation training according to Jacobson, 60 minutes 2x/week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 12:19:48 +1000" MODIFIED_BY="[Empty name]">
<P>Primary endpoint:</P>
<UL>
<LI>Cancer-related fatigue: Fatigue Assessment Questionnaire (FAQ)</LI>
</UL>
<P>Secondary endpoints:</P>
<UL>
<LI>Quality of life: EORTC QLQ-BR23 questionnaire</LI>
<LI>Depression: CES-D</LI>
<LI>Cognitive function: Trail Making Test</LI>
<LI>Body composition: bioimpedance analysis, weight, height, waist and hip circumference</LI>
<LI>Muscle strength: isometric and isokinetic strength of representative muscle groups for upper and lower extremity measured at the IsoMed2000W</LI>
<LI>Cardiorespiratory fitness: spiroergometry (VO<SUB>2 </SUB>peak)</LI>
<LI>Flexibility: range of motion measured at the IsoMed2000W</LI>
<LI>Biomarkers</LI>
</UL>
<P>Outcomes measured before start of radiotherapy (baseline, T0), postradiotherapy (week 7, T1), and postintervention (week 13, T2)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 12:20:40 +1000" MODIFIED_BY="[Empty name]">
<P>BEST study, registered at ClinicalTrials.gov (NCT01468766)</P>
<P>Funding: Interdisciplinary Research Funding Program (intramural) of the National Center for Tumor Diseases (NCT), Heidelberg, Germany (grant number IFP project VI.1); foundations &#8220;Stiftung Leben mit Krebs&#8221; and the "Manfred-Lautenschlaeger-Stiftung&#8221;</P>
<P>Conflict of interest: None declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 14:31:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Travier-2015">
<CHAR_METHODS MODIFIED="2016-08-27 14:18:49 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: conducted between 2010 and 2013</P>
<P>Length of intervention: 18 weeks</P>
<P>Length of follow-up: 18 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 14:19:48 +1000" MODIFIED_BY="[Empty name]">
<P>Patients with breast or colon cancer undergoing cancer treatment (204 breast cancer patients of 237 patients in total), intervention started 6 weeks postdiagnosis. Unpublished data (final values) for breast cancer patients used in the analyses of this review<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 14:20:41 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 102): supervised group exercise (aerobic and resistance) program based on Bandura&#8217;s social cognitive theory</P>
<P>Control (n = 102): asked to maintain their habitual physical activity pattern</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 14:31:19 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome:</P>
<UL>
<LI>fatigue: MFI and FQL</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>HRQoL: SF-36</LI>
<LI>cancer-specific quality of life: EORTC QLQ-C30 (Version 3)</LI>
<LI>anxiety and depression: HADS (Dutch version)</LI>
<LI>physical fitness: VO<SUB>2 </SUB>peak; peak power output</LI>
<LI>strength: thigh muscle strength, handgrip strength</LI>
<LI>body composition: BMI, body fat distribution</LI>
<LI>physical activity level: Short QUestionnaire to ASsess Health enhancing physical activity (SQUASH)</LI>
<LI>self efficacy about the performance of physical activity (design paper)</LI>
<LI>perceived impact of the disease on participation and autonomy assessed: Impact on Participation and Autonomy (IPA) questionnaire (design paper)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 14:27:19 +1000" MODIFIED_BY="[Empty name]">
<P>Trial registration: Current Controlled Trials (ISRCTN43801571), Dutch Trial Register (NTR2138)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:38:25 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-van-Waart-2014-high">
<CHAR_METHODS MODIFIED="2016-01-11 00:57:18 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: recruitment between March 2010 and December 2012<BR/>Length of intervention: approximately 20 weeks</P>
<P>Length of follow-up: 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 14:39:04 +1000" MODIFIED_BY="[Empty name]">
<P>Patients with breast or colon cancer receiving adjuvant chemotherapy, 230 patients with breast cancer of 253 patients in total.</P>
<P>Both intervention groups started exercising in the week of the first cycle of chemotherapy and continued until 3 weeks after the last cycle of chemotherapy. Mean length of chemotherapy 119.6 days (17 weeks)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:38:25 +1000" MODIFIED_BY="Melina L Willson">
<P>1. Intervention group (n = 77): Onco-Move, a relatively low-intensity, home-based, individualised, self managed physical activity program</P>
<P>
<B>2. Intervention group (n = 76): OnTrack, a relatively high-intensity exercise program supervised by a physical therapist in an outpatient or general physical therapy practice setting</B>
</P>
<P>3. Control group (n = 77): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-09 20:26:27 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Primary outcomes:</P>
<UL>
<LI>Cardiorespiratory fitness: Steep Ramp Test; endurance test at 70% of the estimated maximal workload</LI>
<LI>Muscle strength: microFET handheld dynamometer for elbow flexion and knee extension; grip strength dynamometer; lower limb muscle endurance with the 30-second chair stand test</LI>
<LI>Fatigue: MFI; FQL</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Cancer-specific quality of life: EORTC QLQ-C30</LI>
<LI>Chemotherapy completion rates</LI>
<LI>Psychological distress: HADS</LI>
<LI>Self reported physical activity level: Physical Activity Scale for the Elderly</LI>
<LI>Functioning in daily life: Impact on Participation and Autonomy</LI>
<LI>Quality of sleep: Pittsburgh Sleep Quality Index</LI>
<LI>Return to work: Return to work questionnaire (study specific)</LI>
<LI>Anthropometric measures: skinfold measurements (Harpenden); waist and hip circumferences</LI>
</UL>
<P>Outcomes assessed: before random assignment and start of chemotherapy (T0), at completion of chemotherapy (T1), and 6 months after completion of chemotherapy (T2)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 14:45:44 +1000" MODIFIED_BY="[Empty name]">
<P>Published protocol. Trial registration: The Netherlands Trial Register (NTR 2159)</P>
<P>Funding: Supported by Alpe d'Huzes/Dutch Cancer Society Grant No. ALPE-2009-4299, the CZ Fund, Zilveren Kruis Achmea, and the Comprehensive Cancer Centre of the Netherlands.</P>
<P>Conflicts of interest: 2 authors disclosed research funding by pharmaceutical companies</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-16 11:38:29 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-van-Waart-2014-low">
<CHAR_METHODS MODIFIED="2016-01-11 00:57:42 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: recruitment between March 2010 and December 2012<BR/>Length of intervention: approximately 20 weeks</P>
<P>Length of follow-up: 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 14:51:51 +1000" MODIFIED_BY="[Empty name]">
<P>Patients with breast or colon cancer receiving adjuvant chemotherapy, 230 patients with breast cancer of 253 patients in total.</P>
<P>Both intervention groups started exercising in the week of the first cycle of chemotherapy and continued until 3 weeks after the last cycle of chemotherapy. Mean length of chemotherapy 119.6 days (17 weeks)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-09-16 11:38:29 +1000" MODIFIED_BY="Melina L Willson">
<P>
<B>1. Intervention group (n = 77): Onco-Move, a relatively low-intensity, home-based, individualised, self managed physical activity program</B>
</P>
<P>2. Intervention group (n = 76): OnTrack, a relatively high-intensity exercise program supervised by a physical therapist in an outpatient or general physical therapy practice setting</P>
<P>3. Control group (n = 77): usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 14:54:31 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:</P>
<UL>
<LI>Cardiorespiratory fitness: Steep Ramp Test; endurance test at 70% of the estimated maximal workload</LI>
<LI>Muscle strength: microFET handheld dynamometer for elbow flexion and knee extension; grip strength dynamometer; lower limb muscle endurance with the 30-second chair stand test</LI>
<LI>Fatigue: MFI; FQL</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Cancer-specific quality of life: EORTC QLQ-C30</LI>
<LI>Chemotherapy completion rates</LI>
<LI>Psychological distress: HADS</LI>
<LI>Self reported physical activity level: Physical Activity Scale for the Elderly</LI>
<LI>Functioning in daily life: Impact on Participation and Autonomy</LI>
<LI>Quality of sleep: Sleep Quality Inventory</LI>
<LI>Return to work: Return to work questionnaire (study specific)</LI>
<LI>Anthropometric measures: skinfold measurements (Harpenden); waist and hip circumferences</LI>
</UL>
<P>Outcomes assessed: before random assignment and start of chemotherapy (T0), at completion of chemotherapy (T1), and 6 months after completion of chemotherapy (T2)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 14:55:01 +1000" MODIFIED_BY="[Empty name]">
<P>Published protocol. Trial registration: The Netherlands Trial Register (NTR 2159)</P>
<P>Funding: Supported by Alpe d'Huzes/Dutch Cancer Society Grant No. ALPE-2009-4299, the CZ Fund, Zilveren Kruis Achmea, and the Comprehensive Cancer Centre of the Netherlands.</P>
<P>Conflicts of interest: 2 authors disclosed research funding by pharmaceutical companies</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 15:02:55 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Visovsky-2014">
<CHAR_METHODS MODIFIED="2016-08-27 14:57:10 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: final enrolment completed August 2010, otherwise not reported<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: 12 weeks' postintervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 14:57:23 +1000" MODIFIED_BY="[Empty name]">
<P>Breast cancer patients receiving weekly paclitaxel for 2 months, randomisation after 4 cycles of doxorubicin and cyclophosphamide were completed, and prior to the first paclitaxel infusion</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 14:59:36 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 9): home-based aerobic (walking and progressive interval training) and resistance exercises for upper and lower extremities using resistance power bands. Brisk walking 5 to 7 days per week for the first 4 weeks, weeks 4 to 12 interval-based workout consisting of light- to moderate-intensity exercises performed for 30 minutes.<BR/>Strength training sessions: 3 times/week, initially: 1 to 2 sets of each exercise for 8 repetitions 1 to 2 times per week. From week 4, the number of sets was increased to 2 to 3 sets and 8 to 12 repetitions of each exercise per session.</P>
<P>Control group (n = 10): breast cancer educational information, avoiding those topics related to exercise/physical activity in order to prevent contamination between groups. Educational sessions at the same intervals as intervention group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 15:02:34 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Neuropathic symptoms: FACT-Taxane</LI>
<LI>Cancer-specific quality of life: FACT-G</LI>
<LI>Gait and balance: Timed Get-up and Go Test</LI>
<LI>Symptom experience: Symptom Experience Scale</LI>
</UL>
<P>Outcomes were assessed at baseline, 4 weeks, 12 weeks, 24 weeks.</P>
<P>Adverse events: No injuries or falls were reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-27 15:02:55 +1000" MODIFIED_BY="[Empty name]">
<P>Funding: This study was supported by a grant from the University of Nebraska Medical Center, Eppley Cancer Center, Dean&#8217;s Grant.<BR/>
</P>
<P>Conflict of interest: None reported.</P>
<P>Registered prospectively on ClinicalTrials.gov: NCT00869804</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-09-10 23:30:22 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Winningham-1988">
<CHAR_METHODS MODIFIED="2016-08-27 15:24:01 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 3 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 10 weeks<BR/>Length of follow-up: end of intervention<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 15:24:50 +1000" MODIFIED_BY="[Empty name]">
<P>42 breast cancer patients, after surgery, receiving chemotherapy, within the first 6 months of chemotherapy, but having had at least 3 treatments prior to entering the study program, not on doxorubicin, Karnofsky 60% to 100%. None of the participants received antiemetic medication</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 15:31:15 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 16): aerobic training (cycling, interval training), 60% to 85% HRmax, 20 to 30 min per session, 3/week, 10 weeks, supervised</P>
<P>Control group 1 (n = 12): no intervention</P>
<P>Control group 2 (n = 14): "placebo" mild stretching, conversation, 1/week, supervised</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-10 23:30:22 +1000" MODIFIED_BY="Anna C Furmaniak">
<UL>
<LI>Nausea: Symptom Checklist 90 Revised (SCL-90-R)</LI>
<LI>Somatisation: SCL-90-R</LI>
</UL>
<P>Outcomes measured at baseline and end of intervention<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-08 00:23:05 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Not reported</P>
<P>Conflict of interest: Not reported<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-27 15:45:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2011">
<CHAR_METHODS MODIFIED="2016-08-27 15:37:05 +1000" MODIFIED_BY="[Empty name]">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: 2008 to 2009<BR/>Length of intervention: 12 weeks<BR/>Length of follow-up: end of intervention<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-17 04:16:36 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>44 sedentary breast cancer patients randomised, 40 completed the study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 15:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 19): home-based walking program, developed using the American College of Sports Medicine guidelines. Walking starting 2 to 3 days after each chemotherapy session, included 5 minutes warm-up, 30 minutes brisk walking (60% to 80% of age-adjusted HRmax), 5 minutes cool-down</P>
<P>Control group (n = 21): maintenance of their previous lifestyle for 12 weeks<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 15:45:52 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>symptom severity: MDASI-T</LI>
<LI>symptom interference with daily life: MDASI-T</LI>
<LI>emotional distress: Profile of Mood States-Short Form</LI>
<LI>self reported physical activity level: Seven-Day Physical Activity Recall</LI>
</UL>
<P>Outcomes measured at baseline, 6 and 12 weeks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-05 03:16:55 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Funding: Taipei Medical University Hospital (95TMU-TMUH-19), Taipei, Taiwan, Republic of China.</P>
<P>Conflict of interest: None declared</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>6-MWT: 6-minute walk test<BR/>ACSM: American College of Sports Medicine<BR/>BDI: Beck Depression Inventory<BR/>BMI: body mass index<BR/>CES-D: Center for Epidemiological Studies-Depression Scale<BR/>DASH: Disabilities of the Arm, Shoulder and Hand Questionnaire<BR/>DEXA: dual-energy X-ray absorptiometry<BR/>EORTC QLQ-BR23: European Organisation for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire<BR/>EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 36<BR/>FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue Scale<BR/>FACT-An: Functional Assessment of Cancer Therapy-Anaemia<BR/>FACT-B: Functional Assessment of Cancer Therapy-Breast<BR/>FACT-ES: Functional Assessment of Cancer Therapy-Endocrine Symptoms<BR/>FACT-G: Functional Assessment of Cancer Therapy-General<BR/>FACT-Taxane: Functional Assessment of Cancer Therapy-Taxane<BR/>FQL: Fatigue Quality List<BR/>GLTEQ: Godin Leisure-Time Exercise Questionnaire<BR/>GXT: Graded Exercise Test<BR/>HADS: Hospital Anxiety and Depression Scale<BR/>HRmax: maximum heart rate<BR/>HRQoL: health-related quality of life<BR/>IPAQ: International Physical Activity Questionnaire<BR/>IQR: interquartile range<BR/>ITT: intention-to-treat<BR/>L-Dex: lymphoedema index<BR/>MDASI-T: Taiwanese version of the MD Anderson Symptom Inventory<BR/>MET: metabolic equivalent of task<BR/>MFI: Multidimensional Fatigue Inventory<BR/>MOS SF-36: Medical Outcomes Study 36-Item Short Form Health Survey<BR/>MQOLS-CA: Multidimensional Quality of Life Scale-Cancer<BR/>MVPA: moderate to vigorous physical activity<BR/>QoL: quality of life<BR/>QR: Quartile Range<BR/>PAL: physical activity level<BR/>PANAS: Positive and Negative Affect Schedule<BR/>PFS: Piper Fatigue Scale<BR/>POMS: Profile of Mood States<BR/>RCT: randomised controlled trial<BR/>SD: standard deviation<BR/>SF-36: 36-Item Short Form Health Survey<BR/>SPAQ: Scottish Physical Activity Questionnaire<BR/>SWLS: Satisfaction With Life Scale<BR/>VO<SUB>2</SUB> max: maximal oxygen uptake</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-08-27 16:38:19 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:51:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aaronson-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:51:20 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:12:36 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Adamsen-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:12:36 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:53:41 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Aghili-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:53:41 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Duration of exercise intervention less than 6 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:53:47 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Backman-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:53:47 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:51:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Banasik-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:51:30 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:12 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Banerjee-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:12 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:51:35 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Basen-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:51:35 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:14:03 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Baumann-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:14:03 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:14:07 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Baumann-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:14:07 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-05 20:26:26 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Bower-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-05 20:26:26 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Burnham-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Exercise intervention not concurrent with adjuvant cancer treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:51:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cantarero_x002d_Villanueva-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:51:44 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:51:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cantarero_x002d_Villanueva-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:51:48 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:51:51 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carson-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:51:51 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:16:43 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Charbonnier-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:16:43 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:54:18 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Chetiyawardana-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:54:18 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Radiotherapy ongoing for maximum 3 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:52:21 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Courneya-2003a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:52:21 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients (40%), exercise as part of a complex intervention (group psychotherapy plus exercise)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:52:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Courneya-2003b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:52:06 +1000" MODIFIED_BY="[Empty name]">
<P>Exercise intervention not concurrent with adjuvant cancer treatment (&lt; 50% under current hormone therapy)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:52:13 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Courneya-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:52:13 +1000" MODIFIED_BY="[Empty name]">
<P>Participants were post-treatment. Exercise intervention not concurrent with adjuvant cancer treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:52:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Culos_x002d_Reed-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:52:27 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:16 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Danhauer-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:16 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:52:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Demark_x002d_Wahnefried-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:52:48 +1000" MODIFIED_BY="[Empty name]">
<P>No clinical trial, protocol status, exercise as part of a complex intervention (diet and exercise-based counselling program)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 02:01:48 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Demark_x002d_Wahnefried-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 02:01:48 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>No clinical trial, design paper</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:17:40 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Demark_x002d_Wahnefried-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:17:40 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Complex intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:17:39 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Demark_x002d_Wahnefried-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:17:39 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Complex intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-25 20:11:40 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Demark_x002d_Wahnefried-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-25 20:11:40 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Complex intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dimeo-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:00 +1000" MODIFIED_BY="[Empty name]">
<P>Participants not predominantly breast cancer patients<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Duijts-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:04 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Duijts-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:06 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Emami-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:09 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ergun-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:11 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fairey-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Exercise intervention not concurrent with adjuvant cancer treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fairey-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:22 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fairey-2005a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:24 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernandez-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:26 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:19:24 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Galantino-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:19:24 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>No exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 02:01:31 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Given-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 02:01:31 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 02:01:34 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Gomes-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 02:01:34 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gomez-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:32 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:56:12 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Griffith-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:56:12 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-26 01:08:43 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Hartmann-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-26 01:08:43 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hatchett-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:37 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herrero-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:40 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ho-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>No exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:59:45 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Huang-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:59:45 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>No health-related outcome measure (adherence study)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Irwin-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:47 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Irwin-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:48 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:51 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Irwin-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:51 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Janelsins-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:52 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:53:55 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:53:55 +1000" MODIFIED_BY="[Empty name]">
<P>Complex intervention: exercise and stress management training</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:54:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kleine_x002d_Tebbe-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:54:09 +1000" MODIFIED_BY="[Empty name]">
<P>Data were not analysed to be used for a full publication (personal communication September 2013)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:20:59 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Kohler-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:20:59 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:20 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Kovacic-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:20 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Latikka-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>No clinical trial, review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:54:35 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Latka-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:54:35 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:22:17 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Lauridsen-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:22:17 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Exercise restricted to shoulder</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:55:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:55:22 +1000" MODIFIED_BY="[Empty name]">
<P>Qigong</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:55:41 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ligibel-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:55:41 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:55:44 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ligibel-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:55:44 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:55:46 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ligibel-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:55:46 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:57:13 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-MacVicar-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:57:13 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:57:21 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Mamom-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:57:21 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Duration of exercise intervention less than 6 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:55:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martin-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:55:52 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:57:26 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Maryam-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:57:26 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:55:56 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McGuire-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:55:56 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-McKenzie-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention and adjuvant treatment not concurrent</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:57:32 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Milecki-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:57:32 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Radiotherapy ongoing for maximum 5 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:24 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Moadel-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:24 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mock-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Exercise as part of a complex intervention (walking plus support group)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-01-08 01:57:40 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Mock-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-01-08 01:57:40 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:12 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mock-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:12 +1000" MODIFIED_BY="[Empty name]">
<P>Trial does not compare 2 groups as assigned by investigator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mock-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>No exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-29 04:15:40 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Moller-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-29 04:15:40 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:17 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mulero-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:17 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Murtezani-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:19 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Musanti-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:22 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mustian-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>No clinical trial, review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mustian-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:38 +1000" MODIFIED_BY="[Empty name]">
<P>Less than 6 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pickett-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>No health-related outcome measure (adherence study)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pinto-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Exercise intervention not concurrent with adjuvant cancer treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pinto-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:45 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:47 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pinto-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:47 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:49 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rabin-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:49 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-05 20:26:33 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Raghavendra-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-05 20:26:33 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:52 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rahnama-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:52 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:29 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Rao-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:29 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:35 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Rao-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:35 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:56:56 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rogers-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:56:56 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:27:01 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Sandel-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:27:01 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an exercise intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmitz-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:00 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwartz-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:03 +1000" MODIFIED_BY="[Empty name]">
<P>Trial does not compare 2 groups as assigned by investigator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:08 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwartz-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:08 +1000" MODIFIED_BY="[Empty name]">
<P>Trial does not compare 2 groups as assigned by investigator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scott-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:11 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Segar-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Exercise intervention not concurrent with adjuvant cancer treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-07-21 01:52:52 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Shaw-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-07-21 01:52:52 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>No clinical trial, protocol status, exercise as part of a complex intervention (calcium-rich diet and exercise)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:27:34 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-So-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:27:34 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sprod-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:21 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-05 20:28:58 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Stevinson-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-05 20:28:58 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Commentary</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-05-25 20:14:38 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Swenson-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-05-25 20:14:38 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Complex intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:28:20 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Swenson-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:28:20 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Complex intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Twiss-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:25 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-26 01:42:40 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Vadiraja-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-26 01:42:40 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Yoga</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-05 20:28:52 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Vadiraja-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-05 20:28:52 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Commentary</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vallance-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:29 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vallance-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:31 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vallance-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:34 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-12-06 07:28:41 +1100" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Vincent-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-12-06 07:28:41 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:57:38 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Waltman-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:57:38 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:58:06 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:58:06 +1000" MODIFIED_BY="[Empty name]">
<P>Exercise intervention does not coincide with adjuvant therapy at least 6 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-07-21 01:52:30 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-Wilkie-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-07-21 01:52:30 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Participants not predominantly breast cancer patients (63% female), duration of intervention programme 4 weeks</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:58:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yeh-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:58:25 +1000" MODIFIED_BY="[Empty name]">
<P>Qigong</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-08-27 15:58:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yuen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-08-27 15:58:32 +1000" MODIFIED_BY="[Empty name]">
<P>Post-treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2016-08-27 16:48:45 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2016-08-27 16:42:58 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lotzke-2016">
<CHAR_METHODS MODIFIED="2016-08-02 14:13:09 +1000" MODIFIED_BY="Melina L Willson">
<P>RCT, 2 groups</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 16:39:14 +1000" MODIFIED_BY="[Empty name]">
<P>Women with stage I to III breast cancer during (neo-)adjuvant therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 16:42:18 +1000" MODIFIED_BY="[Empty name]">
<P>Weekly 60-minute physical exercise session together with individual home-based, self contained 20-minute sessions twice a week.</P>
<P>Control group: weekly 60-minute Iyengar yoga session together with individual home-based, self contained 20-minute sessions twice a week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 16:42:58 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Health-related quality of life: EORTC QLQ-C30</LI>
<LI>Fatigue: Cancer Fatigue Scale German</LI>
<LI>Life satisfaction: Brief Multidimensional Life Satisfaction Scale (BMLSS)</LI>
<LI>Mindfulness: Freiburg Mindfulness Inventory (FMI)</LI>
<LI>Spiritual/religious attitudes and disease coping (SpREUK-SF 10)</LI>
<LI>"Inner Correspondence and Peaceful Harmony with Practices&#8220; (ICPH)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2016-08-27 16:48:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petrella-2012">
<CHAR_METHODS MODIFIED="2015-12-06 07:29:11 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
<P>Study start and stop dates: not reported<BR/>Length of intervention: 6 months<BR/>Length of follow-up: 6 months after the end of the intervention</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 16:46:09 +1000" MODIFIED_BY="[Empty name]">
<P>Women who were within 4 to 12 weeks of surgery for stage I to III breast cancer and undergoing adjuvant chemotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 16:46:22 +1000" MODIFIED_BY="[Empty name]">
<P>Structured exercise program (6 months), aerobic and resistance training</P>
<P>Control group: usual oncology care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 16:48:45 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>cancer-specific quality of life: FACT-B</LI>
<LI>quality of life: SF-36</LI>
<LI>body composition: weight, waist circumference, waist-hip ratio, per cent body fat</LI>
<LI>cardiorespiratory fitness: peak oxygen</LI>
<LI>strength</LI>
<LI>arm volume</LI>
</UL>
<P>Outcomes assessed at: baseline and 3-month intervals through 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-07-23 22:52:22 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 36<BR/>FACT-B: Functional Assessment of Cancer Therapy-Breast<BR/>RCT: randomised controlled trial<BR/>SF-36: 36-Item Short Form Health Survey<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-09-10 23:31:24 +1000" MODIFIED_BY="Anna C Furmaniak" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-08-27 17:01:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-ACTRN12614000051640">
<CHAR_STUDY_NAME MODIFIED="2014-07-22 03:00:33 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Preventing &#8216;chemo-brain&#8217;: Can exercise mitigate chemotherapy-induced cognitive impairment in breast cancer patients?</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-07-22 03:04:33 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 16:50:07 +1000" MODIFIED_BY="[Empty name]">
<P>Breast cancer patients scheduled to receive adjuvant chemotherapy with fluorouracil-epirubicin-cyclophosphamide-docetaxel (FEC-T) or docetaxel-cyclophosphamide (TC) regimens, target sample size: 66</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 16:52:45 +1000" MODIFIED_BY="[Empty name]">
<P>Combination of resistance (i.e. lifting weights) and aerobic exercise (e.g. walking, jogging, cycling), 2 times/week in an exercise clinic. moderate to high intensity (i.e. a perceived exertion of somewhat hard to hard) and will be relative to each participant's capabilities. Progressive exercise prescription, modified according to individual response.</P>
<P>Approximately 60 min/session, small groups under the supervision of an accredited exercise physiologist.</P>
<P>Length of program: will vary from 2.5 to 4 months according to the duration of the chemotherapy regimen</P>
<P>Control group: usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 17:01:31 +1000" MODIFIED_BY="[Empty name]">
<P>Primary outcome:</P>
<UL>
<LI>Cognitive function: Hopkins Verbal Learning Test-Revised, Trail Making Test, Controlled Oral Word Association of the Multilingual Aphasia Examination.</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Quality of life: Medical Outcomes Study 36-Item Short Form Health Survey, Functional Assessment of Cancer Therapy for patients with breast cancer questionnaire</LI>
<LI>Psychological distress: Brief Symptom Inventory-18 (BSI-18), Hospital Anxiety and Depression Scale (HADS)</LI>
<LI>Fatigue: Functional Assessment of Chronic Illness Therapy-Fatigue</LI>
<LI>Neuropathies: Functional Assessment of Cancer Therapy-Neurotoxicity</LI>
<LI>Musculoskeletal symptoms including myalgias and arthralgias: Muscle and Joint Measure questionnaire</LI>
<LI>Sleep quality: Insomnia Severity Index</LI>
<LI>Physical function: 400-m walk (aerobic capacity), 1 repetition maximum in the leg press (muscular strength), repeated chair rise (muscular power), usual and fast pace 6-m walk (ambulation), backwards tandem 6-m walk (dynamic balance), and Sensory Organization Test (static balance)</LI>
<LI>Physical activity level: Godin Leisure-Time Exercise Questionnaire</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-02-05 15:20:07 +1100" MODIFIED_BY="Melina L Willson">
<P>June 2014 first participant enrolment</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-07-22 02:58:50 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Dr Prue Cormie ECU Health and Wellness Institute Edith Cowan University 270 Joondalup Drive Joondalup, WA 6027, Australia</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-11-29 08:22:13 +1100" MODIFIED_BY="Anna C Furmaniak"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-08-28 04:55:14 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT01943695">
<CHAR_STUDY_NAME MODIFIED="2016-08-27 17:02:09 +1000" MODIFIED_BY="[Empty name]">
<P>Aerobic training during or after adjuvant therapy</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-07-22 02:53:08 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 4 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 17:02:25 +1000" MODIFIED_BY="[Empty name]">
<P>Sedentary breast cancer patients, estimated enrolment: 160 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 17:08:46 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Aerobic training during therapy: target of 3 treadmill walking sessions/week at 60% to 85% of baseline VO<SUB>2 </SUB>peak for 150 minutes/week.</LI>
<LI>Aerobic training after therapy: target of 3 treadmill walking sessions/week at 60% to 85% of baseline VO<SUB>2 </SUB>peak for 150 minutes/week.</LI>
<LI>Continuous aerobic training: This group will follow the identical aerobic training during and after therapy prescription as described for Groups 1 and 2 for the first 24 weeks (i.e. during therapy). After primary therapy (i.e. at ~24 weeks, T1), the aerobic training prescription will be re-prescribed based on the end-of-therapy VO<SUB>2 </SUB>peak assessment (at T1) with the goal of 3 exercise sessions per week, for 30 to 45 minutes/session at 60% to 85% of VO<SUB>2 </SUB>peak.</LI>
<LI>Control group: educational information.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-28 04:55:14 +1000" MODIFIED_BY="[Empty name]">
<P>Primary:</P>
<UL>
<LI>Change in VO<SUB>2</SUB> peak (functional capacity)</LI>
</UL>
<P>Secondary:</P>
<UL>
<LI>Quality of life</LI>
<LI>Sleeping patterns</LI>
<LI>Depression</LI>
<LI>Physical activity</LI>
<LI>Skeletal muscle function</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-11-29 08:21:52 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>January 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-08-27 17:10:19 +1000" MODIFIED_BY="[Empty name]">
<P>Lee W Jones Duke University Medical Center Durham, NC, USA, 27710</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-11-29 08:21:53 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Estimated study completion date: August 2017</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-08-27 17:14:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02117011">
<CHAR_STUDY_NAME MODIFIED="2016-08-27 17:11:12 +1000" MODIFIED_BY="[Empty name]">
<P>Effects of a structured exercise program on cancer-related fatigue in women receiving radiation therapy for breast cancer</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-08-10 11:38:54 +1000" MODIFIED_BY="Melina L Willson">
<P>RCT, estimated enrolment: 30</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 17:12:46 +1000" MODIFIED_BY="[Empty name]">
<P>African-Americans undergoing radiation therapy for localised breast cancer.</P>
<P>Sedentary, as defined as &lt; 60 minutes of recreation or work requiring modest physical activity/week based on the 7-day physical activity recall questionnaire.</P>
<P>Having completed neo-adjuvant or adjuvant chemotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 17:13:51 +1000" MODIFIED_BY="[Empty name]">
<P>8-week, moderate-intensity aerobic exercise program</P>
<P>Participants will be required to meet and maintain a goal of 75 min/week of aerobic exercise by using portable cycle ergometers, that is 15 min/day, 5 days/week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 17:14:15 +1000" MODIFIED_BY="[Empty name]">
<P>Fatigue: FACIT-F</P>
<P>Cancer-specific quality of life: FACT-G</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-04-06 01:49:29 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>June 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-11-29 08:21:00 +1100" MODIFIED_BY="Anna C Furmaniak"/>
<CHAR_NOTES MODIFIED="2016-05-30 00:06:08 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Estimated study completion date: December 2016</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-08-27 17:21:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02159157">
<CHAR_STUDY_NAME MODIFIED="2016-08-27 17:16:06 +1000" MODIFIED_BY="[Empty name]">
<P>A randomized, controlled trial to determine the effects of an exercise intervention on physical activity during chemotherapy for patients with early stage breast cancer</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-05-30 00:07:13 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 17:18:53 +1000" MODIFIED_BY="[Empty name]">
<P>Women or men with histologically confirmed breast cancer and no evidence of metastatic disease with a recommendation to begin chemotherapy within 4 weeks.</P>
<P>Sedentary: participants must have a baseline activity level of &lt; 150 minutes/wk of moderate to vigorous activity as calculated using the moderate to vigorous components of the Leisure-Time Exercise Questionnaire for physical activity (completed during screening).</P>
<P>Karnofsky performance status &gt; or = to 80%.</P>
<P>Estimated enrolment: 120 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 17:19:29 +1000" MODIFIED_BY="[Empty name]">
<P>A physical therapist will design an exercise plan for each participant on the intervention arm. The participants randomised to the intervention arm will also receive phone calls to assist with tracking the study participant's exercise and motivating the study participant to adhere to the exercise prescription.</P>
<P>Exercise prescription aimed at increasing physical activity by a minimum of 10 MET hours/week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 17:21:37 +1000" MODIFIED_BY="[Empty name]">
<P>Primary:</P>
<UL>
<LI>Change in activity: Activity Log</LI>
</UL>
<P>Secondary:</P>
<UL>
<LI>Received dose intensity of chemotherapy</LI>
<LI>Fatigue: FACIT-F</LI>
<LI>Body composition: % of total body fat, bone density (g/cm<SUP>2</SUP>), and T score, change in waist-hip ratio from baseline</LI>
<LI>Change in resting heart rate from baseline</LI>
<LI>Change in steps recorded from baseline: pedometer data</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-04-06 01:26:24 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>June 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-05-30 00:06:59 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Contact: Mary Chamberlin, MD</P>
<P>
<A HREF="mailto:Cancer.Research.Nurse%40Dartmouth.edu?subject=NCT02159157,%20D12030,%20A%20Randomized,%20Controlled%20Trial%20to%20Determine%20the%20Effects%20of%20an%20Exercise%20Intervention%20on%20Physical%20Activity%20During%20Chemotherapy%20for%20Patients%20With%20Early%20Stage%20Breast%20Cancer">Cancer.Research.Nurse@Dartmouth.edu</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-11-29 08:20:49 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Estimated primary completion rate: June 2017 (Final data collection date for primary outcome measure)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-08-27 17:31:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02240836">
<CHAR_STUDY_NAME MODIFIED="2016-08-27 17:22:26 +1000" MODIFIED_BY="[Empty name]">
<P>Energy Balance and Breast Cancer Aspects-II (EBBA-II)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-05-29 23:42:38 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT, 2 groups</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 17:25:32 +1000" MODIFIED_BY="[Empty name]">
<P>Newly diagnosed breast cancer patients undergoing adjuvant therapy, DCIS grade 3, stage I + II breast cancer</P>
<P>Estimated enrolment: 600 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 17:27:37 +1000" MODIFIED_BY="[Empty name]">
<P>12-month exercise program comprised of strength and endurance training.</P>
<P>Exercise groups supervised by experienced physiotherapists, the participants will attend the exercise groups for training 60 min, 2/week. Additionally, home-based exercise for &gt; = 120 minutes a week, aiming to perform a total of 240 minutes of exercise per week.</P>
<P>The control group told to follow standard-care regimen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-27 17:31:22 +1000" MODIFIED_BY="[Empty name]">
<P>Primary: </P>
<UL>
<LI>metabolic profile</LI>
</UL>
<P>Secondary:</P>
<UL>
<LI>Relapse of breast cancer disease, breast cancer-specific mortality, overall mortality, disease-free survival, recurrence-free interval</LI>
<LI>QoL parameters: QoL, fatigue, anxiety, depression</LI>
<LI>Cardiopulmonary function: cardiopulmonary exercise testing (CPET), VO<SUB>2 </SUB>max, forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), diffusing capacity of the lung for carbon monoxide (DLCO)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-04-06 01:38:56 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>September 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-12-06 07:43:37 +1100" MODIFIED_BY="Anna C Furmaniak">
<P>Inger Thune</P>
<P>
<A HREF="mailto:inger.thune%40uit.no?subject=NCT02240836,%202014/945-1,%20Energy%20Balance%20and%20Breast%20Cancer%20Aspects-II">inger.thune@uit.no</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-08-27 17:31:53 +1000" MODIFIED_BY="[Empty name]">
<P>Estimated primary completion date: May 2016</P>
<P>Planned follow-up: 10 years</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-08-27 17:32:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02252991">
<CHAR_STUDY_NAME MODIFIED="2016-05-29 23:45:32 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Adapted Physical Activity in Cancerology (APACAN)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-04-06 02:12:23 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 17:32:29 +1000" MODIFIED_BY="[Empty name]">
<P>Breast cancer patients receiving radio- or chemotherapy or both, estimated enrolment: 200 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 17:32:40 +1000" MODIFIED_BY="[Empty name]">
<P>Physical activity, from 2 to 6 months</P>
<P>Control group: physical activity after treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-05-29 23:47:09 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Fatigue: MFI</P>
<P>QoL: EORTC QLQ-C30</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-04-06 02:11:38 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>September 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-04-06 02:10:30 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Yves-Jean.BIGNON@jp.fr</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-05-29 23:46:47 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Estimated primary completion date: December 2016 (final data collection date for primary outcome measure)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-09-10 23:31:24 +1000" MODIFIED_BY="Anna C Furmaniak" STUDY_ID="STD-NCT02350582">
<CHAR_STUDY_NAME MODIFIED="2015-04-06 02:00:38 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>e-CUIDACHEMO: Telerehabilitation During Chemotherapy in Breast Cancer</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-04-06 02:04:54 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-08-27 17:34:35 +1000" MODIFIED_BY="[Empty name]">
<P>Breast cancer patients with internet access, estimated enrolment: 40 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-27 17:34:46 +1000" MODIFIED_BY="[Empty name]">
<P>Resistance and endurance exercise via telerehabilitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-09-10 23:31:24 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Primary:</P>
<UL>
<LI>cardiorespiratory fitness: 6-MWT</LI>
</UL>
<P>Secondary:</P>
<UL>
<LI>strength</LI>
<LI>fatigue: PFS</LI>
<LI>pain: Brief Pain Inventory</LI>
<LI>cancer-related QoL: EORTC QLQ-C30 and BR23</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-04-06 02:00:52 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>April 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-07 20:27:38 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Manuel Arroyo-Morales marroyo@ugr.es</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-05-30 00:09:14 +1000" MODIFIED_BY="Anna C Furmaniak">
<P>Estimated study completion date: June 2015</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>6-MWT: 6-minute walk test<BR/>DCIS: ductal carcinoma in situ<BR/>EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 36<BR/>FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue Scale<BR/>FACT-G: Functional Assessment of Cancer Therapy-General<BR/>MET: metabolic equivalent of task<BR/>MFI: Multidimensional Fatigue Inventory<BR/>PFS: Piper Fatigue Scale<BR/>QoL: quality of life<BR/>RCT: randomised controlled trial<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-09-10 23:29:57 +1000" MODIFIED_BY="Anna C Furmaniak">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-08-27 15:49:44 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:40:36 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Drawing of numbers (1 to 20) by the participants. Participants who drew even numbers were placed into the experimental group, while participants who drew odd numbers were placed into the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:10:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>A computer program randomly assigned each study participant with equal probability to the exercise group or the usual-care group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:47:00 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Computerised randomisation program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-12-26 23:51:34 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Computer-generated numbers, stratification by adjuvant cancer treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:13:14 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Block randomisations with variable block size, 1:1, no stratification, further details not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:30:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Computer-generated program, stratification by centre and chemotherapy protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:40:28 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Computer-generated program, stratification by centre and chemotherapy protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:49:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>A random numbers table was utilised prior to the initiation of the study to randomise participants to 1 of the 2 groups. Consecutive numbers on the table were used with numbers ending in an even integer assigned to the exercise group, and numbers ending in an odd integer assigned to the comparison group. Each number was placed in an envelope that was then sealed. The outside of the envelope was then numbered in consecutive order<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:31:27 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Reported as randomised, but method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:49:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 17:09:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Computer-generated, unblocked sequence of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 20:43:59 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>"Block randomisation using four blocks was used to allocate patients into one of two groups by the researcher. Within each group of four patients, two were allocated to the intervention group and two to the control group; the allocation of groups within each block was random."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:15:38 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>Participants were randomised to intervention or control groups using a computer-generated randomisation sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:32:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Individually computer-generated non-blocked</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:43:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Individually computer-generated non-blocked</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:59:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>Computer-generated program (n = 10/group)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 20:51:24 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>"The random assignment of subjects to the intervention group or to the control group was carried out by the use of concealed envelopes, drawn by the research assistant prior to the first data collection."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:19:08 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:26:32 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Stated to be randomised, but method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 01:42:49 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Computer-generated randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:41:48 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Stated as randomised, but method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:43:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Randomised permuted blocks of length 4 and 6</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:51:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Random number sequence table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:11:40 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>"Randomization will occur by drawing cards entitled 'exercise' or 'control' from an envelope and then assigning the patient to this group." (ClinicalTrials.gov)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:15:55 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Study described as "randomized", method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:32:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>"randomly allocated 1:1": predetermined lists with random block size, stratified by age and baseline physical fatigue level</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:33:10 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Method of randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:33:19 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Method of randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:49:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Random numbers table<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:49:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Random numbers table<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:22:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Predetermined list generated with a blocked randomisation SAS procedure with a fixed block size, stratified by age and baseline physical fatigue level</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 02:56:11 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Concealed computer-generated randomisation, 1:1 ratio, stratified per age, adjuvant treatment, use of tissue expander, and hospital by sequential balancing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:04:21 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Randomisation was generated using sealed envelopes that were numbered and selected sequentially</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:32:31 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Stated as randomised. The generation of the random sequence was not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:46:59 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 00:58:48 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>"Patients were randomly assigned to Onco-Move, OnTrack, or UC using the minimization method, which balanced groups with respect to age, primary diagnosis, treating hospital, and use of trastuzumab."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 00:59:29 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>"Patients were randomly assigned to Onco-Move, OnTrack, or UC using the minimization method, which balanced groups with respect to age, primary diagnosis, treating hospital, and use of trastuzumab."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-09-10 23:27:07 +1000" MODIFIED_BY="Anna C Furmaniak" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 13:58:29 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:11:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>The randomisation code for each participant was obtained by the principal investigator (who was not involved in recruitment or data collection) only after baseline measures for that woman had been completed, and staff conducting clinic visits did not have access to the randomisations program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:47:11 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:57:36 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:13:15 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 01:26:03 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>&#8220;The allocation sequence was...concealed from the project directors at each site who assigned participants to groups&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:28:46 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>&#8220;The allocation sequence was...concealed from the project directors at each site who assigned participants to groups&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 01:58:11 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>Sealed envelope.</P>
<P>Comment: it was not mentioned if the envelope was opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:31:29 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 01:30:21 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 17:09:21 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:04:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:17:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>The randomisation sequence was entered into numbered, opaque, sealed envelopes by a study investigator and was held secure in an administration office separate from that of the investigators. Envelopes were only opened after completion of the initial assessment after which intervention or control programs were provided to participants according to the allocation sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 23:03:49 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:31:32 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:59:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>The allocation sequence was concealed from the study co-ordinator who assigned participants to groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:09:03 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>"concealed envelopes"</P>
<P>Comment: it was not mentioned if they were opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:19:09 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 01:40:47 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:33:28 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Consecutively numbered, sealed, opaque envelopes, opened after baseline testing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:41:58 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-03 00:38:01 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>&#8220;Randomisation was done by telephone to an interactive voice response system&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 04:48:33 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Participant assignment to groups at enrolment was concealed from the project director</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:27:07 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>An unlabeled envelope was opened by the research co-ordinator to place the participant in either the control or boot camp arm of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:16:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:32:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Allocation was performed by a biostatistician uninvolved in recruitment, based on predetermined lists with random block size, stratified by age and baseline physical fatigue level. Other study personnel did not have access to the randomisation lists</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:47:09 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:52:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:57:45 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Study co-ordinator revealed group assignment after baseline testing.</P>
<P>Method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:02:12 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Study co-ordinator revealed group assignment after baseline testing.</P>
<P>Method not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:22:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Allocation is done by the biometrician based on a predetermined list generated with a blocked randomisation SAS procedure with a fixed block size, stratified by age and baseline physical fatigue level.</P>
<P>To prevent possible bias, study personnel involved in the recruitment and the baseline assessment do not have access to the randomisation lists and are not aware of the block size. Conversely, the biometrician does not have influence on the recruitment procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 02:56:21 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>"After the patient signed informed consent, the researcher (who was with the patient) called the data management department and provided the participants study number and the information necessary for stratification. The data manager then performed the randomization using a computer program and informed the researcher about the allocation (and also noted the allocation in the randomization log)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 21:31:14 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Sealed envelopes.</P>
<P>Comment: not mentioned if they were opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 05:05:10 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 21:33:01 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:46:02 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:55:29 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-12-02 20:12:35 +1100" MODIFIED_BY="Melina L Willson" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="GROUP" MODIFIED="2016-08-27 15:47:37 +1000" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Blinding of participants</NAME>
<DESCRIPTION>
<P>
<I>Performance bias </I>due to knowledge of the allocated interventions by participants during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-09.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-10 04:06:31 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-10 04:01:04 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-26 14:47:19 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-10 04:04:15 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-26 15:13:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Open study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-11 01:29:35 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-11 01:28:55 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-26 16:06:18 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-26 16:31:30 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-09 01:30:14 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-26 17:09:23 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 07:04:08 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>There is no masking of participants or the research team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 07:18:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>Sham intervention control group provided with what looked like an exercise program with an equivalent amount of supporting material. The video material was of similar content to that in the intervention program (though the actual exercises described differed).</P>
<P>Comment: Participants would still have been aware if they were in the exercise group or the stretching group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-10 23:03:58 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-11 01:32:17 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 07:59:57 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>It was not possible to blind participants or exercise staff to group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 08:09:08 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 08:19:11 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 08:27:01 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Placebo group analysed for functional capacity did stretching exercises.</P>
<P>Comment: participants would have been aware if they were in the exercise group or the stretching group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-07-21 05:57:12 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-09 01:49:01 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 10:43:31 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 10:53:11 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2014-09-02 04:04:09 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 11:16:02 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 11:32:50 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 11:47:13 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 11:52:02 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-11 01:37:35 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-01-11 01:38:39 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 12:22:44 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2015-06-22 21:26:32 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>"not possible"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2015-01-13 00:24:47 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 15:32:42 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Placebo group</P>
<P>Comment: Patients in the placebo group would have been aware that they were not in the exercise group, but in the stretching group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 15:47:37 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 14:46:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-09.01" MODIFIED="2016-08-27 14:55:30 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" MODIFIED="2016-08-27 15:05:11 +1000" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Blinding of personnel/care providers</NAME>
<DESCRIPTION>
<P>
<I>Performance </I>bias due to knowledge of the allocated interventions by personnel/care providers during the study.</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-10.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 20:16:50 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-10 01:56:36 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:24:20 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:24:39 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-08-26 15:13:19 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Open study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:26:25 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:28:50 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:26:50 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:29:15 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:30:24 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:30:33 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-08-27 07:04:11 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>There is no masking of participants or the research team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:33:05 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:31:25 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:32:18 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-08-27 08:00:00 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>It was not possible to blind participants or exercise staff to group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:36:49 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:38:00 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:40:28 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:43:03 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:49:04 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:54:09 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:55:36 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:58:16 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 01:59:28 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 02:00:17 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:34:01 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:34:18 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:37:36 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 01:38:41 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 21:27:34 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-08-27 14:28:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-08-27 15:05:11 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>The research nurses conducted all recruitment, data collection, and study interventions. The principal investigator provided ongoing supervision of the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 03:02:16 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-09 03:03:20 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 00:58:53 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-01-11 00:59:32 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-12-02 20:12:35 +1100" MODIFIED_BY="Melina L Willson" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2016-08-27 15:47:43 +1000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.02" NO="2">
<NAME>All outcomes except fitness outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1" REF_IDS="CMP-001.01 CMP-001.08 CMP-001.02 CMP-001.03 CMP-001.05 CMP-001.04 CMP-001.12 CMP-001.07 CMP-001.06 CMP-001.11 CMP-001.14 CMP-001.15 CMP-001.16 CMP-001.13 CMP-001.17 CMP-001.18 CMP-001.19 CMP-001.10 CMP-001.20 CMP-001.09 CMP-002.02 CMP-002.03 CMP-002.06 CMP-002.01 CMP-002.05 CMP-002.07 CMP-002.04 CMP-002.08 CMP-002.12 CMP-002.09">
<NAME>Fitness outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:06:28 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 13:58:36 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-06 00:02:00 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 14:11:46 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:06:46 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 14:47:51 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:07:36 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 14:57:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Self administered questionnaires were returned to researcher in sealed envelopes.</P>
<P>Comment: high risk because items were self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-26 15:13:20 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Open study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 15:13:22 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Self reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:08:30 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 15:30:59 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 01:28:52 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 15:40:48 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 02:09:54 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>"The study participant&#8217;s group assignment was blinded to the exercise physiologists performing the fitness testing at the week 13 appointment. Study participants were requested to not disclose which study group they had been randomized to."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 16:06:29 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-26 16:31:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Cardiopulmonary exercise testing was performed in the exercise physiology lab by laboratory staff blinded to the participant&#8217;s group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-09 20:34:29 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Not reported for other outcomes.</P>
<P>Comment: probably not done or self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 02:29:55 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-26 16:53:40 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-06 00:00:19 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-10 04:18:00 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-06 00:00:00 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 07:04:14 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>There is no masking of participants or the research team</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 02:15:18 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>"blinded outcome assessment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 07:18:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>Self reported outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-05 23:40:13 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>"assessors blinded to group allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-10 23:04:04 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>All outcomes except outcomes with clinical assessment: self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-05 23:40:52 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>"assessors blinded to group allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-11 01:32:22 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>All outcomes except outcomes with clinical assessment: self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-27 08:00:19 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>Study exercise physiologists conducting the baseline and postintervention (12 weeks) assessments were blinded to group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-09 20:49:51 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:25:28 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 08:09:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:26:29 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-11 02:23:46 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Not reported or self reported items</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:26:19 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-10 04:27:18 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>No other relevant outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:27:59 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 08:33:35 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-05 23:58:11 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Moros-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-09 01:49:38 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 02:24:51 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>&#8220;We took steps to blind the evaluation of outcomes by having questionnaire responses in sealed envelopes and ensuring that outcome measures were taken by researchers who were not involved in exercise classes&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 10:43:41 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-05 23:42:25 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Physicians monitoring graded exercise tests were blinded to participant group assignment. Similarly, a physical therapist or an exercise physiologist, blinded to participant assignment, performed strength assessments. </P>
<P>Comment: No fitness outcomes reported in this paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-01-09 01:56:06 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:32:27 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-06-05 23:57:22 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Rao-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 02:24:17 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 11:16:15 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:33:33 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 11:32:55 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 01:34:02 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 11:47:17 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>No other relevant outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 01:34:20 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-06-05 23:56:29 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 01:37:45 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 11:57:58 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 01:38:45 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 12:02:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-10 04:36:19 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Not reported</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 12:22:47 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-27 14:28:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Outcome measures were assessed by researchers not involved with the participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 14:28:30 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-27 15:05:41 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>The research nurses conducted all recruitment, data collection, and study interventions. The principal investigator provided ongoing supervision of the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 15:06:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-05 23:54:56 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 15:32:48 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-05 23:54:07 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 15:47:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 00:58:54 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 14:46:10 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-11 00:59:34 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Not reported.</P>
<P>Comment: probably not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2016-08-27 14:55:34 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Self reported items</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-08-27 15:47:46 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 13:58:41 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>There was no description of missing outcome data or attrition from the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 14:38:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>5 women (10%) had missing 6-month data (3 exercisers and 2 usual-care group participants).</P>
<P>All analyses were conducted according to the intention-to-treat principle. Baseline QoL values were carried forward for the 5 IMPACT study participants who had missing 6-month data. Not reported for other outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 14:50:32 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>3 participants were not able to start the study owing to changes in treatment plan and were not included in any analysis.</P>
<UL>
<LI>exercise group: n = 13 at baseline, n = 8 at 6 months</LI>
<LI>control group: n = 12 at baseline, n = 9 at 6 months</LI>
</UL>
<P>&gt; 30% drop-out</P>
<P>Treatment of missing data was not described<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 14:58:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group: 2/12 (16.7%)</LI>
<LI>Control group: 1/10 (10%)</LI>
</UL>
<P>All participants: 3/22 (13.7%)</P>
<P>No imputation of missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 15:18:37 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Cardiorespiratory fitness and strength: 30/42 participants (68%) took part in all fitness evaluations.</P>
<P>QoL, fatigue, psychological distress, physical activity: 19/42 (45.2%) participants in the analysis at the end of the intervention.</P>
<P>ITT analysis for cardiorespiratory fitness (VO peak, 6-MWT) and strength with imputation for missing values. "Several methods were tested and last observation carried forward (LOCF) was used."</P>
<P>Otherwise no imputation for missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 15:31:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group 1 (aerobic): 5.1% (4/78)</LI>
<LI>Intervention group 2 (resistance): 7.3% (6/82)</LI>
<LI>Control group: 11% (9/82)</LI>
</UL>
<P>All participants: 7.9% (19/242)<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 15:40:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group 1 (aerobic): 5.1% (4/78)</LI>
<LI>Intervention group 2 (resistance): 7.3% (6/82)</LI>
<LI>Control group: 11% (9/82)</LI>
</UL>
<P>All participants: 7.9% (19/242)<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 16:06:35 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>Missing data were reported for 2 participants for strength assessment.</P>
<P>"A second strength was the adherence by both groups in maintaining activity logs and completing all study measures."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 16:32:34 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Early intervention during adjuvant treatment 7/44 (15.9%)</LI>
<LI>Late intervention after adjuvant treatment 4/36 (11.1%)</LI>
<LI>Usual-care group 2/39 (5%)</LI>
<LI>Late intervention and usual care: 6/75 (8%)</LI>
<LI>All participants: 13/119 (10.9%)</LI>
</UL>
<P>ITT, no imputation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 16:53:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group: 0/13 (0%)</LI>
<LI>Control group: 2/10 (20%)</LI>
</UL>
<P>All participants: 2/23 (8.7%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-26 17:09:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Drop-out all participants:</P>
<UL>
<LI>Intervention: 5/73 (6.8%)</LI>
<LI>Control: 1/70 (1.4%)</LI>
</UL>
<P>Retention was 97% at 6 months and 96% at 12 months.</P>
<P>No imputation of missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 07:04:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>5 participants in the exercise group (20%) discontinued the intervention (4 due to hospitalisation and 1 due to medical difficulties), but completed all follow-up measures and were included in the analysis.</P>
<P>ITT analysis, no imputation described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 07:18:53 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>Intervention group: more than 30% of outcome data was missing at 6 months</P>
<P>Control group: more than 30% of outcome data was missing at 6 months</P>
<P>Handling of dropouts and missing data not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 07:34:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Drop-out: all participants</P>
<UL>
<LI>Face-to-face intervention group: 6</LI>
<LI>Telephone intervention group: 4</LI>
<LI>Usual-care group: 4</LI>
</UL>
<P>All participants: 14/194 (7.2%)</P>
<P>Comment:</P>
<P>For the 142 participants undergoing adjuvant therapy:</P>
<P>More than 20% drop-out for 3-min step test (cardiorespiratory fitness)</P>
<P>High risk for cardiorespiratory fitness</P>
<P>ITT analysis, no imputation of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 07:45:17 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Drop-out: all participants</P>
<UL>
<LI>Face-to-face intervention group: 6</LI>
<LI>Telephone intervention group: 4</LI>
<LI>Usual-care group: 4</LI>
</UL>
<P>All participants: 14/194 (7.2%)</P>
<P>Comment:</P>
<P>For the 142 participants undergoing adjuvant therapy:</P>
<P>More than 20% drop-out for 3-min step test (cardiorespiratory fitness)</P>
<P>High risk for cardiorespiratory fitness</P>
<P>ITT analysis, no imputation of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 08:01:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>19/20 (95%) completed all study procedures.</P>
<P>ITT, handling of 1 dropout not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 08:11:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>Post1: immediately after chemo; Post2: 6 months' follow-up</P>
<P>60 of 67 (89.6%) participants completed the data collection at time point 1. Comment: low risk.</P>
<P>52 of 67 (77.6%) participants completed the data collection at time point 2. Comment: high risk.</P>
<P>ITT analysis for fatigue data. Per-protocol analysis for physical activity (IPAQ)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 08:19:20 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Study closed early</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 08:27:58 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Drop-out rate for all participants: 17/62 (27.4%)</P>
<P>45 of 62 participants were analysed for functional capacity.</P>
<P>Per-protocol analysis (n = 45) of n = 62, who entered the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 08:34:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group: 6/60 (10%)</LI>
<LI>Control group: 5/59 (8.5%)</LI>
</UL>
<P>All participants 11/119 (9.2%)</P>
<P>Reported both ITT and per-protocol analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 08:42:12 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group: 1/11 (9%)</LI>
<LI>Control group: 4/11 (36%)</LI>
</UL>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 10:44:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Drop-out:</P>
<P>Intervention group:</P>
<UL>
<LI>Week 12: 19/101 (18.8%)</LI>
<LI>6 months' postintervention: 17/99 (17.2%)</LI>
</UL>
<P>Control group:</P>
<UL>
<LI>Week 12: 10/102 (9.8%)</LI>
<LI>6 months' postintervention: 7/102 (6.9%)</LI>
</UL>
<P>Comment: Differing rate between groups.</P>
<P>Long term (18 months and 5 years &gt;): 30% attrition</P>
<P>ITT, no imputation of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 10:54:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Numbers randomised to each arm are as well as completion rates are unclear.</P>
<P>"we used regression modeling to impute missing values to conduct our analyses."</P>
<P>Amount of missing data was not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 11:09:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>10 women were randomised and completed all study parameters and were included in the analysis.</P>
<P>All women were analysed in their respective group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 11:17:58 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Drop-out (did not complete the 12-week assessment):</P>
<UL>
<LI>Exercise group: 1/22</LI>
<LI>Control group: 2/19</LI>
</UL>
<P>Outcome data not reported for non-adherent women in the exercise group.</P>
<P>Per-protocol analysis: The statistical analyses for fatigue, QoL, aerobic capacity, and shoulder flexibility compared the 12 women who practiced Nia to the 17 women randomised to the control group for whom data were collected at baseline, 6 weeks, and 12 weeks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 15:17:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Pre- and postintervention assessment of the primary endpoint was available in a total of 95 of 101 (94%) participants, 49 in exercise group and 46 in relaxation control group.</P>
<P>"intent-to-treat-basis". "As very few fatigue values were missing (3%), we performed complete-case analyses"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 11:47:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group 1 (aerobic): 8.3% (2/24)</LI>
<LI>Intervention group 2 (resistance): 8.7% (2/23)</LI>
<LI>Control group: 8% (2/25)</LI>
</UL>
<P>All participants: 8.3% (6/72)</P>
<P>No data imputation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 11:52:28 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Intervention group 1 (aerobic): 8.3% (2/24)</LI>
<LI>Intervention group 2 (resistance): 8.7% (2/23)</LI>
<LI>Control group: 8% (2/25)</LI>
</UL>
<P>All participants: 8.3% (6/72)</P>
<P>No data imputation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 11:58:16 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<UL>
<LI>Self directed intervention group: 7/40 (17.5%)</LI>
<LI>Supervised intervention group: 10/42 (23.1%)</LI>
<LI>Control group: 7/41 (17.5%)</LI>
</UL>
<P>End-of-intervention (26-week) data were obtained for 99 participants (80.4%)</P>
<P>ITT with imputation (most recent observed)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 12:02:38 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<UL>
<LI>Self directed intervention group: 7/40 (17.5%)</LI>
<LI>Supervised intervention group: 10/42 (23.1%)</LI>
<LI>Control group: 7/41 (17.5%)</LI>
</UL>
<P>End-of-intervention (26-week) data were obtained for 99 participants (80.4%)</P>
<P>ITT with imputation (most recent observed)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 15:19:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Pre- and postintervention assessment of the primary endpoint was available for a total of 155 (97%) participants, 77 in the exercise group and 78 in the relaxation control group.</P>
<P>Data were analysed on an ITT basis. As the number of missing fatigue values was very low (3%), we performed complete-case analyses<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 14:30:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Drop-out after 18 weeks:</P>
<UL>
<LI>intervention group: 13/102 (12.7%)</LI>
<LI>control group: 9/102 (8.8%)</LI>
</UL>
<P>Follow-up: high risk</P>
<P>Drop-out after 36 weeks:</P>
<UL>
<LI>intervention group: 15/102 (14.7%)</LI>
<LI>control group: 25/102 (24.5%)</LI>
</UL>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 15:06:51 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>No dropouts or missing data reported.</P>
<P>All study participants were evaluated according to the randomisation schema regardless of completion of exercise sessions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 15:32:54 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>All participants were accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 15:47:46 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Drop-out:</P>
<UL>
<LI>Exercise group: 3/22 (13.6%)</LI>
<LI>Control group: 1/22 (4.5%)</LI>
</UL>
<P>Total: 4/44 (9%)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 14:46:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Outcome data were available for 204 participants (89%) directly after chemotherapy, and for 196 (85%) at the 6-month follow-up. ITT without imputation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-27 14:55:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Outcome data were available for 204 participants (89%) directly after chemotherapy, and for 196 (85%) at the 6-month follow-up. ITT without imputation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-09-10 23:29:57 +1000" MODIFIED_BY="Anna C Furmaniak" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 13:58:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Dissertation with all assessed outcomes available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:38:15 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>Study protocol not published prospectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:50:35 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:58:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 06:29:28 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Trial prospectively registered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 06:34:51 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:28:39 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:06:55 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>Detailed results only available for cardiorespiratory fitness</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:35:19 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Cardiopulmonary fitness was tested but not reported as an outcome. It was unclear if cardiorespiratory fitness was a predefined outcome or only measured to individualise the exercise prescription.</P>
<P>In 1 of 5 related publications, a quality of life questionnaire was mentioned (MQOLS-CA), but no results were reported in any publication.</P>
<P>Outcomes were not reported completely, and could not be extracted for use in a meta-analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:53:53 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 17:09:53 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>Registered prospectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:04:49 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>Measures of cognitive function (mentioned in the design paper and study registration) were not reported in the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-24 04:32:10 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>The trial was registered prospectively with the Australia New Zealand Clinical Trials Registry (ACTRN12606000047594)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 23:04:13 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Registered prospectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:32:28 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Registered prospectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:01:13 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:11:55 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:19:25 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>No results reported because study closed early</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:28:40 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>It is unclear why data for only 2 groups was analysed for weight change and body composition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:34:11 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:42:18 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 04:31:36 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Study protocol available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:53:52 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Further outcomes to be reported in another paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-04 20:36:07 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>"Improving fitness levels" not reported in results paper </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:18:03 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>No study protocol published, study not registered prospectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:38:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Registered at ClinicalTrials.gov (NCT01106820), study protocol published,</P>
<P>not all outcomes reported in this publication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:47:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:52:30 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>No study protocol published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:58:52 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>No study protocol published prospectively. FACT-G and FACT-B: no detailed results, but stated that no significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:03:13 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>No study protocol published prospectively. FACT-G and FACT-B: no detailed results, but stated that no significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:23:55 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Registered at ClinicalTrials.gov (NCT01468766), study protocol published.</P>
<P>Not all outcomes reported in this publication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:50:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Design paper published.</P>
<P>EQ-5D, IPA (Impact on Participation and Autonomy), self efficacy (items based on social cognitive theory) mentioned in the design paper, but not in the publication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:08:15 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Outcomes muscle strength, cold thermal sensation, and vibratory sensation, which were mentioned on ClinicalTrials.gov, were not reported. Results for symptom experience were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:29:57 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Participants answered all 90 items of the SCL-90-R. Hereby, "the investigators hoped to avoid sensitizing patients to awareness of any one symptom". Results for other items apart from nausea and somatisation part were not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:47:58 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>No study protocol published, study not registered prospectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:50:01 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Differences between design paper and final publication (EQ-5D, anthropometric measures and actigraph not mentioned in the final publication).</P>
<P>Chemotherapy completion rate mentioned as outcome in the final publication, but not in the design paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:55:58 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Differences between design paper and final publication (EQ-5D, anthropometric measures and actigraph not mentioned in the final publication).</P>
<P>Chemotherapy completion rate mentioned as outcome in the final publication, but not in the design paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2016-08-27 15:48:16 +1000" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Group similarity at baseline</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 13:58:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>No significant differences for weight, age, body fat, fitness (cardiorespiratory and strength)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-05 15:19:12 +1100" MODIFIED_BY="Melina L Willson" RESULT="UNKNOWN" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>"No differences between exercise and usual care groups at baseline. Exception: exercisers were more likely to receive lumpectomy than usual care group participants (P &lt; 0.05)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:50:37 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>No significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:58:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Similarity for the most important prognostic indicators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:18:56 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>Significant baseline differences in cardiorespiratory fitness and BMI</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 04:14:55 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>No significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:29:10 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>No significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 04:12:50 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>"The groups were balanced in terms of demographic and disease characteristics."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 06:41:01 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>"The three groups of patients did not differ significantly in any of the demographic, disease, or treatment characteristics on entry into the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:53:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Similarity for the most important prognostic indicators</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 17:10:48 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>For 111 participants during adjuvant treatment: more with chemotherapy in the treatment group: 47/58 (81%) vs 36/53 (68%)</P>
<P>For all participants: "There was no evidence of failure of randomization (i.e. all baseline group differences were P &gt; 0.05), however there were some notable group differences (&gt;=10%) in terms of income (&lt;$52,000 per annum), receipt of radiotherapy at baseline, overall receipt of chemotherapy, surgery type and lymph node status."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:05:15 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>There were no significant differences between groups in sociodemographic or treatment-related variables. Using ITT, there were no significant between-group differences in baseline measures of anxiety, depression, fatigue, self esteem, mood, or subjective ratings of physical activity. There was a small difference between groups in 2 subscales of mood: vigour and confusion<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-03 00:32:43 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>"Control group participants also appeared to be healthier at baseline."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:34:38 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>Slight imbalance in numbers, place of treatment (public vs private hospital), and rates of mastectomy between groups following randomisation. Rate of mastectomies higher in telephone group. This group has the biggest difference in QoL</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:45:59 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>Slight imbalance in numbers, place of treatment (public vs private hospital), and rates of mastectomy between groups following randomisation. Rate of mastectomies higher in telephone group. This group has the biggest difference in QoL</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-05 23:59:20 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>"The groups were balanced on all study outcomes at baseline." </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:11:58 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>No significant differences in baseline values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 01:39:01 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>"No clinically meaningful or statistically significant differences between groups."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:28:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Educational status differed. Data for 17 women not shown for baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-10 06:46:15 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>No significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:42:25 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>There were more obese women in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:45:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>"No obvious imbalances existed between study groups."</P>
<P>Long term: Differences in baseline demographics between participants that did and did not return for follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:54:31 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>"found no significant differences with respect to demographic, cancer stage, treatment, and exercise characteristics."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:10:05 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>There were no statistically significant differences between groups with regard to tumour size, age, BMI, tumour grade, C-peptide levels, or initial Ki-67</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:18:10 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>"The two groups did not differ statistically in their demographics, although clinical differences appear to exist in age and employment, with the Nia group aged, on average, five years younger and more likely to<BR/>be working full time than the control group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:17:28 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Baseline characteristics, fatigue, and QoL were similarly distributed between both intervention groups, except for depression, which was significantly more common in the relaxation control group than in the exercise group.</P>
<P>2 in control group with metastasised cancer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:34:10 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>No significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:34:37 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>No significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:38:12 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>"Baseline demographic, body weight, aerobic capacity, prior level of physical activity, and disease treatment characteristics of the subjects did not differ among the three groups. There were no baseline differences among groups for the eight SF-36 scales"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:38:53 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>"Baseline demographic, body weight, aerobic capacity, prior level of physical activity, and disease treatment characteristics of the subjects did not differ among the three groups. There were no baseline differences among groups for the eight SF-36 scales"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:20:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Demographics and treatment characteristics did not differ significantly between both intervention groups. All primary and secondary outcome variables were equally distributed in exercise and relaxation control groups at baseline (all P &gt; 0.05), except for the EORTC symptom dry mouth (P = 0.033)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:35:12 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>"were comparable on most characteristics"</P>
<P>Comment: More women in the intervention group were highly educated, had triple-negative breast cancer, and were postmenopausal.</P>
<P>Total physical activity levels tended to be higher in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:08:18 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>"No significant differences"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:35:50 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>"similar in age, height and body weight". Participants in control group were higher educated than those in exercise and placebo groups. Placebo group had more married women than exercise and placebo groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:48:16 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>The groups were generally balanced at baseline regarding demographic and disease-related characteristics</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 00:59:10 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Baseline characteristics were balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 00:59:45 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="YES" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Baseline characteristics were balanced across groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-01-10 02:00:39 +1100" MODIFIED_BY="Anna C Furmaniak" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2016-09-10 23:28:32 +1000" MODIFIED_BY="Anna C Furmaniak" NO="12">
<NAME>Adherence</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:40:49 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>"The adherence rate among all the subjects was 100%." All study participants completed the study protocol. One participant missed 1 week of exercise for reasons unrelated to the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:39:31 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>Participants performed 144 (SD = 75) minutes of activity per week throughout the 6 months (range: 0 to 253). 64% met the goal of 150 min per week</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:51:16 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Once peripheral neuropathy developed, these participants (12 of 13) adopted a sporadic pattern of "walking only", which lasted for approximately 4 weeks before coming to an abrupt end.</P>
<P>Participants in this study were not able to recall the times they exercised during the telephone contacts.</P>
<P>The investigator was not able to measure adherence, which was defined as the number of sessions attended by each participant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 20:26:32 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Adherence: 70% of all sessions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:19:39 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>9 of 14 participants took part in more than 70% of the exercise program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:08:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Aerobic exercise group: 72% sessions; 95.6% met duration; 87.2% met intensity<BR/>Resistance exercise group: 68.2% sessions; 96.8% completed all 9 exercises; 96.9% completed 2 sets each; 94.5% completed 8 to 12 repetitions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:08:30 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Aerobic exercise group: 72% sessions; 95.6% met duration; 87.2% met intensity<BR/>Resistance exercise group: 68.2% sessions; 96.8% completed all 9 exercises; 96.9% completed 2 sets each; 94.5% completed 8 to 12 repetitions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:11:19 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>The nurse researcher used the logs of both groups to assess adherence to the structured exercise program.</P>
<P>Adherence defined as completion of 80% of the individualised targeted endurance and strength exercise, frequency, duration, and intensity. The intervention group walked a mean of 113 minutes per week, as<BR/>compared to 53 minutes by the comparison group. "The intervention group also demonstrated commitment to following the exercise intervention across the study period."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:16:44 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>Group 1 (exercise during and after adjuvant treatment) reported an adherence rate of 73% at T2 and 75.7% at T3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:55:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Adherence defined as 21 minimum sessions out of 35 possible sessions</P>
<P>Adherence per group:</P>
<UL>
<LI>Intervention group: mean 25.8 sessions, SD = 10.1 (73.7%)</LI>
<LI>Control group: mean 29.2 sessions, SD = 7.7 (83.4%)</LI>
</UL>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:23:00 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>41.2% at 6 months' postsurgery and 52.2% at 12 months' postsurgery met the criteria for aerobic activity. 45.6% at 6 months' postsurgery and 40.3% at 12 months' postsurgery met the criteria for strength.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:05:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>20 (80%) out of the 25 participants randomised to the physical activity group adhered to the intervention and completed walking diaries.<BR/>5 participants discontinued participation within the first few weeks of the 12-week intervention<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:20:13 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>Participants were to document adherence in log books on a weekly basis and were asked about adherence in the last 2 weeks of 12 months.</P>
<P>At the 12-month review, 11 of 37 intervention group participants interviewed reported completing the strength/balance/shoulder mobility component of the program at least once in the past 2 weeks, whilst 7 reported completing it at least 3 times. The endurance component was completed at least once by 12, and at least 3 times by 7</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:35:28 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>25% did not meet the intervention goal at mid- or postintervention and did not increase their total physical activity by 30+ min (a priori deemed clinically relevant) between baseline and mid- or postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:46:12 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>25% did not meet the intervention goal at mid- or postintervention and did not increase their total physical activity by 30+ min (a priori deemed clinically relevant) between baseline and mid- or postintervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:02:08 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>Overall attendance to planned exercise sessions was 82% (296 attended/360 prescribed; range 0 to 100%).</P>
<P>Overall adherence to the planned exercise prescription was 66% (194 adhered sessions/296 attended). Adherence was calculated as the number of exercise sessions successfully completed (i.e. participant completed the exercise session at the planned duration and intensity) divided by the number of planned sessions attended</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:14:29 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>17% adhered to the walking prescription of minimum 210 minutes/week of MVPA. 15% of the participants in the intervention group achieved the prescribed number of strength training (3/week) sessions.</P>
<P>58% met the general recommendations of 150 minutes/week of MVPA, and participants carried out approximately 2 sessions of resistance band exercises per week</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:19:30 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>Only 38% met all exercise targets</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:28:48 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>Adherence complete (missed sessions repeated)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:25:52 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Not adherent: 15/54 (28%). 72% were adherent in the sense of the studies' definition (85% of minimum prescription)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:42:27 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:45:21 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Participation in classes:</P>
<UL>
<LI>&gt; 70% classes: 39/99 (38.8%)</LI>
<LI>30% to 69% classes: 30/99 (30.6%)</LI>
<LI>&lt; 30% classes: 30/99 (30.6%)</LI>
</UL>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:55:54 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Completed an average of 83% of their scheduled hospital-based exercise sessions (M = 9.9, SD = 3.3 sessions); 76.9% completed all 12 sessions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:10:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>All 5 women in the exercise group completed &gt; = 80% of the advised exercise sessions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:18:26 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>Assessed by reviewing participant logs. Logs were not uniformly maintained.</P>
<P>Only 12 of 22 participants in the Nia group were adherent</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:18:54 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Median attendance was similar in both groups, with 17 out of 24 scheduled sessions attended (71%; interquartile range 11 to 22 in the exercise group and 11 to 23 in the relaxation control group)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:47:48 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>No adherence data available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:52:36 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>No adherence data available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:38:18 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Adherence in intervention groups:</P>
<UL>
<LI>Home based: 93/130 sessions (71.5%)</LI>
<LI>Centre based: 93/130 sessions (71.5%)</LI>
</UL>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 01:38:55 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Adherence in intervention groups:</P>
<UL>
<LI>Home based: 93/130 sessions (71.5%)</LI>
<LI>Centre based: 93/130 sessions (71.5%)</LI>
</UL>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:28:32 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>The median attended number out of 24 scheduled sessions was 19 in both groups (79%).</P>
<P>(QR: 13 to 23, range 1 to 24) in exercise group and (QR: 12 to 22, range 0 to 24) in relaxation control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:36:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>Participation in 83% (IQR 69% to 91%) of the classes.</P>
<P>Reported to be physically active in 11 (IQR 6 to 14) of 18 weeks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:09:28 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Participants were given a diary to record both aerobic and resistance exercises. In order to objectively capture the aerobic exercise component, each exercise group participant was given a pedometer to be worn for each walking session throughout the entire 24-week study.</P>
<P>Mean walking time per week in minutes: 44.6</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:36:02 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:48:36 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>"About 20% did not completely adhere." Adherence was about 77% of the prescribed exercise sessions and 100% of the prescribed exercise intensity</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:50:45 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>On average, participants in OnTrack attended 71% of the planned sessions. On the basis of the exercise diary, 48% of the OnTrack group and 55% of the Onco-Move group followed the recommendations regarding daily activity levels at least 75% of the time<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:56:23 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>On average, participants in OnTrack attended 71% of the planned sessions. On the basis of the exercise diary, 48% of the OnTrack group and 55% of the Onco-Move group followed the recommendations regarding daily activity levels at least 75% of the time<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="STUDY" MODIFIED="2016-09-10 23:16:18 +1000" MODIFIED_BY="Anna C Furmaniak" NO="14">
<NAME>Contamination</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 13:59:04 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Battaglini-2004">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:42:52 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cadmus-2007">
<DESCRIPTION>
<P>Women didn't have to be sedentary at baseline.</P>
<P>36% of IMPACT study control group participants reported no sports/recreational physical activity at 6-month follow-up; the remaining 64% of controls reported between 35 and 378 min/week of activity, with a median of 181 minutes.</P>
<P>Obese cohort (mean BMI &gt; 30 kg/m<SUP>2</SUP>)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:51:19 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Caldwell-2009">
<DESCRIPTION>
<P>Participants did not have to be sedentary</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 14:58:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Campbell-2005">
<DESCRIPTION>
<P>Control group more physically active at baseline than intervention group (421 min vs 330 min). Controls remained at baseline level, whereas intervention group increased level. The self reported levels of physical activity at baseline for both groups and at follow-up for the control group were similar to those found in sedentary populations</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:19:47 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cornette-2013">
<DESCRIPTION>
<P>The control group was not asked to abstain from physical activity</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:34:59 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Courneya-2007-AET">
<DESCRIPTION>
<P>Women were asked not to initiate an exercise programme. Otherwise not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 15:41:49 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Courneya-2007-RET">
<DESCRIPTION>
<P>Women were asked not to initiate an exercise programme. Otherwise not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:13:09 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Crowley-2003">
<DESCRIPTION>
<P>The intervention group walked a mean of 113 minutes per week, as compared to 53 minutes by the comparison group. Thus the intervention group was considered to be performing at a moderate level of activity per week, while the comparison group had a low level of activity over the study period. Study participants were asked to commit to not initiating participation in a formal exercise program during the study period. Continuation of an ongoing exercise regimen was acceptable<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-09-10 23:16:18 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="NO" STUDY_ID="STD-Dodd-2010">
<DESCRIPTION>
<P>44% of group 2 (exercise after adjuvant treatment) reported meeting ACSM 1998 guidelines (aerobic activities 3x/week, for 20-minute duration, and at a moderate intensity) at T1, by T2 group 2 had decreased to 27%. 34% of group 3 (no exercise) reported meeting minimum criteria at T1, this decreased to 31% at T2.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 16:55:30 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drouin-2002">
<DESCRIPTION>
<P>Obese cohort (mean BMI &gt; 30 kg/m<SUP>2</SUP>). Otherwise not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-26 17:14:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Eakin-2012">
<DESCRIPTION>
<P>30% to 40% of control group were active during the study period. They started out as being as active</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:06:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gokal-2013">
<DESCRIPTION>
<P>Sedentary patients at baseline. Self report of perceived physical activity for control group: 23/25 moderately inactive to inactive<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:21:40 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haines-2010">
<DESCRIPTION>
<P>In addition to the program provided, 25 out of 37 intervention group participants and 21 out of 36 control group participants had commenced other forms of exercise (e.g. walking, dancing, gymnasium, and aerobics)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:36:49 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hayes-2013-FtF">
<DESCRIPTION>
<P>The Active Australia Survey showed that the usual-care group was more active (more minutes per week) than the FtF group and as active as the Tel group at 6 months. At 12 months, the usual-care group was more active than the FtF group and less active than the Tel group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 07:46:46 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hayes-2013-Tel">
<DESCRIPTION>
<P>The Active Australia Survey showed that the usual-care group was more active (more minutes per week) than the FtF group and as active as the Tel group at 6 months. At 12 months, the usual-care group was more active than the FtF group and less active than the Tel group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:02:14 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hornsby-2014">
<DESCRIPTION>
<P>"There were no significant differences between groups for self-reported exercise behavior." Otherwise not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-10 11:38:22 +1000" MODIFIED_BY="Melina L Willson" RESULT="NO" STUDY_ID="STD-Husebo-2014">
<DESCRIPTION>
<P>The control group had a mean exercise volume of 144 (SD 84) MVPA minutes per week, and 39% performed 150 minutes/week of MVPA or more. Data on exercise volume indicates that 48% of participants in both groups exercised according to the general recommended physical activity level or more.</P>
<P>"there was a tendency of a significantly larger mean exercise volume in the intervention group compared to the control group (P = 0.051)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:19:38 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ingram-2010">
<DESCRIPTION>
<P>"The women in the control group were unexpectedly quite active." Were asked not to begin a new exercise program</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:29:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacVicar-1989">
<DESCRIPTION>
<P>"No subject participated in any other exercise or rehabilitation program during the 10 week data collection period."</P>
<P>Comment: amount of physical activity outside of programs unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:35:18 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Mock-2004">
<DESCRIPTION>
<P>Contamination: 21/54 (39%) of the control group were exercising</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 08:42:29 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moros-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-09 01:54:47 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Mutrie-2007">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 10:56:36 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perna-2010">
<DESCRIPTION>
<P>Contamination not reported/GLTEQ scores increased from baseline by 32.7% in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:11:21 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rao-2012">
<DESCRIPTION>
<P>Women were allowed to engage in their own exercise regimens and diet modifications. (ClinicalTrials.gov)</P>
<P>BMI &gt; 25, therefore "unlikely to have previously exercised"</P>
<P>Comment: amount of physical activity not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:19:00 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reis-2013">
<DESCRIPTION>
<P>"66% of participants (n = 27) reported engaging in aerobic activity for at least three 20-minute sessions per week prior to the cancer diagnosis. About 74% of those women (n = 20) continued to exercise during radiation therapy. No significant difference existed in the exercise history of the Nia group compared to the control group."<BR/>
</P>
<P>Women in the control group reported engaging in aerobic exercise 0 to 41 times, or an average of almost 3 days per week (34 days in 6 weeks average)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:40:19 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schmidt-2014">
<DESCRIPTION>
<P>Patients already participating in systematic intensive resistance or aerobic training (at least 1 hr twice/week) were excluded. Otherwise not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:47:59 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-AET">
<DESCRIPTION>
<P>Not reported. Control group not sedentary before cancer diagnosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:52:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2007-RET">
<DESCRIPTION>
<P>Not reported. Control group not sedentary before cancer diagnosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 11:59:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Segal-2001-SD">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:03:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Segal-2001-SU">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 12:28:12 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Steindorf-2014">
<DESCRIPTION>
<P>Patients already participating in systematic intensive resistance or aerobic training (at least 1 hr twice/week) were excluded. Otherwise not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 14:37:50 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Travier-2015">
<DESCRIPTION>
<P>High level of physical activity reported by 56% of the controls at 18 weeks</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:12:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Visovsky-2014">
<DESCRIPTION>
<P>Participants completed the Leisure Time Exercise (LTE) questionnaire at the baseline interview; "No significant differences"</P>
<P>Participants assigned to the attention control group agreed not to begin a new exercise program or change their level of exercise during the course of the study. Level of exercise during study not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-27 15:36:36 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Winningham-1988">
<DESCRIPTION>
<P>Contamination not reported. Inclusion criterion: "not in an exercise program". Control participants were advised to notify project personnel if they began exercising on a regular basis either as part of a group or on their own</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-17 04:13:22 +1000" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-Yang-2011">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 00:58:44 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-van-Waart-2014-high">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-11 00:59:26 +1100" MODIFIED_BY="Anna C Furmaniak" RESULT="UNKNOWN" STUDY_ID="STD-van-Waart-2014-low">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2016-01-09 22:52:09 +1100" MODIFIED_BY="Anna C Furmaniak" NO="13">
<NAME>ITT analysis</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-09-16 12:10:26 +1000" MODIFIED_BY="Melina L Willson">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-09-16 12:10:26 +1000" MODIFIED_BY="Melina L Willson" NO="1">
<TITLE MODIFIED="2016-08-28 05:25:58 +1000" MODIFIED_BY="[Empty name]">Exercise compared with control for women receiving adjuvant therapy for breast cancer</TITLE>
<TABLE COLS="5" ROWS="14">
<TR>
<TD COLSPAN="5">
<P>
<B>Exercise compared with control for women receiving adjuvant therapy for breast cancer</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>
<B>Population: </B>women receiving adjuvant therapy (chemo- or radiotherapy or both) for breast cancer</P>
<P>
<B>Settings: </B>supervised or home based</P>
<P>
<B>Intervention: </B>aerobic or resistance exercise or a combination of both</P>
<P>
<B>Comparison: </B>control intervention (usual care or intervention that was not exercise, such as stretching)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Relative effects* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Exercise vs control</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Physical fitness</B>
</P>
<P>assessed with: 6- or 12-minute walk test, peak oxygen uptake, and other scales</P>
<P>(follow-up: 18 weeks to 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean physical fitness in the intervention group was <B>0.42 standard deviations higher</B> (0.25 to 0.59 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1310</P>
<P>(15 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>SMD 0.42 (95% CI 0.25 to 0.59)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Fatigue</B>
</P>
<P>assessed with: FACIT-F scale, (revised) Piper Fatigue Scale, Multidimensional Fatigue Inventory and other scales</P>
<P>(follow-up: 18 weeks to 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean fatigue in the intervention group was <B>0.28 standard deviations lower</B> (0.41 lower to 0.16 lower)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1698</P>
<P>(19 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>SMD -0.28 (95% CI -0.41 to -0.16)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cancer-specific quality of life</B>
</P>
<P>assessed with: FACT-G, EORTC QLQ-C30 and other scales</P>
<P>(follow-up: 12 weeks to 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean cancer-specific quality of life in the intervention group was <B>0.12 standard deviations higher</B> (0.00 to 0.25 higher)<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1012</P>
<P>(12 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>3</SUP>
</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>SMD 0.12 (95% CI 0.00 to 0.25)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Health-related quality of life</B>
</P>
<P>assessed with EQ-5D visual analogue scale (higher scores indicate higher quality of life, score range from 0 to 100)</P>
<P>MID: 7 points</P>
<P>(follow-up: end of intervention)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean health-related quality of life in the intervention group was <B>1.10 points higher </B>(5.28 lower to 7.48 higher)</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68</P>
<P>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>4,5</SUP>
</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MD 1.10 (95% CI -5.28 to 7.48)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cancer site-specific quality of life</B>
</P>
<P>assessed with: FACT-B (higher scores indicate better quality of life, score range from 0 to 144)</P>
<P>MID: 7 to 8 points</P>
<P>(follow-up: end of intervention)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean cancer site-specific quality of life in the intervention group was <B>4.24 points higher</B> (1.81 lower to 10.29 points higher)</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>262</P>
<P>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MD 4.24 (95% CI -1.81 to 10.29)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Depression</B>
</P>
<P>assessed with: BDI, CES-D</P>
<P>(follow-up: 6 months)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean depression in the intervention group was <B>0.15 standard deviations lower</B> (0.30 lower to 0.01 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>674</P>
<P>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>8</SUP>
</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>SMD -0.15 (95% CI -0.30 to 0.01)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cognitive function</B>
</P>
<P>assessed with: Trail Making Test</P>
<P>(less time in seconds needed for completing the test means less cognitive dysfunction)</P>
<P>(follow-up: end of intervention)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean time needed for completing the test in the intervention group was <B>11.55 seconds less</B> (22.06 seconds less to 1.05 seconds less)</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>213</P>
<P>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>9,10</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MD -11.55 (95% CI -22.06 to -1.05)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Lymphoedema</B>
</P>
<P>assessed with: volumetric arm measurements and bioimpedance spectroscopy</P>
<P>(follow-up: 8 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk<SUP>11</SUP>: <BR/>85 per 1000<BR/>
<BR/>Corresponding risk:</P>
<P>60 per 1000 (30 to 123)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>436</P>
<P>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>12,13</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>RR 0.71 (95% CI 0.35 to 1.45)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>BDI:</B> Beck Depression Inventory; <B>CES-D:</B> Center for Epidemiological Studies-Depression Scale; <B>CI:</B> confidence interval; <B>FACIT-F:</B> Functional Assessment of Chronic Illness Therapy-Fatigue Scale; <B>FACT-B:</B> Functional Assessment of Cancer Therapy-Breast; <B>FACT-G:</B> Functional Assessment of Cancer Therapy-General; <B>MD:</B> mean difference; <B>MID: </B>minimally important difference; <B>RCT:</B> randomised controlled trial; <B>RR:</B> risk ratio; <B>SMD:</B> standardised mean difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="5">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Lack of blinding, low adherence and high or unclear contamination, several randomisation and many allocation concealment procedures were unclear, therefore we downgraded by one level.<BR/>
<SUP>2</SUP>Lack of blinding, low adherence and high or unclear amount of contamination, many allocation concealment procedures were unclear, therefore we downgraded by one level.<BR/>
<SUP>3</SUP>Lack of blinding, low adherence and high or unclear amount of contamination, and a high rate of incomplete outcome data, therefore we downgraded by one level.<BR/>
<SUP>4</SUP>Lack of blinding, low adherence and high amount of contamination, high rate of incomplete outcome data, and group similarity at baseline was at high risk, therefore we downgraded by one level.<BR/>
<SUP>5</SUP>Small number of participants and null effect and appreciable benefit included in the confidence interval for the mean difference: imprecision, therefore we further downgraded by one level.<BR/>
<SUP>6</SUP>Lack of blinding, low adherence, a high or unclear amount of contamination in three of four trials in the meta-analysis, two of four allocation concealment procedures were unclear, therefore we downgraded by one level.<BR/>
<SUP>7</SUP>Small number of participants, wide confidence intervals for two of the four trials, and null effect and appreciable benefit included in the confidence interval for the mean difference: imprecision, therefore we further downgraded by one level.<BR/>
<SUP>8</SUP>Lack of blinding, low adherence and unclear or high contamination, two published studies could not contribute to the meta-analysis, and in one of those there were no changes in the depression scores in any of the groups, therefore we downgraded by one level.<BR/>
<SUP>9</SUP>Lack of blinding, low and unclear adherence and unclear contamination, group similarity at baseline for one study was at high risk of bias, therefore we downgraded by one level.<BR/>
<SUP>10</SUP>Small number of participants: imprecision, therefore we further downgraded by one level.<BR/>
<SUP>11</SUP>Assumed risk based on the mean control group risk in the included studies.<BR/>
<SUP>12</SUP>Lack of blinding, low adherence and unclear or high contamination, one of two allocation procedures was unclear, group similarity at baseline was at high risk of bias for one study, therefore we downgraded by one level.<BR/>
<SUP>13</SUP>Small number of participants and null effect and appreciable harm and benefit included in the confidence interval for the risk ratio: imprecision, therefore we further downgraded by one level.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2016-01-08 02:13:54 +1100" MODIFIED_BY="Anna C Furmaniak"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-09-16 11:05:09 +1000" MODIFIED_BY="Melina L Willson">
<COMPARISON ID="CMP-001" MODIFIED="2016-09-16 10:38:13 +1000" MODIFIED_BY="Melina L Willson" NO="1">
<NAME>Exercise versus control</NAME>
<CONT_OUTCOME CHI2="37.529018342120956" CI_END="0.5929714168706035" CI_START="0.24940075717712556" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.42118608702386456" ESTIMABLE="YES" I2="49.37251002199751" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2016-09-16 10:32:10 +1000" MODIFIED_BY="Melina L Willson" NO="1" P_CHI2="0.006808973531309492" P_Q="1.0" P_Z="1.5438698488874113E-6" Q="0.0" RANDOM="YES" SCALE="2.73" SORT_BY="STUDY" STUDIES="20" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.06860356004626214" TOTALS="YES" TOTAL_1="785" TOTAL_2="525" UNITS="" WEIGHT="100.00000000000001" Z="4.805471818185051">
<NAME>Physical fitness</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0555967262446333" CI_START="-0.9734475583613071" EFFECT_SIZE="0.041074583941663134" ESTIMABLE="YES" MEAN_1="1761.87" MEAN_2="1749.0" MODIFIED="2015-12-28 04:36:10 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="35" SD_1="343.7" SD_2="245.47" SE="0.5176228493510041" STUDY_ID="STD-Caldwell-2009" TOTAL_1="7" TOTAL_2="8" WEIGHT="2.2826702489830697"/>
<CONT_DATA CI_END="2.4808258193260824" CI_START="0.4056169266216578" EFFECT_SIZE="1.44322137297387" ESTIMABLE="YES" MEAN_1="1423.0" MEAN_2="1083.0" MODIFIED="2015-12-28 04:36:11 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="70700" SD_1="261.0" SD_2="176.0" SE="0.5293997514937538" STUDY_ID="STD-Campbell-2005" TOTAL_1="10" TOTAL_2="9" WEIGHT="2.2019895610029567"/>
<CONT_DATA CI_END="1.1135105816580753" CI_START="-0.11805236112414363" EFFECT_SIZE="0.49772911026696576" ESTIMABLE="YES" MEAN_1="549.0" MEAN_2="517.5" MODIFIED="2015-12-28 04:36:13 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="36" SD_1="53.0" SD_2="69.3" SE="0.3141799932286078" STUDY_ID="STD-Cornette-2013" TOTAL_1="20" TOTAL_2="22" WEIGHT="4.5914223393112135"/>
<CONT_DATA CI_END="0.724664452011039" CI_START="-0.08214586588659423" EFFECT_SIZE="0.3212592930622224" ESTIMABLE="YES" MEAN_1="25.7" MEAN_2="23.5" MODIFIED="2015-12-28 04:36:15 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="32" SD_1="7.4" SD_2="5.4" SE="0.20582274068851522" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="71" TOTAL_2="36" WEIGHT="6.922832737717914"/>
<CONT_DATA CI_END="0.5105387074780806" CI_START="-0.27420576038621536" EFFECT_SIZE="0.11816647354593265" ESTIMABLE="YES" MEAN_1="24.2" MEAN_2="23.5" MODIFIED="2016-01-03 20:58:33 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="31" SD_1="6.1" SD_2="5.4" SE="0.2001935938757702" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="77" TOTAL_2="37" WEIGHT="7.068417578058259"/>
<CONT_DATA CI_END="2.086955180913748" CI_START="0.16965478830887404" EFFECT_SIZE="1.1283049846113111" ESTIMABLE="YES" MEAN_1="22.6" MEAN_2="16.6" MODIFIED="2015-12-28 04:36:18 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="70701" SD_1="6.2" SD_2="2.2" SE="0.48911623063696447" STUDY_ID="STD-Drouin-2002" TOTAL_1="13" TOTAL_2="8" WEIGHT="2.4954759387985384"/>
<CONT_DATA CI_END="0.6355132363130074" CI_START="-0.4052646454266706" EFFECT_SIZE="0.1151242954431684" ESTIMABLE="YES" MEAN_1="545.0" MEAN_2="535.0" MODIFIED="2015-12-28 04:36:20 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="98" SD_1="83.0" SD_2="88.0" SE="0.2655094404665599" STUDY_ID="STD-Haines-2010" TOTAL_1="27" TOTAL_2="30" WEIGHT="5.522713435174727"/>
<CONT_DATA CI_END="0.471383763716967" CI_START="-0.6976729163791541" EFFECT_SIZE="-0.11314457633109355" ESTIMABLE="YES" MEAN_1="-123.2" MEAN_2="-121.3" MODIFIED="2016-01-03 20:58:34 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="789" SD_1="15.36" SD_2="19.17" SE="0.29823422504635055" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="38" TOTAL_2="16" WEIGHT="4.8760173152342245"/>
<CONT_DATA CI_END="0.551419122601828" CI_START="-0.6002329888709187" EFFECT_SIZE="-0.02440693313454539" ESTIMABLE="YES" MEAN_1="-121.7" MEAN_2="-121.3" MODIFIED="2016-01-03 20:58:34 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="790" SD_1="14.92" SD_2="19.17" SE="0.29379420248454347" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="42" TOTAL_2="16" WEIGHT="4.958752345800287"/>
<CONT_DATA CI_END="2.0115267630329696" CI_START="0.0638983515584256" EFFECT_SIZE="1.0377125572956976" ESTIMABLE="YES" MEAN_1="22.1" MEAN_2="16.0" MODIFIED="2015-12-28 04:36:23 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="37" SD_1="7.0" SD_2="4.0" SE="0.49685311231154966" STUDY_ID="STD-Hornsby-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="2.4351325908104284"/>
<CONT_DATA CI_END="0.7588949386315875" CI_START="-0.2580238747013306" EFFECT_SIZE="0.25043553196512847" ESTIMABLE="YES" MEAN_1="644.02" MEAN_2="628.33" MODIFIED="2015-12-28 04:36:24 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="38" SD_1="63.3" SD_2="60.44" SE="0.2594228315811525" STUDY_ID="STD-Husebo-2014" TOTAL_1="29" TOTAL_2="31" WEIGHT="5.652550798584463"/>
<CONT_DATA CI_END="1.107772756893073" CI_START="0.488744355103598" EFFECT_SIZE="0.7982585559983355" ESTIMABLE="YES" MEAN_1="1135.0" MEAN_2="984.0" MODIFIED="2015-12-28 04:36:25 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="34" SD_1="143.0" SD_2="221.0" SE="0.15791831040577584" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="8.212406927056987"/>
<CONT_DATA CI_END="1.1226405226768628" CI_START="-0.3699355793109615" EFFECT_SIZE="0.37635247168295066" ESTIMABLE="YES" MEAN_1="1568.0" MEAN_2="1433.0" MODIFIED="2015-12-28 04:36:26 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="121" SD_1="259.8" SD_2="398.4" SE="0.3807662063591663" STUDY_ID="STD-Reis-2013" TOTAL_1="12" TOTAL_2="17" WEIGHT="3.5966836311385846"/>
<CONT_DATA CI_END="1.6767026942944834" CI_START="0.1927104895689934" EFFECT_SIZE="0.9347065919317384" ESTIMABLE="YES" MEAN_1="1228.0" MEAN_2="944.0" MODIFIED="2015-12-26 09:11:05 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="30" SD_1="322.0" SD_2="241.0" SE="0.3785763964111155" STUDY_ID="STD-Schwartz-2007-AET" TOTAL_1="22" TOTAL_2="12" WEIGHT="3.624904280859076"/>
<CONT_DATA CI_END="1.2823592098989018" CI_START="-0.20365880347318221" EFFECT_SIZE="0.5393502032128599" ESTIMABLE="YES" MEAN_1="1055.0" MEAN_2="944.0" MODIFIED="2016-01-03 20:58:35 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="33" SD_1="177.0" SD_2="241.0" SE="0.37909319382743883" STUDY_ID="STD-Schwartz-2007-RET" TOTAL_1="21" TOTAL_2="11" WEIGHT="3.6182190620444445"/>
<CONT_DATA CI_END="0.7506586000498139" CI_START="-0.3257353750857652" EFFECT_SIZE="0.2124616124820243" ESTIMABLE="YES" MEAN_1="26.3" MEAN_2="25.1" MODIFIED="2016-01-05 20:40:02 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="70702" SD_1="5.3" SD_2="6.1" SE="0.2745953455333969" STUDY_ID="STD-Segal-2001-SD" TOTAL_1="40" TOTAL_2="20" WEIGHT="5.33451428931695"/>
<CONT_DATA CI_END="0.724466826167865" CI_START="-0.3256439059475228" EFFECT_SIZE="0.19941146011017105" ESTIMABLE="YES" MEAN_1="26.2" MEAN_2="25.1" MODIFIED="2016-01-05 20:40:03 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="70703" SD_1="5.1" SD_2="6.1" SE="0.26789031339313557" STUDY_ID="STD-Segal-2001-SU" TOTAL_1="42" TOTAL_2="21" WEIGHT="5.472747846206326"/>
<CONT_DATA CI_END="0.47921444433460947" CI_START="-0.17673505010187715" EFFECT_SIZE="0.15123969711636617" ESTIMABLE="YES" MEAN_1="21.51" MEAN_2="20.71" MODIFIED="2015-12-28 04:36:28 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="178" SD_1="5.52" SD_2="4.9" SE="0.16733712956220945" STUDY_ID="STD-Travier-2015" TOTAL_1="83" TOTAL_2="63" WEIGHT="7.95197714529182"/>
<CONT_DATA CI_END="1.4993057522080382" CI_START="0.6226723297562344" EFFECT_SIZE="1.0609890409821363" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="5.1" MODIFIED="2016-01-03 20:58:33 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="159" SD_1="9.0" SD_2="5.4" SE="0.22363508446241268" STUDY_ID="STD-van-Waart-2014-high" TOTAL_1="71" TOTAL_2="33" WEIGHT="6.476373945302892"/>
<CONT_DATA CI_END="0.9025699927836028" CI_START="0.062005442920528064" EFFECT_SIZE="0.4822877178520655" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="5.1" MODIFIED="2015-12-26 09:11:13 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="160" SD_1="9.0" SD_2="5.4" SE="0.21443367237697752" STUDY_ID="STD-van-Waart-2014-low" TOTAL_1="69" TOTAL_2="33" WEIGHT="6.704197983306832"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="29.571128843687887" CI_END="-0.15954566853219881" CI_START="-0.40551243560626765" CI_STUDY="95" CI_TOTAL="95" DF="21" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.28252905206923323" ESTIMABLE="YES" I2="28.984787456017052" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2016-09-16 10:32:19 +1000" MODIFIED_BY="Melina L Willson" NO="2" P_CHI2="0.1009510325762637" P_Q="1.0" P_Z="6.712256930843975E-6" Q="0.0" RANDOM="YES" SCALE="2.16" SORT_BY="STUDY" STUDIES="22" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.02312697508173023" TOTALS="YES" TOTAL_1="953" TOTAL_2="745" UNITS="" WEIGHT="99.99999999999999" Z="4.502614505439974">
<NAME>Fatigue</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.8826402610448931" CI_START="-3.115294564872996" EFFECT_SIZE="-1.9989674129589445" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="3.23" MODIFIED="2016-05-12 20:08:00 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="41" SD_1="1.13" SD_2="1.16" SE="0.5695651352369214" STUDY_ID="STD-Battaglini-2004" TOTAL_1="10" TOTAL_2="10" WEIGHT="1.1329288066959073"/>
<CONT_DATA CI_END="1.0525675617797179" CI_START="-0.8537012347352622" EFFECT_SIZE="0.09943316352222781" ESTIMABLE="YES" MEAN_1="10.5" MEAN_2="10.0" MODIFIED="2015-08-25 19:01:36 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="44" SD_1="6.41" SD_2="2.6" SE="0.4863019962487538" STUDY_ID="STD-Caldwell-2009" TOTAL_1="8" TOTAL_2="9" WEIGHT="1.5165761550883305"/>
<CONT_DATA CI_END="0.26969077673040676" CI_START="-1.5922974431936527" EFFECT_SIZE="-0.6613033332316229" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="4.35" MODIFIED="2015-08-25 19:01:36 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="70708" SD_1="1.94" SD_2="3.48" SE="0.47500572322021856" STUDY_ID="STD-Campbell-2005" TOTAL_1="10" TOTAL_2="9" WEIGHT="1.5827803949660284"/>
<CONT_DATA CI_END="0.4602507150370088" CI_START="-1.3698942062621344" EFFECT_SIZE="-0.4548217456125628" ESTIMABLE="YES" MEAN_1="41.9" MEAN_2="49.8" MODIFIED="2016-01-10 22:26:05 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="49" SD_1="14.8" SD_2="18.4" SE="0.46688228348456723" STUDY_ID="STD-Cornette-2013" TOTAL_1="10" TOTAL_2="9" WEIGHT="1.6330090788802047"/>
<CONT_DATA CI_END="0.22931120922381687" CI_START="-0.5685353514081588" EFFECT_SIZE="-0.16961207109217097" ESTIMABLE="YES" MEAN_1="-36.8" MEAN_2="-34.9" MODIFIED="2015-12-26 09:14:36 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="42" SD_1="10.4" SD_2="12.5" SE="0.2035360258977429" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="74" TOTAL_2="36" WEIGHT="6.099219763182409"/>
<CONT_DATA CI_END="0.26093690267700653" CI_START="-0.5256436289157912" EFFECT_SIZE="-0.1323533631193923" ESTIMABLE="YES" MEAN_1="-36.3" MEAN_2="-34.9" MODIFIED="2015-12-26 09:14:38 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="43" SD_1="9.4" SD_2="12.5" SE="0.20066198608679664" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="76" TOTAL_2="37" WEIGHT="6.210989790626421"/>
<CONT_DATA CI_END="0.6552892072691041" CI_START="-1.1128418008544756" EFFECT_SIZE="-0.22877629679268577" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.9" MODIFIED="2015-12-26 09:14:39 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="70706" SD_1="1.9" SD_2="2.4" SE="0.45106211697520243" STUDY_ID="STD-Drouin-2002" TOTAL_1="13" TOTAL_2="8" WEIGHT="1.7376705345674"/>
<CONT_DATA CI_END="0.0789012193830696" CI_START="-0.6701794544465446" EFFECT_SIZE="-0.2956391175317375" ESTIMABLE="YES" MEAN_1="-36.95" MEAN_2="-33.7" MODIFIED="2016-05-12 19:56:48 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="104" SD_1="11.05" SD_2="10.77" SE="0.19109552005502828" STUDY_ID="STD-Eakin-2012" TOTAL_1="58" TOTAL_2="53" WEIGHT="6.601254670656262"/>
<CONT_DATA CI_END="-0.6671842108661976" CI_START="-1.892986964601838" EFFECT_SIZE="-1.2800855877340178" ESTIMABLE="YES" MEAN_1="26.04" MEAN_2="33.6" MODIFIED="2015-12-26 09:16:25 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="174" SD_1="3.8" SD_2="7.29" SE="0.31271053024561063" STUDY_ID="STD-Gokal-2013" TOTAL_1="25" TOTAL_2="25" WEIGHT="3.256244807475997"/>
<CONT_DATA CI_END="0.2877895017546741" CI_START="-0.6516865770375234" EFFECT_SIZE="-0.18194853764142463" ESTIMABLE="YES" MEAN_1="11.1" MEAN_2="11.9" MODIFIED="2015-12-26 09:15:58 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="40" SD_1="4.2" SD_2="4.5" SE="0.2396666689292928" STUDY_ID="STD-Haines-2010" TOTAL_1="36" TOTAL_2="34" WEIGHT="4.88696275856906"/>
<CONT_DATA CI_END="0.399807740051063" CI_START="-0.6737804700734883" EFFECT_SIZE="-0.13698636501121264" ESTIMABLE="YES" MEAN_1="-36.0" MEAN_2="-34.4" MODIFIED="2015-12-26 09:15:59 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="102" SD_1="11.65" SD_2="11.26" SE="0.27387957600059953" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="45" TOTAL_2="19" WEIGHT="4.012027738735688"/>
<CONT_DATA CI_END="0.23483865048869634" CI_START="-0.8237761758242836" EFFECT_SIZE="-0.29446876266779365" ESTIMABLE="YES" MEAN_1="-37.3" MEAN_2="-34.4" MODIFIED="2015-12-26 09:16:00 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="103" SD_1="8.99" SD_2="11.26" SE="0.2700597650424188" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="45" TOTAL_2="20" WEIGHT="4.098807223765412"/>
<CONT_DATA CI_END="1.8106523201116507" CI_START="-0.0921252389199535" EFFECT_SIZE="0.8592635405958485" ESTIMABLE="YES" MEAN_1="-32.8" MEAN_2="-42.2" MODIFIED="2016-05-12 20:08:05 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="45" SD_1="14.8" SD_2="3.4" SE="0.4854113580760847" STUDY_ID="STD-Hornsby-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="1.5216486473304986"/>
<CONT_DATA CI_END="0.25872757124026335" CI_START="-0.7581671189934628" EFFECT_SIZE="-0.24971977387659974" ESTIMABLE="YES" MEAN_1="12.01" MEAN_2="13.13" MODIFIED="2015-12-26 09:16:03 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="46" SD_1="4.38" SD_2="4.47" SE="0.25941667761623727" STUDY_ID="STD-Husebo-2014" TOTAL_1="29" TOTAL_2="31" WEIGHT="4.3542467554740965"/>
<CONT_DATA CI_END="0.2979801899284531" CI_START="-0.45671849826439714" EFFECT_SIZE="-0.079369154167972" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="3.7" MODIFIED="2015-12-26 09:16:05 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="70705" SD_1="2.4" SD_2="2.6" SE="0.1925287133196878" STUDY_ID="STD-Mock-2004" TOTAL_1="54" TOTAL_2="54" WEIGHT="6.540959566197999"/>
<CONT_DATA CI_END="0.009978892279521756" CI_START="-0.58850953789028" EFFECT_SIZE="-0.28926532280537914" ESTIMABLE="YES" MEAN_1="-120.8" MEAN_2="-113.3" MODIFIED="2015-12-26 09:16:06 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="48" SD_1="26.7" SD_2="25.0" SE="0.15267842544317195" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="8.478640260688696"/>
<CONT_DATA CI_END="0.5103247186240708" CI_START="-0.9731775063847102" EFFECT_SIZE="-0.23142639388031971" ESTIMABLE="YES" MEAN_1="-136.8" MEAN_2="-132.9" MODIFIED="2015-12-26 09:16:08 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="120" SD_1="15.67" SD_2="16.85" SE="0.37845139928857296" STUDY_ID="STD-Reis-2013" TOTAL_1="12" TOTAL_2="17" WEIGHT="2.366832508673893"/>
<CONT_DATA CI_END="-0.00813075450487083" CI_START="-0.8218623472649611" EFFECT_SIZE="-0.414996550884916" ESTIMABLE="YES" MEAN_1="36.1" MEAN_2="44.8" MODIFIED="2015-12-26 09:16:09 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="111" SD_1="20.6" SD_2="21.0" SE="0.20758840447546517" STUDY_ID="STD-Schmidt-2014" TOTAL_1="49" TOTAL_2="46" WEIGHT="5.945769046617989"/>
<CONT_DATA CI_END="0.07998077983576224" CI_START="-0.5519899484847788" EFFECT_SIZE="-0.23600458432450827" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="5.9" MODIFIED="2015-12-26 09:16:11 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="106" SD_1="2.3" SD_2="1.9" SE="0.16121998498580725" STUDY_ID="STD-Steindorf-2014" TOTAL_1="77" TOTAL_2="78" WEIGHT="8.015828665162223"/>
<CONT_DATA CI_END="0.06948838865082266" CI_START="-0.5293826314801164" EFFECT_SIZE="-0.22994712141464688" ESTIMABLE="YES" MEAN_1="11.82" MEAN_2="12.74" MODIFIED="2015-12-26 09:16:15 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="177" SD_1="4.23" SD_2="3.69" SE="0.1527760267165002" STUDY_ID="STD-Travier-2015" TOTAL_1="91" TOTAL_2="82" WEIGHT="8.473200510655833"/>
<CONT_DATA CI_END="0.019191460860328635" CI_START="-0.8139816271812456" EFFECT_SIZE="-0.39739508316045846" ESTIMABLE="YES" MEAN_1="13.1" MEAN_2="14.7" MODIFIED="2015-12-26 09:16:12 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="163" SD_1="3.9" SD_2="4.2" SE="0.21254806073314028" STUDY_ID="STD-van-Waart-2014-high" TOTAL_1="71" TOTAL_2="33" WEIGHT="5.764382088319303"/>
<CONT_DATA CI_END="0.16806220158698035" CI_START="-0.6644952081664982" EFFECT_SIZE="-0.24821650328975894" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="14.7" MODIFIED="2015-12-26 09:16:13 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="164" SD_1="3.9" SD_2="4.2" SE="0.21239099705927894" STUDY_ID="STD-van-Waart-2014-low" TOTAL_1="69" TOTAL_2="33" WEIGHT="5.770020227670352"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.410830208057889" CI_END="0.24742614067740887" CI_START="-0.003663723975447994" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.12188120835098044" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2016-09-16 10:32:28 +1000" MODIFIED_BY="Melina L Willson" NO="3" P_CHI2="0.9428322008708733" P_Q="1.0" P_Z="0.057070929527943015" Q="0.0" RANDOM="YES" SCALE="1.56" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="554" TOTAL_2="458" UNITS="" WEIGHT="100.0" Z="1.9027671952462952">
<NAME>Cancer-specific quality of life</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5371877695459445" CI_START="-0.5715575044669804" EFFECT_SIZE="-0.017184867460517932" ESTIMABLE="YES" MEAN_1="89.3" MEAN_2="89.5" MODIFIED="2015-08-11 00:02:02 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="60" SD_1="11.1" SD_2="11.8" SE="0.2828483795515035" STUDY_ID="STD-Cadmus-2007" TOTAL_1="25" TOTAL_2="25" WEIGHT="5.128552454604573"/>
<CONT_DATA CI_END="1.2745521995120037" CI_START="-0.5452640876122035" EFFECT_SIZE="0.36464405594990007" ESTIMABLE="YES" MEAN_1="71.7" MEAN_2="64.8" MODIFIED="2016-01-10 22:23:48 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="78" SD_1="18.9" SD_2="17.1" SE="0.46424737941071514" STUDY_ID="STD-Cornette-2013" TOTAL_1="10" TOTAL_2="9" WEIGHT="1.9037208656366302"/>
<CONT_DATA CI_END="0.5808834623408357" CI_START="-0.21715853933982948" EFFECT_SIZE="0.18186246150050311" ESTIMABLE="YES" MEAN_1="144.7" MEAN_2="139.9" MODIFIED="2015-08-14 00:19:46 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="76" SD_1="25.2" SD_2="28.2" SE="0.2035858842242813" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="74" TOTAL_2="36" WEIGHT="9.89935426851333"/>
<CONT_DATA CI_END="0.43120306735510255" CI_START="-0.3546582927406245" EFFECT_SIZE="0.03827238730723901" ESTIMABLE="YES" MEAN_1="140.9" MEAN_2="139.9" MODIFIED="2015-08-14 00:19:48 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="77" SD_1="24.8" SD_2="28.2" SE="0.20047852059897558" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="76" TOTAL_2="37" WEIGHT="10.208607210911614"/>
<CONT_DATA CI_END="0.6025736005331996" CI_START="-0.3708241498804546" EFFECT_SIZE="0.11587472532637254" ESTIMABLE="YES" MEAN_1="75.8" MEAN_2="74.0" MODIFIED="2015-08-11 00:02:05 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="100" SD_1="15.2" SD_2="15.5" SE="0.24832031560061602" STUDY_ID="STD-Haines-2010" TOTAL_1="33" TOTAL_2="32" WEIGHT="6.653921741711815"/>
<CONT_DATA CI_END="0.4720622908725404" CI_START="-1.3565066839017683" EFFECT_SIZE="-0.442222196514614" ESTIMABLE="YES" MEAN_1="80.2" MEAN_2="85.9" MODIFIED="2015-08-14 00:20:05 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="61" SD_1="16.7" SD_2="6.2" SE="0.46648024892238515" STUDY_ID="STD-Hornsby-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="1.8855396591405669"/>
<CONT_DATA CI_END="1.448333539412709" CI_START="-0.5162227563300814" EFFECT_SIZE="0.46605539154131376" ESTIMABLE="YES" MEAN_1="70.0" MEAN_2="60.7" MODIFIED="2015-08-11 00:02:07 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="75" SD_1="18.9" SD_2="19.0" SE="0.5011715294870109" STUDY_ID="STD-Moros-2010" TOTAL_1="10" TOTAL_2="7" WEIGHT="1.633538627546694"/>
<CONT_DATA CI_END="0.5352222672629013" CI_START="-0.062218204281419776" EFFECT_SIZE="0.23650203149074078" ESTIMABLE="YES" MEAN_1="81.0" MEAN_2="77.3" MODIFIED="2015-08-11 00:02:08 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="62" SD_1="16.8" SD_2="14.4" SE="0.15241108414666169" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="17.663187823708466"/>
<CONT_DATA CI_END="0.8364922997144922" CI_START="-0.642441461177344" EFFECT_SIZE="0.09702541926857407" ESTIMABLE="YES" MEAN_1="91.7" MEAN_2="90.6" MODIFIED="2015-08-11 00:02:08 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="119" SD_1="10.96" SD_2="11.06" SE="0.37728595335360166" STUDY_ID="STD-Reis-2013" TOTAL_1="12" TOTAL_2="17" WEIGHT="2.882444268449923"/>
<CONT_DATA CI_END="0.78755155623324" CI_START="-0.12523414517641202" EFFECT_SIZE="0.33115870552841403" ESTIMABLE="YES" MEAN_1="61.7" MEAN_2="54.9" MODIFIED="2015-08-11 00:02:09 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="110" SD_1="18.3" SD_2="22.9" SE="0.23285777407380676" STUDY_ID="STD-Schmidt-2014" TOTAL_1="45" TOTAL_2="32" WEIGHT="7.566947285612473"/>
<CONT_DATA CI_END="0.4084674760618191" CI_START="-0.2365059223391767" EFFECT_SIZE="0.08598077686132119" ESTIMABLE="YES" MEAN_1="64.0" MEAN_2="62.0" MODIFIED="2015-08-11 00:02:10 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="107" SD_1="25.0" SD_2="21.0" SE="0.16453705361130705" STUDY_ID="STD-Steindorf-2014" TOTAL_1="76" TOTAL_2="72" WEIGHT="15.155656715054382"/>
<CONT_DATA CI_END="0.36484276639050733" CI_START="-0.23509113772410278" EFFECT_SIZE="0.06487581433320226" ESTIMABLE="YES" MEAN_1="70.43" MEAN_2="69.3" MODIFIED="2015-11-21 23:35:53 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="168" SD_1="18.29" SD_2="16.15" SE="0.15304717557230954" STUDY_ID="STD-Travier-2015" TOTAL_1="93" TOTAL_2="79" WEIGHT="17.516670201127077"/>
<CONT_DATA CI_END="0.5370963990944109" CI_START="-1.2836105026134736" EFFECT_SIZE="-0.37325705175953133" ESTIMABLE="YES" MEAN_1="3.25" MEAN_2="3.44" MODIFIED="2015-08-17 23:42:08 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="79" SD_1="0.37" SD_2="0.57" SE="0.4644745811834779" STUDY_ID="STD-Visovsky-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="1.9018588779824561"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2016-09-16 10:32:35 +1000" MODIFIED_BY="Melina L Willson" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="34" TOTAL_2="34" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health-related quality of life</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.4785239887037624" CI_START="-5.278523988703745" EFFECT_SIZE="1.1000000000000085" ESTIMABLE="YES" MEAN_1="80.4" MEAN_2="79.3" MODIFIED="2014-06-29 21:41:23 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="74" SD_1="12.7" SD_2="14.1" SE="3.2544087743533745" STUDY_ID="STD-Haines-2010" TOTAL_1="34" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.023001934734058" CI_END="10.289751136159715" CI_START="-1.8103133349197318" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="4.239718900619992" ESTIMABLE="YES" I2="25.428820351827245" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2016-09-16 10:32:45 +1000" MODIFIED_BY="Melina L Willson" NO="5" P_CHI2="0.25899110894827604" P_Q="1.0" P_Z="0.16959813844986546" Q="0.0" RANDOM="YES" SCALE="36.91" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="10.067430923590155" TOTALS="YES" TOTAL_1="126" TOTAL_2="136" UNITS="" WEIGHT="100.0" Z="1.3734962106441784">
<NAME>Cancer site-specific quality of life</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="10.425392789117266" CI_START="-7.425392789117266" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="116.6" MEAN_2="115.1" MODIFIED="2016-01-06 04:43:40 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="57" SD_1="16.0" SD_2="16.2" SE="4.553855509345899" STUDY_ID="STD-Cadmus-2007" TOTAL_1="25" TOTAL_2="25" WEIGHT="30.93125534214624"/>
<CONT_DATA CI_END="37.40938920957108" CI_START="-3.60938920957107" EFFECT_SIZE="16.900000000000006" ESTIMABLE="YES" MEAN_1="111.2" MEAN_2="94.3" MODIFIED="2016-05-12 20:09:53 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="70715" SD_1="14.1" SD_2="28.4" SE="10.464166368028453" STUDY_ID="STD-Campbell-2005" TOTAL_1="10" TOTAL_2="9" WEIGHT="7.969126793173771"/>
<CONT_DATA CI_END="9.491364991025176" CI_START="-19.89136499102518" EFFECT_SIZE="-5.200000000000003" ESTIMABLE="YES" MEAN_1="105.7" MEAN_2="110.9" MODIFIED="2016-05-12 20:10:26 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="58" SD_1="21.3" SD_2="7.6" SE="7.495732119012793" STUDY_ID="STD-Hornsby-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="14.381719769640052"/>
<CONT_DATA CI_END="13.098819773050867" CI_START="0.5011802269491268" EFFECT_SIZE="6.799999999999997" ESTIMABLE="YES" MEAN_1="106.5" MEAN_2="99.7" MODIFIED="2016-05-12 20:09:49 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="59" SD_1="21.9" SD_2="20.3" SE="3.2137426109536484" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="46.717898095039935"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.7339751518250424" CI_END="0.007669240981302117" CI_START="-0.30209160102208465" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.14721118002039127" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2016-01-08 02:04:15 +1100" MODIFIED_BY="Anna C Furmaniak" NO="6" P_CHI2="0.5883164291446661" P_Q="1.0" P_Z="0.06247463358154544" Q="0.0" RANDOM="YES" SCALE="1.136480019634581" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="377" TOTAL_2="297" UNITS="" WEIGHT="100.0" Z="1.8629121040318883">
<NAME>Depression</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.27626070753178444" CI_START="-0.83838888490892" EFFECT_SIZE="-0.2810640886885678" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="10.0" MODIFIED="2015-03-29 06:04:14 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="67" SD_1="7.1" SD_2="7.6" SE="0.2843546109094142" STUDY_ID="STD-Cadmus-2007" TOTAL_1="25" TOTAL_2="25" WEIGHT="7.7228270514788"/>
<CONT_DATA CI_END="0.2815341764416733" CI_START="-0.515628039526753" EFFECT_SIZE="-0.11704693154253981" ESTIMABLE="YES" MEAN_1="9.7" MEAN_2="10.8" MODIFIED="2014-06-09 01:15:31 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="64" SD_1="9.3" SD_2="9.4" SE="0.20336144496948413" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="74" TOTAL_2="36" WEIGHT="15.09939758611093"/>
<CONT_DATA CI_END="0.37192628167785563" CI_START="-0.4138891551594284" EFFECT_SIZE="-0.02098143674078641" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="10.8" MODIFIED="2014-06-09 01:16:02 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="65" SD_1="9.5" SD_2="9.4" SE="0.20046680526675387" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="76" TOTAL_2="37" WEIGHT="15.538601188867123"/>
<CONT_DATA CI_END="-0.06972467286982298" CI_START="-0.6702178439789331" EFFECT_SIZE="-0.36997125842437806" ESTIMABLE="YES" MEAN_1="8.6" MEAN_2="11.5" MODIFIED="2016-01-04 21:27:22 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="66" SD_1="6.8" SD_2="8.6" SE="0.1531898483456134" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="26.6095105604346"/>
<CONT_DATA CI_END="0.4041106385750502" CI_START="-0.5110066696247301" EFFECT_SIZE="-0.053448015524839916" ESTIMABLE="YES" MEAN_1="20.4" MEAN_2="21.1" MODIFIED="2015-03-29 06:04:20 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="112" SD_1="12.8" SD_2="13.2" SE="0.23345258265409688" STUDY_ID="STD-Schmidt-2014" TOTAL_1="45" TOTAL_2="31" WEIGHT="11.457753989964388"/>
<CONT_DATA CI_END="0.3190062095652611" CI_START="-0.3190062095652611" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="25.0" MODIFIED="2015-03-29 06:04:35 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="108" SD_1="18.0" SD_2="17.0" SE="0.16276126096272245" STUDY_ID="STD-Steindorf-2014" TOTAL_1="75" TOTAL_2="76" WEIGHT="23.571909623144165"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.8095741767161038" CI_END="-1.047401444851106" CI_START="-22.061245928309937" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.554323686580522" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2016-09-16 10:33:00 +1000" MODIFIED_BY="Melina L Willson" NO="7" P_CHI2="0.368246231952599" P_Q="1.0" P_Z="0.031134727983327757" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="112" TOTAL_2="101" UNITS="seconds" WEIGHT="100.00000000000001" Z="2.155346520170725">
<NAME>Cognitive function</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.38840319350927643" CI_START="-35.81159680649071" EFFECT_SIZE="-18.099999999999994" ESTIMABLE="YES" MEAN_1="91.2" MEAN_2="109.3" MODIFIED="2014-12-24 09:30:07 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="113" SD_1="28.6" SD_2="41.4" SE="9.03669503429529" STUDY_ID="STD-Schmidt-2014" TOTAL_1="40" TOTAL_2="28" WEIGHT="35.19132362951012"/>
<CONT_DATA CI_END="5.051455362180153" CI_START="-21.051455362180153" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="98.0" MEAN_2="106.0" MODIFIED="2014-12-24 08:44:15 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="109" SD_1="37.0" SD_2="43.0" SE="6.6590281582357465" STUDY_ID="STD-Steindorf-2014" TOTAL_1="72" TOTAL_2="73" WEIGHT="64.80867637048989"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="29.37725123624048" CI_END="0.4974035428778468" CI_START="0.04279576441462604" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.27009965364623645" ESTIMABLE="YES" I2="59.15206666716145" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2016-09-16 10:33:08 +1000" MODIFIED_BY="Melina L Willson" NO="8" P_CHI2="0.003462057044671285" P_Q="1.0" P_Z="0.01986026942184441" Q="0.0" RANDOM="YES" SCALE="2.9" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0958406321873281" TOTALS="YES" TOTAL_1="577" TOTAL_2="335" UNITS="" WEIGHT="99.99999999999999" Z="2.328977278712336">
<NAME>Strength</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9940059410280013" CI_START="0.09759375849803187" EFFECT_SIZE="1.0457998497630165" ESTIMABLE="YES" MEAN_1="116.3" MEAN_2="102.7" MODIFIED="2015-08-29 01:44:04 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="50" SD_1="8.9" SD_2="15.2" SE="0.48378750770132173" STUDY_ID="STD-Battaglini-2004" TOTAL_1="10" TOTAL_2="10" WEIGHT="4.077060010901761"/>
<CONT_DATA CI_END="0.03972419923450343" CI_START="-1.1990522075492034" EFFECT_SIZE="-0.57966400415735" ESTIMABLE="YES" MEAN_1="24.0" MEAN_2="28.2" MODIFIED="2016-06-21 18:11:55 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="55" SD_1="5.5" SD_2="8.3" SE="0.3160201964309082" STUDY_ID="STD-Cornette-2013" TOTAL_1="20" TOTAL_2="22" WEIGHT="6.872359551827241"/>
<CONT_DATA CI_END="0.41407940742828003" CI_START="-0.38795655875740026" EFFECT_SIZE="0.01306142433543986" ESTIMABLE="YES" MEAN_1="24.7" MEAN_2="24.6" MODIFIED="2015-08-29 01:44:05 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="53" SD_1="7.5" SD_2="7.8" SE="0.20460477144275038" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="71" TOTAL_2="36" WEIGHT="9.767238684375084"/>
<CONT_DATA CI_END="1.133587315476979" CI_START="0.32610155846664174" EFFECT_SIZE="0.7298444369718105" ESTIMABLE="YES" MEAN_1="31.9" MEAN_2="24.6" MODIFIED="2016-06-21 18:11:48 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="54" SD_1="10.8" SD_2="7.8" SE="0.20599504975083266" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="77" TOTAL_2="37" WEIGHT="9.726915955516622"/>
<CONT_DATA CI_END="0.7774461342152083" CI_START="-0.9853882254799603" EFFECT_SIZE="-0.103971045632376" ESTIMABLE="YES" MEAN_1="31.3" MEAN_2="32.0" MODIFIED="2016-06-21 18:11:55 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="70704" SD_1="6.5" SD_2="6.4" SE="0.44971090632281535" STUDY_ID="STD-Drouin-2002" TOTAL_1="13" TOTAL_2="8" WEIGHT="4.512154267537081"/>
<CONT_DATA CI_END="0.5827809670409545" CI_START="-0.43838417689575365" EFFECT_SIZE="0.07219839507260045" ESTIMABLE="YES" MEAN_1="81.9" MEAN_2="80.2" MODIFIED="2015-08-29 01:44:06 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="56" SD_1="25.6" SD_2="20.5" SE="0.2605060990894548" STUDY_ID="STD-Haines-2010" TOTAL_1="30" TOTAL_2="29" WEIGHT="8.215955934732154"/>
<CONT_DATA CI_END="1.1931407339216373" CI_START="0.09616659788677195" EFFECT_SIZE="0.6446536659042046" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="6.8" MODIFIED="2016-01-03 01:09:23 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="565" SD_1="2.66" SD_2="3.45" SE="0.2798454830516421" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="45" TOTAL_2="19" WEIGHT="7.722959935212566"/>
<CONT_DATA CI_END="1.0202401392169875" CI_START="-0.09327969465799052" EFFECT_SIZE="0.46348022227949853" ESTIMABLE="YES" MEAN_1="8.1" MEAN_2="6.8" MODIFIED="2016-01-03 01:09:23 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="566" SD_1="2.44" SD_2="3.45" SE="0.28406640189775945" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="43" TOTAL_2="18" WEIGHT="7.618830670435338"/>
<CONT_DATA CI_END="1.4475967381362804" CI_START="-0.005605207855996497" EFFECT_SIZE="0.720995765140142" ESTIMABLE="YES" MEAN_1="13.72" MEAN_2="9.5" MODIFIED="2015-08-29 01:44:07 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="51" SD_1="6.4" SD_2="4.1" SE="0.3707215942371769" STUDY_ID="STD-Schwartz-2007-AET" TOTAL_1="22" TOTAL_2="12" WEIGHT="5.765661032760659"/>
<CONT_DATA CI_END="0.9973238930996605" CI_START="-0.468201528510091" EFFECT_SIZE="0.26456118229478476" ESTIMABLE="YES" MEAN_1="10.8" MEAN_2="9.5" MODIFIED="2015-08-29 01:44:37 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="52" SD_1="5.1" SD_2="4.1" SE="0.3738653957852361" STUDY_ID="STD-Schwartz-2007-RET" TOTAL_1="21" TOTAL_2="11" WEIGHT="5.708379456978343"/>
<CONT_DATA CI_END="0.1987951945147723" CI_START="-0.4422071289854213" EFFECT_SIZE="-0.12170596723532451" ESTIMABLE="YES" MEAN_1="30.11" MEAN_2="30.85" MODIFIED="2015-08-29 01:44:42 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="179" SD_1="5.68" SD_2="6.49" SE="0.16352400568488454" STUDY_ID="STD-Travier-2015" TOTAL_1="85" TOTAL_2="67" WEIGHT="10.972241014473537"/>
<CONT_DATA CI_END="0.9906972576616244" CI_START="0.14985100535021617" EFFECT_SIZE="0.5702741315059203" ESTIMABLE="YES" MEAN_1="30.6" MEAN_2="27.5" MODIFIED="2015-08-29 01:44:37 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="161" SD_1="5.3" SD_2="5.6" SE="0.2145055365669717" STUDY_ID="STD-van-Waart-2014-high" TOTAL_1="71" TOTAL_2="33" WEIGHT="9.481525956245155"/>
<CONT_DATA CI_END="0.5334104854447413" CI_START="-0.2969028703353596" EFFECT_SIZE="0.11825380755469088" ESTIMABLE="YES" MEAN_1="28.2" MEAN_2="27.5" MODIFIED="2015-08-29 01:44:08 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="162" SD_1="6.0" SD_2="5.6" SE="0.2118185237916377" STUDY_ID="STD-van-Waart-2014-low" TOTAL_1="69" TOTAL_2="33" WEIGHT="9.558717529004438"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.13624845880693826" CI_END="3.4063176712203562" CI_START="-4.450816137978676" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5222492333791598" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2016-09-16 10:33:16 +1000" MODIFIED_BY="Melina L Willson" NO="9" P_CHI2="0.9341444297177153" P_Q="1.0" P_Z="0.7944392420548637" Q="0.0" RANDOM="YES" SCALE="37.22" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="140" TOTAL_2="91" UNITS="" WEIGHT="100.0" Z="0.26055040253442063">
<NAME>Subjective upper body function</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.462372763433405" CI_START="-5.342372763433404" EFFECT_SIZE="0.0600000000000005" ESTIMABLE="YES" MEAN_1="13.68" MEAN_2="13.62" MODIFIED="2015-08-03 18:38:01 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="181" SD_1="15.21" SD_2="13.83" SE="2.7563632832269525" STUDY_ID="STD-Eakin-2012" TOTAL_1="58" TOTAL_2="53" WEIGHT="52.880945670436546"/>
<CONT_DATA CI_END="8.158362321467488" CI_START="-9.158362321467488" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="15.5" MEAN_2="16.0" MODIFIED="2015-08-14 00:53:14 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="179" SD_1="17.9" SD_2="14.91" SE="4.417612971342098" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="41" TOTAL_2="19" WEIGHT="20.58717690176304"/>
<CONT_DATA CI_END="5.926937061793437" CI_START="-9.326937061793435" EFFECT_SIZE="-1.6999999999999993" ESTIMABLE="YES" MEAN_1="14.3" MEAN_2="16.0" MODIFIED="2015-08-14 00:53:20 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="180" SD_1="11.88" SD_2="14.91" SE="3.8913659240443916" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="41" TOTAL_2="19" WEIGHT="26.53187742780041"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2016-09-16 10:33:25 +1000" MODIFIED_BY="Melina L Willson" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="9.37" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="82" TOTAL_2="92" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Shoulder mobility</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.663577586102075" CI_START="1.5364224138979272" EFFECT_SIZE="3.1000000000000014" ESTIMABLE="YES" MEAN_1="33.2" MEAN_2="30.1" MODIFIED="2015-08-01 01:36:11 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="177" SD_1="4.6" SD_2="5.9" SE="0.797758325375045" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.030008294661668575" CI_END="6.294926745041208" CI_START="-4.072342184290287" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="1.11129228037546" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2016-09-16 10:33:32 +1000" MODIFIED_BY="Melina L Willson" NO="11" P_CHI2="0.9851078561129316" P_Q="1.0" P_Z="0.6743492703261413" Q="0.0" RANDOM="YES" SCALE="42.68" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="148" TOTAL_2="92" UNITS="" WEIGHT="100.0" Z="0.42018642724140043">
<NAME>Arm morbidity</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.865451997234329" CI_START="-5.865451997234329" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="120.99" MEAN_2="119.49" MODIFIED="2015-08-17 19:07:07 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="173" SD_1="19.87" SD_2="19.69" SE="3.7579527253215232" STUDY_ID="STD-Eakin-2012" TOTAL_1="58" TOTAL_2="53" WEIGHT="49.53018276937018"/>
<CONT_DATA CI_END="11.729873382717166" CI_START="-9.529873382717177" EFFECT_SIZE="1.0999999999999943" ESTIMABLE="YES" MEAN_1="118.8" MEAN_2="117.7" MODIFIED="2015-08-17 19:04:10 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="174" SD_1="19.64" SD_2="19.9" SE="5.4235044452674925" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="45" TOTAL_2="19" WEIGHT="23.78003855891308"/>
<CONT_DATA CI_END="10.43371780639657" CI_START="-9.633717806396588" EFFECT_SIZE="0.3999999999999915" ESTIMABLE="YES" MEAN_1="118.1" MEAN_2="117.7" MODIFIED="2015-08-17 19:04:32 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="175" SD_1="16.98" SD_2="19.9" SE="5.119337847808054" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="45" TOTAL_2="20" WEIGHT="26.68977867171674"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.2522047465833568" CI_END="1.4554130768430675" CI_START="-4.3586590519845245" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.4516229875707283" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2016-09-16 10:33:44 +1000" MODIFIED_BY="Melina L Willson" NO="12" P_CHI2="0.881524602602429" P_Q="1.0" P_Z="0.32772610615490116" Q="0.0" RANDOM="YES" SCALE="29.5" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="206" TOTAL_2="125" UNITS="" WEIGHT="100.0" Z="0.9787043269250886">
<NAME>Anxiety</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.3404656928411365" CI_START="-7.140465692841134" EFFECT_SIZE="-2.3999999999999986" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="37.4" MODIFIED="2014-06-09 01:23:36 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="69" SD_1="11.7" SD_2="12.0" SE="2.4186493885772" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="74" TOTAL_2="36" WEIGHT="37.60614562353198"/>
<CONT_DATA CI_END="3.806560919618451" CI_START="-5.806560919618451" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="36.4" MEAN_2="37.4" MODIFIED="2014-06-09 01:24:08 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="70" SD_1="12.7" SD_2="12.0" SE="2.4523720627174734" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="76" TOTAL_2="37" WEIGHT="36.579009149323504"/>
<CONT_DATA CI_END="5.011575812388672" CI_START="-6.431575812388673" EFFECT_SIZE="-0.7100000000000009" ESTIMABLE="YES" MEAN_1="37.5" MEAN_2="38.21" MODIFIED="2015-08-14 01:12:21 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="163" SD_1="14.4" SD_2="15.83" SE="2.9192249742953096" STUDY_ID="STD-Eakin-2012" TOTAL_1="56" TOTAL_2="52" WEIGHT="25.814845227144517"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.3474289332816414" CI_END="-0.6011052234845142" CI_START="-1.4021550221768455" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-1.0016301228306799" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2016-09-16 10:33:51 +1000" MODIFIED_BY="Melina L Willson" NO="13" P_CHI2="0.5098114221211602" P_Q="1.0" P_Z="9.512436816202846E-7" Q="0.0" RANDOM="YES" SCALE="4.92" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="57" TOTAL_2="54" UNITS="" WEIGHT="100.00000000000001" Z="4.901465476386887">
<NAME>Mood disturbances</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.2213715586500532" CI_START="-1.5997918884213393" EFFECT_SIZE="-0.689210164885643" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="23.9" MODIFIED="2015-08-21 22:22:38 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="96" SD_1="22.1" SD_2="32.0" SE="0.46459104897755704" STUDY_ID="STD-Drouin-2002" TOTAL_1="13" TOTAL_2="8" WEIGHT="19.34733632992639"/>
<CONT_DATA CI_END="-0.6543455404990177" CI_START="-1.8777106560231682" EFFECT_SIZE="-1.266028098261093" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="27.76" MODIFIED="2015-08-21 22:23:14 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="175" SD_1="14.67" SD_2="21.35" SE="0.3120886723363027" STUDY_ID="STD-Gokal-2013" TOTAL_1="25" TOTAL_2="25" WEIGHT="42.875267884129364"/>
<CONT_DATA CI_END="-0.20990721438103566" CI_START="-1.5132045503188492" EFFECT_SIZE="-0.8615558823499424" ESTIMABLE="YES" MEAN_1="25.84" MEAN_2="37.33" MODIFIED="2015-08-21 22:22:39 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="97" SD_1="12.87" SD_2="13.25" SE="0.3324799195847619" STUDY_ID="STD-Yang-2011" TOTAL_1="19" TOTAL_2="21" WEIGHT="37.77739578594425"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.14" MODIFIED="2016-09-16 10:34:15 +1000" MODIFIED_BY="Melina L Willson" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="44.17" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Hospital Anxiety and Depression Scale</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.5519779375806224" CI_START="-9.648022062419377" EFFECT_SIZE="-6.1" ESTIMABLE="YES" MEAN_1="9.8" MEAN_2="15.9" MODIFIED="2015-08-19 04:13:10 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="352" SD_1="1.9" SD_2="5.4" SE="1.8102486017119306" STUDY_ID="STD-Cornette-2013" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.92526558876874" CI_END="3.3863071416073733" CI_START="-0.005746971399553491" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="1.69028008510391" ESTIMABLE="YES" I2="56.680361763087596" I2_Q="0.0" ID="CMP-001.15" MODIFIED="2016-09-16 10:34:33 +1000" MODIFIED_BY="Melina L Willson" NO="15" P_CHI2="0.07431841741431078" P_Q="1.0" P_Z="0.050781373436073855" Q="0.0" RANDOM="YES" SCALE="9.72" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="1.6935158657891167" TOTALS="YES" TOTAL_1="200" TOTAL_2="123" UNITS="" WEIGHT="100.0" Z="1.9533226653935731">
<NAME>Self esteem</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.18343225287451" CI_START="-2.5834322528745157" EFFECT_SIZE="-0.20000000000000284" ESTIMABLE="YES" MEAN_1="34.3" MEAN_2="34.5" MODIFIED="2014-06-30 05:12:00 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="85" SD_1="4.9" SD_2="3.6" SE="1.216059209084821" STUDY_ID="STD-Cadmus-2007" TOTAL_1="25" TOTAL_2="25" WEIGHT="23.604398997380443"/>
<CONT_DATA CI_END="3.439652622540863" CI_START="-0.8396526225408687" EFFECT_SIZE="1.2999999999999972" ESTIMABLE="YES" MEAN_1="34.5" MEAN_2="33.2" MODIFIED="2016-01-03 00:06:36 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="86" SD_1="5.1" SD_2="5.5" SE="1.0916795611644767" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="74" TOTAL_2="36" WEIGHT="25.95263061698668"/>
<CONT_DATA CI_END="3.508052527807303" CI_START="-0.5080525278073029" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="34.7" MEAN_2="33.2" MODIFIED="2016-01-03 00:06:34 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="87" SD_1="4.2" SD_2="5.5" SE="1.0245354218988538" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="76" TOTAL_2="37" WEIGHT="27.29692256932524"/>
<CONT_DATA CI_END="6.713530305370879" CI_START="1.8464696946291235" EFFECT_SIZE="4.280000000000001" ESTIMABLE="YES" MEAN_1="23.8" MEAN_2="19.52" MODIFIED="2016-01-03 00:10:56 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="176" SD_1="4.59" SD_2="4.18" SE="1.2416199096341842" STUDY_ID="STD-Gokal-2013" TOTAL_1="25" TOTAL_2="25" WEIGHT="23.146047816307636"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.982347468480979" CI_END="0.4669692113935444" CI_START="0.12216161311176768" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.29456541225265603" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.16" MODIFIED="2016-09-16 10:34:48 +1000" MODIFIED_BY="Melina L Willson" NO="16" P_CHI2="0.541812111535816" P_Q="1.0" P_Z="8.117636741233925E-4" Q="0.0" RANDOM="YES" SCALE="1.68" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="294" TOTAL_2="255" UNITS="" WEIGHT="100.0" Z="3.3487521851800914">
<NAME>Physical activity</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9625857105913331" CI_START="-0.9421729939679564" EFFECT_SIZE="0.010206358311688424" ESTIMABLE="YES" MEAN_1="3831.25" MEAN_2="3805.0" MODIFIED="2014-07-06 23:10:36 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="99" SD_1="2865.75" SD_2="1996.89" SE="0.4859167616302603" STUDY_ID="STD-Caldwell-2009" TOTAL_1="8" TOTAL_2="9" WEIGHT="3.276979474231796"/>
<CONT_DATA CI_END="1.2585360055414667" CI_START="-0.4891612254720212" EFFECT_SIZE="0.3846873900347228" ESTIMABLE="YES" MEAN_1="2656.8" MEAN_2="1848.56" MODIFIED="2016-01-10 22:24:13 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="95" SD_1="2301.62" SD_2="1781.65" SE="0.4458493229465186" STUDY_ID="STD-Cornette-2013" TOTAL_1="9" TOTAL_2="12" WEIGHT="3.8924340113736235"/>
<CONT_DATA CI_END="0.6159170565457025" CI_START="-0.13178252485914257" EFFECT_SIZE="0.24206726584327995" ESTIMABLE="YES" MEAN_1="171.38" MEAN_2="127.17" MODIFIED="2016-01-10 22:24:14 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="164" SD_1="176.6" SD_2="186.47" SE="0.19074319408484133" STUDY_ID="STD-Eakin-2012" TOTAL_1="58" TOTAL_2="53" WEIGHT="21.266664510974056"/>
<CONT_DATA CI_END="0.46304838624235495" CI_START="-0.6097420693713891" EFFECT_SIZE="-0.07334684156451705" ESTIMABLE="YES" MEAN_1="146.5" MEAN_2="160.2" MODIFIED="2015-08-11 03:09:51 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="165" SD_1="146.45" SD_2="254.64" SE="0.2736760634572314" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="45" TOTAL_2="19" WEIGHT="10.33055972624088"/>
<CONT_DATA CI_END="0.5496662283546547" CI_START="-0.5470932092065128" EFFECT_SIZE="0.0012865095740709088" ESTIMABLE="YES" MEAN_1="160.5" MEAN_2="160.2" MODIFIED="2015-08-11 03:09:56 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="166" SD_1="219.88" SD_2="254.64" SE="0.2797907120264112" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="44" TOTAL_2="18" WEIGHT="9.883958076576908"/>
<CONT_DATA CI_END="0.8900595611251436" CI_START="-0.13229173204739886" EFFECT_SIZE="0.3788839145388724" ESTIMABLE="YES" MEAN_1="1621.12" MEAN_2="1018.97" MODIFIED="2014-06-30 06:05:03 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="92" SD_1="1734.42" SD_2="1396.25" SE="0.2608086937404766" STUDY_ID="STD-Husebo-2014" TOTAL_1="29" TOTAL_2="31" WEIGHT="11.37505103091517"/>
<CONT_DATA CI_END="0.7262900591806655" CI_START="0.1241465635473813" EFFECT_SIZE="0.4252183113640234" ESTIMABLE="YES" MEAN_1="585.0" MEAN_2="416.0" MODIFIED="2014-06-30 05:55:05 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="93" SD_1="385.0" SD_2="405.0" SE="0.15361085723587659" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="32.790924110561"/>
<CONT_DATA CI_END="1.3768337078699942" CI_START="0.09033035054523653" EFFECT_SIZE="0.7335820292076153" ESTIMABLE="YES" MEAN_1="272.03" MEAN_2="221.13" MODIFIED="2014-06-30 05:49:33 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="94" SD_1="98.61" SD_2="5.99" SE="0.3281956626429189" STUDY_ID="STD-Yang-2011" TOTAL_1="19" TOTAL_2="21" WEIGHT="7.183429059126563"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.7841027604103599" CI_END="8.602008536703124" CI_START="-1.3160749953578001" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="3.642966770672662" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.17" MODIFIED="2016-09-16 10:35:11 +1000" MODIFIED_BY="Melina L Willson" NO="17" P_CHI2="0.37588934448116895" P_Q="1.0" P_Z="0.14992083351730975" Q="0.0" RANDOM="YES" SCALE="52.79" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="91" TOTAL_2="39" UNITS="" WEIGHT="100.0" Z="1.4398111579346486">
<NAME>Neuropathic pain</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="13.459924707728003" CI_START="-1.259924707728004" EFFECT_SIZE="6.1" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="10.9" MODIFIED="2015-07-31 03:03:02 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="172" SD_1="18.86" SD_2="11.0" SE="3.755132627835078" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="46" TOTAL_2="19" WEIGHT="45.39926157050361"/>
<CONT_DATA CI_END="8.31117413964693" CI_START="-5.11117413964693" EFFECT_SIZE="1.5999999999999996" ESTIMABLE="YES" MEAN_1="12.5" MEAN_2="10.9" MODIFIED="2015-07-31 03:04:37 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="173" SD_1="15.98" SD_2="11.0" SE="3.4241313578125996" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="45" TOTAL_2="20" WEIGHT="54.60073842949639"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.18" MODIFIED="2016-09-16 10:37:03 +1000" MODIFIED_BY="Melina L Willson" NO="18" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="3.64" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="9" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Neuropathy symptoms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3334596832197203" CI_START="-0.7534596832197202" EFFECT_SIZE="-0.20999999999999996" ESTIMABLE="YES" MEAN_1="0.65" MEAN_2="0.86" MODIFIED="2015-08-14 02:07:11 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="174" SD_1="0.38" SD_2="0.78" SE="0.2772804436747108" STUDY_ID="STD-Visovsky-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.19" MODIFIED="2016-09-16 10:37:26 +1000" MODIFIED_BY="Melina L Willson" NO="19" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="19.06" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="82" TOTAL_2="92" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Endocrine symptoms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.094303434170415" CI_START="-1.4943034341704067" EFFECT_SIZE="1.3000000000000043" ESTIMABLE="YES" MEAN_1="41.6" MEAN_2="40.3" MODIFIED="2015-07-31 18:41:08 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="175" SD_1="9.1" SD_2="9.7" SE="1.4256912148445173" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="92" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.3285020291510898" CI_END="0.46112559835707345" CI_START="-0.25241447749980694" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.10435556042863323" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.20" MODIFIED="2016-09-16 10:37:38 +1000" MODIFIED_BY="Melina L Willson" NO="20" P_CHI2="0.5146588935972681" P_Q="1.0" P_Z="0.5664475135475451" Q="0.0" RANDOM="YES" SCALE="2.25" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="60" UNITS="" WEIGHT="100.0" Z="0.5732912472533329">
<NAME>Gait and balance</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2880422287857016" CI_START="-0.7529321268526219" EFFECT_SIZE="0.26755505096653986" ESTIMABLE="YES" MEAN_1="7.1" MEAN_2="6.43" MODIFIED="2015-08-03 03:09:03 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="178" SD_1="2.74" SD_2="1.97" SE="0.5206662907423986" STUDY_ID="STD-Caldwell-2009" TOTAL_1="7" TOTAL_2="8" WEIGHT="12.222544990082417"/>
<CONT_DATA CI_END="0.5994297304457707" CI_START="-0.23893921555769626" EFFECT_SIZE="0.18024525744403724" ESTIMABLE="YES" MEAN_1="-15.1" MEAN_2="-15.8" MODIFIED="2015-12-26 01:04:04 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="791" SD_1="3.5" SD_2="4.2" SE="0.2138735590593537" STUDY_ID="STD-Haines-2010" TOTAL_1="46" TOTAL_2="42" WEIGHT="72.43798714126284"/>
<CONT_DATA CI_END="0.5268678872445398" CI_START="-1.2949846558766762" EFFECT_SIZE="-0.38405838431606815" ESTIMABLE="YES" MEAN_1="5.51" MEAN_2="5.89" MODIFIED="2015-08-03 03:10:30 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="179" SD_1="0.62" SD_2="1.16" SE="0.4647668420164239" STUDY_ID="STD-Visovsky-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="15.339467868654749"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.9900183325131776" CI_END="1.4531125332597972" CI_START="0.35066356118287023" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7138302429235837" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.162299248627887" LOG_CI_START="-0.4551093610058826" LOG_EFFECT_SIZE="-0.1464050561889978" METHOD="MH" MODIFIED="2016-09-16 10:38:13 +1000" MODIFIED_BY="Melina L Willson" NO="21" P_CHI2="0.8036672217298538" P_Q="1.0" P_Z="0.35261663601986615" Q="0.0" RANDOM="YES" SCALE="69.68" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="294" TOTAL_2="142" WEIGHT="100.0" Z="0.9295258692787228">
<NAME>Lymphoedema incidence</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.494012310050357" CI_START="0.3347324536134668" EFFECT_SIZE="1.2264957264957266" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.6526342577091937" LOG_CI_START="-0.47530217906149475" LOG_EFFECT_SIZE="0.08866603932384952" MODIFIED="2016-01-04 05:08:41 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="215" O_E="0.0" SE="0.6625554463345119" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="78" TOTAL_2="41" VAR="0.4389797194675243" WEIGHT="29.962366366349862"/>
<DICH_DATA CI_END="2.369375408476138" CI_START="0.10551303905056876" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.37463387664211834" LOG_CI_START="-0.9766938679700806" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2016-01-04 05:08:42 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="216" O_E="0.0" SE="0.7937766063654232" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="82" TOTAL_2="41" VAR="0.6300813008130081" WEIGHT="20.874879424467924"/>
<DICH_DATA CI_END="2.503968516091038" CI_START="0.14234476944411004" EFFECT_SIZE="0.5970149253731343" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.3986288639258154" LOG_CI_START="-0.8466584866715435" LOG_EFFECT_SIZE="-0.22401481137286408" MODIFIED="2016-01-04 05:13:40 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="217" O_E="0.0" SE="0.7314879540126902" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="67" TOTAL_2="30" VAR="0.5350746268656715" WEIGHT="24.581377104591105"/>
<DICH_DATA CI_END="2.503968516091038" CI_START="0.14234476944411004" EFFECT_SIZE="0.5970149253731343" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.3986288639258154" LOG_CI_START="-0.8466584866715435" LOG_EFFECT_SIZE="-0.22401481137286408" MODIFIED="2016-01-04 05:13:41 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="218" O_E="0.0" SE="0.7314879540126902" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="67" TOTAL_2="30" VAR="0.5350746268656715" WEIGHT="24.581377104591105"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-09-16 11:05:09 +1000" MODIFIED_BY="Melina L Willson" NO="2">
<NAME>Exercise versus control follow-up</NAME>
<CONT_OUTCOME CHI2="16.801483438803842" CI_END="0.5709486719148908" CI_START="-0.05558097881756047" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.25768384654866516" ESTIMABLE="YES" I2="70.24072298013724" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2016-05-12 19:39:53 +1000" MODIFIED_BY="Anna C Furmaniak" NO="1" P_CHI2="0.004892102787687924" P_Q="1.0" P_Z="0.10691460104710852" Q="0.0" RANDOM="YES" SCALE="1.593565984407797" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.10374247346472884" TOTALS="YES" TOTAL_1="338" TOTAL_2="274" UNITS="" WEIGHT="100.00000000000001" Z="1.6122175799427667">
<NAME>Physical fitness</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0990601391015027" CI_START="-0.13138482015643144" EFFECT_SIZE="0.4838376594725356" ESTIMABLE="YES" MEAN_1="552.0" MEAN_2="522.3" MODIFIED="2016-01-03 03:31:11 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="117" SD_1="54.2" SD_2="65.2" SE="0.31389478810925275" STUDY_ID="STD-Cornette-2013" TOTAL_1="20" TOTAL_2="22" WEIGHT="12.629624325431754"/>
<CONT_DATA CI_END="1.0940026661177806" CI_START="-0.005891433677832847" EFFECT_SIZE="0.5440556162199739" ESTIMABLE="YES" MEAN_1="678.62" MEAN_2="643.39" MODIFIED="2016-01-03 03:31:13 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="148" SD_1="73.27" SD_2="54.0" SE="0.2805903854538751" STUDY_ID="STD-Husebo-2014" TOTAL_1="25" TOTAL_2="28" WEIGHT="13.999980479304076"/>
<CONT_DATA CI_END="0.9359811170961978" CI_START="0.33023501161888597" EFFECT_SIZE="0.6331080643575419" ESTIMABLE="YES" MEAN_1="1127.0" MEAN_2="1013.0" MODIFIED="2016-01-03 03:34:44 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="149" SD_1="166.0" SD_2="190.0" SE="0.15452990724711263" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="95" WEIGHT="20.01712286943165"/>
<CONT_DATA CI_END="0.11161210980570471" CI_START="-0.5487168440826564" EFFECT_SIZE="-0.21855236713847584" ESTIMABLE="YES" MEAN_1="23.51" MEAN_2="24.78" MODIFIED="2016-05-12 19:37:41 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="186" SD_1="5.78" SD_2="5.78" SE="0.16845435913541054" STUDY_ID="STD-Travier-2015" TOTAL_1="78" TOTAL_2="65" WEIGHT="19.335734493805614"/>
<CONT_DATA CI_END="0.6179679847312654" CI_START="-0.21851063726819558" EFFECT_SIZE="0.19972867373153486" ESTIMABLE="YES" MEAN_1="13.7" MEAN_2="11.7" MODIFIED="2016-01-03 03:31:07 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="165" SD_1="10.0" SD_2="9.8" SE="0.2133913246869579" STUDY_ID="STD-van-Waart-2014-high" TOTAL_1="71" TOTAL_2="32" WEIGHT="17.113164064359815"/>
<CONT_DATA CI_END="0.43702281595216386" CI_START="-0.4162225372671662" EFFECT_SIZE="0.010400139342498844" ESTIMABLE="YES" MEAN_1="11.8" MEAN_2="11.7" MODIFIED="2015-05-03 06:34:53 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="166" SD_1="9.4" SD_2="9.8" SE="0.21766863063546588" STUDY_ID="STD-van-Waart-2014-low" TOTAL_1="62" TOTAL_2="32" WEIGHT="16.9043737676671"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.502313919929832" CI_END="-0.06683224880454317" CI_START="-0.3533017697807048" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.210067009292624" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2016-09-16 10:38:34 +1000" MODIFIED_BY="Melina L Willson" NO="2" P_CHI2="0.720438668099737" P_Q="1.0" P_Z="0.004047084473881421" Q="0.0" RANDOM="YES" SCALE="1.4" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="479" TOTAL_2="335" UNITS="" WEIGHT="99.99999999999997" Z="2.8744682586169104">
<NAME>Fatigue</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3230709261932507" CI_START="-1.2427143513883199" EFFECT_SIZE="-0.4598217125975346" ESTIMABLE="YES" MEAN_1="38.0" MEAN_2="44.2" MODIFIED="2015-08-18 02:02:44 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="114" SD_1="12.3" SD_2="13.9" SE="0.399442359638311" STUDY_ID="STD-Cornette-2013" TOTAL_1="14" TOTAL_2="12" WEIGHT="3.347283010238506"/>
<CONT_DATA CI_END="0.37182915892667967" CI_START="-0.4874937510641666" EFFECT_SIZE="-0.05783229606874349" ESTIMABLE="YES" MEAN_1="-42.1" MEAN_2="-41.5" MODIFIED="2015-03-18 09:49:28 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="243" SD_1="10.5" SD_2="9.8" SE="0.21921905626049143" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="68" TOTAL_2="30" WEIGHT="11.113326219602477"/>
<CONT_DATA CI_END="0.49258808216705097" CI_START="-0.357728355632413" EFFECT_SIZE="0.06742986326731899" ESTIMABLE="YES" MEAN_1="-40.8" MEAN_2="-41.5" MODIFIED="2015-03-18 09:49:32 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="244" SD_1="10.5" SD_2="9.8" SE="0.21692144460476098" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="73" TOTAL_2="30" WEIGHT="11.349995630910811"/>
<CONT_DATA CI_END="0.5423508484723463" CI_START="-0.5362661791700147" EFFECT_SIZE="0.003042334651165771" ESTIMABLE="YES" MEAN_1="10.43" MEAN_2="10.42" MODIFIED="2015-03-18 10:03:34 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="146" SD_1="3.27" SD_2="3.21" SE="0.275162461185602" STUDY_ID="STD-Husebo-2014" TOTAL_1="25" TOTAL_2="28" WEIGHT="7.053786323143362"/>
<CONT_DATA CI_END="-0.041076098414463746" CI_START="-0.6362445746487146" EFFECT_SIZE="-0.33866033653158917" ESTIMABLE="YES" MEAN_1="-41.3" MEAN_2="-37.6" MODIFIED="2015-03-18 09:56:24 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="145" SD_1="9.7" SD_2="11.8" SE="0.15183148285602793" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="95" WEIGHT="23.16738432138326"/>
<CONT_DATA CI_END="0.10146618032163407" CI_START="-0.5208466997257517" EFFECT_SIZE="-0.2096902597020588" ESTIMABLE="YES" MEAN_1="10.15" MEAN_2="11.03" MODIFIED="2016-01-04 03:33:46 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="184" SD_1="4.1" SD_2="4.26" SE="0.15875620290885706" STUDY_ID="STD-Travier-2015" TOTAL_1="84" TOTAL_2="76" WEIGHT="21.190405346210603"/>
<CONT_DATA CI_END="0.0416719119637074" CI_START="-0.7996015516224722" EFFECT_SIZE="-0.37896481982938235" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="11.7" MODIFIED="2015-05-03 06:34:14 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="167" SD_1="4.6" SD_2="4.1" SE="0.21461452103764078" STUDY_ID="STD-van-Waart-2014-high" TOTAL_1="71" TOTAL_2="32" WEIGHT="11.595312656499237"/>
<CONT_DATA CI_END="0.16648246667395178" CI_START="-0.6901782305916617" EFFECT_SIZE="-0.261847881958855" ESTIMABLE="YES" MEAN_1="10.6" MEAN_2="11.7" MODIFIED="2015-05-03 06:34:14 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="168" SD_1="4.2" SD_2="4.1" SE="0.21853990788168653" STUDY_ID="STD-van-Waart-2014-low" TOTAL_1="62" TOTAL_2="32" WEIGHT="11.182506492011736"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.39714540839397" CI_END="0.3475892777253783" CI_START="0.011488952710554862" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.17953911521796656" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2016-09-16 10:38:51 +1000" MODIFIED_BY="Melina L Willson" NO="3" P_CHI2="0.49376205425862496" P_Q="1.0" P_Z="0.03626360653485776" Q="0.0" RANDOM="YES" SCALE="1.37" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="330" TOTAL_2="253" UNITS="" WEIGHT="100.0" Z="2.093959294016641">
<NAME>Cancer-specific quality of life</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0275206128756713" CI_START="-0.5173534920582914" EFFECT_SIZE="0.25508356040868996" ESTIMABLE="YES" MEAN_1="75.0" MEAN_2="69.9" MODIFIED="2014-12-27 03:22:10 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="115" SD_1="16.7" SD_2="21.7" SE="0.39410777879586883" STUDY_ID="STD-Cornette-2013" TOTAL_1="13" TOTAL_2="13" WEIGHT="4.733165362063974"/>
<CONT_DATA CI_END="0.5865068961044451" CI_START="-0.27381818795123125" EFFECT_SIZE="0.1563443540766069" ESTIMABLE="YES" MEAN_1="156.3" MEAN_2="152.4" MODIFIED="2015-03-18 10:12:00 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="249" SD_1="24.0" SD_2="26.4" SE="0.21947471760752002" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="68" TOTAL_2="30" WEIGHT="15.262043733978823"/>
<CONT_DATA CI_END="0.444065973251225" CI_START="-0.406059553768076" EFFECT_SIZE="0.01900320974157449" ESTIMABLE="YES" MEAN_1="152.9" MEAN_2="152.4" MODIFIED="2015-08-29 02:17:31 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="250" SD_1="26.0" SD_2="26.4" SE="0.21687274198020542" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="73" TOTAL_2="30" WEIGHT="15.630459688154874"/>
<CONT_DATA CI_END="0.6979900477084475" CI_START="0.10114695435802362" EFFECT_SIZE="0.39956850103323555" ESTIMABLE="YES" MEAN_1="83.2" MEAN_2="77.1" MODIFIED="2016-01-03 03:49:55 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="147" SD_1="12.8" SD_2="17.0" SE="0.15225868894996183" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="95" WEIGHT="31.711553626915457"/>
<CONT_DATA CI_END="0.30538501833753356" CI_START="-0.31562514831890626" EFFECT_SIZE="-0.005120064990686357" ESTIMABLE="YES" MEAN_1="78.92" MEAN_2="79.0" MODIFIED="2016-01-04 03:47:23 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="185" SD_1="16.35" SD_2="14.59" SE="0.1584238719575688" STUDY_ID="STD-Travier-2015" TOTAL_1="85" TOTAL_2="75" WEIGHT="29.291421249491982"/>
<CONT_DATA CI_END="1.3727541068026878" CI_START="-0.4577327011737862" EFFECT_SIZE="0.4575107028144508" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.19" MODIFIED="2016-01-04 03:47:24 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="212" SD_1="0.4" SD_2="0.47" SE="0.46696950107632595" STUDY_ID="STD-Visovsky-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="3.371356339394893"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2630794298151087" CI_END="-0.05561766960971895" CI_START="-0.4802996368441266" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.26795865322692275" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2016-09-16 10:39:03 +1000" MODIFIED_BY="Melina L Willson" NO="4" P_CHI2="0.5317727511903357" P_Q="1.0" P_Z="0.01338605003956368" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="223" TOTAL_2="155" UNITS="" WEIGHT="100.0" Z="2.473329927760943">
<NAME>Depression</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.06779102491714728" CI_START="-0.797680720545575" EFFECT_SIZE="-0.3649448478142139" ESTIMABLE="YES" MEAN_1="7.2" MEAN_2="10.2" MODIFIED="2015-03-18 20:25:40 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="255" SD_1="7.5" SD_2="9.5" SE="0.22078766556157484" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="68" TOTAL_2="30" WEIGHT="24.078079958276174"/>
<CONT_DATA CI_END="0.3664583744137968" CI_START="-0.4838077102320373" EFFECT_SIZE="-0.05867466790912022" ESTIMABLE="YES" MEAN_1="9.6" MEAN_2="10.2" MODIFIED="2015-03-18 20:25:55 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="256" SD_1="10.4" SD_2="9.5" SE="0.2169085991764707" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="73" TOTAL_2="30" WEIGHT="24.946977093808815"/>
<CONT_DATA CI_END="-0.027160104571760102" CI_START="-0.6219799451679824" EFFECT_SIZE="-0.32457002486987124" ESTIMABLE="YES" MEAN_1="8.4" MEAN_2="10.8" MODIFIED="2015-03-18 20:23:46 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="150" SD_1="7.2" SD_2="7.5" SE="0.1517425435589851" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="95" WEIGHT="50.974942947915004"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.86823238585272" CI_END="0.3008844589002523" CI_START="-0.30181128277080105" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="SMD" EFFECT_SIZE="-4.634119352743651E-4" ESTIMABLE="YES" I2="48.87728019714294" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2016-09-16 10:39:17 +1000" MODIFIED_BY="Melina L Willson" NO="5" P_CHI2="0.11820020491155048" P_Q="1.0" P_Z="0.9975951578091283" Q="0.0" RANDOM="YES" SCALE="1.56" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0455062939520082" TOTALS="YES" TOTAL_1="235" TOTAL_2="151" UNITS="" WEIGHT="99.99999999999997" Z="0.003014027278923399">
<NAME>Strength</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.1271198438905795" CI_START="-1.1036792804308497" EFFECT_SIZE="-0.48827971827013505" ESTIMABLE="YES" MEAN_1="24.6" MEAN_2="28.6" MODIFIED="2016-01-03 03:54:43 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="118" SD_1="7.1" SD_2="8.8" SE="0.3139851379999366" STUDY_ID="STD-Cornette-2013" TOTAL_1="20" TOTAL_2="22" WEIGHT="16.40579600999582"/>
<CONT_DATA CI_END="0.2505174769744491" CI_START="-0.40070332736077013" EFFECT_SIZE="-0.07509292519316053" ESTIMABLE="YES" MEAN_1="30.3" MEAN_2="30.77" MODIFIED="2016-01-03 03:54:41 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="187" SD_1="6.48" SD_2="5.89" SE="0.16613080890056292" STUDY_ID="STD-Travier-2015" TOTAL_1="82" TOTAL_2="65" WEIGHT="32.33617133646731"/>
<CONT_DATA CI_END="0.8079928498371678" CI_START="-0.03357178065064498" EFFECT_SIZE="0.3872105345932614" ESTIMABLE="YES" MEAN_1="29.7" MEAN_2="27.5" MODIFIED="2016-01-11 09:17:45 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="169" SD_1="5.7" SD_2="5.5" SE="0.21468879967335294" STUDY_ID="STD-van-Waart-2014-high" TOTAL_1="71" TOTAL_2="32" WEIGHT="25.80810388061941"/>
<CONT_DATA CI_END="0.4423167111350964" CI_START="-0.41093554236694896" EFFECT_SIZE="0.015690584384073704" ESTIMABLE="YES" MEAN_1="27.6" MEAN_2="27.5" MODIFIED="2016-01-03 03:54:40 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="170" SD_1="6.7" SD_2="5.5" SE="0.21767039094401486" STUDY_ID="STD-van-Waart-2014-low" TOTAL_1="62" TOTAL_2="32" WEIGHT="25.449928772917442"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.8317690513338456" CI_END="0.6104655774602679" CI_START="-0.0467919380543983" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.2818368197029348" ESTIMABLE="YES" I2="29.37277144624694" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2016-09-16 11:04:26 +1000" MODIFIED_BY="Melina L Willson" NO="6" P_CHI2="0.2427111501509951" P_Q="1.0" P_Z="0.09278355940790238" Q="0.0" RANDOM="YES" SCALE="2.07" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.027233848837896476" TOTALS="YES" TOTAL_1="123" TOTAL_2="138" UNITS="" WEIGHT="100.00000000000001" Z="1.6808937230714245">
<NAME>Physical activity</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.5842271046639502" CI_START="0.1052555927919635" EFFECT_SIZE="0.8447413487279568" ESTIMABLE="YES" MEAN_1="2810.0" MEAN_2="1581.92" MODIFIED="2016-01-03 03:47:39 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="116" SD_1="1209.4" SD_2="1607.93" SE="0.37729558388264406" STUDY_ID="STD-Cornette-2013" TOTAL_1="16" TOTAL_2="15" WEIGHT="16.577744704125312"/>
<CONT_DATA CI_END="0.6800230191368116" CI_START="-0.4000153228557758" EFFECT_SIZE="0.14000384814051792" ESTIMABLE="YES" MEAN_1="2105.63" MEAN_2="1844.94" MODIFIED="2016-01-03 03:47:31 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="152" SD_1="2104.75" SD_2="1555.35" SE="0.2755250480396048" STUDY_ID="STD-Husebo-2014" TOTAL_1="25" TOTAL_2="28" WEIGHT="27.255525118503975"/>
<CONT_DATA CI_END="0.4805968109937351" CI_START="-0.11155638020300432" EFFECT_SIZE="0.18452021539536537" ESTIMABLE="YES" MEAN_1="492.0" MEAN_2="427.0" MODIFIED="2016-01-03 03:47:29 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="151" SD_1="327.0" SD_2="370.0" SE="0.15106226335472697" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="95" WEIGHT="56.166730177370724"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.7914373959058025" CI_END="0.026633896084069963" CI_START="-7.2394407323935255" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.6064034181547275" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2016-09-16 11:04:26 +1000" MODIFIED_BY="Melina L Willson" NO="7" P_CHI2="0.3736658902463337" P_Q="1.0" P_Z="0.05170335582375094" Q="0.0" RANDOM="YES" SCALE="20.99" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="60" UNITS="" WEIGHT="100.0" Z="1.9455954348727638">
<NAME>Anxiety</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.14773674253974622" CI_START="-10.252263257460246" EFFECT_SIZE="-5.199999999999996" ESTIMABLE="YES" MEAN_1="32.2" MEAN_2="37.4" MODIFIED="2015-03-18 20:46:14 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="252" SD_1="11.2" SD_2="12.0" SE="2.5777327018822067" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="68" TOTAL_2="30" WEIGHT="51.70919448953729"/>
<CONT_DATA CI_END="3.328024734338637" CI_START="-7.128024734338634" EFFECT_SIZE="-1.8999999999999986" ESTIMABLE="YES" MEAN_1="35.5" MEAN_2="37.4" MODIFIED="2015-03-18 20:46:29 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="253" SD_1="13.0" SD_2="12.0" SE="2.6674085725945105" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="73" TOTAL_2="30" WEIGHT="48.29080551046271"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.014785339301546034" CI_END="2.813037549101443" CI_START="-0.4104508593519556" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="1.2012933448747436" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2016-09-16 11:04:25 +1000" MODIFIED_BY="Melina L Willson" NO="8" P_CHI2="0.903219791880153" P_Q="1.0" P_Z="0.1440608395049387" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="60" UNITS="" WEIGHT="100.0" Z="1.4608345943777206">
<NAME>Self esteem</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.3942349814719757" CI_START="-1.1942349814719728" EFFECT_SIZE="1.1000000000000014" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="33.9" MODIFIED="2015-03-23 09:32:46 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="258" SD_1="4.7" SD_2="5.6" SE="1.1705495608942853" STUDY_ID="STD-Courneya-2007-AET" TOTAL_1="68" TOTAL_2="30" WEIGHT="49.353327562629566"/>
<CONT_DATA CI_END="3.564752036021721" CI_START="-0.9647520360217126" EFFECT_SIZE="1.3000000000000043" ESTIMABLE="YES" MEAN_1="35.2" MEAN_2="33.9" MODIFIED="2015-03-23 09:32:54 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="259" SD_1="4.6" SD_2="5.6" SE="1.1555069653757883" STUDY_ID="STD-Courneya-2007-RET" TOTAL_1="73" TOTAL_2="30" WEIGHT="50.64667243737043"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.09" MODIFIED="2016-09-16 11:05:09 +1000" MODIFIED_BY="Melina L Willson" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="13.23" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="82" TOTAL_2="95" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Endocrine symptoms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exercise</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.250626286211227" CI_START="-1.6506262862112324" EFFECT_SIZE="1.2999999999999972" ESTIMABLE="YES" MEAN_1="41.0" MEAN_2="39.7" MODIFIED="2015-07-31 18:40:25 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="176" SD_1="9.8" SD_2="10.2" SE="1.5054492375805848" STUDY_ID="STD-Mutrie-2007" TOTAL_1="82" TOTAL_2="95" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.10" MODIFIED="2016-09-16 11:05:09 +1000" MODIFIED_BY="Melina L Willson" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.27" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="9" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Neuropathy symptoms</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.08212210034292328" CI_START="-0.9821221003429232" EFFECT_SIZE="-0.45" ESTIMABLE="YES" MEAN_1="0.32" MEAN_2="0.77" MODIFIED="2016-01-04 03:41:03 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="213" SD_1="0.27" SD_2="0.81" SE="0.27149585632197043" STUDY_ID="STD-Visovsky-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.11" MODIFIED="2016-09-16 10:40:36 +1000" MODIFIED_BY="Melina L Willson" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.69" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="9" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Gait and balance</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4498302157975689" CI_START="-1.6298302157975686" EFFECT_SIZE="-0.5899999999999999" ESTIMABLE="YES" MEAN_1="5.62" MEAN_2="6.21" MODIFIED="2016-01-04 03:43:50 +1100" MODIFIED_BY="Anna C Furmaniak" ORDER="214" SD_1="1.04" SD_2="1.27" SE="0.5305353690167864" STUDY_ID="STD-Visovsky-2014" TOTAL_1="9" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.08257088063273836" CI_END="1.6947060851111597" CI_START="0.3716372717882077" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7936094416988658" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-002.12" LOG_CI_END="0.22909438886205202" LOG_CI_START="-0.4298807367660648" LOG_EFFECT_SIZE="-0.1003931739520064" METHOD="MH" MODIFIED="2016-09-16 10:40:50 +1000" MODIFIED_BY="Melina L Willson" NO="12" P_CHI2="0.7738432093560825" P_Q="1.0" P_Z="0.5503798742626027" Q="0.0" RANDOM="YES" SCALE="21.61" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="134" TOTAL_2="60" WEIGHT="100.0" Z="0.5971909942793194">
<NAME>Lymphoedema incidence</NAME>
<GROUP_LABEL_1>Exercise</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exercise</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.745580741780148" CI_START="0.29209133620167543" EFFECT_SIZE="0.8955223880597015" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.4386342199244587" LOG_CI_START="-0.5344813245588242" LOG_EFFECT_SIZE="-0.04792355231718279" MODIFIED="2015-08-06 01:04:03 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="377" O_E="0.0" SE="0.5716128878291132" STUDY_ID="STD-Hayes-2013-FtF" TOTAL_1="67" TOTAL_2="30" VAR="0.32674129353233833" WEIGHT="45.85737840065952"/>
<DICH_DATA CI_END="2.0088674137658207" CI_START="0.2554945233783198" EFFECT_SIZE="0.7164179104477612" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.3029512740453914" LOG_CI_START="-0.5926184046958699" LOG_EFFECT_SIZE="-0.14483356532523925" MODIFIED="2015-08-06 01:04:04 +1000" MODIFIED_BY="Anna C Furmaniak" ORDER="378" O_E="0.0" SE="0.5260620624340234" STUDY_ID="STD-Hayes-2013-Tel" TOTAL_1="67" TOTAL_2="30" VAR="0.27674129353233834" WEIGHT="54.14262159934048"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-09-16 11:49:00 +1000" MODIFIED_BY="Melina L Willson">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-08-28 11:01:33 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoIAAAO2CAYAAAB8bPYaAACAAElEQVR42uydD2QdWfvHf6xVVWuV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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-09-10 23:29:58 +1000" MODIFIED_BY="Anna C Furmaniak" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAdMAAAZSCAIAAADj15wJAACAAElEQVR42uydsU4zS7a2W0JCBA4I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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-09-16 11:49:00 +1000" MODIFIED_BY="Melina L Willson" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Exercise versus control, outcome: 1.1 Physical fitness.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2QAAAGwCAMAAADxBlbqAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2016-09-16 11:49:00 +1000" MODIFIED_BY="Melina L Willson" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Exercise versus control, outcome: 1.2 Fatigue.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA00AAAHQCAMAAABKunGqAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2016-09-16 10:32:29 +1000" MODIFIED_BY="Melina L Willson" NO="5" REF_ID="CMP-001.03" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Exercise versus control, outcome: 1.3 Cancer-specific quality of life.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0QAAAFACAMAAACryUwjAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2016-09-10 23:29:58 +1000" MODIFIED_BY="Anna C Furmaniak" NO="6" REF_ID="CMP-001.06" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_ROB_TABLE:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Exercise versus control, outcome: 1.6 Depression.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzYAAADQCAMAAADiZARxAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-09-08 07:10:52 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-09-08 07:10:52 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2016-01-11 02:01:52 +1100" MODIFIED_BY="Anna C Furmaniak">CENTRAL</TITLE>
<APPENDIX_BODY MODIFIED="2016-08-10 11:36:29 +1000" MODIFIED_BY="Melina L Willson">
<P>#1 MeSH descriptor: [Breast Neoplasms] explode all trees<BR/>#2 breast near cancer<BR/>#3 breast near neoplasm*<BR/>#4 breast near carcinoma*<BR/>#5 breast near tumour*<BR/>#6 breast near tumor*<BR/>#7 #1 or #2 or #3 or #4 or #5 or #6<BR/>#8 MeSH descriptor: [Exercise] explode all trees<BR/>#9 MeSH descriptor: [Exercise Movement Techniques] explode all trees<BR/>#10 MeSH descriptor: [Physical Education and Training] explode all trees<BR/>#11 MeSH descriptor: [Exercise Therapy] explode all trees<BR/>#12 MeSH descriptor: [Physical Fitness] explode all trees<BR/>#13 exercise or exercise movement technique or exercise therapy or physical education or physical fitness or weight or training or strengthening endurance<BR/>#14 #8 or #9 or #10 or #11 or #12 or #13<BR/>#15 #7 and #14</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-09-08 07:10:52 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2016-08-28 11:03:58 +1000" MODIFIED_BY="[Empty name]">MEDLINE search strategy (via OvidSP)</TITLE>
<APPENDIX_BODY MODIFIED="2016-02-05 15:21:07 +1100" MODIFIED_BY="Melina L Willson">
<P>
<BR/>
</P>
<TABLE COLS="2" ROWS="56">
<TR>
<TD>
<P>
<A HREF="http://ovidsp.tx.ovid.com.ezproxy1.library.usyd.edu.au/sp-3.8.0b/ovidweb.cgi?&amp;S=GGLOFPFAMEDDENKHNCOKIFOBCHLKAA00&amp;Sort+Sets=descending"># &#9650;</A>
</P>
</TD>
<TD>
<P>
<B>Searches</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>1</P>
</TD>
<TD>
<P>randomized controlled trial.pt.</P>
</TD>
</TR>
<TR>
<TD>
<P>2</P>
</TD>
<TD>
<P>controlled clinical trial.pt.</P>
</TD>
</TR>
<TR>
<TD>
<P>3</P>
</TD>
<TD>
<P>randomized.ab.</P>
</TD>
</TR>
<TR>
<TD>
<P>4</P>
</TD>
<TD>
<P>placebo.ab.</P>
</TD>
</TR>
<TR>
<TD>
<P>5</P>
</TD>
<TD>
<P>Clinical Trials as Topic/</P>
</TD>
</TR>
<TR>
<TD>
<P>6</P>
</TD>
<TD>
<P>randomly.ab.</P>
</TD>
</TR>
<TR>
<TD>
<P>7</P>
</TD>
<TD>
<P>trial.ti.</P>
</TD>
</TR>
<TR>
<TD>
<P>8</P>
</TD>
<TD>
<P>(crossover or cross-over).tw.</P>
</TD>
</TR>
<TR>
<TD>
<P>9</P>
</TD>
<TD>
<P>Pragmatic Clinical Trials as Topic/</P>
</TD>
</TR>
<TR>
<TD>
<P>10</P>
</TD>
<TD>
<P>pragmatic clinical trial.pt.</P>
</TD>
</TR>
<TR>
<TD>
<P>11</P>
</TD>
<TD>
<P>or/1-10</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>12</P>
</TD>
<TD VALIGN="TOP">
<P>exp Breast Neoplasms/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>13</P>
</TD>
<TD VALIGN="TOP">
<P>(breast adj6 cancer$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>14</P>
</TD>
<TD VALIGN="TOP">
<P>(breast adj6 neoplasm$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>15</P>
</TD>
<TD VALIGN="TOP">
<P>(breast adj6 carcinoma$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>16</P>
</TD>
<TD VALIGN="TOP">
<P>(breast adj6 tumour$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>17</P>
</TD>
<TD VALIGN="TOP">
<P>(breast adj6 tumor$).mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>18</P>
</TD>
<TD VALIGN="TOP">
<P>12 or 13 or 14 or 15 or 16 or 17</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>19</P>
</TD>
<TD VALIGN="TOP">
<P>exp Exercise/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>20</P>
</TD>
<TD VALIGN="TOP">
<P>exp Exercise Movement Techniques/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>21</P>
</TD>
<TD VALIGN="TOP">
<P>exp Exercise Therapy/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>22</P>
</TD>
<TD VALIGN="TOP">
<P>exercise.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>23</P>
</TD>
<TD VALIGN="TOP">
<P>exp "Physical Education and Training"/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>24</P>
</TD>
<TD VALIGN="TOP">
<P>physical-education-and-training.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>25</P>
</TD>
<TD VALIGN="TOP">
<P>exp Physical Fitness/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>26</P>
</TD>
<TD VALIGN="TOP">
<P>physical fitness.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>27</P>
</TD>
<TD VALIGN="TOP">
<P>Physical Exertion/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>28</P>
</TD>
<TD VALIGN="TOP">
<P>exertion.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>29</P>
</TD>
<TD VALIGN="TOP">
<P>exp Sports/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>30</P>
</TD>
<TD VALIGN="TOP">
<P>sport$.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>31</P>
</TD>
<TD VALIGN="TOP">
<P>physical activity.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>32</P>
</TD>
<TD VALIGN="TOP">
<P>physical activities.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>33</P>
</TD>
<TD VALIGN="TOP">
<P>exp Walking/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>34</P>
</TD>
<TD VALIGN="TOP">
<P>walking.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>35</P>
</TD>
<TD VALIGN="TOP">
<P>exp Jogging/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>36</P>
</TD>
<TD VALIGN="TOP">
<P>jogging.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>37</P>
</TD>
<TD VALIGN="TOP">
<P>exp Swimming/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>38</P>
</TD>
<TD VALIGN="TOP">
<P>swimming.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>39</P>
</TD>
<TD VALIGN="TOP">
<P>exp Bicycling/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>40</P>
</TD>
<TD VALIGN="TOP">
<P>bicycling.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>41</P>
</TD>
<TD VALIGN="TOP">
<P>cycling.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>42</P>
</TD>
<TD VALIGN="TOP">
<P>weight.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>43</P>
</TD>
<TD VALIGN="TOP">
<P>training.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>44</P>
</TD>
<TD VALIGN="TOP">
<P>muscle.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>45</P>
</TD>
<TD VALIGN="TOP">
<P>strengthening.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>46</P>
</TD>
<TD VALIGN="TOP">
<P>endurance.ti,ab.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>47</P>
</TD>
<TD VALIGN="TOP">
<P>19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>48</P>
</TD>
<TD VALIGN="TOP">
<P>adjuvant therapy.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>49</P>
</TD>
<TD VALIGN="TOP">
<P>chemotherapy.mp. or exp Drug Therapy/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>50</P>
</TD>
<TD VALIGN="TOP">
<P>radiotherapy.mp. or exp Radiotherapy/</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>51</P>
</TD>
<TD VALIGN="TOP">
<P>hormonal therapy.mp.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>52</P>
</TD>
<TD VALIGN="TOP">
<P>48 or 49 or 50 or 51</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>53</P>
</TD>
<TD VALIGN="TOP">
<P>11 and 18 and 47 and 52</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>54</P>
</TD>
<TD VALIGN="TOP">
<P>Animals/ not Humans/</P>
</TD>
</TR>
<TR>
<TD>
<P>55</P>
</TD>
<TD>
<P>53 not 54</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2016-09-08 07:08:02 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2016-08-28 11:04:13 +1000" MODIFIED_BY="[Empty name]">EMBASE search strategy (via Embase.com)</TITLE>
<APPENDIX_BODY MODIFIED="2016-02-05 15:21:18 +1100" MODIFIED_BY="Melina L Willson">
<OL>
<LI>'breast cancer'/exp OR 'breast cancer'</LI>
<LI>'breast carcinoma'/exp</LI>
<LI>'breast neoplasm'</LI>
<LI>'breast tumour'</LI>
<LI>'breast tumor'/exp</LI>
<LI>#1 OR #2 OR #3 OR #4 OR #5</LI>
<LI>'exercise'/exp</LI>
<LI>exercise*</LI>
<LI>'exercise movement techniques'/exp OR 'exercise movement techniques'</LI>
<LI>'physical education training'</LI>
<LI>'physical education'/exp OR 'physical education'</LI>
<LI>'physical training'/exp OR 'physical training'</LI>
<LI>'physical fitness'/exp OR 'physical fitness'</LI>
<LI>'exercise therapy'/exp OR 'exercise therapy'</LI>
<LI>'exertion'/exp OR exertion</LI>
<LI>'sports'/exp OR sports</LI>
<LI>'walking'/exp OR walking</LI>
<LI>'jogging'/exp OR jogging</LI>
<LI>'swimming'/exp OR swimming</LI>
<LI>'cycling'/exp OR cycling</LI>
<LI>'bicycling'/exp OR bicycling</LI>
<LI>'endurance'/exp OR endurance</LI>
<LI>'weight'/exp OR weight</LI>
<LI>'training'/exp OR training</LI>
<LI>'muscle'/exp OR muscle</LI>
<LI>strengthening</LI>
<LI>'endurance'/exp OR endurance</LI>
<LI>#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR <B>#23</B> OR <B>#24</B> OR<B>#25</B> OR <B>#26</B> OR <B>#27</B> </LI>
<LI>'adjuvant therapy'/exp OR 'adjuvant therapy'</LI>
<LI>'chemotherapy'/exp OR chemotherapy</LI>
<LI>'radiotherapy'/exp OR radiotherapy</LI>
<LI>hormonal AND ('therapy'/exp OR therapy)</LI>
<LI>#29 OR #30 OR #31 OR #32 </LI>
<LI>random* OR factorial* OR crossover* OR cross NEXT/1 over* OR placebo* OR (doubl* AND blind*) OR (singl* AND blind*) OR assign*OR allocat* OR volunteer* OR 'crossover procedure'/exp OR 'double blind procedure'/exp OR 'randomized controlled trial'/exp OR'single blind procedure'/exp</LI>
<LI>#6 AND #28 AND #33 AND #34 </LI>
<LI>#35 NOT ([animals]/lim NOT [humans]/lim)</LI>
<LI>#36 AND [embase]/lim</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2016-08-28 11:04:28 +1000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2016-08-28 11:04:28 +1000" MODIFIED_BY="[Empty name]">WHO ICTRP search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2013-02-26 14:15:56 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Basic Searches:</B>
</P>
<P>1.     Exercise for women receiving adjuvant therapy for breast cancer</P>
<P>2.     Breast cancer AND exercise </P>
<P>
<B>Advanced Searches:</B>
</P>
<P>1.       <U>Title:</U> Exercise for women receiving adjuvant therapy for breast cancer</P>
<P>
<U>Recruitment Status:</U> ALL</P>
<P>2.       <U>Condition:</U> breast cancer</P>
<P>
<U>Intervention:</U> exercise</P>
<P>
<U>Recruitment Status:</U> ALL</P>
<P>3.       <U>Condition:</U> breast cancer</P>
<P>
<U>Intervention:</U> exercise% OR exercise therap% OR physical education</P>
<P>
<U>Recruitment Status:</U> ALL</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-08-28 11:04:40 +1000" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2016-08-28 11:04:40 +1000" MODIFIED_BY="[Empty name]">ClinicalTrials.gov search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2013-02-25 10:12:00 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Basic Searches:</B>
</P>
<P>1.     Exercise for women receiving adjuvant therapy for breast cancer</P>
<P>2.     Breast cancer AND exercise</P>
<P>
<B>Advanced Searches:</B>
</P>
<P>1.       <U>Title:</U> Exercise for women receiving adjuvant therapy for breast cancer</P>
<P>
<U>Recruitment:</U> All studies</P>
<P>
<U>Study Results:</U> All studies</P>
<P>
<U>Study Type:</U> All studies</P>
<P>
<U>Gender:</U> All Studies</P>
<P>2.       <U>Condition:</U> breast cancer</P>
<P>
<U>Intervention:</U> exercise OR exercises OR exercise therapy OR exercise therapies OR exercise movement technique OR exercise movement techniques OR physical education OR physical training OR physical fitness OR physical activity OR physical activities</P>
<P>
<U>Recruitment:</U> All studies</P>
<P>
<U>Study Results:</U> All studies</P>
<P>
<U>Study Type:</U> All studies</P>
<P>
<U>Gender:</U> All Studies</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2015-02-24 19:40:40 +1100" MODIFIED_BY="Anna C Furmaniak">
<EXTENSION ID="AFF_z1303102210438809665558378173458_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="z1303102210438809665558378173458">
<ADDRESS>
<DEPARTMENT>Department of Psychosomatic Medicine and Psychotherapy</DEPARTMENT>
<ORGANISATION>University of Bonn</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Bonn</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;26 studies, involving 31 comparisons, included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;32 studies, involving 37 comparisons, included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;7 studies included in previous version of review, 1 study awaiting assessment now included&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;3 additional records belonging to a study in the previous version and 55 records relating to 24 new studies included in the qualitative synthesis. 2 studies are awaiting assessment&lt;/p&gt;&lt;p&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;146 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;3297 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;598 duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;3892 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;3 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;3152 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;86 full-text articles excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>